>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bLgbLgRsbRgbRsbRsbRhRsLsmbRsRsmbRgbRsbRsRsmbRgbRgbRsRsmbRgbRgLsbRsbRgb
RgbRgbRsRsLsRsmbRgbRsbRsRgbLoRsbLsbLibLgbLobRobRiRsRimbRgbRsbRsRgbsbRg
LsRsRsRsLsmmbRsbLsbRsRsmbsbLsRsRsmbRsbRgbsbsbLsbRgLsbRgbLsRgbRsbLsRsbR
gbLsRsRsmbLsRgbRgRsmbLsRgbRsbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bLeLsbLibLibsbRiLsbLibLgbRsLsbRsbRsLsbLsbLsbLsLsmbRsbLsbLsbLgbLsbRsbLs
bRgLsbRsbRsbLsbLsbLsLsmbsbRsbLsLsmbRsLsbLsbLsbLsLsmbLsbLsbLsbRsbRgbRsR
smb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bRgbRcRsRsRgRsRsmmmmbRsRsRiRhmbLsRsbRsRsmbRsRsRsRsmmmbLsbRgbRibRiRsLsm
bLsRsbRgbRgbRgbRsRsmbRgRsmbRgbRsRgRsmbRibRsbRsbRsLsbRsLsbLsbRiRsmbRgbs
bsbRiLsbRgRsmbRiLsbRgLsbLsLsmbsbLgLsbLsRsbRgbsbsbsbsbsbRcRsmbRgbRhbRgR
sRsRsmmmbRgRsLsmbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bRsbsbRsbLsLsRsmbLsbLgbRsbRgbRgbLsbRsbRsbLgLsbRgLsbRsbRsbRsbRsbRsbRsLs
bLsbRgbRsbLsbRsbLsbRsRsmbRsLsbRsbRsRsmbRsbRsbRsbRsbRsRsRsmmbRsbRsbRsbR
sRsmbRsbRgbLsbRsbRgbRsbRsRsmbRsRsmbLsbLsbLsbRgbLsbLjbsbLeLsbLsbLsbRcRs
RsmmbLsbRgbRsbRsbRgLsbRsRsmbRoLsbRsLsbRsbRgbRsbLhbRsbsbLsbsbsbLibRsbRs
bLgLsbLgbLsbLsRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsbRebLgLsLsmbLcbRgRsmbLsbLsbLibRebLibRiLsbRgbRsbRibLibRoLsbLobRoRsmb
LjRsbLjbLobRgRsmbRgbRsbRsbRobRhbLibRgbRcbLgbLsbRsRsmbRobLgbLsbRobRgbLs
bRgbRsbLsbRgbLsbLobRgbRsRsmbRsbRgRsmbRgbRsbRgbRgbRibLsbRgbsbRsbRsbRgbR
gbLebRsbLgbRibRgbRjbsbRgRsmbLjbLsbRsbLibRebRsbRsLsbRsbLhbLibLgbLgbLgRs
bLhLsbRcRobRsRgRsmbLsbsbsbRsbRsRsmbRibRibRibLgbRsRsmbLsbRsbRsbLcbLibRg
bRgbRibRibLibLibLibRibRibRgbRsRsmbRibLhbLibRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bRsRsmbLebLsbLobLsbLgbLoRsRsmbRsbLsbLgbLibLibLsbLsLsmbLsRsLsbLsbRgLsbR
sbRgbRsRsmbRiRsmbRgRsmbRgbRgbRgbRsbRsbLsRsbRsbRsLsRsbLsbLeRsbLgbLsbLsb
RsbLgLsbLsLsmbLgbLgbLgbLibLcLsmbLsLsmbLsbsbLsbLsbLgbLgbLgLsLsmbLgbLsbL
sbRsbLcbLgbLibLsLsmbsbLsRsLsbRsbLgbLsbLgLsbLgbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 7; Drug: APO 0.5
bLibsbRiLsbRgbRsbLebLcbLgLsbRjbLoRsRsmbRjbRcbRsbRibRibLibRgbRgbRgbLsbL
gbRobRgbRjbRhbLsbLsbRsbRobLgbLibRgbRcbRibRgbLsbLibRjbRhbLebLibLgbRjbLi
bLibRsbRhLsbRibRibRhLsbLsRcbLcbLsbLgbRsbLsbRgbLjLcbLobLhbLgRsbRjbLebRi
bRjbLsLsmbLjbLoRsbLcbLibLgbRsbRgbRgbRsbRgbLsbLsbLcbLgbLgbLgbLgRsbLsbLg
bRsbLgRsbRobRgbLsRsbRibRsRsmbLsbLjbLobLsbRsbRcbLibsbLobLgRsbRjbLhbRcbL
ibLibLgbLjbRobRcbRgbLsbRobRibRjbLiRsbLgbRjbRcbLibLjbRsLoLsmbLsbLgbRsLs
bLcRsbRhbsbRhLsbLjbLjbRobLsbRhLsbRibLsLsmbLgbLsbRgbRcbLsRsbRiRsmbLsbRs
bRgbLjbRjLsbRjbRibRibLcbLibLobLibRgbLibLsLsmbLgbRsbLsLsRsmbLgbLgbLsbRj
bLgbRjbRhbRibRgbRgLsbLcbLcbLgbRgbLibRjbRcLsbRgbLjbLjbRebRibLeRsbRsbLob
LoRsbLjbRjbRjbLibLcbLgbRcbLjbLibLgbRobRcLsLsmbLjbRjbRsbLgbLgRsLsbRsbLg
LsbLsLsLsmmbLsbLsbLsbLsbLgbLjRsbLobLjbLhbLgbRcbRgbRhbRibLiRsbRsLsbRgbL
obLibRjbLibLjRsbLibRcbLgbLgbRjbRcLsbRgbLibsbLgLsbRsbLsbRsbLgbLsLsmbRsb
RsbLibRcbRhbRsbRcbLibRgbRgbRgbLsbLjbLgbLjLsmbRjbRibLibLgbLgbRcbRebLsbL
jbLibRgbLgbLcbRebRgbLobRjbsbRhbRjbRjbRibRjbRibRjbRgbLjbRibRcbRgRsmbLjb
RhbRsbRgbLgbLcLsLsmmbRibRgLsbRgbRibLcbLsRsbLsbLhbLibRjbRcbLsbLjbLcbLcb
LhbRsRsLsmbRgRsmbRibRsRsmbRgbLsLsmbLjbLobLjRsbLiRsbLsbLgLcbLibLgbLibLh
bLsRsbRsbRibLsbLsbLgbLoRsbRjLsbRsRcbsbRibLiRsbRibLibLobLcbRiRsmbRcbRgb
LgbLsbRcbLsbReRsRsmmbLibLobLhbRgbRgbLcbLsRsbLsbLsbRhbRsbLcbLsLsLgmbLgb
LsbLsbRibRhbRibRibLibRsbRiRsmbLsbRgRsRsmmbRsRsmbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 8; Drug: APO 0.5
bRibRsbRhbRibRgbRhbRiRsmbLsbLgbRsbLsbRoLsbLibRsRobRcbRjbLsRcbRibRsbRgb
RgRsmbRobRiLsbRgbRgbLgbLgbLsbLiLsbRgRsmbRobLgbRhbRiLsbLsbRcbRibRhbLgbR
sRsmbRgbRgbLsbRgbRibRsbLiRsbRsbLgbRhbLgbRcbLgbRgbLgbRibRibLgRsbLibRjbL
ibLibLibLibLgbLsbRjRsmbLsbRsRsmbLsbsbsbsbsbRcbRsbLcbLcbRsbLjbLcbLcbLsb
RsbsbRsbsbLsbLhLsbRibsbLsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 9; Drug: APO 0.5
bRhRsmbRibRgLsbLibRgbRobRibRgbRibRgbRgRsmbRgbRebRhLsbLsbLobRibsbRebRcb
LoLsmbRiLsLsmbLibRsLsLsmbLsRebLcbLsbRcbLebRibLhbLsbRgbsbLibsbLobLibRcR
smbLsbRibRgbRgRsmbLcbsbRibLcbRsbLebLeLsLsLsmmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 10; Drug: APO 0.5
bLsbRsbLsbLjbLibLsbLibLjLsmbRsbLsbLsbLgbLgbRgRsLsmbLsbLsLsmbLsbLsLsmbL
sbLgbRsbLobLgbLcbLibLgbRgbRibRibLgbLsRsbRsbRibRibRsbRiRsmbLsbLsbLgbRib
RsbRibRhbLsbRgbLgbRhbRcbLsbLsbRibRgbLsbLgLsbLsbRgRsmbRgRsmbLsbRgbRsbLs
RsbLcbLjbRgbLibLibRgbRsbRsLsbLhbRibLibLgbLibRibLcbRsbRgbRsbRsbLjbLibLi
bLgRsbLgLsbsbRjbRhbRcbRibRcbRibLgbLibLsbRsbLsbLjbLibLsbLsbRgbRjbLibLgb
LobRjbRgbRgbRsbRsbRgbRebRibRgbLsLgLsbLgLsbLsRsbLgLsbLgLsbLsLsLsmmbLgbL
ibRgbRcbLibRjbRcbRjbRjbRcLsbLsbRsbRsbLsbLsbRhbLjbRhbRcbLiLsbLgbRibLgbL
sbLjbLjbRjbRjbLcbLgbLgRsbRcbRsRcbRgbLsbLibRibRgbLcbLhbLsbLhbRjbRjbLhbL
jbLcbRibRibRgbRibRgbLgbRsbRibLjbLobLhbLibRibLibLgbLsbLjbRjbRcbRcbRsbLi
bLcbLjbRhbRobRibRibRibRgRsmbRsbLsbRgbRgbRsLjbRjbRsbLjbRsbLhbLcbLgbLsbL
gbRjbRcbRjbLjbLjbRjbRjbLcbRcbLhbRiLsbRsLsbRsbLgRsbRgbRgbRgbRoLsbLsbLsR
jbRjbRcbLhbRjbRcLsbRgRsmbLsbRibLibRsbLibRjbRcbLcbLhbRebRibLsbRgbRjbReb
RibLibLgbLiLsLsmbLjLsLsmmbRsbLgbRgbLibRjbLhbRibLjbLsbRjbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 11; Drug: APO 0.5
bRebLobRobLobLobLobRibLcbRobRobRsbRibLhbRcbLobLcbRibLebRebLgbLebLcbRgb
LibLcbLibLobRebLobLebRebRobLobRebLgbRobLobRebRobRibLobLobLsbLobLobLcbR
cbLebRobRcbRobRebRobRobRobRgbLobRebRsbRobLobLgbRobRobRobRebLebRobLebLo
bRcbLobLobLobLebLobLsbRgbRobRobRobLebRobRsbLobRobLobRobLgbRobLebLobRob
LebRcbRcbRcbLobRobLobLebRobLibRebRcbLcbRobLobLobRibLobLcbRcbRgbLcbRcbR
ebRgbRobLgbLobRobLibLibLobLebRebRobRcbLebLobLobLhbLobRobLobRobRgbRsbRo
bRcbLcbRobRobLobLsbRobLobRcbLobRebRibLobLcbLcbRobRobRebRobRcbRgbRebLob
RobLibLobRebLebLobRcbRcbRobLgbLsbRgbRobRobRebRgbRobLobLebLobRobRcbLcbR
ebRobRsbLcbLibRebRebRobLibRibLgbLobLobLcbRsbRobRgbRsbLobLobRobRebLobRc
bLgbRcbRcbLebLibRebLobRobLobLibRgbRebLebRobLobRobRobRobRobRobLobLebReb
LgbLobRhbLcbRgbLobRebLibRsbLebRobLcbRobLobRebLebRgbRebLgbLebLobRobRobR
obLebLcbRhbLobRebLibRebLobRebRobLcbRobLebLobLebLobLibRcbLebLcbRebLobLc
bRobLobRebRobLhbRcbLobRebLsbLgbRobLobRcbRobRcbLobRgbLobLcbLcbRcbRibRob
RgbRobLobLibRibRebRibLobRibLcbRobRcbRobLcbLsbLcbLcbLobLcbRobRebRebLobR
obRcbRebRebRobRcbLcbLobLjbLobLobRhbLebRcbRobLcbLobRobRhbLebRebLobRobLi
bLebRobRobLebLibRobLobLobLobRobRcbLobRibLcbRobLobLobRcbLobRcbLcbLsbRcb
RcbRobRibRobRobLobRcbRcbLebLobLibRebLebRsbLibRebRobRebLcbRgbRibLebLhbL
obLobRobRgbLebLebRibRobRsbRgbLobRobRgbRobLebLcbRobLobRsbLebLobLobLebRe
bLsbLsbLobRebLobRebRobRibRebLobRobRebLobLebRobLgbRebRobLgbLobLebLebRgb
RebRobRebLobLebRobLgbRebRobRobRebRcbLobRcbRobLobLobLgbLebRcbRobLsbRcbL
obRsbRebLobRgbLobRebLebRgbLebRgbRebRhbLebRcbLcbLobLebLobRebRibRebRobRg
bRebRibRebRobRibRobRcbLgbRobLobRgbRcbLobLsbLobRjbRhbRcbRobLobRobLebLob
RobLsbLobRobRhbLobLebLgbLgbLobLobRebLobLgbLcbRebLobLobRobLobLjbRobLobR
obRebLebRgbRebLhbLgbLobLobLgbLebLsbLobLobLsbRebRgbRebRobLebRobLebLobLe
bLobRibLgbLcbRobLobLobRebRcbRobLgbLebRobRsbLobLebRcbRebRcbLhbLcbLcbRob
LibRebRobLcbRebLibLebLcbLsbLobRgbLsbRgbRobLcbRsbRobRsbRebRobLobLsbLobR
cbLcbLobRhbRebLobLobRebRobRebLobLobRgbLsbRibLobLgbRibLebRebLebRcbLobLo
bLhbRcbLobLebRobLebLcbLgbRobRhbLcbLobRobLsbLobLobLobRobRibRcbRobRobRob
LobLobLobLhbRobLebLobRobLjbLibLibLebLcbRhbRibRobLibLobLobLobRsbRgbLebR
obLibLcbLobRobLgbRobRibRobLcbLcbLebRibLobLobRibLebRibRebLobLjbRcbLcbRo
bRsbRobRobLobRgbLobRebRcbLebRobLgbLibLcbRgbLobLobRobLebRobLobRibRcbLeb
RobLebLebLobLebRibLebRebLebLobLobRebLobLcbLcbLobLebRgbRobRibLobRebLebL
ebRobLobLobRobLgbRcbLobRobRebRobLibRobLobRgbRcbLcbLobRcbRcbLcbLcbRibRc
bLobRobRibRebRobLcbRobLcbLobLebLcbLobLcbRobLobLibRobRobRobRcbRebRcbLcb
RobLobRobRebRcbRobRcbRebRobLcbRobLobRcbLcbLgbRobRobRobRcbRobLobRobLhbR
obLebLobRobRibLobRcbLobRobRebLobLcbRibRobLobRobLebLobRebLobLobLebRcbRo
bRgbRobRobRobLibRobRibLcbRobLobRebRobLobLobRhbRobLobLjbLobRgbLgbRcbRib
RhbRebLebRobLebLobRobRebRobRobLobLobLebLebLobLebLobRobRebRobRebRcbRhbL
sbLcbRebRebRobLebRobLcbRobLcbRebRhbLobLcbRibRobRobLobRebRobRcbRobLobRs
bLcbRobLcbLobLobRebRibLgbRobLebLgbRobLobRobRibRcbRibLobLgbRobRgbRobRcb
RobRebRcbLcbLebRobRobLobRibLobLebLobLibLebLebLcbRebLebLibRcbLobRgbRobL
sbLobRobRebRcbRgbLebLobLgbRebLobLcbRobRcbRebLsbRibRobRsbLobLhbRsbLgbLc
bRibRgbRibRebRgbLebRobLsbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 12; Drug: APO 0.5
bLobRcbLibLsbRebLibLjbsbLsbLibLcbLobRjbRsbLjbLsbLsbLsbLsbLobLobRsbRsbL
sbLobRjbRsbRcbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRibRibLgbRgbLibLibLibRjbRcRsmbLgbRsRsmbRibRcbRobRjbLiRsbLibsbRjbLibRc
bRobRiRsmbRgbLsbLibLobRibLibLgbLgbRibLsbLgbRgRsmbLgbLgbRgbLgbLgbLsbLsb
LgbLgbLgbRsbLgbLgbLsbsbRsbLsbLsbRsbLgbLsbRsbLgRsbRsRsmbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLgbRgRsmbRgRsmbRiRsmbLibRgRsmbRgRsRsmmbRsbRsbRsRgbRibRsbLsbLgbLoLsmbR
gbLhLsbRsLsbLgbLeLsbRsLsbRsbRsbRibRsbLsRsbRibRsbRsbRobRibRibRcbRsbRsbR
gbRoRibLsbLibLsLsmbLgbLgbLibLsbLcbRebLsbLsRsbLcbsbsbRjbRoLsLsmbLgbLebL
sbLiLsbLsLsmbLsbLgbsbRgbLoRsbRhbRsbRibRibRibRibLiLsbLjbLibLsbLgbLcbLib
RjbRebRcLsLsmbLcbRsbRgRsmbLgLsbRobLibLhbLsbRiRsmbRsbRibRgbLcbLebRibRsb
RibRibLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bsbRgbLsbRgbRcbLibLibLibRgbRsbLsbLibRobLsLsmbLebLjbRsbRgbLcbRhbLebRcbR
sbLebLebLoRsbLibLibRibRsbRgbLhbRibLgLsbRiLsbLobLebLibLiLsbRoLsbLobLhbR
oLsbLoLsmbLobLcbLcbLcbLobRebLobRjbLebRcbLsbRobLcbRcbLcbLobRcbRhbLobReb
sbRcbsbLcbRcLsbsbRgbLobLibRcbLgbRjbRibLsbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bRgbLcbLcbLibLibLgLjbLoLsmbRjbRgbLsRsbLsbRsbRibLsbRobLebLobLgbLibLsbLs
bLsbLsbLsLsmbRgbLgbLebLsLhLsbRsbRibLsbRsRsmbLgbLobsbRjbLsbRsbLibLibRiR
smbLibRebLjbRhbLiLsbLhRsbRhbLsbLgLsbLgbLibRsLsbLsbLsbLsbLsLsmbLhbRgbRs
bRgbLgbLsbRsbRobRobLibRgbLgbLhbLibLcbRcbLsbLiLsbLcbRibRgbRebLgbLsbRsbR
gbLgbRgbLgbRsbLhbRsbRsLsRsbLsbLibsbsbLcbLsLsmbLsbRjbLgbLgbLsbLsLsmbRsL
sbLiRsbLjbRjbLebRsbRsbRgbLgbRsbRgbLsbRgbLgbRgbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRgbsbsbRobLobLibLsbsbsbsbsbsbRgLibLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLsRsbsbLibLsbLibLibRsbRsbLibsbLibLhbRgbLsbLibRgbLibRjbRhbRcbRcLsbRcbR
obLsbLjbLsbLibLgRsbRsRsmbLgbRjbRsRibRcbRcbRcLsbLibLibLobRibRsRsmbRsbRg
bLsLsmbsbRgRsmbRgRsRsmmbRsbLgRsbRcbLibLhLsbLibRoLsbRhLsbLjbRjbRcbLibLs
bRcbRcbLhbLsbRcbRibLsbRibRgRsRsmmbLsRsbRsbRibLsbRgbRibRibLjbLhbLobRibR
gbLsRcbLjbRcbRibLgbRibLgbRgbRibLsbLgbRibRgbRsRgbRsLsbRsbRgbRsRsmbRsRsm
bRgRsmbRsbRiLsbRobsbLgbLgLsbLsbLgbLibLsbLsbRjbRibLjbLcbLgbLibRsbRsbLgb
LgbLsbRsbLibRsbRsbLsbLsbRjbLcbLsbRjbRobRibRjbRebLibRcbLibRibLsbLjbLibR
gbRibRsbRsbRoLsbRsLsbRsbLgbLibLgbLsLsmbLgbLgbLgbLsbLsbLgLsbLgbLgbLgbLs
bLgbLsbLgLsLgLsbLibRsLgbLgbLsLsmbLgbRjbLcbLibRgbLsbLibLsbRsbLsbRjbRjbL
obLiRsbRcbRjbRgbLgbRjbLcRsbLjbLhbLobRibLibRsbLsbLsbLsbLjbRcbRibLjbsbLc
bRibRjbRiLsbLjbRibLjbRibLcbLiRsbLgbLgbRsbRsbLsbLsbLgbLjLsmbLsbRjbRjbRi
bRjLsbRgbLibRiLsbLgbLgbRjbLjbRibRhbRibRgbLgRsRsmbRgbRgRsmbRgbLjbLibRjb
LgbRhbRsLcbLibRhbLjbLcbLibRsbLsbLhbRgbsbRsbLsbRsbLsbRhbLobRhbLjbLibRcb
RoLsbLiLsbRibLjbLobLibLsbLsbRsLsbLsbLgbLiRsbLibLgbLibLsbRsbRsbLhbLsLsm
bLibRgbLgbLsbLsLsRsmbLsbLsbLgbRgbLjbLgbLiRsbLgLsbLsbRjLsbLcbRgbLsbLgbL
sbLibLsbLgbLgbLgbRgbLgbLgbLibLgLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRibRcbRibLobRgbRobLibLcbLcRsbLiRsbRsbLsbRcbRjbRsbRibRibRsbLsbRsbLsbLs
bLsbLgbRsbLgbRhbLgLsbLjbsbRoLsbLjbLibLgbRgbLsbRsbLgbLsLsmbLgbLobLsbLsb
LsbLgLsbLgbLibRgbLgLsbLibRgbLibRgbLcbLiLsbRgbLsLsmbLgLsbLgbLgbLgbLgLsb
LsbLgbRsRebRoLsbLhbLhbLibRjbRobLjbLhLsLsmbLsLsmbRjbRcbRibLibRgLsbRgbLj
bLsbRgbRjbRhbLjbRsbRsbLsRsRsmbRsbRiRsmbLjbLebLibLiLsbRsbLsbLsRsbsbLgbR
gbRgbLsbRsbRsRsmbLsRsbRcbsbRsbsbLsbRsbRsbLgbLgbLgbRsbLsbRsbLsRsbLsLsmb
Rsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRsbRsbRsRsRsmmbRsbRsbRsbRsbRebRobRjbRibRobRsLsbRsbRsRsRsLsmmbsbRsRsmb
RsbRsbRsLsbLsRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRgbsbLibLiLibRjbRsRsmbLibLcbRjbLibRsbLibRobRibRoLsbRibRgbRgbRoLsbLibL
ibRsbLgLiRjbRgbRhRsmbLgbLibLgbLsLsRsmbLsbLsbLgLsbRsbLsbsbsbsbRsbLibLsb
LgbLgLsbLsLsRsRsmmbLgbLsbLsLsmbLsbLgbLgbRsbLgRsbLgbLgbRsbRsbLsLsmbLgbR
sbLgbLsbLsbLgbLgbLsbLgbLsbLgbsbRgbsbsbsbLsbRsRsmbLsLsmbRsbRsbRsbRsbRsb
RsbLsRsbLsbLsbRsbsbLsLsRsmbLsbLsLsmbsbRsbRsLsbLsbLsRsbLsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bRsbRsRebRibRsbRsRsmbLobRgbLoRsbRibLsbLsLsmbLgbLcbRiRsmbLsbLsRsbLiLsRs
bLgbRcbRgbRgbRgbRgbRgbRsbRsbLgLsbRgbRoRsLsmbRjbLobLibLcbRsbRcbLsbLsbRg
bLsbRsbRebLibRhbLgbLgLsRebRsLsbLsbLiLsbLgbLeLgbLgbRgbRgRsmbLgRsbRjbLcb
RjbLibRsbLsbLgbLsbLgbLsbLsLsmbRsLsLsmbLsbLgbLsbLsbLgbRjbRsbLsbLebRgbLs
bLsbLsbRsbLsbRgbRibRsbLibLibLsbRsbLsbLhbLgbLgLsbLsbLgbLgRjbLgLhbLgbLgb
RgbLgbLsbLsbLgbLgbLibLibLsbLsbLsbLsbLgbLsLiLsbRsbLgbLgbLgbLgbLgLgbLibR
sRsmbLgbLsbLgbLsbLsbLgLsRsbLsbLgLsbLgbLgbLsbLgLsbLgbLsbLsLsmbLgbLgbLsb
LsbLsLsmbLsbLgbLsbLgbLgbRsbRsbLjbLgbRsbRhbRsbLibLsbRsbLjbsbLgbLsbLgbLi
LsbLsbLsbLsbLibLgLsLsmbLibsbsbLsbLsLsmbLgbLgbLgbRsbRsbLgbLgbLgbLgbLsLs
mbLsbLsLsLsLsmmmbLsbLsLsmbLsbLgbLgbsbRgbRsRsmbLsbLgbLsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRibLsRsbRsbLgbLsbRibRgbLcbLibLiRsbLgbLsbLsbLsbRsbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRgbsbRibRgbRiLsbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgRsmbRsRsmbRsRgR
smbRgbRgbRgbRsbRsLsLsmbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsbRgRsmbRgbRgbRgbRg
RsmbLgbRsRsmbRsbRibRsbRsbRsbRsbRibRsbRibRsbRgbRibRgbRsRsRsmmbRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bsbRsRsmbsbRibRgbRoLsbLibRhbRsbLiRsbLsbLsLibRgbRibLsbLcbRibLibLgbRsLsb
RibLibLsbLoRsbRhbLsbLcbLiLsbRjbLsbRebsbRcbRcbRjbLsbRgbLobRjbRibLibRsbL
sRsbRgbRibsbLsbRsbLibsbRsbRiLsbRgLsbLjbRibRgbLobRibRjbRiRsmbRgbRjbLsbL
cbRgbRibLoRsbLcbLgbLgLsbLcbLibLgbLgbRgbLgRsbRgbRgbLibLsbLcbRsbLgbLgbLg
bLgLsbLgbLgbLibRgbLobRgbLsbLgbLibLgbRgbLgbLgLsbLibLibLgbLgbRsbLiLsbLgb
RsbLibRsbLgbLibLgbLgbLibRsRsmbLgLsbLsbRjbLhbRsbRjbLgbRgbLgbLebLgbLgbLg
bLsbLgbLjbRjbLgbLcRsbRobRiLsbLsbRgbRgbRiRsmbRsbLjbLibLibRsbsbsbsbLcRsR
gbLgbLobRobLgbRsbLhbLobRgbRiLsbLibsbLgLsbLgbLibLhbLibLibRgbRebLobRiLsL
smbLgbLibRgbLobRgbLcbRgbRgbsbRsbRsbRsbRgRsmbLgbLebLibLibLobRibLgbLgbLc
bRjbLgbLeRsbRhbLgLsbLibLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bsbsbLobRgbLcbRsbLibsbRobRibRobLgbLsbLsbLsbLhbRiLsbRobLgbLsbLsbLgbLsbL
gRsbLgbLsbRobRobLgbLhbRsbRsbRsbRibRibLsbLobLibLgbRibRsbRcbRgbRgbLgRsbR
ibRibLobRjRsmbRhbLibRibRgbRgbRobLgbRobLibRgbRgbRsbRibRiRsmbRhbRsbLsbLo
RsRsmbRgbRibLgbRebLgbRobLgLsbRobRgbRjbRcbRibLsbLgbRebRhLsbRcbLobRgbRob
sbsbLgLsbLsbLsbRgbLiLsbLsLsmbRsRsmbLsbLsbLsbLgbLiRsbRgLsbRgbsbRjbLcbLc
bsbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLhRsLsbLebLgbLgLsbLibLhbLgbLgbLgbLsbLgbLgbLsLsmbLgbLgLsbLgLsbLgbLgbLs
LsmbLgLsLsmbLsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bsbLsbLsLsmbRsRsmbLsbLgbLgbLgbLsbRsbLobLgbRiRsmbLsbRgRsmbRiLsbRgbLsbRs
RsmbRibRcbLsbLsbLibLsbLgbLibLgbLsbLsbLgbLsbRobLsLsmbLgbLsbLsLsRsmbLsLs
mbLgRsbLgbLsRsbLsLsmbLsLsRsmbLgbLsbLgbLsbLsbLgbLsbLgbRsLsbRsLsLsmbRsbL
sbLsLsmbLsbRsbRgLsbLgbLsbLsbLsbLgbLsLsLsmmbLsLsmbLsbLsbLsbLsbLgbLsLsmb
LsLsmbLsbLgbRgbRhbRsbRgRsmbRsbRgbRsbLsbRsbRsbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLsbLsbLsbLgbLsbLsLsmbLsbLgLsbLgLsbRsbLsbLsbLsbLsRsbLsLsmbLiLgbRsbLsLs
mbLgbLgbLsbLsLsmbLsbsbLsbLibLjbLsLsmbLsLsmbLgbLsbLsbRsbLgbLgLsbLgbsbLs
bLsbRgbLsLsmbLsbLgbRsbLsbLsbLsbLgbLsbLgbLsbLsbLsbLsLsRsmbRsbLgbLsLsmbL
sbRsLsbLgbLgLsbLsbLsbLgbLgbRsbLgLsbLsbLsbLsbLgbLsLsmbLsbRsbLsbLsbLsbRs
bLgbLgLsbLsbLsbLsbLsRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 31; Drug: APO 0.5
bLsbRsLsbLsbLsbsbLcbRobRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 32; Drug: APO 0.5
bRjbRobRgbRsbRgbRsbRgbRgbRsbRsbRgbLgbRhbRsbRgbLgbLeLsbLibLgbRgbRcbRgbR
cbRsbLsbLibRcbRibLcLsmbLsbLgbLsLsmbLsbLsbLsbRgbRgbRgbRgbRsbsbRsbRsbRsR
smbRsbRsRgLsbsbsbLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 33; Drug: APO 0.5
bRobRhRsmbRcbRobRjRobRibLobRcbLsRebRobRcLsLsmbLibRcbRjRobLcbLibRjbRcbR
ebLsbRcbLiLsbRobLcbLobRibLibRgbRcbRibRebRjbLibLgbRjbLebLsbRsLsbRsbRebR
sbRjbRcbLcbLebRhbLgbRjbLjbRiRsmbLgRsbLhbRsbRebLibLgbLcbRgbRcbLsLsmbLob
LhbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 34; Drug: APO 0.5
bRcLsbRibRhLsbRjLsbLebRgbRoLsbRcbLobLibRhbRjbRiLsbLcbRibLibRibLibRsbLi
bLgbLibLibRibRgbLgbLgbLibLhbRcbRsbLgbRsbRhbRsRobLebRibRibRcbRibRibLcbL
cbLgbLibLibLcRsbLgbLibLobLgbLoRsbRcRsmbLibLgbLibLgbRsbLibLibLgbRgbRsbL
gbLebRcbLcbLgbLibLibLibLibLgbLibLjRsbLcRsRsRsmmbRgbLgbLjbLgLsbLibLebLo
RsbRcbLibLibLcLsmbLibLgbLgbLibRsLjbRhbLjbLcRsbLibLibRcbLcbLgbRibRiLsRs
bRibRebLhbLiLsbLibLjbLgbRsbRsRgbLsbLgbLsbLgbLhbRibLibRibRjbLcbLobRibRc
bRibRebLcbRcbLcRsbLobLhRsbLsbLgbLibRcbRjbLibLgLsbLcbLgbLgbRgbLibLibRhb
LobLcbLibRibLjbLebLhRsbLsbRebLoRsbLcbLsbLibLcbRibLsbRoLsLsLsmmbRebRhbR
ibLcbRoLsbLgbRebLiLcbRhbRibLcbRgbLobLjbLcbRebLgbLcbLsRibRjbLsbLcbRibLo
bRibLebLjbRcbLibLebLobRgbRiRsmbRibLgbLobLcbLhbLsbLsbLcbRibLsbLsbLcbLsb
LsLsmbRsRsmbLsLsmbLsbLgbLsRsbLsbLgLsbLsLsmbLgbLgbLsbRjbRjbRcbLjLsmbRib
LhbRgbRsbLcbRibLsbRgbRebLibLibLibRcbLhbLhbLgbLsbLibLibLsRsbLgLsbLgbLob
RcbLobLiRsbLibLsbLgbLibLcRsbLgbLcbLcbLcbLhbLcbLhbLibLcbLiRsbRgbRibRsLo
bLcbRsbLibRjbRibLcbLebLibLibRhbLibLobLibLjLibLiLsbRjbLjbLcRsbRibLsbLgb
LsbLhLsRsbLgbLsbLgbRsLsbLgRsbRsLsbLsLsLsmmbLgbRibLibLibRgbLibLsbLgbLsb
LiLsbRsLsbLgbLcbRgbLgbLgbRibLhbRgbLhbRjbLsbRsbLibLobRhbLcbLjbRsbRgbLjb
LiLsbLgbLibLcbLobLgbRgbRjbLibLcbLibRjbRobRoLsbLibRibLgbRebLibLobRibReb
LibRhbLsbRibRgbRgRsmbRibLjbLibRebLsbLibRobRibRgbLhbLibLibRgbRibLobLobR
hbRgRsmbLhbRibRebLcbLibLcbLcbLcbRjbLcbLcbLcRsbLcbLhbRibLibLibLibLgRsLs
bLgbLhRsbLhbRobLcbLobLsbLibLhbLgbLgbLhbLibLjbRcbLibRcbRibRcLsbRiLsbRcL
sbLibLhbLibRibRsbLibRibRcbRibLcbRhbLcbLiLsbLsLsmbLibRoRsmbRobRgbRcbLhL
sRsbLsbLiLsbLsRsbLsLsmbLibLsbLsbLgbRsLsbLsLsmbLgbLsLsLsmmbLsbLgbLsbLsb
LsbLjbLibsbRgbLibRjbLjLsmbRcbLibRcbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 35; Drug: APO 0.5
bRibLebRhbRsbRobRhLsbLsbLgbRhbRhbRsbLgRsbRiRsmbRhRsmbLgLsbLgbRjbRcbLeb
RebLibRebLobLobRcbRsbRiRsLsRsmbRsLgbRsbRibRibRibRibRhbLgbRcbRcbLebRsRs
mbLsbsbRgRsmbRgbRsbRgbLsbRsbRgbRsbsbRjbLsbLcbRibLsbRgbRibRiRsmbRsbLsRs
bRgbRgbRibLhbLibsbsbRcbRibLsbRgbRsRsmbRsbLsbRibRgbLsRsbRgLsbLsbRibLibL
cbRhbsbRjbRhbRibRcbLcbLhRsbLgbRjbRibRhbRibRhbReRsLsmbRibRibLiLsbRsbLcb
RibRibLobRibRcbRibRibRiRsmbRibLibRibRjbRcbRibRibRcbRhb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 36; Drug: APO 0.5
bRcbRebRcbRcbLsbRsbLcbRcbLoLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsbLgbLsLsmbLgLsbLsbRcbRgbLgbLsbRgbRgbRibRibLsbRgbRgRsmbLgbRsLs
bRgbRgbLsbRgbLsbRiLsbRebLibRsbLsbLgbRsbLgbLgLsbLsbRsbRcbLcbRgLsbRgbRgb
LsbRsRsmbRsbRgRsmbLsbRgbRgbRgbLsbRgbRgbRsbRibLgbRsRsmbRsbLsbRgbRgbRgRs
mbRsRsmbRgbLsbRgRsmbRgbRgbRgbLsbRiRgbLsbRgbLsbRsbRsRibRgbRgbRsbRgbRsbR
gbLsbRgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bRobLjbLobRoLsbLjLsmbLoRsRsRsmmbLibLhbLgbLsbLgbLgbLoLsRsmbRibLcbLibLsb
LgbLgbLgbLgbLsbLobRgbLoRsbLsbLibRsbLibRjRsmbLgbLsbLsbLgbLgbLsbLsbLgbLs
LsmbLsbLsbLgbLgbLgbLsbLsbLsbLsbLgbLsbLsbLgbLsLsmbLgbLsbRsbLcbLcbRsbLsb
LsbLibLgbLibRsbLsbLgbLsbLsbLsbLgbLgRsbLsbLsLsmbLsLsmbLsbLsbLsbLsbLsbLs
LsmbLgbLgbLgbLsbLsbLgbLsbLgbLgbLsbRsbRobLcbLibLgbLgbLgbLsbLgLsbRsRsmbL
gbLgLsbLsbRoLsbLjbRhbRobLibRsbRgbRgbRgbRjbRhbLibRibRobLgbRcbLibRsbRjbR
ibLjbLjbLibLsbLgbLsbLsbLsbLgLsbLsbRsbLsRsLsbRsbLsLsmbLgbLgbLgLsbRobRib
RcLsbsbLgbRobLibLsbLsbLiRsbLgbLgbLgLsbLsbLsbLsbLgbLgbLgbLsLsmbRjbRcbLj
bRhbLjbLibLgbLgbLgLsbLgbLsbLsbLgbLgbLgbLsbLsbLsbRcbRibLibRibLjbRgbLjbL
sbLgbLgLsbLsbLgbLgbLsbLsLsmbLgbLsbLsRsbLsbLgbLsLsmbLgbLsbLgbLsbLgbLgbL
gLsbLsbRhLsbLsLsmbRibRibRcbRgbLiRsLsbLsRsLsbRsbLibRsLsbLsbLgbRsbLgbLsL
smbRoLsbsbRibLcbLiLsRsLsbRobRcbLgbRobRcbLgbLsbLibLgbRsbLsbLgRsLibLgbLg
LsbLsbLgbLsbLsbLgbRgbRcbLhbRhbRcbLibLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bRcbRibLibLsbsbsbRcbRcbRhbLibRibLibLsbRgbRcbRhbRcbLgbLgbLibRcbLhbRhbLh
bsbRcRsmbLjbRsbRiRsmbRsRsmbRsbRsbRsbRsRsmbRsRsmbLsbLobRjbLhbLobLibLjbR
jbRsbLcbRcbRcbRcbRjbLcbLsbsbRhbLjbLsbRibRsbLsLsRsmbsbLibLsbRjbRibRibRe
bLgbsbRcbRgbLibRsbLsbRebRjbLibRhbRjbRsbRhbRebLgbLcbRcbRsRsmbLgLsbRsRsm
bRsbRgbRgbLcbLsLcRsbRcbRobRsLsbLjbLgbLibRgbRcbRsbRsbRobLibRibLgbLibRob
RibLsLsmbLsbLsbsbRgRsmbRibLgbRibLjLsmbRibRgLsbRsbLsbRgbRsbRjbRjbLsbRcb
RgbRhbsbRibLhbRibRcbRcbRgbLsbRebLhbsbRgLsbRsbLjbRsbRibRhbRjbLibRibLgbR
hbRcbLibLjbRsbRgbRgbRibRgbLsbsbRjbLgbLjbRcbLoLsmbRgbLcbRibRjbRhbLibRjb
RsbRgbRibLgbRobLgbLibRgbRsbRsRjbRhbLjbRiLsbRjbRcbRsbRsRsmbLsLsmbRibRsb
LjbRgLsbRcbLgLsbLsbRcbLibRcLsbRibLsbRibRhbRibLgLsbRgbLsbLcbRibLcbRhbRi
bLjbLgbLobLcbRsRsmbRjbLgLsbRjbRiRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bLjbLcbLgbLiRsbLhRsbLibLibLibRsbLsbLsbRsbRsLibLsbLibLsbRiRsmbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRgRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bLgbLsbLgbLgbRsbLobRgbLgbLgbRgbLgbLgbRgLsbLgbLgbLgbLgbLobLsbRibRcLsbRs
bRibRgbLibLobRhbLcbLibLcbRgbLibLsbRsbLcbLcbLgLsbLsbsbLibLjbRcbRhLsbRib
LsbLsbRibLcbRgbLobLcRsbLgbRibLgbRibLsbRibRjLsbRcbLibLibLsbRsbRsbLjbLob
RibRibLgbRobLibRobLibLcRsbLobLibRhbLjbLibLsbLibLgbLsbLgbRcbRibLcbLcbRh
bLobsbLiLsbRgRsLsmbLsbRibRhbLibRsbRibLjRsbRsbLiLsbLibRsbLgbLgbLsbLgbLg
bLsbLgbLgbLgbRebLcbLgbLgbLsbLgbLibRibRgbLgbRjbRobRobLoRsbLcbRobRibLsbL
gbRgbLcbLgbLgbLsbLgbRjbLibRhLsbLebRjbLobRibRcbLsLsmbRhbLgbLcbLjLsmbRob
RcRsmbRsbLoRsbLiLsbLhbLgbLsbLsbLiLebLgbLgbLsbRsLgbRsbLgbLgbRebLcbRgbLi
LsbLgbLgbLsbRgbRoLsbRcbRhbLgbLgLsbRgbLcbRgRsmbLgbRjbLibLibRibLgbLsbLjb
RgRsmbLeRsbRibLcbRiRsmbLgbLgRsbLiLsLsLsmmbLsbLgLiLiLgbLeRgbRcbLcbRhbRi
bLgbLgbRgbLibRobRhbRibLibLibRsbRcbLsbLgLsbRobRhbRgbLgbLsbLsLsmbLsbLhRs
bRgRsmbLgbLobLiLsbLsbRsbRoLsbLibRhLsbLgbRcbLibLibLibLsbLgbLgbLsbLsbLiR
sRsmbLcLsmbLcbRsbRhLsbRcRsmbRsbRsbRsbsbLcbLibLsbRsbLibRsbRoLsbLsbRobRi
bRgbLibRobLcLsmbRcbRiLsbRsbLjbLhRsbLgbLgLsbLibLsbLobLhbRsbRibLsbRsbRhb
RcbRgbLsbRobLhbLibLsLgbLgbLobLcbLcbRsbRsbLcRgLsbLsLsmbRsbLsLibLcbLsbLg
bRjLsbRiLsbLibRgbLgbRibLebRibLcbRcLsbLgbLobRsbLibLsbRcbRibRhbRoLsbRjbL
ibRoLsbLibRobLhbRcbLibLcbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbRsbLobRsRsmbRsbRsbRsbRibRsLsbLcbRgLsbLgbLgbLgLsLsmbLgLsLsmbLgbLsbR
cbRoLsbLgRsbLebRsbRgbRgRsmbRsRsmbRsRsmbRgbRgbRgLsLsmbLebRsbLgbLgbLgbLg
bLgLsbLsbLgbLibRgbRgbRgbRgbRgbRgbRgbRgbLsbLobLgbsbLgbLgbLsbLgbLgLsbLgb
LgbLgLsbLgbLgbRsbRobLsbsbRgbRiLsbLsbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRgbR
gbLsbRoLsbsbLibRsbRgRsmbRgbRsbRgbRsbRgbRgbRgbRgbRsbRgRsmbRgbRsbRgbRgbR
sbRsbRsbRgbRsRsRgRsmmbRgbRsbRsbRibRgbRsbRsRsmbRsbRgbRsRsmbRgbRgbRsbRgL
sbRgbRsbRgbRgbRgbLsbRsbLjbLjbRjbLjbLgbLgbLsbLsbLgbLgbLgbLsbLsbLgbLgbLs
bRsLgbLsbLgbLsbLsLsmbLsbsbRsbLgbLgbLgbLgbLgbLsbLsbLgbLibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bRsbLsbLsRsbRcbLjbRibRsbRibLgbRgbRobLgbLcRsbRhbLgbLibLsbRgbLibLsbLgbRs
bLsbRsLcbRiLsbLgbLgbLgbLgLsbRsRsmbLgLsbRsbLgbRsbRsbLgbLgbLsbLsbLsbLobR
ibRsbLgbRjbRgbLcbLsLsmbsbLibLsLsmbLgbLsbRsbLgbLgbLgLgbLsLsmbRgbLgbLsbR
ebLjbRgbLsbLgbLhbLibRjbRcbLibLgbRcbRsbLibLgRsbRobLgbLiLsbRsbRebRsbLsLs
LsmmbLgbRibLjbRibRsbRcRsmbLibRjbsbRibLhbRjbLgbLgbRsbLgRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bRiLsbLgbRobLgbRsLgbRgbRgbRgRsmbLsbRsbLibRibLibRgRsmbRgbReLibRoRsmbLob
RebRgbRibLgbRsbRibRobRsbRsRsmbRsbRibRibRsRsmbRsbRsbRsRsmbRgRsmbRgbRsRs
LsmbRgbRgbRgRsmbRsbRgbRsLsbRgRsmbLsRgRsmbRgRsmbRgbRgbRiLsbRobRgbLibLgb
RibRebRgRsmbRgLsbRgbRgbRibLsbLibLebRjLsbRibRgbLibRibLiRsbRgbLebRoLsbRi
bRgLsbRsbRgbRgbRgRsmbRsRgbRgbRgRsmbRgRsmbRgbLcbLibRobLgbLobLibLibRgbLi
LsbLgbRibLsbRsbLsbRebLobLgbLcbsbRebLibLibRebLsbLsbLibLebLgbRebLobRebRi
bLsbRsbsbRsbLiLsbRsLsLsmbLgRsbLsbLsLsmbLgbLsbLsbLsLsLsmmbLsLgRsbLgbLgb
LgbRibLhbRsRgbLoRsRsmbRjbRhbLobRgbRsbLsbRsLsbRibRgbLsbLsbRibRgLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRsbRgbRgbRgbRsbRgbRsbRgRsmbLsbRgbRgbRsbRebRebRsbRgbLsbLgbLgbLcbRgbRib
RgRsmbRgbLsLsmbRibLsbRsbRibLgbRibRsbRsbRsbLsbRgRsmbRgRsmbLsbRgbRgbLgbL
ibRibRgbRgbRsbRgbRsbRsRsmbRsRsmbRsbRsRsmbRsbRsLsbRsbRsbRsbRsbRgbRsbRsb
RgbRsRsmbRgbRsRsmbRgRsmbLsRsbRsbRgbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bLcbLibRobRobLsbRobRsbRoLsbRiRsmbRoRsmbLgbRcbRibLsRsbRobLsbLgLsbRobRsb
RgbRsLsbRgLsbRsbRibLsLsmbRsbRobsbLgLsbRsbRebLsbRobLibLibLgbRsbRhbLebLi
bLgbLsbRjbRsbRcbsbRebLcbRgbLsbLjbRsbRsRsmbLsbLgLsbRjbLiRsbRgbLobRebLhb
LibsbLjbLgbRoLsbsbLsbLgLsbRobLsbRcbRibRobLsbRgbRobRobLgbRhbRgbRsbRibLo
bRgbRibRgbLgbRibLobRsbLgbRsLsbRjbRcbRebLcRsbRgbRcRsmbRhbRsbRebLobRobRo
LsbRobLsRsbRobRgbRgbRsbRgbLsLsmbLsbLibRobRobLoRsbLibRgbLsbRgbRebLgbLcb
RsbLobRgbRebLoRsbRsbRobRobLjbRibLebLibLib

>ZF Recording 2016-04-14; tW: 300s; Start: 130627; End: 131127;
Recording: 1-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bRsbLoRsbRiLsbLibLsbLgbRsbLibLsbLhbLibRsbLsbLsLsmbLhbLsbLsbLgbLibRsbRg
bLobLibLibRibLhbLcbLsbLcRsbLsLsmbRgbLcbLibLgbRsbRgbsbLsLibLhbLsbLibLib
LgbLgbLjbRcbLcbLgbRsbLibLhbLibLsLsLsmmbRgbLibLgbLibLeLsbRgbLgbLgbRgbRo
LsbLjLsmbLsbLhbLibLgbsbRcbRgbRiLsbRgbLcbRsbRgLsbLsbLcbLoLsLsmmbRjbLgbR
gbLibRsbsbRgbLgbLibLgbLgbRcbLcbLibLsbLsbLgbRjbLgbRebRcbsbLcbRsRibLcbLi
bRsbLcRsbLibRsbRebRgbRgbLgbRgbLcbLjLgbLibLjbRibRhbLhbRiLsbLibLibLibRgb
LgbLgbRgbLcbRjRsmbLibLsbRsbLibLsbLgbLgLsbRsbLgbLgRsbLgbRsbLibsbRgLsbRs
RsmbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRgbRgRsmbRsbRsRsmbRgbRsbRgbRgbRgbRgbRsRsRsmmbRgRgRsmbRsRgbRgRsmbLsRgR
smbRsRgRgbRgbRgbRsRsRgRsRsmmmbLjbLibLhRsRsmbRgbReRsmbLoRsRsmbRebRsbRsR
smbRsRsmbLsRsRsRsRsRsLsmmmmbLsRsbsbRibRsRsmbRgbRsbRsRgRsmbLsLsmbsbLsRs
bLsbsbLsRsbLsbsbLsRsRsmbRsbRsbsbLsLsRsLsmbLsRsLsRsLsbLsbLsRsRsLsLsRsmm
bsbsbsbLsbsbRgbLsbRsbsbsbRsRsRsmmbRsRsmbRsbLsRsbRsRsmbRsRsmbRsRsRsmmbR
sRsmbLsRgbRgbRsRsmbRsbRgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bRsbRsbRsRsRsmmbRgRsmbRgbRsbRgbsbRsLsbRsbRsbRoLsbsbRgbRgbRgbRgbRgbLcbR
sbLsbRsLsbRsbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bRebRobLsLsmbRsbLiLgLsbRsbRsbLgbRcbLsbsbLsLsmbRsbLsbLsLsLsmmbLgbLgbRsb
RobLsbRibRgRsRsmmbRsRgbRgbRgLsbRsRsRsRsmmmbRsRgRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsRsRsmbRsRsRsmmbLsbRsbLsRsbRsbLsbLsbLsbLsRsbRsRsRsmmbRgbsbLsbRsbRiLs
RsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsbRgbsbsbsbLsbLibLsbRgbRsbRgbLgbLgbLsbRsbRgbLgbsbLgbLebLgbLebLcRsbLs
bLcbLebLgbLsbLgbRsRsmbRsbRgRsmbLsbRgbRsbRsbLgLsbLhbRsbsbLsbRibRgRsRsmm
bLsbLsLsmbRsbLsbRsRsmbLsbLsbRsbLsbRsbRsbRsRsmbLsbLsbRgbRsbLgbLsbRsbRgb
RsbRsRsmbRsbRsbRgRsmbRgbLibLsbLgbLibRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bRsbLsRsbRsbRsbRsbRsbLsbRsbRgRgRsmbLsbRgbRsbLsbRgbLgbRsbLgbLgbLgbLgbLg
bLibRsbRgbRsRsRsRsRgmmmbRsLsbLsbLcbLgbLsRsbLibsbLcbLsbLibsbsbLsbLgbLsb
RsbLcLsmbLiLsbLsLsmbLoRsbLsLsmbRsRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 7; Drug: APO 0.5
bLobLjbLobRibRgbLsbLibLsbLsbsbRcbRibRsRsmbRsbLcbRobRsbRibRcbRjbRibLhbR
gbLsLsmbLgbRjbRjbRobLiRsbRgbRiRsmbRgbRobRibLsbLsbLgbRcbRibLsRsbRjLsbRg
LsbLcbLcbRjbRjRsmbRgbLhbRgbRcbRibRibRibLibRcbRibLiLsbLgbLsbLsbLgbLgLsb
LsbLsLsmbRjLsbRcbRcbLcbRobRsRgbLcLsmbLgbRobRcLsbLgbRcLsbRibLgbRsbRgbRg
bRjLsbLobLjRsbLgbLobLgbRjRsRsmmbRsbRsbLsbLebLjLsmbRjbLibRsLsbLsbLibLsR
sbLgbLsbRcbRhbLgbRsbRcbLgbLcbLobLcRsbLibLcLsmbRsbLgbLgbLsbLoRsbRibLgbL
gbRhbRibRcLsbLiRsbLjRsbLobsbRgbsbsbLobLiRsbRgbRgbRcbRibLobLcbRgbLcbRgb
RcbRhbLibLsbRibRsbRibLsRsbRgRsmbLjbLibLiRsbsbLhbRsbRsbLibLsbLibRjbRcLs
RsbLsLsmbRhbLsLsmbRcbLsbLgbLgLsbLsbLgbLsbLsbLsbLgbLjbLgbLibLjRsbRgbRcb
LgRsbRsRsmbRsbRjbRgbLcbLcbLibRsbLcbLhbLgbRsRhbLsbLgbLjbLibLhRsbLhbLobL
gbLcbLgbRsLsRsbRobRibRgbRibRgbRgbLsbLgbRjbLhbLibRjbRobRibLiRsbRhbLcbLc
bLibLoRsbRsLsbRibLsbLibLoRsbRgbLiLsbLgbLsbLsbLgbLgLsbLobRcbRcbRibLiRsb
RjLsbRjLsLsmbsbLcbLhbLibRgbLgbRsbRobRibLgbRibRcbLibLgbRcRsmbRibRcbLgbL
sbRgbLjbRhbRcbRgbLibRgLsbRgRsmbRiRsRsmmbLcbRhbRsbRhbLsbLjbLhbLibRsbLcb
LibRibLsLsmbLsbRjbRibLcLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 8; Drug: APO 0.5
bLobLgbLoRsbRsRsmbRgbLebRsReRsmbLcbsbLsbRsbRsbLjbLcbLcbRsRgbRsbRgbRsbR
sbLobsbLibsbRsbRgRsmbRsbLibRsbLiLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 9; Drug: APO 0.5
bRibLcLsmbLsbRoRsmbLobLsRcbLiLsbRcbLibLgbLjbsbRgbRibLcbRgbLcbLgbRsbRsb
LobLhbLjLgbsbRcbLcbsbsbRibRhbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 10; Drug: APO 0.5
bRjbRcbLibRcbRebRjbRcbRgbRsbRsbRgbRgbRgbLibLobRibRjbRgbLjbRibLjLsmbLob
RcbLiRsbLjLsmbRjbRibLgbRibLibRgbRibRobRibRibRgbLjbLibLibRsbLebLhbRibLg
LsbRgbLgbRibRibLcbLhbRgbRgbLibRgbLgbRjbsbLjbRsbRobLibRhbRibRibLibLgbRj
bRjbLgbRgbRgbRgbLjbLjbRcbLhbRibLibRhbRjLsbRjRsmbLhLsbLjbRjbRibLibRibLs
bRcRsmbLibLhbLgbLiLsRsbLsbLsbRjbRibLjbRcLsbLhbRjbRjbRcbRibLibLgbRgbLsb
LibLgbsbLobLhbLcbLibLgbRibLgbLibRsbRsLsbRgbLsbLibLibRjbRjbLjbRgbRgbRgb
LsbRgbLsbRibLibRsbLcbRjbRobRgbRgbLsLsmbLgbLjLsmbLgLsRsbRibLjbLibRibLjb
RibLjbRibLhbRjbLibRgbLsbLsbRgbRgbRsRibLgbLjbRibLcbRjbRjbLjbLibRibLibRj
bLibRsbLsbLsbLibLgbRcbRhbLibRgbLgbRgbLjbRibRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 11; Drug: APO 0.5
bLsLsmbRsbRsRsmbRsbsbLsbLsbLsbRsbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 12; Drug: APO 0.5
bLibsbLsbRibRebLhbLobLgbLiRsbLhbLibRebLibRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bLsLsmbLgbLsbLgRsbLiRsRsmbLibsbsbLgbLibsbRgbLsbLsbRgLsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRsLsbsbsbRiRsmbRiLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bRjbRcbLobLcbLgbLhbRcbRgbRibRcbLcbRcbRibRgbLibRiLsbLibRcbLjLsmbLiLsbLi
bRgbLibLgbLgRsbLibLibLibRhbLsbLobRcbLcbRobRiLsbLjbLcbLjbRcbLiRsbRhbLib
LgLsbRhbLcLsmbLsbLhLsbLibRebLgLsbLibLibLibLiLsbLhbRgbRjbLibLibLibRib

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bRgbsbsbRhRsmbLsRsbLibRsbRsbRsbRsbRgbRsbsbRgbLsbRgbRsbLsbsbLsLsLsLsmmm
bLgLsbLsbLibRob

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bsbsbsbsbRsbLsbRsLsbLsbLsbRsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLgbLsLsmbLsbLgbRjRsmbLibLgbLiRsbLsbRsbRsbLibRsbRjbLiRsbRobLibLebLibRi
bLiLsbRsbLsRsbLsbLgbLgbRjbLibLcRsbRjbRcbRoLsbLiLsbLibRsbLibRsbRhLsbLob
RjbRhbRcbLibRjbRobLgbLibRhLsbRibLobRsbRsbRibLgbLgbRcbRsbRibLjbLhbRhbRh
LsLsmbLjbRibLjbRcbRgbRibRjLsbLobRjbRcbLibRgbRsbLjLsmbRibRibLibLjbRjbRi
bLcbRcbRhLsbLjbRcLsbRcLsbLgbLcbRsbRgbLsbRibRibLcbRcbRhbLjbRjLsbRgbRsRs
mbLsbRebRcbLgLsbLgbRgbRjbRhbLsbRcbRibRhbLsbRiLsLgbRgbRgbLebRjbRhbLjbRe
LsbLibRibLsbRibRjLsbLjbRjbRobsbLibLsbLsbRibRibRibLsbRibRsRsmbRibLibRhb
LjbRibLsbRhbLgbRcbRcLsbLhbRhbLjbRcbLgbRibRhbRgbRsbRgbLsbLhRsbRcbRibLjb
RjbLjbRibRgbLcRsbRgbRibLjbLhbLhbRsbRibLsbsbLibLsbRibRgbLcbRhbLhbRibRsL
sbRgRsmbRsLsbRgRsmbRiRsmbLsbRgLsbsbLcbsbsbRjbLjLsmbRhbRcbLibRcbLgbRibL
sbLibLgbRcbLibRsbRjbRibLcbLibRobRjLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRsbLgLsbLsbLsbRsbLsbLsbRgbLsbRgRsmbLsbLsbLgbLsbLsLsmbLsbLsbRsLsbLgLsb
RsbLsRsbRgbRgRsmbLsbRgbRgbLibLibLgLsbLsbRobLsbLsLsmbLgLsbLgbLjbRoLsbsb
RsLsbRgbRgbRsbLsbRgbLcbLgRsbLsbLsbLsbLgbLsRsbLsbRgbRobRsbRibLjbRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bLobRebLcbLebLobRobRobLebRobRibLobRcbLebRhbLobLebRsbLibLobRobRobRobLsb
LibRobRobLebRobLobLobRobRsbRgbLebLibRobRsbRobRobLobRgbLgbRobLcbLobRebR
obLcbLsbRebRsbRgbRibLibLgbLebRobLcbRebLcbRgbLhbRibRobLebRsbRibRobRibRo
bRobLobRcbLcbLobLcbRobLsbRhbLobLibLsbLebLebRobRebLcbRebRebLobLgbLobReb
LebRobLobLobRobLobLobRhbLebLcbLibLebRcbLcbLebLobRcbRobLebLcbLsbRobLobL
ibRebRebRebLcbLgbRcbRcbLibLebLobRgbLsbRcbRobRobRcbLibRgbLobLebRobLobRi
bLobLibLcbLcbRcbLcbRobLsbRcbRobLgbLebRobRsbLobLobRgbRibLobLibLcbRobLeb
LcbRobLhbRcbRobRcbLcbRobLebLobLebRobLgbLobLsbLcbRgbLobRcbRcbRobRobRobR
ebLebLebLjbLobLcbRcbRibRebLebRcbLobLobLobLsbRobRgbLhbRebRcbRibLibRebRo
bRobLobRcbRobRgbLobLcbRsbLobLebLebRebLobRcbRobRebLgbLebLobRebRcbRcbLcb
LobRebRebLobRobLobRobLebRobLobLhbLobLobRsbLobRobRobRcbLebLcbRebLobRobR
ebRgbRobLcbRobRibLgbLebLcbRgbRibLcbRobLobRebLobLebRobLgbRibRibRsbLhbLo
bRibRobRobLobRgbRcbLcbLobRobLhbRsbLebRobLcbRobLcbLebRcbRcbLobLhbRobReb
LobRobRobRobLebRebRobLobLebLhbRebRibRebLobRobRebLobRgbLebRebLcbRhbLebL
ebRgbRobLobRcbRcbRobRobRsbRibRcbRebRcbRobLcbRgbRobLhbRebLobRsbRebRcbLe
bRobRgbLcbRobRgbRcbLcbRobLebRebRibRcbRebLobLobLibLebLebRcbRcbLibRebReb
RobRobLobLobRibRebLobRobLgbLebRcbRobLebLobRcbRcbRhbRobLobLobLobLebLobR
obRebRobLibLebLebLsbLobLobLobRsbRsbLgbRobRobLcbRsbLebRobRebRebLebLibRo
bLcbRobLobRobLcbLobRcbRebLibRsbRobRgbRcbLobRobLebRcbLhbLibRebRobRebRib
LobLebRebRsbLobLibLobRcbLgbRebRobLcbRobLobRobLobLobLibLebLcbLgbLcbLsbL
obRcbLebLsbRcbRobLebRobLobLobLcbLobLebLcbRobRebLebLobLibRcbLibLobLebLg
bRhbLebLcbLobRibLibRcbLobRobLebLobRgbLcbRobRobLcbLobRebLobLcbRobRebRob
RebLebRibLgbRcbLobRobRebRobRobRibRibLcbRebLcbRhbRibRcbRebLobLibLebLobR
sbRobLcbLobRcbRebLobLsbLibRibRcbLebRobRobRobLebRcbLobRcbLibRobLcbLjbLo
bLobRibLobRcbLibRebLobLobLcbLobLobLobRobRebRobRibLsbRobLobRobLebLsbReb
LibLgbRebRobLebRebLobLcbRobLsbRcbLcbLcbLebLibRobLobLebRsbRebLobRebLgbL
gbLgbLobRibLobLobLobRobLcbRobRcbLcbLebLcbRgbRibLebRobLobLobRebLcbRcbLh
bRobLgbRcbLgbRobLobLobRgbRhbRobLobRebRebRobLebLgbLgbLgbRcbLebRcbLobRcb
RgbRebRobLebRgbLibRobRebRebLobRjbLobRobRobLcbLobLobLobRsbRebLebLobLcbR
obRebLobLibRcbRcbLobRebRobRobRebLobLobRebRebLobRebLobLobLobLobLcbLcbRc
bRebRobLebLobLobLobRhbLcbRhbRgbLcbLsbLcbRcbRobLobLobLobLobRebLibLcbLeb
RcbLobLobLibLsbRobRobRebRcbLsbRebRobLobRobLgbLobRibRebLobLgbLcbRcbRcbR
ebLobLcbLcbRobRobLibLobLgbLobLobRobRebLebLsbRebLibRobLebRebRebLsbRsbRs
bLobLobRebRobRebRebLobRgbRcbLobRobLebLebLebRgbRobLobRsbRobRobLobLcbReb
LcbRebLebLobRobLcbLobRebLobLcbLsbLhbLgbRcbLcbLobRibLobLcbLhbLobRobRgbL
ebRobRobRcbRobRobLobRobRsbLobRsbRebRobRebRibLebLobLobRobLebLibRcbRobRg
bLsbLibLobRhbRobLhbRobRcbRebLibLgbRgbLhbLgbRcbRobRebLobLebLcbRcbLobRcb
RsbLebLobLobRobLobRobRcbRgbRsbRebLcbLebLebRobLcbRsbLebLebLebRibRcbLobR
ebRobRobLebLobRcbRobRobLobRobLibRgbRibRobLgbRobRobRobLobRobRcbRhbRebLc
bLsbLobLebLibRebLobRcbRcbRibRobRobLobRobLebLobRobRebLcbLebRebLebLobRob
LebLobLobRhbLcbRebRobRcbRobRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bLobRobLcbLgRsLobLobLobRcbRsLsLsmbReLsLsmbLsbRsbLsRsLsLsmbLsbLebLobLsb
LobLsbRsbLsbLobRobLobLobLcRsbLebLsbLsbReRsmbLebRobRsbLobRebRebLebRsbRs
bRobRcbLobLsbLsbRcRsRombRsbLobRsbRsbRoRsmbLoLjbRsbLsRobRobLsbLobRsbRsb
RobLebRobRebLsbLebRsbRcbLgLsbLsbLoRsbRsRsLsRsRembRebLsbLobRebLsbLobReL
sbLsLobLebRobLsbLsbLobRoRsmbRsbLsbRsLsRsbLobLsbRsRsmbLobRsbLebRsRobLsR
eLsbLsLsmbLobRobRsbLoLobRebLjbRsbLsbRsbRsbRebLobLsRsRsmbRsbRebLebLoRsb
LebLsbLobLebRsbRebRgbRsbLobLsbRsLebRsRebLoLebLobReLsLebRcbLcbRobRsLsbR
ebLsLobLoLsmbRsbRsbLsbRsLsbRcbLjbRsLsbRoLjbLsRebLsbLcbRjbLgbLgbRoReRsm
bLebLobRebLeLsbRsbLsRsbLsbRoRsLsmbRobLsbRsbLebRsRsmbRgbRsbRsbRebRsbRob
RebRsbLsRsReRsmbRebRcbRsbLebLjbLsbLsbRsbRoRsmbRsbLebLcbReLebLebLoLsLom
bLobLcbRobLsbLobLobLsbLsRsbRebRjbRoLebRobRibLcbLebLebLsbLobLcLsmbRebLo
bLobRobRoLsRsbLebLebLsbLoRjbLsLobRjbRsRobRoLsbLsRsbLobLebRsRsmbRebLobR
ebRebRsbRcbLsLebLobLebRobLeRsbLobRebRobLebLebRsLebRobLjbLobLsbRobRobRs
bRcbLjbRebRsbRobLibRjbLebRobLobRobLsbLobLobLebLebLebRebRsbRcLebLobLobR
obRebLebRebRcbRebLobLobRobLsbLjbLsbLoLjbLobLobRsbLobRobRcbRsbLobLebRsb
LobRsbRobLcbRebLobLobRobLobLobRebRobLjbLobRobRoRebLebLobRsbLjbLobRcbLo
bRobLjbRobLobLobRobRobLjbRobLsbRcbLebRebRebRcbRebLobRobLobLebRcbLjbRsb
RebRsbLjbLobLjbRoRsmbRebLoRobLobRebLgbRebLobRsbRsbLobRobLobRsbLobLobRe
bLcbLobLcbLsbLjbLcbLsbLsbRsbLsbLgbLjbLjbRsbRjbRsbRgbLsbRsbRsbRcbLjbLsb
LobLjbLsbLsbRsbLsbRebLsbRobRobLobRsbLsbLsbLebRsbLjbLsbLsbLobRebReLjbLs
bRsRsmbLsbLsbLsRsRsmbLsbLjbRcbRsbRoLobRsLsLsmbRsbLsbRebLsLobRsbLsbRsbR
sRsmbLjbRsLsRsbRobRsbLebLsLsmbRsLsbRsbRsbLobRsbRobLsLsmbRobLsbLsbsbRsb
LsbLsbRsbsbRsbRsRsmbRsbLoRsbsbRsLsLsmbLsRsbLsLsmbLsbRsRsmbLsbRsbLsbRsb
LsbLsbLsLsmbLsLsmbRsbRsRsmbRsbRsbLsbLsbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLebRsbRobLobLobLobRobRobLhbLebLcbRcbLobLebRobLebRobRcbRobLebRobRcbLgb
RobLcbLobRgbRobLcbLobLgbRcbLebRobLobLcbRcbRgbRebLobRebRcbRebLobRebRibL
obRebRobLobRebRibLebLebLebLebRebRebLibLebLobLcbLobLcbLobRebRobRobRcbLc
bLebLobRebLhbRebLibRobRebLebRobLobLobLibRobLcbLgbRcbLsbLebLgbLobLcbLob
RobRobLebRibLebLjbRcbRobRcbLobLobRhbRebRobLobLobLebLcbLebLibLcbRgbRobL
ebLobRobRobLobRobRobLobLobRobLobRcbLcbRobRebRebRcbLhbRcbLobRgbLhbLibLe
bRebRebLgbLobLobRcbLcbRobRsbLcbLobRcbLibLebRobRcbLcbRebRobRobRebLsbLgb
RjbLjbRcbLibRebRibRcbLobRcbRobLebLobRobLebRcbRobLebRebRcbLcbLebLobLobL
gbRgbLibRobLobRcbRobRobLebRebRcbLobLebRobLobRobLobLebRcbLobLcbLcbLcbRo
bRobLcbLsbLebLobLobRibRebRobLcbRibLcbLobRibRobLebLcbRobRebLobLcbRobLgb
RsbLibLebRobRebRibRobRebLcbRsbRobRobRebLebRobLgbLobRobRobRobRjbLobLcbR
ebLibRobLobRobRebLcbLcbLobRobRibRebLcbLobLcbRobLobRhbRobRebRebRsbLibRh
bRsbLibLgbLobRebRebRobRobRebRsbRebLgbLobRobLebRebRcbLobRobLobLibLsbRgb
RobRobLebLobRcbRobLobRobLebRobLobRobLcbLgbLobRebRebRobRebRobLcbRobLobR
ibLibRobRobRhbLobLebRobLgbLobLobRcbLjbLcbLjbRebLobLcbLcbLsbLebLobRebRe
bLsbLcbLobRcbRebRebRibRebLobRobRobRibLobRsbRobLebRsbLebRobRobLgbRcbRob
LebLobLcbRibLobRobRebRebRebRcbLsbRcbRcbLcbLobRcbRgbRobRebRobRcbLobLsbL
ebRebRebRcbLibRobLibRobRobRobLobLobLcbLcbLsbRsbRebLobRcbLcbRibLobRebRg
bLhbLcbLsbRobRebLebRobLibRsbLsbRebLcbRobRobRobRebRsbRcbLebLhbLcbRhbRob
LobRobLobLobLebLobRobLcbRobRcbRsbLibLobRsbRcbLhbLobLebLgbLebRgbRebLobR
obRgbRcbLebRcbLcbLjbLobLebLobRobRcbLibRebLibLebRibLibRsbRgbRgbRsbRgbRo
bRebLgbLobRobRcbRobLibLobLcbRebRgbRobRgbRcbLebRobLebRebLebLcbRobLobReb
LsbLcbRobRebLibLcbLobLsbRibLgbLobLebLobRebLcbRobLcbRebRebLobLibLibRebL
sbRsbLobLobLcbRobLsbLobRebRobRobLjbRobLobLebRebLcbRebRebRobLobRobLibRc
bLibRcbLobLobLcbLsbLsbRobRebLobLebRgbRcbLobRebRcbLcbRgbLgbLcbRsbRebReb
LobRobLsbRobLcbRcbRhbLobRcbRcbLebLebLobRobLobRcbLebRobRebLobLebRobLebR
ebRebRebLgbRobRobRebLcbRobRobLobLgbLobRobLobLobRebLobRobRcbRebLobLobRe
bLobRcbRibRcbLcbLcbRobRcbRebLibRobLebLcbLobLsbRcbLibRobLgbLobLebRgbLcb
LcbRcbRobLebLcbLobRibRcbLcbLcbLobLebRebLebRobLibRsbLobRcbLebRebLibLebR
cbLebRcbRhbLebLgbRebLebRjbRobLsbRebRcbLobRibLobRobRobLobLcbRibRhbLsbRo
bLibRobRobLobRgbRcbLobRsbLobRebRobLobRobRebRebRebLcbLgbRgbRebLibLobRcb
RebLcbRobLobLhbRebRebRobRsbLobLcbRebLsbLgbLebRebLebLebRibLibLsbLebRebR
obLobLgbRobLgbRobRobRjbRibLebLobLcbRcbLibRobRobRgbLcbLobLobRcbRobRebRg
bLcbLibLcbRobLebRobLebRibLcbLobRebLcbRebRibLobLcbLobLgbRebLebLobLobRgb
LobRebLgbRcbLcbRobLobLhbLebRsbRcbLcbLebRobRobLebRobRobRebRebRobLobRobL
cbLcbLgbRgbRcbLobLebLcbLcbRcbLebLibLobRebLobRcbLobLebLobLebRebLobLcbLe
bLebRobLcbLibRibRcbRobLebRobLcbLcbRobRobLebLcbLobRgbLobRobLcbRcbRobLeb
RebLgbLebRebRobLebLobRobLebLgbLebLsbLibLsbLcbRcbLcbLebRcbRobLobRsbRobR
obRcbRgbRobLgbLibLebLobLobLebLobRibLcbLobLcbLobRobLibRobLob

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLsLsmbLsLsRsmbLsbLsbLsbLgbLsbRsbsbLsRsbRsbRgbRsbRsbLsbLsbLsbLsbLsbLsb
LsbLsbsbLgbLsbRsbLsbsbLsLsmbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLgbRibRcbRobRobLobLcbRibRsbRcbLibRsbLobLebLibRobLobRsbLobLibRcbRobRsb
LebLobLobRobRcbRobLcbLobLcbLhbLobLebLjbRobLobRobLebRobLcbLcbRobLobRebR
ibLcbLebRsbRobLcbRebLcbLobRcbRgbLobLobLhbRcbLsbLibRgbLcbRsbLobRobLobLo
bLebLobRebLcbLgbLobRobLhbRsbRcbLjbRebLobRcbLebLsbRcbLobRobRebLebLcbRcb
RebRebRobLobLobLebRebLobRobRibLobLebLobRebRobRobRobRcbRobRebLobLcbLibL
cbRgbLebLobRibLsbRobRobRebLobLjbRobRobLgbLebLibRcbLebRibLobRcbRobLebLo
bLebLcbLibRibRhbRobRebRebRcbLobRebLobRebRobLobLobLobRibRgbLcbLebLgbRob
LsbRobLibLebRobLsbRebRobLobRibLibLobRebRobLobLcbLsbRobRebLobLobRcbRebR
obLebLobRcbLibLobRobLebLobRgbLjbLobRebRobRebLsbLobLebLebRhbLobRebLebLo
bRibLebLebLcbLobRcbLebLebLibLobLobRebRjbLobRcbRgbLobRcbRobRobLobLebReb
RobLobRibLebLobLebRobLebRgbLebLgbLcbLobRcbRebLibLebLobLebLcbRhbLgbLebL
obRobRebLcbRobLobRhbRcbRgbLobRsbLebLgbRobLobLebRcbLebRobRebRebRobLibLe
bRcbLobRebRobRhbRsbLibRebRcbRebLebLobRcbRcbLjbRobRgbRcbRgbRibRobRobRib
RcbLcbRcbLibRsbLjbLcbLjbRebRibRobRgbRobLebRobRcbLsbRhbLobRgbRgbLobRobL
ibLebRebLebRcbLcbLcbLcbRobLgbRebLibRobLcbLgbLcbLgbRobLcbRobLebRobRobLe
bRobRebRjbLebLcbRgbRobLcbRebRebLcbLobRsbLobLcbRebLsbRgbLobLobRibRsbRob
LobLobLebRobRjbLobLhbRobRobRcbLobLibRgbLobLsbRobRobRebLsbLgbLibLobRgbL
obRibRebRebRcbRcbLobLebRobLgbLobRebRobRobRobLcbRcbLobRebLobRobLobLobRh
bLibLobLobRobLcbLgbRibRobLcbLobLobRcbRebRebRobRibRebLobLobLcbLgbRebLcb
RobRsbRobRcbLebLcbLobLebLhbLobLebLibRibRobRgbRcbLcbLobLsbRibLobLgbLsbL
obRsbLebLebRobRcbLcbRebRobLobRobRebLebRebLobLcbRebLcbLsbRebLebLcbRebLi
bLgbRcbRebLebLibLgbLebLcbLebRibLobRobLobLebRcbLobRsbLibRobRebRjbRibRhb
RobRebRcbRobRcbRcbRebRebLjbRibLobRcbRebRobLebLcbLibLobRebLebLcbRobLobL
obRobLebLebLobRobLhbRobLobLebRebRebLobRobLobLibRcbRobLebRcbRgbRobLobRo
bRobRobRobRobLobLobRobRobLcbLebRsbRcbLobLobRebRobRcbRobLibLebRsbRobLcb
RebLibLobLgbRebLobLobLobRibLibLobRhbRgbRebRsbRebLebLebLebRibRobLebLebL
obRobRobLcbRebRebLibRebRgbRobRobRobLobLobRibLcbRebLobLcbRsbLebRobRibRs
bLgbRhbRgbRobLgbLibRebRobRcbRobRcbLcbRebLjbLibRobRobLebLobRobLobLsbReb
RcbLobRjbLebRgbRebRobLebRsbRcbLobLobRebLcbRobRobLcbRobLcbLsbLobRcbRsbL
ebLgbLsbRcbLcbRgbRobLcbLcbLebLebLhbLibRobRcbRobRebLebLebLsbRgbRgbRebLo
bLibLobRobLebRobLebRobRhbRobRobLobLobLcbLcbRebRebLcbLibRebLcbLobLobRob
LsbRobRobRobLibLobRobRobRebLebLgbLobLgbRobLebRobLcbLobRobLebLobRebRcbL
obLebLhbLobLobRgbRibRebLjbRgbLibRebLobLibLobLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRgbRgbRsbRsbRsbRgbRgbRsbRgbRgRsmbRsRsmbRsbRgbsbsbRjbLsLsmbLsbRsbsbLcb
LsLsmbLsRsbRsbRsbRgbRgRsmbRebRsbRsbRgbRsbRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bLiRsbLsbLoRsRsmbRibRgbRgbRgbLsbLgbRibLgbLjbRsLsbRjbRhbLjbLgbLibLsbLgb
LcbRibLcbLoRsbLjbRibRibLibRebRebRsbRsbRebRiLsRsbRgLsbRgRsmbRgbLgbRgbRi
bLibsbRgbRgbLgbLiRsbLsbLobLsbLsbLsbRgLsLsmbLgRsRsmbRgbRgbLoRsbLoRsbRjL
sbLcbRibRsbLoRsbRjRsmbLgbLibRgbRsbLibRcbRgbRoLsbLcbLsbLibLebRibLsbRgbR
eRsmbRiLsRsbRsbRgbLoRsbRsbLoRsbRibRsbLgbRgbLgbRcbLgbLjbRibLcbLobRsbLgb
RgLsbLgbLjbLsbsbLibLhbRgbRgbLibRsbLsRsbLobRibRgbRsbLibLgbRsbLgbRibsbRs
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLsbLsbLsbLsLsmbLsLsmbLsbRsbLgbRsbReRsLsmbLibRsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLobLibLcbLebRebLcbRsbRgbLcbRebRebLcbLebRcbLhbRibLebLobRibLcbRobRobRcb
RhbLobRebLgbRgbRsbLcbRebRhbLcbLobRebLibLibRobLobLobLebLebRobLebRobLobL
sbRibRcbLobLobRebRobRcbLobRebLcbLibLsbRgbRobRcbLobRobLebLobLobRibLsbLc
bRobLcbLsbRcbRebRebLebLcbRobLcbLcbRobRsbLobRsbLgbRobLobLobLebLibRobLsb
LebRebLebLobRebRobRcbRibRebLobRobLgbLebLsbLcbRcbLcbLgbRobLibLcbLobLobR
cbLobLobRobLebRobLobRcbLcbRibLobLcbLebRhbRebRobLcbRobRobRobLobRcbLobLo
bLibRebLebLobLgbLobRibLebLcbLebLobLebRobLcbLgbLcbRobLebLobRobLebLebLob
RobRobRebLcbRobRhbLgbLobLcbRgbLobRobLebRebRobLebLobLebLcbRobLibLobLcbL
ebRcbRgbRibLobRebRobRsbRibRebLcbRobRebLcbRgbRebLcbRgbRobRebRhbLebRebRe
bLebLobRobLobLobRgbLcbLobLobRebLobLobRebLcbLobLobLsbLcbRobLcbLibRebRcb
RobLobLobRcbLcbLobLobLcbRebRobLobRebLobLebLobRibRobRgbRobLebLobRgbRobR
cbLobRobLobLobRebLebRobRcbLebLsbRobRcbRobRobRebLgbRebRgbRobLebLobLjbRi
bLebLobRobRobRobLgbLebLebLobRobRebLsbLobLobLobRgbRobLobLobRgbLebRhbLob
LibLibRobLgbRcbLibRsbLebLcbLcbLebLhbRebLobLobLebRobRobRobLcbLobRebRebR
ebRgbRobLsbLobRebRobLibRebLebRcbLobRobLobLebRsbRobRebLebLobLobLebLobRe
bLobLgbRobLebRebLcbLobLebLebRobLobLibRibRebRsbRgbRcbLebRhbLebRebRcbLeb
RsbLcbLgbLgbRhbLobLibLebLibRcbLebRhbRobLibRcbLcbRcbRobLgbLebRsbRebRobL
ibLsbRsbLebRebLobLobRcbLebLcbLebRsbRobLobRibRcbRibRobLcbRobLsbRobLobLc
bLobRgbLobRgbLobLebLobRobRobRobRobLebLobLibLobRcbLcbRebRobRobLgbLobLib
RebRobRcbRebRobLobLebLebRobLebRebRobRobLcbRebLcbRobLebLcbLcbRcbRgbRobL
obRibRgbLobRgbLibLobRobLcbLcbLcbRibRebLebLcbRebRobLcbRobLebRgbLcbLibRe
bRcbRebLgbLcbLobLobLibLebLobLsbLcbRebRcbLibLobLcbRobRebLibLobLcbRobReb
RebLobRcbRsbRgbLcbRobLobRcbLhbLobLobRibRcbRibRobLebRobRgbLobRcbRibRcbR
cbRobRibLgbRobLebLobLcbLcbRgbRibLebLibLebLcbLobRobRobRebRsbRebRebRsbRe
bLgbRobRobLobLibRcbLobRobLebRobRobLobLobRobLobRobRcbRibRobLsbLebLcbLob
LcbLobRgbRebRobLobLcbRsbRebLebLobLobLgbRobLcbRobLgbRsbRobRebLobRibLobR
ebRgbRobLobLobLcbRobLebRibLobRsbLebLebRcbRcbLobLebLobLobRebRobRebRobRs
bLgbLcbLibLebLobLebRebLgbRcbRcbRcbLobLobLebRobLgbLebRebLcbRebLobRcbRob
LobRjbLobRobLebLibRjbRcbRobRcbLobLibLobLsbRcbLsbLobLsbLgbLhbRobLobRibR
ibLebLebRcbLebRebRobLebLobLibLgbLobLobRobRibLobRcbRebLobRobLebLobLebLo
bLibLobRgbLobLobLcbRobRebRebRsbLebLcbLebRebLebLebLcbRebRebLebRobLobLob
RcbLobLibRcbLobRibRebRcbLsbLobRebRobLsbRcbLobRhbLibLsbLibLebRgbLobRobL
cbLobRibRcbLebLibRobLibLibLebRebLibLebLibRgbRebRibLcbLobLcbLobRcbRobLo
bRcbLobRgbLebLebLobRebRsbLebLebLjbRobRcbRcbLebLebLobLhbRobLcbLgbLhbRib
LebRebRobRobLobLobLhbLcbRobLobLcbLsbRobLobRobLibRebRobRobLcbLobLcbLebL
obLcbRobLcbLobLsbRcbRobLobLgbLobRobLcbLobRibRobLgbLgbRobLobLebRibRcbLc
bLgbLobLobRebRobLobLobLobRobRsbLobLobLebRebRebRsbRebRebLobLibRebLobReb
LobLobLibRsbRebLobLobRebLobLgbLebRobLebLobRcbLobLebLibLgbRobLebLcbLobL
obRobLibLobRobLobRjbRebRcbLobLebRgbLobRobRobRibRobLebRcbRobLcbRobRsbRc
bLcbLebRsbRobLebRcbRebRcbLcbRebLebLibRhbLobRobLgbRobLcbLebRcbLobRebLeb
RobLjbRjbLgbRebRebLebLobLobLebRobRebLsbRcbLebLgbRobLobRebLebRebRobLcbR
obLobLobLcbRobRobLebLobRjbLobLobRgbLgbRebLebRcbLobRjbRebRgbLebLebLobRc
bRhbLcbRobLobLgbRcbLobRcbLjbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bLsbLsbsbRgbLiLsLsmbLsLsRsmbLgbLsRsbLsbLibLsLsmbLsbLsbLgbRgbLsbRsbRebR
sRsmbLcbLsbsbRsbLsbLibLgLsbRsbLsLsmbsbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLsbLsbLsbLsRsbLsbRsbLsbLsLsmbRsbLgbLgLsbLsbLgbLsbLgbLsbLsLsmbLgbLsbLs
bLsbLgbLgbLgbLsLsmbLsbsbLgbLsbLgbLgbRsbLsbRsbLsLsmbLsbRsbsbLsbLgRsbLsb
LsbLsbLsbLgbLsLgLsbLgbLgbLgLsbsbLgbLgbLgbLsbLgbLsbLsbLgbLsLsLsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 31; Drug: APO 0.5
bRsRsmbRsbRhbRcLsbLsLsRsmbRgLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 32; Drug: APO 0.5
bLsRibLobRsbLebRiRsRcmbRibRhbRgbRiRsRsmmbLgRsbRgbRsLsRsbRsbRibLhLsbRib
Leb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 33; Drug: APO 0.5
bLgLsbRibRobLobRebLobRibLsbLjbLgbLcRsLsbLiLsbLebLeLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 34; Drug: APO 0.5
bLcbRobRibRhbLcbRiRsmbRibRgRsmbLhbLcbRhbRgbLcbRcRsRgRsmmbRiLsbRgbLsbLs
bLjbRhbLgbRgbRgbLjbLgbRcbLibRibRgbLibRibRibLjbLjbRjbLcbLsLcbRibRiRsmbR
ibLhbRjbRibRobRibRibRibRsbRibLgbRibLjbLcbLibRibRibLebLjbRibRjbLobRibRc
bLibLibLibRhLsbLgbRibLsbRibRibLcbLibRjbLgbLcRsbsbLhbLoRsbLhbRjbLhbLobR
hbRibLibRjbLjRsbRjbLhbLhbRebLhbLibLibLcbLibLibRiRsmbLgbLibRhLsbLgbLobL
cbRgbLcbLsbRhbLibLobRhbLcbRcbRcbRhLsbRgRsmbRjRsmbRibRgbRibRgbRjbReLsbL
ibLsbLsbRjbRcbRcbLgbLibLgbLjbLcbRsbRiRsmbRjbLcbLjbLobRsbLjbLeRsbLibRgb
RsbLjbRobLsLsmbLebLibLibLibLcbLibLgbLgLsbLcbRgbLjRsbLcbLoRsbLjbLcbRibR
gbRsbRgbLoRsbLibLsbLibLgbLhbLibRjbLibLcRsbRcbRebRcLsbRiLsbRobLebRgbLob
RsLgbRibRibRsRsmbRgbLibLsbRjbRgbLjbLsbRibLjbRhbRhbLhbLcbLebRibLgbLibLc
RsbLjbRsbLhbRgbLhbLibLcbLibLgbRebLsbLgbLgRsbRsbRsbLsbsbRjbLgbRibLibRjb
LiLsbLibRsbRebLibLiRsbRcbRebLhbRebLcbLgbLsbRsRcbLhbLgRsbLgbLgbRcbLcbLi
bRsRobLcbRcbLibRjbLsbLobLgbLgbRsbLgLsbLobLibRibLsbLibLgbLjbLcbRibLhbLg
bLibLiLsbLibRcbRcbRcLsbRgbRhbRcLsbLcbLgbLcbLgbLgbRibRgbLcbLobLsbLhLsbL
gbLsLcbLibLgbRgbLgbLcbLgbRibLcbRhbLcbRgbLibLgbLibLsbLibLgbRsbLibLsRsbL
ibLsbRcRsmbLsbLibRgbReLsbRcbLcbLgbLibRjLsbRobLhb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 35; Drug: APO 0.5
bRcbRgbLsbRibRhbLobRibRjbRgbRcRsmbRcLsbRiLsbsbRibRgbRibRibRgbRibRibRsb
RgbRibRgbRibRcbRcbRibRhbRibLgbRhbLobLcRsLebsbRgbRsLsRsbRibLibRibRobLgR
iRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 36; Drug: APO 0.5
bRibLcbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLgbRsRsmbRgbRsRsmbLgbRgbsbLgbLibRsbLsLsmbLgbLsbLsLsLsLsmmmbRsbLsbLibL
sbRsbLsbLsLsmbLgbRsLsbLsLsmbLgbRsbLsbLgbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLibLsbLsbRhbsbRobsbsbLobRibLobLobLgbLgbLgbLibLibLgbRsbLgbLgbLsLsmbLsb
LgbLgbLgbLsbLsLsmbLsbRgLsbLibRhRsmbRibLsLsmbRcbLsbLibLjLsmbLoRsbLgbLgb
RsLsbLsbLsbRibRgbRgbRsbLobLibLhbLsbsbLibLsbsbsbLibLgbLsbLsbLsbLcbLibsb
sbsbsbsbsbLobLibLibRcbsbLsbRsbLsbsbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLcLsmbLibRjbRibRcbLibRsbLcbsbLjbLgbRiLsbLibRjbRibLgbRibRcbRjbRibRcbRc
bLcbRgbRcbRibRgbRibLcbLgbRgRsmbRjbRsbRcbRgbRgRsmbLgbLobLcbRjbLgbLibRib
RibRcbLsbLjbRibLhbRibRcbRobRhbRibRsRsRsmmbLsLsmbRsbLibRjbRibLibLsbRgLs
bRgbLgbLsRgbRhbLcbRgbRgbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRgbRiLgbRjbLobRsbLcbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRebRobLcbLsbRgbRobRhbRobLobLcbRebRebLobLcbLsbRgbRgbLgbRobLebLcbRebLcb
RobLobRobRobLibLobLobLibRebLcbLsbRebRhbRobRebLebRcbLobLobLebRebRebRebR
ebRgbRcbRibRsbLobRibRebLobLcbRebRebRobRobRgbRobRobRebLebLcbRobRebLibLo
bRobRobRobLobRcbLsbLobLobLgbLobLibRobRebRobRsbRobLcbLobLobLcbRebLibReb
LgbRobLobLgbRibLcbRibRobLcbLobRibRcbRibLobRebRobLebLobLebRebRibRibRobR
gbLobRcbLsbRobRgbRobLobLebRsbRcbRebRgbRgbRebRcbLebRibLsbRcbRcbRhbLebLe
bRcbLobRebRibRebLgbRcbLcbRobLibRobLebRobLebLobLcbRgbLebRobLobLebLebLob
LobRgbRebLcbRcbRobLcbLobRobRebLgbRobRobRobLobRcbRsbLobLgbLobRcbLebLebR
obLgbRebRobRsbRebLobRobLobLebRobRgbLobRcbRobLcbLebRcbLsbRcbLsbLobRobRe
bLgbRebLobRhbLsbRebRobRobRobRebRebRgbRebLobLgbLebLibLobLcbLebLibLobReb
LobLobRobRobLobRhbRebLcbLobLobLebRobLgbLibLsbLobLhbRebRobRsbLobRobRibR
obRibRobLcbLobRcbLsbLcbRebRebRcbRebLibLobLebLobLobLgbRibRgbRobRobLcbLo
bLcbLebLebLebLebRcbRgbRobLobRcbRobRobRobRobLgbRobRobLcbLobRhbRgbRobRob
LcbLobRcbLobLibRebLibRobLobLobLibRobRgbRsbLebRcbLjbLobRobRobLebLhbRebL
sbLobRjbRebRcbLobLebRcbRcbLcbLobLebRhbLebRobRobLgbRebRebRobLsbRobRsbRi
bRcbRobRobRsbLcbRobRebLebLebLebRobLcbLebLobRgbRebLebRebRcbRebRcbLibRob
RibRobRebRobRebRsbLobRsbRobLobRebRobLcbRibRobLgbLobLebRobLobLgbLsbRobR
cbRobLibLcbRgbLobRobRcbLcbRebRebRgbLobRobRebLgbRobLobLobRebRebRgbRhbLc
bLibLcbRobRibRgbRibRobRobRebLobRebRobRebRebRobRibLjbRobLobRcbRebRebLib
LobRebLobRebRobRibRibRibRcbRebLgbLobLebRcbLobLebLibRibLebLobLobLibLobL
cbRebLcbLobLcbLhbRgbLobLibRebLobLobRcbLobLebLebLsbRcbRcbRobLsbRobRobLi
bLobRobLobLobLobRgbLobRcbLobRibRibRcbLibRcbRobRobLobLebRcbRobLobLcbReb
LsbRobLobRobRibLebRobRobRcbLobRebRcbLcbLcbRobRcbLobRebLcbRobRobLgbRgbL
cbRhbRobLcbLebLcbLobLcbRcbLebLobRebLobRobLsbLobLcbRcbRebLobRgbLebLsbRc
bLcbRebRebRobLobLebRebLsbLobLcbLcbRobLobRebLcbRebLobRebLobLgbRibLibRcb
LobLobLebRsbRgbRebLobRcbRobRebRebLibLibRobLobRgbRobRibLebRebRgbRcbRcbR
obRebRobRebRebLebRobLobRobRobLebLobRcbRobLobLgbLobRcbRobRebLsbRobRobRi
bRcbRobRobLobRobLebLobLebLobLgbRcbLebLcbRobRgbRobLcbRobLobLobRcbRobLgb
LsbRobRcbRobLobRobLobLcbLobRibLibRobLebRgbLobLebRobRebRhbLobLcbLebLibR
ibLcbRsbLebRobRgbLobRcbLobLebLobLobLcbLebRibLobRebLcbLcbLgbRobLobRobLo
bLcbRgbRebLhbRobLgbLobLobRgbLobRebRebRcbRcbLobRibLgbRgbLebRobRebRobReb
RibLobRebRobRobLobLsbRcbRobRibLebLobLgbRobLcbRcbRobLobRcbRebLibLgbRhbL
ibRebLcbLebLobRibLobLhbLibLgbRebLobLebLobRcbLcbLobLobRsbRobLebRebRebLo
bRobLibLjbLobRgbLobRobLcbLibLebLibLcbRcbRhbRobLobLobRobLibLebRobRebLsb
RobLcbRcbRobLobLgbLcbLebLebLhbLibRobLobLobRcbLobLhbLobRobLobRhbLcbRobL
gbRobLobRobLebLobLobRcbRgbLsbLobRobLibLibLobLobRobLebRobRobRobLobLobLo
bRobLebLebLibRcbLobLebLjbLsbRebLgbRebLcbRobRebLebRebLebRebLcbRsbRebLcb
RebRcbLebRobRebRebRobRebRobRobRebLobRobRcbRobRebRsbLcbLebRobLhbLobLebR
obRobLgbRobLobRobRebRobLebLgbLcbLobRobLebLebRobRibLebLebLcbRobRobRebLi
bLgbLobLebRobLobLibLsbRobLebLcbRcbRobLgbLibLcbLobLcbLcbLebLobLcbRcbLob
LobLibLgbLgbRhbLcbLobLebLibRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRiLsLsmbRcbLibRiLsbLjbLcbLibLcbRgbLgbRgbLebLcbRsbLobRgbLibLgbLiLsbLsb
LiLsLsLsLsmmmbLgbLgbLsLsmbLgbRjbLgbRoLsbRobRebLsbLgbLsLsmbLgbLgbRsbLgb
LgbLgbLgbRcRsmbRibLcbLebsbLobRsbLibRsbLcbLiLsLsRsmbLsbLgbLsbLgbRcLsbRo
bLibLsbRhbLcbLjbLibRgbRibRobLibLcbLcbRjbRsbLobRsbLibRsbRibRhLsLsLsmmbR
sbLoRsbRgbLcbLhbRgbRibRibRcbLibLhbRsLsbRgbRiRsmbRobRsLsbsbLgbRobLjbLhb
RgbRobLjbLhbRcRobRsbLcbLibRcbLhbRgbLgbRsbRjbLcbLibLibLsbRcbLjbRoLsbLgb
LiRsbLjbRobLibLsbRibRoLsbRobLsbRobRibLgbLobRsbLibLiLsbRsbLsRsLsRsbLsRs
bRsbsbsbsbRsbRcbRobRsbLsLsmbRgbRcLsbLhbsbLebLob

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bLgbRsbLsbRsbLsbLsLgbLgbLgbLgbLgbRsbLgbLsbLgRsbLgbRjbLcRsbsbRsbLsbLgbL
gbRsbLsbLgbLgbLsLsmbLibRiLsbRsbLsbLgbLgbLgbLgbLsbLiRsbLibRsbLgbLgbLgLs
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bRsbLsbLgbLgbRjbsbLjbLsbLsbsbRjbRibLgbLgbLgbRjbRsbRgbRiLsbLjbRgbLsbLib
RcbLjbRcbLsbLsbLsbLsbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLjbLgRebLobRoLsbRobLsbRgbRgRsmbRsRsmbRgbRibRiLsbRibRjLsbLobRjLsbRgbRc
bRjLsLsmbRcbLjbRebLoLibLcbRcLsbRebLiLsbsbRsbRsbRebsbsbsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bsbRsbRsbRsbLsRsRsmbRsRsmbRgbRsRsRsmmbRgbRgbRsRsmbRsbRsRsmbRsbRsbRsbRs
bRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsbRsRsmbLsRsRsmbRsbRsRsRsmmbRsRsRsmmbR
sRsmbRsRsmbRsbRsbRsRsmbRgbRsRsmbRsbRsbRsRsmbRsRsmbRsRsmbRsbRsRsmbRsbRs
bRsbRsRsmbRsbRsbRsbRsbRsbLsRsbRsbRsbRsRsmbRsRsmbRsbRsRsmbsbRsbRsbRsbRs
bRsRsmbRsbRsRsRsmmbRsbRsbRsbRgLsbRsRsmbRsRsmbRsbRsbRsbLsbRsRsmbRsRsmbR
sRsmbRsRsmbsbRsRsRsmmbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRibLobRibLgbRjRsmbLebRebRoLsbRcbRjbLoRsbRgbRjbRoLsbLobRoLsbLjbLoRsbLc
bRibLhbRibRgbRgbLcbRobRiRsmbRsbRobRhbRibLsbLiRsbRgbLgRsbRsbRobRsRsmbRi
bRgRsmbLebRcbLobLibLgbRibsbLsbLibLibRoLsLsmbRjbRebRsbRsbRsbRobRobRjbRo
bRobsbRsbLjRsbLgbRsLsbRsRsmbLsLsmbRsbLsbLibLsbRgRsmbRsbLiRsbRibLgbRgbL
ib

>ZF Recording 2016-04-14; tW: 300s; Start: 131129; End: 131629;
Recording: 2-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLibLsRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRjbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRsRsmbRgbRsbRsbRgbRsLsLsmbLsbLsRsLsLsRsmbsbRsbLsbRsbRgRsmbRgbRsRsmbRs
RsmbRsRsmbRgLsbRsRsRsmmbRgbRgRsLsmbRsRsRsmmbRgRsRsmmbsbLsLsmbsbsbLsbLs
RsbRsRsmbsbsbsbRibsbRgbsbsbsbsbRsLsLsmbsbRsbRsRsmbRgRsRsmmbRsbRgbRgbRg
bRiRsmbRgRsmbRsbsbLsbRsbRsbRsRsmbRgbRgLsbsbsbRibRgbRgLsbRgbRcbLsbLgbRs
bsbLsbRsLsbLibLgbLsLgbLsbLsLsLsLsmmmbLgbLgLsbLgbLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bLsbLsbsbsbLsbLsbRsbsbsbsbsbLsbLgRsbLsLsLsLsLsmmmmbLgbsbsbsbLsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsRgRsmbRgbRgbLsRsbRsbRcRsmbLgbRsbsbRibRgbRgbLgRsbRsbLsbRibRsRsmbRsbR
gbRsRsmbRgbLsLsmbRgbRibRsRsmbLsLsmbRsRiRsmbRsbRsbRsbRgRsmbRgRsRsmmbRsR
sRsmmbRsLsbRsRsRsmmbLsbRsRsmbRsRsmbRsRsmbLsbRgbRgbRobLgbRobRcbRgbLsLsL
smmbsbsbLsbsbLsbLhLsbLsLgRsbLsbLsbLgbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bsbRsbRsbRsRsmbRibRibRsRsmbRgRsmbRhRsRsmmbRsRgbRgRsmbLsbRibRsbRsbRsbRg
bRsbRsbRgbRsbRsbRoRsmbRsbRsRsmbsbLibLgbLgbLgbLsbRsbRobRsRsRsmmbRgbLsbL
sbRsRsmbsbRsRsmbsbLsbLsbsbRsLsRsRsmbRsRsmbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsRsmbRsbLsbLsLsmbLgbLgbLgLsLsmbLiLsbLsbLgLsbLsLsmbLsLgbLsbLibLsLsmbL
sbLgbRoRsmbLsbLsbLsbLsbLsRsbLsbLgbLgbRsLsbLgbLgbLsbLsbLsbLgLsbLgbLsbLs
LsmbLgbLgLsbLsLgbLsbRsbLsbLsbRsbLsbLgLsLsmbLsbLsbLsbsbLgbLsbLgLsbLgbRs
bLsRsbLgbLsbLsLsmbLgbLsLsmbLsRsbLsLsmbLgbLsbLsbLsLsmbLgbLsRsbLsLsmbLsb
LgbLsbLsbLsbLsbLcbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLibLsbLsLsmbLcbLsbRsLsbLgbLebLgLsbLibLibLgbLiRsbLsbLcbRsRsRsmmbRsbLob
LcbRgbRsbRsbLibLsbLgbLsbsbsbRiLsbLsbLsbLsbLsbsbLgbRsbLsLsLsLsmmmbLcbLs
bRjbRebRibsbRsbLsbLebLhbRsbRobLsbRsbRgbRgbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 7; Drug: APO 0.5
bRgbLsLsmbLobLiRsbLgbLsbLsbRjbLjbRjbLjbLcbLibLgbLibLcRsRsmbRgbRjbRobsb
RhbLhbLsbRibLsbLgRsbReLsbRcbRgbRiLsRsbLsbLjbLibRobRsbRsbLgLsbRgbRgRsmb
RsbLjbLcbLiRsbRebRhbLjRsbRsLeLsbLhbRsbLhbLsbsbsbLjRsbLsbLsbRsbLsbLgbLc
bLobLiRsbLoRsbLgbLibLhRsbLjRsbLgbLsbRsbRcbRibRobLgbRsbLiLsbRcbRiLsbLsL
sRsmbRhLsLsmbsbRobLibLgbLibLsbLibRcbRiRsmbLjbLjbLiRsbLibLsbRsbRibRibLs
LibLibLcRsbRibLobRsbLibRsbLgLsbLgbLjbLgbRcbRcbsbRibLjbsbLcbLjLsmbRgbLi
bLgbLgbRsbLsbLsbLsbLobLcbLjbLiLsbRibLibRsbLhLsbLibRgbLgbLsbLoRsbRjbRcb
LcbLibLiRsbRcbRobRibRsbLsbRgbLsbLgbLobLiLsbLibLsbRjbLibLsbRcbRibRsLibL
sbRobLjLgbLgbLgbLsbRjbRcbRiLsbRsbLsbLibRsbRibRcbsbLgbRcbLsLsmbLsbRiRsm
bLjbLjRsbLjLgLsbLsLsmbLcbLcbLhbLjbLibLsbRsbLibRebRjbRsbLsbLibLcbLgbRjb
RcbRgbLgbLjbLibLjbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 8; Drug: APO 0.5
bRibsbsbRibRsbRgbLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 9; Drug: APO 0.5
bRobRibLsbRsbRcbRcbRcLsbRsRsmbRibRebRsbRcbRcbRsbRcbLcbRebLsbRibLcbLsbL
sbLibLcLsmbLibRcbRgLsbLgLsLsmbLibLebRsbRcbRcbLgbLibLibsbReLsbLsbLibLeb
LobLhbLgbLgLsLsmbLgLsbLebLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 10; Drug: APO 0.5
bLsbLibRjbLgbRhbRobRibRgbLibLsbRjbLibLgbRcbRibLibLsbRjRsmbRjRsmbLibRgb
RgbRgbLsbRgbRsbRsbRgbLsbRjbsbRibRsbRsRsmbLsbLsbLgbRibLibLibRhbRibRjbLj
bRibRhbRobRcbRibRgbLgbLsbRsbRjbRibRsbLjbRibRibRcbRibRibRgbLgbRsbLgbLjb
LjbRjbRhbRsbRcbRhbLibRgbLsLsmbLgbRsbRgbRgbRgbRsbLsbLjbLhbRjRsmbRjRsmbL
jbRibRgbRgbLsbRsbLjbLcbLjbRjbRjbRjbLjbRgbRjbRcbRibLibRibRsbLsbLgbLgbRs
bRgbLgbsbLjbRgbLibLjbRjbsbRhbLhbRjbLcbRsbRibRibRgbLjbRibRgbRcbLibLsbLs
bLsLsmbRgbRgbRibRgbLjbRibLjbLibRjbRibLjbRjbLcbLibLgbRjbRjbRgRsmbLjbReb
LgbLsRibRibLsbLibRsLiLsLsmbLgLsbLsLsmbLsbLibLibRgbRjbsbLgbRjbRcbRibRgb
LgbRgbLsbRibLsbLjbRgbRgbLjbLjbRibLibRjbLiRsbRsbLjbLgbLsbRjbRjbRjbLjbLc
bRgbLjbLobLjbLjLsmbLibLibRjbLibLsbRjbRhbLibRibRgRsRsmmbRsbLjbLjLsmbRib
LiLsbLgbLgLsbLgbLjbLcbLibLibRibRsbLjbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 11; Drug: APO 0.5
bLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 12; Drug: APO 0.5
bRsbRibsbRsbRsbRjbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRsRsmbRgbRsRsmbLebLjbLsbRsbRgbRsbsbsbRsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRsRsmbRgbRgbRgbsbRgbRsbRsbLsRsbRsbRsbRsbRsbLsbRsbRsRsmbLsRsbRgbRgbRsb
LsbsbsbLsbRgbRsbsbLsbLsbRsbRsbLsbLgRsbLsLsmbLsLsRsRsmmbLsbRsbLebLsLsmb
LsbLsLsmbLgbLsbRsbLsbRsbLsbRsbRsbRsbLsbLsbLsbRsbRsbRsbLsbRsbRsbRsbLsbL
sbRsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bRjbRgbLibLibRsbRjRsmbsbRsbsbsbsbLcbRobRsbRibLhbLjbLibLoLsmbLcbRcbLcbL
obRhbLgbLgbLibLibLebLcbLcbLibLhbRibLibRsbRibRhbLsLsmbLcbLcbLibLjLsmbLo
bLcbLsbsbLjbLgRsbLibLibLibRgbLcLsmbLsbLoRsbRibRgbLibLibLsbRgbRibLobLoL
smb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bRgbLsbRsbRsRsmbRsbRgbLsRsbRgbLgbLjbRgbsbRcRsmbLsbLsbRjRsmbRsbLsRsbRib
RgbRsbsbLsbLebLgbLsbLsbLsbsbLgbLgLsbLibLgbLgbLibLgbLgbLgbLgbsbsbRgbLgb
RsbRibRsbLebLcbLsbLsLsmbLgbLgbLibLib

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bsbLsbLsbLsbLsRsbLsbRjbLsbLsbLsbRsbRsbRsRsmbRsbLsRsbLsbLgRsRsmbRobRibs
bsbsbsbLsbsbsbsbsbRsLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRibLibLsbRgbLjbLibLsbLibRjbLibLgbLgbLgbLgbLgbLgLgRsbRsbLgbLgbLgbLgbLs
bsbLgbLsbLgbLgbRjbRibRobLgbRiLsbLsbLibLsbLgbRsbRibLjbRibLcbLibRobRibRj
bLobLsbLibRjbLsbLibRhbRgbsbsbsbsbsbsbRibLsLsmbLsRsbLcbLibRhbLsbLsLsmbR
jbRiLsbLsbLsbRobLgbRcLsRsLsbLibRibLgbRibLsbRibLibRiRsmbRhbLobRibLcbRsb
RebLibLsbRsbRhbRgbLjbLjbLibRcbRibLibRjbLcbRcLsbLgbLjbLiLsbRsbRjbLsbLgb
LsbLsbLgbLgbLgbLgLsbLsLsmbLgbLgLsbLgLsbLgbLgbRsbsbLgbRsbLsbLgbLsLsmbRs
bLgbLsLsLsmmbLgbLgbLgbLsLgbLgbLibLgRsbLsbLgbLsbLgbLgLsLsmbLsLsmbLibLgb
LgLsbLgbLgLsLgbLgbLgbsbLsLsmbLgbLsbLgRsLgLsbLgbLgLsbLsLsRsLsmbLsbLgbRj
bRhbRibLobRcbLibRsbRcbRhbLcbRibLsbRjbLjLsmbRhbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRebRsLsbRsRsmbRgbLsbsbLsbRsbLsbLsbLiLsbsbLibsbLgbLsRsbLgbRcLsbLgbLsbL
gbLgbLsbRgbLsRsbRsLsbRsbRibsbRiLsbRgRsmbRgbRsRsmbsbLebLcbRsbRsLsbLhLsb
LibLsRsbRsbLsbRgbRgbLsbRsbRgbRsbLsbLsbLsbLsbRsbRgbRgbRgRsmbRsbRsRgbRsb
sbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bLebLobLcbRebLgbRobLcbLobLebRobRebLobLebRibLobLebLebLgbRobLobRgbRebReb
RobRcbRibRebLobRobRobRobLcbLgbRobLebRobLobRebLebLebRobRsbLobLobRobLobL
cbRobRebLobRebRobRebRgbRebRibLebRobRibLobLobLsbLcbRobLobRebLobLebLobRc
bLebLebLibRgbLebLebLobRobLobRobRcbLhbLcbRobLobRobLobRobLsbLebLcbRcbReb
RcbLobLcbRcbRobLobRobRcbRobLibRobRebLebLibRhbRobRcbLcbRebRebLsbLobLhbL
cbRobRobRebRsbRobRgbRibRgbRobRcbRebLobRcbLcbLobRobLebLobLebLobLibRobLe
bRobRsbRibRgbLcbLobRibRobRcbRobRobRcbRibLobRobLobRobRobLsbRebRobRebLcb
LibLebLebRebRebRcbLobRobRobLobLobLobRcbLcbLcbLobLcbLobLobRgbRebLcbRobR
ebLgbRobRcbRjbRobRobRhbLobLsbLhbRebLobLgbLobLcbLibRobRobLobLcbRobLcbRe
bRcbLcbRobLsbRebRobRebLebRobRebRobRsbLobLobRobLcbRhbRobLebLcbRibRobRcb
RcbRebRebRcbRobLobLhbLobLcbLibRcbRobRobRibLcbLebRebLebRgbRcbRobRobRcbL
obLcbLebLibLobLcbLebLibRebLibLebRobLgbLobRjbRebRebLgbRobLobRgbLebRobLg
bRibRcbLebLibRobLobRobLcbLcbRobLebLebLcbRibLobRgbLobRebLgbRsbRebRgbLcb
LebLhbLobRcbRsbLcbRebRebLobRebLobRebLcbLgbRobRcbRobLebRobRcbLobRibRobL
ebRhbRhbLcbRobRgbLebRcbLobRcbLobLibLobLobLobRobRebRgbRibRobLobRjbLibLj
bRobRibRobLcbLebLcbRibLebRobRebRobRobLcbLebRebRcbRcbRobRobLcbLobLcbRcb
LobLibRobRsbLgbRobLobRebLibLobLcbLebRobRcbLobRobLobLgbLobRobRobRobLobL
obRcbLebRcbRcbRebRcbLebLgbLibRobLibRobRgbRobRgbLgbRebLibLgbLobLcbLobRc
bRebRcbLobRebRobRobRebLobRobRcbRgbRobLcbLobLibRcbRobLebLebLobRebRobRob
LcbRibRobLsbRobRobLcbLebRgbLobLobLobLcbLobLebRgbLsbRobRcbRobLibRhbRobR
sbLobRsbLobLcbLibRibLobRobRobLobLobRibLibRebLsbLgbRobLobRobRobLobLobLc
bLebLobLobLgbRibLcbRcbLsbRobLobRcbRibLcbLcbLobRcbLcbRebRobLobRebLcbRib
LebLibLebLcbLobLobLobRhbRobRibRibLobRsbRobLcbLgbRcbLhbLobLibLsbLobLobR
obRsbRebLsbRobLobRebLobRobLgbRsbLsbRcbRcbRibRobRobRhbLobRcbLebLcbRebRe
bRobLobRobLobRcbLobRobLcbLcbRobRobRebRobLcbRobLobLobRobRobRobRobLcbRob
RobLebLsbRebRgbLcbRobLcbLobRobLibLobLobRobRobLobRebLebLcbLobLcbRobLobR
obLobLobRebLcbRebLebLebLebLobLobLhbRebRebLobLebRobRobRobRcbLsbLibLgbRg
bRcbLsbLsbRebRobRobRcbRebLebRobRobLebRibLebRcbRibRcbLobRgbRobLobRobReb
LobRjbRobRibLobRsbRgbLjbRcbRobLobLobRcbLebRibLobLgbRgbRebRobRibLcbRcbR
obLobRebLebRobRobLcbRebLobLcbLobLobLobRobLobRgbRobLibRsbRobLobRgbRobLo
bRobRebRgbRobRebRebLebLobRebRobRjbRebRobRgbRobLgbLebLobRobLsbLebLcbLeb
LebRebRhbLcbRsbLebRobRobLcbRobRobRibLobLibLcbLsbRgbRobRobRcbLobLobLsbL
obRcbRobLibRebLobLebLebLebRhbLebRobLobRebLobRibRebRcbLebLobLobRcbRobRo
bLcbLebLobRcbRebLibRobLsbRobLobRebRibLcbRcbLobLsbLibRebRobRcbLebRsbReb
RobRebLsbRibLcbRgbLobLobLcbLcbRobLebRobRsbRobLcbLobRibRobRcbLgbRobLebR
obRebLcbLobLobLobRebRsbRcbRcbRobLebLgbLgbLebLobLcbRhbRibLcbRobLebRibRs
bLcbLjbLobLcbRobLobRsbRobRcbLsbLcbRobLhbLhbRcbRobRebLobRobRebLobRobRob
RobLcbRobRcbLgbRobRobRebLobRcbRebLebLebLibLsbRobRebRobRsbLibLobLobLcbL
ebLsbRsbRebRcbRebRcbRebRibRjbRsbLobRobRebRgbLebLobLsbLcbLobRsbLobRcbRo
bRebLebRobLobLobRgbLobLjbLobLjbLibLebRcbLgbRebLebLobLcbRobRjbRobRobLib

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bsbLgLsbLgLsLsmbLsLsmbLsbRsRsRsmmbRsbRgRsLsmbRgbRgRsmbRsRsmbRgbRsbRsbR
gRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLobRjbLjbRobRcbRebLobLcbRsbLjbLibRobRcbLsbRebLebRjbRjbLjbRobRebLobRob
LobLobLebLobRobRobLobLcbLebLobRebRobRobLobRjbRsbLobLobLobLobLobRobLsbR
jbLobRcbRebRcbLcbLobRebRcbRebRsbRobRobLobLjbLebRjbLobLjbLjbLjbLebLcbRs
bRcbLobLjbLobLobRobLebRobRcbLjbRjbLcbRobRjbRebRobRcbLebRobLobLebRobReb
RcbLebLjbLobLcbRsbLobRjbLcbRjbRcbRebLobRebRobRebLobLobRobLobLsbRsbRjbL
obLebLjbRcbLcbLebRobRobRjbLebLcbLcbLobRobRjbRobRjbLsbRgbLobRcbRobLobLo
bRobRobLobRebLsbRcbRebRobLebLcbRobRsbRebLobLsbLjbLgbLibLsbRobLjbRebLob
LobRobLobLcbRobLobRebRobLjbLcbRobRobLebRsbRobLebLobRcbRobLcbRjbRjbRjbR
jbLobLebRcbLcbLebRobLobRobLcbRibRgbLobRebLgbLobLcbRebLcbLobLobRobLebRo
bLebRebLebRibRobRobLobLibLobRobRobRibRobRcbLgbRibLobLsbRebLebLobRebRib
RobLobRobLobLebRobLibRebRebRcbLcbRobRibRgbLobRobRobRobLobRsbLhbRhbRibL
obRobRcbLcbRebLcbRobRobRcbRobRebLibLsbRebRobLcbRcbLibRebLgbLobRobLhbRe
bRebLcbLobRgbRgbLobRobLibRebLobRobLibLebLebRcbLebRobLsbRcbRibLobRobLgb
RcbRobLobRibRebRebRobRcbRobLobRebRobRobRobRobRebRgbLobLobLobRobLibLsbR
obRobRcbLcbLebLobRobRhbRibRgbRgbLobRibLobRebLjbLcbLgbLebRcbRobLobLobLh
bLebRobLebLobRibLgbRobRcbRhbRobRebRobRhbLobLebRgbLibRebLobLobRcbLobLgb
RobLobRebLobRebLsbRcbRobLobRgbRibRebRobLgbLobRebRcbRebRobRobRobLebRcbL
obRobRobLobRobLobLobRobRebRobRebRibLebLgbRcbRebRebLhbLebLebLebLobLobLi
bRobRcbRgbLebLobLebRobRobLobRobRsbRibLebLobLebRhbLebRobRobLobLobLobRsb
LebRcbLobRibRobRebRebRobRobRobRgbRcbRibRobRobLobRcbRobLobRobLcbLgbRgbR
cbLebRebLgbLobRibLsbLcbRhbRcbLcbRobRobRobRebLobRobRobRobRcbLobRebLcbRj
bRibLobRobRobRobRebRebRobRebLcbRobLcbLobLobRebLobRcbRhbLobLsbLobLcbLob
LobRobRobLebRcbLebLgbLobLcbRsbLobLobRcbLobLobLobRebRgbRobLgbRcbRobLebL
cbRebLobRcbLebRcbLibLobRobLcbRobRsbLcbLcbRebRgbLobRjbRebRobLobRebLobLe
bRgbRibRebRibLobLgbLcbLebRibRibRobRobLebRibLebRebRibLibLobRobLebLebLob
RebLcbRobRobRebLebLobRebLibLobRobLibRgbLobLobRebRcbRibLcbRobRgbLobRobL
gbRjbLebLobRebRobRibLobRebRcbRebRgbRgbLgbRebLobRcbLcbRsbLcbLobRcbLebLj
bLcbLcbRobRcbLgbLsbLobRobRobRobRobLobRobLebRobRobRobLibRebLgbRobLsbLcb
LebRobLgbRobLcbRobRobLobLsbLobRcbRobLebRobLobLobLebRibRcbRcbRobLcbLobL
ebRebLobLebRobLobRgbRebRebLhbRcbLobRobLgbLcbLgbLobLibLobLibLobRgbRhbRo
bRobLobLibRobLobLebLobRobRobRobRgbLcbRobLobLcbRebLsbRobLobLcbLobRjbLib
RebRcbLobRobRcbLsbLobLcbLjbRebRobLobLebLibLebLobLebRebLibLobLobLobLobL
ibLebRobLobRebLgbLobRobRsbLcbLobLebLcbLebRsbLobRibLobRcbRobRobRebRebLh
bLobRebRobRobLobLebLcbLobLobLsbLobRebRcbRjbLobLhbLgbLsbLebLgbLebRobLib
RcbRobRsbLcbLcbRcbRgbRcbRobRobLebLebRobLcbLhbLebLobRsbRobRobLobLcbRobL
ebLobRcbRcbLgbLobLsbRebRibLebRobLebRobLgbRibRebRcbLcbLobLsbRobLebRgbLc
bRebRgbLebLgbLobRobLobLobRobRjbRobLebLebLobLobLobLjbLobRcbLcbLobLobRob
LcbLsbRobLsbLobRcbLobLibLebLsbRobRebRebRebLibRobRcbLcbLobRsbLobLobLebR
cbRcbRibRobRcbRibRebRebLcbRobLhbLgbRgbRebRhbRibLcbLebLhbRcbRhbLebLebRe
bLobLobLobRcbLobLobRsbRebRebLebRobRobLebLobLibLebRobLobLobRebLibRobLsb
LibLobRibLebLebRobLebLebRgbRhbLebLobLebLsbRobRebLibRcbRgbLebLobRobLebR
ebRibLebLobLobLobRsbLobLibRobLebLobRibRcbLobLobLebRobLobRibRebLobLgbRg
bRobLobRsbLebRcbRhbRebLobLibRobLibLebRsbRebLobLobLsbRgbRobLgbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLgbLsbRsbRsbLgbLsLsmbLsLsLsLsmmmbLsLsmbLsbLsbLsbLsLsmbLsLsmbLgbLsRsbL
sbLsbLsRsbLsbLsbRsRsmbLsbLgbLsLsLsmmbLsbLgLsbLsLsmbLsbLsbLsbLsbLsbLsbL
sbLsbLsbLsbLsbLsLsmbLsLsmbLgbLgbLsbLgbLgRsbLgbRibLgbLsLsmbLgbLgbLgbRgb
RgbRsLsbRsbLsLsmbRsbLsbRsbRgRsmbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bsbsbsbsbRsbsbsbLsbsbsbsbLsbRsLsbRsLsbRsRsmbRsbRsRgLsbRsbRsRsmbRgbRsbR
sbRsRsmbRgbRsbRgbRsbRsbRgbRibRsbRgbRibRgbRsbRgRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bLsLsmbRgbRsbLsbsbsbsbLsRsbLsbLsLsmbsbLsRsbRsbRgbRsbRsRsmbRsbLsLsmbRsb
LsLsRsmbRsLsRsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLgbLgbRsbRgbRhbRgbRgbRgbLsbLcbRobRgbRgbLsLsmbsbRsLsbsbRsbsbRsbRobLiLs
bRsbRgRsRsmmbRsbRsbLibLeRsbRsbLobRibRgbRibLsbRobRsbRgbLcbRsbRibRebLsbR
ibLsbLobRjbLibRsRsLsmbLibLibLsbRebsbRgbRsbRgbRsbRsbRsRsmbRgbRgRsLsmbRg
bRsLsbRsbRgLsbLsbRebRhRsRsmmbRjbsbLibLcbLibRibRgbLhb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bsbLsbLsbLsLsmbLgbLsbLgbLgLsbRsbLgbLsbLsbLgbRgbRjbRgRsmbLobRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLgbLiLsbRsLsbLobLsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsLsmbLgbLgLsbLsLsmb
LsLsmbLsLsmbLgbLhLsLsmbLsbLsbLgbLgbLiLsLsmbLsbRsRsmbLgbLsbLsLsmbLsLsLs
mmbLsbLsbRsLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 31; Drug: APO 0.5
bRhbRhbsbRsRsRsmmbRsbsbLgRsbRjbLcbRebRiLsbLcbLsRsbLsbLobLsbLcbRsbRsbRs
bLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 32; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 34; Drug: APO 0.5
bLgbRjbLebsbRhbLibRiRsmbLsbLobRsLsbRibLibLcRsRsmbRibLhbLibRgbLsbLhbLsb
RebLhbLibLcbLibRiLsRsbLsbLsbLiLsbLsbsbsbLsLsmbLsLsLsLsRsmmmbLsbLsbsbLg
bLgRsbLgLsbLsbLsbLibLsbLiLsbRsbLsbRsbLgbLgbLgbRobLhbLhbsbLcRsRsmbLcbLi
LsbLibRcbRcRsmbLcbLibLcbRcbRhbLjRsbRgbLjbLibRgbLiRsbRcbLhbLgbLibRgbRjb
LcbLoRsbLgbLhRsbRsbsbRhbLgbRgbRgbLgbRsLcRsbLgbLibLibLsbRjLsbRoLsbLibLs
bRsbLiRsbLsbLibLsbLsbLgbLsLsmbLgLsbLibLsbLiRsbsbLiRsbRjbRjbRjLsbRjbLcb
LjbRgbRcbRcbLjbLhbLibRsbLobLcbLibLsLsmbLsbRsbLibLibRibLibRibLgbRibLsbL
hbLgRsbLibLgbRcbRcbRjbLibRsbLjbsbLcbLobRibLhbLgbLgbLgbLsbLsbLibRgbLibR
gbsbRjbLcbRjbRjbLcbLcbRjbLibLgLsbRibRibLcbRjbRhbRibLgbLsbLcbRhbLjbRibL
cbLiRsbRhbLibLhbRjbRsbRsbLcbRsbRgbLibLsbLgbRhRsmbLobRjbRibLeRsbLjbRhRs
mbLibLcbLcbLibLhbRhbLibRibLibLibLibRibRcbRibLhbLsbLibRsbLibLjbLhRsRsRs
mmbLjbLcLsRsLsmbLibLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 35; Drug: APO 0.5
bRsbRibLhbLsLsmbRgbRibLebRgRsRsmmbLsbLibRibRgLsbRcbLhbRjbLgbRjRsmbRiRs
mbRebRsbRcbRsbLebRoLsbRibRibLibRgbRgbRibLsbLcbsbLcbLhbLgbRgbRgbsbRibLi
bRgbRibRib

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 36; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsbLgbLsbLsRsbRsbsbLgbRsbRsRsRsmmbRsLsbLsbLsbLsbLsbRsbLsRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLsbsbsbLsLsmbLsLsmbRsLsbLgLsbRsRsLsmbLgbRsbLsbLsbRibRgRsmbRgbRsbLsLsL
smmbLsbRgbRibRibRgbRibLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLhRsRsmbRsLsbRgbRibRsbRgRsmbRsbRoRsmbLoRsbRsbLsbRcRsmbRobRiRsmbRjbRgb
RibsbRjbLcbRiRsmbRibRsbLsLsmbLobRsLsbRgRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bLoRsLsbLgbLgbLibLhbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRgbRobRibLebRobRobRebRobRibLcbLobLcbLcbRebRobLebLsbLobRebLebLebRebRob
LobLobRgbRcbRebRibLobLcbLebRobRcbLibLobLobLobRobRibRobLobRebRcbRibLhbR
cbRgbLibRobLobLebRobLobLhbLobLobLebLebLgbLibLgbLebLcbLcbLebLgbRobRsbLo
bLobLhbRebRebRobLibRgbRebRcbRgbLobRobRcbRebRcbRobRebLcbRobLobLebLebLeb
RobLobRsbLsbLibLobRobRibRgbLobLobLobRibLobRobRibRebRobRibRcbLobRibLebL
ebRsbRibLgbLebLgbRebLobRebRobLobLebRebRobRobLobLobRobRibLgbRebRgbRebLe
bLibRibLebLobRobRobLcbRcbRobRcbRcbRcbLcbRcbRobRibRebLobLobLhbLobLebRsb
LcbLobLgbRebRebLcbRobRgbLgbLgbLobLhbLobRobRobLcbLsbRebRibLobRobLebLobR
cbRebRobRobRobRobRobRsbLobLgbLibRgbLcbRebLsbRhbLebLobLebLebRobRobRcbRc
bLgbRobRcbLobRobRebRcbRcbLobRobLebLibRebLsbLcbLebRcbLcbRobLobRobRgbRob
LebRobRobRebLhbRobRobRhbRebLobRebRobLobRobRobLibLgbRebRebLebLebRcbLobR
obRebLebLebRsbLcbRobLobLibLobRcbRobLobRobRobLsbLebRobRcbRobRcbRsbRhbLo
bRobLobLibRobLobLobRibLobLobRobLebRobLcbRobLobLebLgbRsbLcbRobLobLgbRob
LibRobLsbLobLobLibLobLjbLobRobRgbLgbLebLebRobRcbLobLebRebLcbLibRhbLebR
obRebRobLebLobLobLebRobRgbRcbRebLsbLgbLebLebLobRebRobLcbLobLcbLgbLebRc
bLcbLobLebRobLebLebRgbLcbRobRibLcbLhbRsbLobRebRebLobRobLobLobLebRobReb
RobRobLobLebLebLcbRobLobRgbLsbLgbRhbRobRebRgbLobRobLgbRobRebLebRobRobL
ebLobLebLobLcbRobLibLebRobLjbRcbLobLebLobLsbLobRgbLobLebLebLibLobRsbRo
bLhbLebLebRobLobRobRibRobRobRobLebLebRobLgbLobRibLobRobLobLobRgbRobLeb
LebLebLibRobLebRcbRcbRebLobRebRebRsbLgbLcbLcbRcbLsbRebLobLebRebLcbRobR
hbLibLebRibLobRcbLcbRobLgbLgbLcbLcbRobLcbLobRibRhbRobRebRibRibLobRcbRo
bRobLibRibLobRebLobRsbLobRibRebLobLgbLhbLebRobRobRobRobRobLobRobRgbLcb
LobRgbRcbLcbLcbRibRhbRgbRebRebRsbLobRobRobLobLebLobLebLebRcbRcbRcbRgbR
ebRebRebLobRobLcbRibLobLobLsbLibRcbLcbLibLgbRcbRobLebLebRobRebLcbRebLo
bLcbRcbRibLebRobRibLobRobLebLebLobLobLcbLcbRcbRebRebLobRcbLgbRgbRibLob
LobLhbRobRcbLobRebLebLobLcbLcbRgbRsbRjbRobLcbLobRobRibLebLobRebRcbRgbL
ebRobRsbRebRcbLebRobLgbLgbLobLcbRobRsbRgbRgbLobRhbRcbRebRebRebRibRebRi
bRibRobRobRgbRibRobRobRcbLobRjbRebRobRibLcbLebLobRjbRobRobLebRebRobReb
LobRobLobRebRobLibLobRobRibRebRibRobRcbLgbLsbLibRgbLebRobRebLebLsbRobL
obRobRobRhbLibRobRebRebRebLobRsbRcbRgbLibLsbLobRibLcbRebLobRebRibRobLe
bRebLobLgbLcbRobRobRobRobRobLebRcbLobLobLhbRobLebRobLcbLobLobRsbRcbLob
RobRobLobRebLgbLgbRobRebLobLobLobLobLebRobLobRobRobLobLgbLobRebRibLobL
sbLobLebRhbLgbLebLobLobRobRobLebRebRobRobLsbRcbLhRebRebRebRebLcbLebRob
LobRobLebLobLibLcbLibRobLcbRibLobLobLebLebRcbLobRobLobRgbRebLebLcbRibR
hbLcbLcbLibRobRsbLobLobLcbRibLcbLobRebLibLgbRobRsbLibLsbLobRobLebLobRs
bLsbLgbLibLobLcbRebLobLcbLsbRobLebLobLibLobLebLcbLibLobLcbRebRcbLibLgb
LebRebRebLcbRgbRgbLibRhbRobLcbRobRobRcbLobLsbRsbLobLebRsbLebLibRobLobL
obRjbLcbLcbRcbRobRebRobLobLobLobRobRsbLebLsbLobLobRebLobLobRobRobLcbLc
bRobLebLcbLobRcbRobLibLibRhbRobRobRobRebRebRebLobLgbLobLobRcbRobRobRob
RcbLhbLcbRcbLibLobRobLobLgbRebLcbRcbRobRobRcbLgbLsbLobLobRobLibRibRebL
obLcbLsbRebLebRebRebRobRebLebRobRcbLgbRcbRebRobRgbRebLcbRibLgbRibRcbLo
bLcbRebLebRgbLcbLcbLobLcbLcbLobLgbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRibLiRsbRsbRsbRcbLjbLgbRcbLibLsbLsRobRsbLjbRobsbLjbRobLcbRibRgbRcLsRs
LsbLibLibLsbRcbLcbLjbLcbLiRibRgbLhbLibRobLobRoLsLsmbLgbLhbRsbLgbLobLib
RobLcbLobRibRgbLcRsbRcbLsbRoLsbRcbLibLsLsmbLjbRcbLibRjLsbRcbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbRsbsbRgbRsRsRsmmbRsbRsRsRsmmbRgbRgbsbsbLgbRsbLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bLcbLjbRgbRgbLjbsbRibLhbRcbLgbLgRsbLsbRjbRjbRgbLjbLsbLibRobRibLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bRobsbLsbLsbLsbLsRsbLsbLsbLsbLsbLsRsbLgbLsRsbLsbLsbLsRsbLsbLgbLsbLsLsm
bLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRsRsmbRsRsmbRsRsmbRsbRsRsmbLsRsbRsbRgbLsbRsbRsRsmbRsbRsbRsRsmbRsbLsbR
sbRsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsLsbLsRsRsmbRsRsmbRsbRsbR
gbRsbRsRsmbRsbRsbRsbRsLsbRsbRsbRgbRsRsmbRsbRsRsmbRsbRsbRsbsbRsRsmbRsbR
sRsmbRsRsmbRsRsmbRsRsmbRsbRsRsRsmmbRsRsmbRsbRsbRsbRsbRsbRsbRsRsmbLsRsb
RsbRsbLsRsbRsRsmbRsbRsRsRsmmbRsRsRsmmbRsbRsbRsbRsbRsRsmbRsRsmbRsbRsbRs
bRsbRsRsmbLsRsbRsbRsRsRsmmbRsbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsRsmbRsRsRsm
mbRsRsmbsbRsbRsRsmbRgbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsRsRsRsmmmbLsRsRsmbR
sRsmbRsRsmbRsRsmbRsbRsbRsbRsRsmbRsbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bLgbRgbLgbRgbLsbRsbRibLsbLsbRsbLsbLgbRsbRsLsbRsbLsbRsbRsbRsbLsbRsbRsbL
sbLsbRsbRsbRsbsbRsbLsbRebLobLibRhLsbLgbRoLsbLsRsbLgbRsLsbRhbLgLsLsmbsb
LobRgbRgRsmbLjbRobRsbLgbLoRsbRsbLsbRsbRgbRobRgLsbRcbRobLoRsbRsbLobRibR
ob

>ZF Recording 2016-04-14; tW: 300s; Start: 131631; End: 132132;
Recording: 3-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bsbLjbRibsbRsbLgbRsRsmbRsbLgbLsbLobsbLjbLsbLgbRsbLsbLsbRsbLcbLsbLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bLgRsbLgbLsLsmbLgbsbLgbLsRsbLsLsmbLgLsLsmbLsLgbLgLsbLibLsbLsLsmbLgLsLs
LsLsLsRsmmmmbLsLsLsmmbLgRsbLgbLsLgLsLsmbLgLsLsRsmbLsLgLsbLgbLgbLgLsLsm
bLgbLsbLgLsbRsLgLgRsbLgRsbLgbLibLibLgLsbRsRsmbLgbLsbLgLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bRibRebRebLobLsbRobRcbRobLobRcbRebLobLibLgbRibLobRobLobRcbLobRobRobRob
RobLobLebRebLobRebRcbLebLebRibRobLobLebLebRobLobLibRebLobLobRibLebRebL
gbRebLjbLobRobLobLcbRobRebRobLibRebLobRcbRcbRebRcbRobRibLobLobRobRibLo
bLcbRebLobLcbLcbRobLgbRobRobLibRebLobLobLibRobLobLebRobLcbLjbRgbRibRob
LobLcbLebLjbRhbRebLebRibRobLobLibRobRebRobRebRobLobRebLebLsbLobRebLcbR
jbRebLebRsbRebRebRebLobLebRcbRebRibLhbLhbLhbLobRobLibLobLcbRcbLobLibLg
bRibRebLgbRebRobLibLcbLcbLcbLcbRcbRcbLebLebLebLebRebRgbRgbRobLgbRebRib
RobLcbRebLebLebRobLcbRobLobLobLhbLebRebRcbLgbLobRobLibLobLsbLcbLebLcbR
ebLebLobRsbRebRobLcbRsbRcbRebLcbLobLcbLobLobRebRobLebLcbRsbRsbRsbLobLs
bRebRsbRebRobLobRsbLobRobLgbRobLebLobLebLcbRobLsbLebLgbRobRibLhbRobLeb
RobRobLgbRobLobRobRsbLobLibRcbLcbRcbRgbRobLobRebLobRebLcbLobLgbLebRobR
cbLobLebLebLgbLobRobRcbRcbRgbLobLobLobLobRebRobRebRobRebLgbRebLobLobRo
bLobRobRcbRobRobLjbRhbLsbLcbLsbRobRobLgbLebRcbLhbRobLcbRobLcbLhbRcbRob
RebLebLebLobRobRsbRobRebRobRobRebLobLebLhbRobRobRobLebLobLebRcbRebLjbR
obRobRobLebLobLobRibRibRobRobLibRcbRobRobLcbRibRibRibRebLibLebRibRebRo
bLsbRsbLebRebRebRcbLebLobLobRobRobRgbRobRobLobRcbRebRobLobLobLebRobLcb
RebRobLsbRcbRobRebLebLgbLebLobRebRcbLobRobRcbLobRebRobLhbRibLobRebRobR
obLobRcbRcbRcbRebLobLobRobLebRcbRebLhbLobLobRebLsbLebRobRobRcbLebLobRc
bLebRibLobRebRobLibRebRobLcbLcbLebLjbRsbRjbLobLebLsbLobLibRgbRcbLibLob
RobRobLcbLibRgbRebLebRebRjbLibRobLobLebLobLobRobLjbLebRebLsbRobRebLebR
obLobLobLobLebRobLobRobRsbRebRebRsbLjbLebRcbLebRobRebRobRcbLobRcbLebRe
bLibRcbLcbRobLobRgbLobRobRobLcbRobLcbRsbRebRibRebRobLcbRebRobLsbLobLib
LcbLsbRebRobLcbRebLjbLcbLobRobLobRcbLebLebRhbLsbLebLebRobLobLjbLibLebR
jbRebLsbRobRcbLcbLobRobLcbRebLobLcbLobRobLebLobRebRcbLcbRcbRebLobRcbRe
bLebLebRcbLobLobLebLobLcbLcbRebLebLibLsbRobLebLsbLobLjbRcbRobLebRcbRsb
RebLebRobLibRcbLsbLoRsbLsbRsbRobRobLebLsbLsbRjbLsbLjbRjbLsbRsbLsRsbLib
LgbLebLobRobRcbLcbRebRebLcbRhbLobLebLebLobLgbRibRebRcbLobRibRebRobLcbR
ebLebLebRebRobRebLebLobRobRobLobRsbRobRebLgbRobLobRibLobRobLgbLobLcbRo
bLebRebLebLcbRobRibRgbRcbRibLgbRsbRcbRebRobRebLjbRobRobRcbLebLibLobRsb
RobLebRobRobLebRebLibLobLcbLibRebRcbRcbLcbRibLobRsbRobLcbLsbRobLobLobR
jbRobRebLobLobRsbRobRebRebRgbRobLcbLobLibLobLjbRsbLobLgbRobLebLebLobRo
bRobLobRebLibRebLobLobRcbRobLobLobRcbRgbRobRobLcbRcbRobLgbRsbRebLebLcb
RobLsbRobRibLebLcbRcbRibRsbRcbRobRobRjbLobLibLobRobLsbLibLobRebLcbLobL
ibRobLobLibLobLebLebRebLcbRobLobLibRobLebLobRobRhbLcbRsbRcbRebRibLibRe
bRsbLebRcbRebLcbRcbRobRcbLcbLobRcbLcbLcbRebRobLcbRobRebLhbRobLsbLobLob
RobLobRsbLcbLcbRsbRebLobRobLobRsbLebRebLebRobLebLgbLobLobRcbRobRjbRibL
obRsbRobRgbRibLobLobLibLobLebLcbRobLhbRobLgbRhbRjbLsbRobRobRebRobLcbLh
bRobLsbRebLgbRebRobRobRcbLcbLobLibRcbRgbRobRgbRebRebRobLcbLcbLobLobRsb
LcbRobRgbLsbRebLebLcbRobRobLebRebLobLebRgbRebLobRobRgbLgbRgbLobLobRebL
jbLcbLcbLebRebLsbRibLebLobLcbRebRsbRsbLobRgbLobLebRjbRcbRgbRcbRebRobRg
bRobRebRebLebRobRgbLobRobLjbLhbRibRebRjbLobLgbRcbLsbLibRcbLobRcbRsbRib
RcbRobRjbLcbLcbLebLobRebRsbLebRibRobLobLobLcbRobLgbRobLobLibLsbRobLobR
obRebRobRjbLebLobRobRsbRjbRebRobLobRebRobLibRibLobRobLgbLjbRobLobLcbRe
bRobRebRhbRcbRobRcbLobLobLebLgbLjbRjbLebLhbLebLebLgbRobLibRgbLobLcbLob
RcbLobLcbRcbRobRebRebRibRobRobLibRsbLobLobRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsLsmbLobRsbRsbLsbRsbLsbRsbLgbLsLcbLgbLsbRebLibLgbLsbLgbRgbRcbRsbRgbR
gbLsRsRsmbRsRsRsmmbLsRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsRsbRsbLgbLsLsLsLsLsmmmmbLgRsbRoRsRsmmbRsRsmbRsRsmbRsRsmbRgbRgbRgbRs
bRoRsmbRsLsbLsRsLsbLsbRsbsbLsRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRibsbLsbsbLsLsRsmbLsLsmbLgLsbLgbLsbLgbLsLsLsmmbLsLsmbLgLsbLgbLgbLsbLs
LsmbLgbLsLsmbLgbLgbLgbLgbLsLsmbLgbLsbLgbLsbLgbLsbLsRsbLgbLgbRgbLsbLsLs
LsmmbLgLsbLsLsmbRsLgbLsLsmbLsbLgLsbLgbLgbLgbLsRsbLgbLsbLsbLgbLsbLsLsLs
mmbLgbLsbLjbLsRsbLgbLsbLgLsbsbLgLsbLsLsmbLsbLgLsbLsbLsbLsbLsLsmbLgbLgb
LsbLgbLgbLgbLgbLgRsbLsLsmbLibLsbLsbLsbLsbLsRsbLsLsmbLgLsbLsbLsLsmbLgbL
gbLsbLsLsmbRsbLgbLsbLgbLgbLsbLgbLgbLgRsbLsbLgbLgLsbLsbLsbLsbLgbLsLsmbL
gbLgLsbLsLsmbLgbLsbLsbLsbLsbLsbLgbLgbLsLsmbLsRsbLsbLgbLgRsbLsbLsbLsLsR
smbLgbLsbLgbLgbLgbLgLsbLsbLhLsbLiLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLsLsmbLsRsbRgbRsbRsbLsbRsbRsbRsbRsbLobLsbRebLcLsLsLsmmmbsbLibLsbRsbLg
bLsbLgbLsbRebsbLsbRsbsbLsbLgbLiLsbLsbLgbLsbLobRsbRsbLsbRsbLsbRsbRsRsmb
sbLsbRibRsbLobRsLsLsRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 7; Drug: APO 0.5
bLibLgbLgLsbRgbLiLsbLgbRobLjbLibRebRcbRibLibRsbRsbRgbRgbLsbRsbLjbLobRj
bLibRjbLgbLibLjbLhbRjbLjbRsRjbLobRjbLibRsbRsbLsbLsbRsbRsRcbRjbLibLgbLg
bLibLcbRgbRgbLsbLjbRobRcbLsbRjbLcbLhbRjbLibRobRiRsmbLjbRjbRgbLsbLibLgb
RibRsbLcbLjRsbRibLibsbLoRsLsbRiLsbRhbRsbLsbLgbLgbRsbLgbsbRebLjbRcbLgbR
jbRgbLsbRsbRsLsbLcLsmbRsbLibLgbLsbRjbLsbLhbsbLobLibRsbLcbRsbRsbLgbRgbL
hbLsbLjbRsbRsbRcbLjbLcbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 8; Drug: APO 0.5
bRsLsbsbsbRsbsbsbsbRibRsbLeRsbRgRsmbLhLsLsmbRibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 9; Drug: APO 0.5
bLeLsbRgbsbsbLgbRsbLibRhbLsbLibLjLibLcbRsbLhbRsbLcLsmbLcbRibLcbLcLsmbR
hbRiRsmbRibRiRsmbLcbLiLsbLgbRgbRgLsbRsbRsRsmbLebsbsbRibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 10; Drug: APO 0.5
bRjbLjbRjbRsbLjbLibRcbLibLibLgbLsbRobRjbRgbLgbLjbLibLsLsmbRjbRjLsbRgbL
jbRjbLsbRibLgbLjbLjbLsbLibRsbLgbRjbRcbLjbRjLsbRibLhbLibRjRgbLhbRsbLobL
sbLobLibLsbRsbRsbRjLsbRsbLgbRsbRsbLsbLgbRjbLibRhbLjbLjbRsRjbLibRibRcbR
gbLhbLebRgbLibRsRsmbLsbLibLgRsbLsbLobRgbRgLsbLgbRibLgbLgbRgbRsbRsLgbLs
bLgbLjbRibRgbLsbLobLibLjbRjbLjLsmbLsbRjbRjbRgbRgRsmbLjbRjbRgbRibRibLib
LcbLibRgbRsbLjbLgbRjbRibLjbLibLsbsbRjbLjbLcbLcbLgbRgbRsbLsbLibRsbLgbLs
bLgbRsbRcbRibLhbRjbLibRjRsmbLjbRibRgbLcbRhbRgbLjbLibRsLsbLgRsbRcbRebLi
bRjbLjbLibRebLgbLjbRjbLibLsbsbRibRgbRjbLsbRgbLsbRsbRgbRjbRcbRsRsRjmbRj
bRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 11; Drug: APO 0.5
bLobRobLcbRebLebRebRobLsbLobLobLobRgbRebRibLgbRobLcbRebLcbRgbRcbLobRob
LebRebRobLobLobLobLobLcbRobRebRcbLobRobRobRsbLcbRobRsbRgbLgbRobRcbLebR
ebRhbLcbRcbRjbLgbLobRobRibRcbLsbLsbRobLgbLobRgbRhbRobLobLsbRobRobLobLo
bRobRsbLobLebLebRsbLobLobLobLgbRobLobRobRcbRobLcbRobRebLebRebRobLibLob
RgbRobLebLhbLobRobRobLobLobRebRebLobLjbLobRobRibLobRcbLgbRobRhbLebRobR
obLobRebLobRobLebRobRcbLcbRcbLobLobLobRobRebRobRjbLobLibRcbLobLobLebLc
bLcbLobLobLobLobRobLobLebLsbLebLgbRobLobLobLcbRebRobLhbRgbRobLobLgbLob
LibLebLcbRebRobLcbLobRhbRebRcbRebLebLcbLgbLcbLebLibLobLobRgbLgbRobRobR
obLobLgbRgbRobLobRgbLebRobLcbRcbLcbLcbRebLcbRobLobRibLobRobLgbLcbRibRo
bRobLebLobRgbRobLsbRcbRgbRsbLobRhbLcbLebRobLobRebRgbRcbRobLebLobLcbLob
LcbRobRobLobRcbRobLobRcbRgbRibRibRobLhbRebRobLcbRobRobLobLcbRobLgbRibR
obLhbLobRobRobRgbLobLebRebLibRibLobLobRcbRebLobRobLobRcbLsbRebLobRobRo
bRebLhbRobRgbLcbLobRebLebRcbLobRebRobLgbLobLsbLobLcbLcbLibRobRsbLobRcb
LobLebLebRobLobRobRgbLobRebLcbLobRcbLsbLcbLgbLobRobLobRebRebRobLobRcbR
obRcbLsbLgbLobRgbRhbRcbLebRobLcbLcbLobRcbLebLobRobRhbLobRcbLibRobRobLg
bRsbRobLobRhbLebLebLobRobLobRobLobLcbRobLgbRsbRebLcbLcbLjbRgbLebLobRcb
RebLsbLebRibLcbLobRebRcbLcbRobRobLobLcbRobRobLobLobRobLibLcbLebLjbLebL
obLobRobRebLobRobRhbRobRobLobRobLobLgbLsbRobRobLobLobRebRsbRsbLhbRgbLo
bLibLobLobLebRebLobLebLcbRobRobRobLobRobRsbRobRcbLebLibLobRobRobLcbReb
LobRibLebRgbRobLebLobLobLobLobRsbRobLebLibLibRcbRobLjbLobLobRibLsbLobL
cbRebLibRebLobLobLobLcbLibRobRebLobRebLibRobRibRobRebLcbRsbLobLobRobLc
bLebLcbRobRebRebLcbLebRobLcbRsbRcbLgbRobRcbRsbLibRebRibLobLobRgbRcbRob
RebLcbLobLebRobRebLibLcbRhbRobLobRibLibLobRcbLobRebLebLcbRgbLobLibLebL
ebLgbRobRibLcbLobRebLhbRebRsbLebLcbLhbRobRibLcbRobRgbLgbLobLebRobLebLc
bRebLebLobRcbRcbRobLebRobRobLobRebRobLebLgbRobRebLgbLebRgbRobRgbLobLeb
RobLibLobRgbLcbLebLobRobLobRsbLgbRebRcbRobLobLibRebLibRobRcbRebLebLebR
obLebRcbLsbRebRobRgbLcbRcbRebLgbLsbLobRcbRobRobLhbRibLebLobRobRebRobRo
bRobRcbRobLcbLobLobRcbLibRebRebRebRcbRgbRsbRibLibRobLhbRgbRcbRobRobLsb
RobLgbLobLibRcbRgbLcbRobLobLobRibLobLebRobLebRebLobLebLobRebRobRobLebL
ebLebLibLebRobLebLsbRebRobRebLobRobRebRcbLobRobLebRebRobLebRgbLibRcbLe
bRebLobLebRcbLobLgbLobRobLebRgbRcbLobLebRobRcbRobLibLibRebLhbLibLcbLob
RobLobRcbRebRobLobLibLobLgbLgbRobLobLebLebLobLobRobLobLcbRobLobLobRobR
ibLobRebLobLobLebRobLhbRebLebRobLobLobLobRcbLobLebRobRobRsbLobLebRobLg
bLobRebRobRobLibRobLebRebRebRebLsbLobRobRcbLobLobLobLobRhbRebLcbRsbRgb
LebLsbRobLebLobLcbRebLcbRebRebRobLebRobRsbRibRgbRebRebRsbLcbLebRcbLobR
obRobLjbLsbLobRobRobRsbLobRcbRgbLobRobLebLobLobLobLgbRobLobLsbLobRibLe
bLebLebRobRjbLobLobLibLobLcbLobLobLobRebLebRibRgbLebRcbRcbRebRobLobReb
RcbLcbRjbLgbRcbLobRgbRebLobLobLobRjbRhbRgbLsbRhbLebLobRgbLobLsbLcbRobL
cbLjbLcbLcbLobLgbLgbLibRobLobRhbLobLebLobLsbRgbLhbLebLcbLobLsbLobRebRg
bLobRobLsbRgbRsbRsbLebLobLebRebLhbRgbLobRobLobRobLobRhbLebRobLobRobReb
LobLcbRebRobLobLobLobRebLobRgbLcbLobLobLebLobRobRhbRibLcbLobRobRobLobL
ebLobRebLobRobLebLebRebLobRobRgbRobLobLobLobLobLibLebLobLobLebRobRobLc
bRobLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 12; Drug: APO 0.5
bRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRsRsmbsbRgbRsbRsbLsRsbRsbRsbRsbLsbsbLgbLgbLsRsbRsbLibLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLsbRsbRsbLsRsbRsbLjbsbsbLjbRsbRsLsbRsbLoLsmbRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLibRibLsLsmbLsbLsbLgbRobLsbRsLsbLibLgLsbRibRsbLhbLjLgbLgbLhbRgbRgbLib
LgRsbLgRsbLiLsbLiLsbLgbsbLgbsbsbRsbRsbsbRsbLsbsbLsRsbsbLsbLsbLsbsbRsLs
bRsbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bRcbRibLsbsbsbsbRsbRsbsbsbLgbLsbLsbLsLsmbsbLeRsbRgbLgbLgbLsbLsbLsbRsRs
mbRibRsRsmbLcLsmbRsbLsLsRsmbLgbLgbLjbLobLsbRsbLjbLibRobRibRsRsRsmmbRsR
sRsmmbRgRsmbRgbLjbsbLgbLsbsbLsbRsLsbRgbRgbRgbLebsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRoRsLsmbLobLobLgbRsbsbRsbsbRgbsbsbsbsbsbRsRsmbsbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLsbLgbLgbLgLsbLgbRsbLgLsbLgbLgbRgbRibLjbLibLjbLibLgbRgLsLgLsbRhbLhbLg
bRcbRiLsbLobLobLobRhbLibRcbLhRsbRibLjbRsbRcbRjbRcbRhbLjbLcbRobRobRebLi
bRjbRcbLjbRibRoRsmbLgbRobRibRobLibRibRjbLcbRhLgbLsLsRsmbLoRsbLcbRsbLgb
RgbLsbRcbRjRsmbLcbLsbRibLjbRjbLibRsbRsbLsbRhbRibLsbRsbRgbLjbLibRjbLcbR
obRibLcbLsbRcLsbLgbRgbLjbLsbLsbLgLsbLgLsbLgbLgbLgbLgbLibRsbRgLsbLsbLib
LsbLibLsbLgbLgbLsbLgbLgbRsbLibRsbsbLiLsbRgLsbLsbLgbRsbLibRsbRjRjbLibRj
RsmbRibLgbLhbRebRjbRoRsmbLsRsbRiLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRsbLsLsmbRsbLsbRgbRgRsmbRgbLiRcLsbRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRgbRgbRiLsbLsbLgLsbLgbsbLsLsmbLgRsbLsbLsbLsbLgbLiLsbLiRsbLgbLsbRsbLsb
RsRsmbRsLsbRgbRsbRsRsmbLsLsmbRsbLsbsbRsbRsbRgRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRhbRcbRgbRcbRhbRibRibLcbRobRebLebRhbLobLcbLebRcbRebRebLibRgbLobLcbRib
LobRebRcbLebLebRgbRobRibRobRobRibRebRobRobLebLobLobLgbLebLgbLobRobLobR
ibLibLcbRobRobRcbRibLibLobLibRcbLcbLobRobRgbLobRcbLgbLobLgbLibLsbLebLo
bRobRobLobRgbLhbRcbRobRobLobLibLebRobRgbLcbLobRcbLobLobRobLobLcbLibLob
RcbLebRobRjbLsbLobRebRcbLebRobLobLobLobLebLobRobLebRobRjbRgbRobLobLobR
cbLobRebLcbLcbLjbRobLcbRobRgbLobLibRebRobLobLgbRobLcbLebLebRebRsbRhbLo
bRibRebRebLgbLgbRobLebRobRcbRobRgbLebLobRobLcbRobRebRobRcbLobRobRobLcb
RcbRobRibLobLobLobRsbLobRobLcbLebRobLobLobLsbRobRcbRebRobLobRjbLobRgbR
obRebLobRebLobRobRibLebLobLobLobRebRobLcbRsbLobLebRobLsbRobLebLobLcbRo
bLobLcbLibRcbRcbLgbLebRobRobRebRebRobLcbRgbLebLobLcbRobLebLebRebLobLob
RebRebRobRobLobRobRebLcbLobRibRcbRcbLebRebRebRobRjbLgbRibLobLebRobLobL
obRhbRgbLebRcbLebLobRobRcbLobLibRebLobLibRgbRobRebRcbLsbRobRobLobLobLo
bLhbLobRsbRebLobRcbLobRhbLebLibLjbLibLobLobLcbLjbLgbLcbLebLebLgbRobLcb
RibLcbRobRobRobLjbRobRobRobRobLcbRebRcbLebRobLebRobRcbLebRobRobRobLebR
ebLcbRhbLobRcbLcbLebRobRcbLgbRgbLobRebLobRibLobRobRgbLobRebLobRgbRobRc
bRobLobRgbLgbLcbLebLgbLcbRobLgbRsbRobLebRobLebLgbRsbRebLebRcbLobLebRib
LobLibRobRibRebRobRcbRobLobRgbRsbLobLebRibRebLcbRsbLobRibRebLobRobRobL
obLcbRebLobLobLobLobLobLobRobRebLobRobLcbRobLebLobLobLcbLobLobLcbRcbRo
bLebLcbRibLobLebRibRgbLobLgbLibRebRobRobLobRcbLebLcbRobRobRobRibLebRob
LobLebRobRobRcbRobLebRcbLebLcbRobRobLobLibRhbLhbLebRibLobLobRebRobRcbL
cbLobLebRsbLsbLobRobRebRobRobRgbRobRobRhbLsbRobRjbRebLcbRobLebRebRobLi
bLobRebRobRibRebLobLobLibRgbRcbRebRgbRcbRobRobLgbRobLobRcbRjbRobRcbLeb
LobLcbRobRobLobRebLjbRobLebLibLobLcbLobLibLcbLhbRobRobRebRobRsbRobLcbL
obLibLcbLebRobRcbRebLgbRebRobLobRobLobRsbLcbRebRcbLjbRobRobRobRcbLobRc
bRcbRobLcbLobLebLgbRcbRcbLobRgbLsbLebRgbRgbRebRebRebLcbRobLibRcbLebRib
RebLebRebLebRebRibLcbLebRebLobRcbLebRcbLcbRebLebRobLgbRobRobRibLcbRobR
cbLebLebLobRcbRobRcbLobRobRebLobLobLobLibRobRcbRebLebRobLebLcbLcbRebLo
bLibRcbRebRebLobRebLebLcbRobRobLobLcbLgbRsbRgbLcbRobLobRgbLibRibRcbLob
LgbLobRebRobRobLobRibRcbRobRibLebLhbRcbRobRebRebRobRebLsbRebLobRobLhbL
obLgbRobRsbLobRebLebLcbLobLcbRobRebLcbRcbLobLebLibRobLobRobRhbRobLobLc
bRobLebRcbRobLebLobRobRobRcbLgbLcbRebRobRsbLobLobRobRobLebRobLobRcbLsb
RobRobRobRcbLobLsbRobLcbLobRebLcbRobRgbLebRgbLobLobRcbRgbRsbRgbLobLebL
ibLobRgbRebRcbLebLobRcbLebLebRsbLobRjbRobRgbRebRebLgbRibLobRcbLobLobLo
bRobRhbRgbRcbRobRobLobRobRcbRgbRobLhbLobLgbRobRebRhbRsbRebLebRebRsbRob
RebRebLebLobRsbRgbRobRsbRibRcbLobLobRobRibRcbRebRobRobLsbLebRcbLhbRobL
obRebRcbRobRobLebRobRebLebLobLhbLobLobRcbLebLobLibLebRobRobLobLhbLcbRc
bLsbRgbLobRobLebLobRobLobLcbLobRibRcbLobRobLebRobLobRsbRobLebLebLobLcb
RobLobRebRsbLibLebRobLibLebRebRobLcbLcbLibLibRebLebLebRobLobLgbLobRcbL
jbLobRobLobRibLcbRibLobLebLcbLobLobLebRcbRobRebRcbRebLobRgbRebLebLobLe
bRobRebLebRobLobLebRhbLebLobLobRobLobLgbLobLcbLibRibRjbRebRobLibRobReb
RebRebRobLobLebRobLobLobLobRgbLobRebRobRobLobRcbRobRebLcbRebRebLebLebL
obLcbRobRebRebRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bRsbRsbLsbRsbLsbRsbRsRsmbRsRsmbRsbRsbRsbRgbRsbRsbsbRsbRsRsmbRsbRsbsbLs
LsmbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRobLobRcbLobLebLgbLcbLebLgbRobRebRibLobRcbRobRebLebLobRobLcbRebLobReb
RebRobRgbLcbRobLebRobLcbLobRobRibRobRcbLobLjbRobLcbRobLobRebLebRibRobR
obLobRobRobLibLcbRebLobRobLcbRcbRhbRobLebRobLobLebLobLobRebRebRobLhbRo
bLebLobLebLebRobLobRgbRcbLebRobLobLobLsbRobLcbLobRcbLobRebLebLobRobRob
RgbRobLcbLhbRobLgbRobRebRobLibRobLebLebLebRcbRjbRobLsbRibLebRebLobLobL
ebRibRcbRobRobRobRebRebLibRcbLcbRsbLibRobLsbRebRcbRcbRibRgbLcbRcbLcbLc
bRobRobRebLibLebRobLhbRobLobRobLobLgbRobRobRgbRsbRgbRebRobLobLobRcbLeb
RcbLsbRobLobLgbRsbLebLebRibRcbRsbRcbLobLebLebLcbLobRjbLobRobLebLcbRobL
cbLobRebLobRebLibRsbLcbRhbRgbRebLebLhbLebRobLobLgbRobLsbRcbLebRobRcbLo
bRibRebLcbRobRcbLobLgbLebRibRebLcbRobLobLgbRobLobLobRobRobRgbLgbRobRob
LobRgbRhbLebLobRcbRobLcbRebLobRebRibLibLobLobRcbRebLsbRsbLebRibRobRebL
obRcbRcbLobLcbLcbRgbRobLcbRgbRhbLhbRobRibRobLobRobLobRgbLobLobRebLcbLo
bRobLebRobRobRibRcbLjbRobLibRobLjbLobRobLobLobRsbLibRobLebRobRobRibLcb
LobRebRebLcbLobLobLebLebRcbRjbLgbLobLsbRhbRebRobLsbLobRobRebRcbRjbRobR
ebRobLhbLsbRobRibLebRebRebRobRgbRobLgbLebRobLobRobLobRobRobLobRobRgbLo
bRobLobLebLobLobLgbRibRsbLebLebLebLcbRobLebRobLobLebRcbRobLobLebLobLhb
RebRcbLobRobRgbLobRobRsbLibRibRcbLibLobLobLobRobLobRcbLebLebLcbLcbLobL
cbLcbLgbRcbRobRcbRebLobLobRobLibRobLcbLebRebRebLebLgbLobRhbLgbRcbRebLo
bLebLibLebLhbRcbRcbLobLebLebRsbRcbRebLcbLcbRebLgbLibLgbLgbLibRcbRcbReb
RebLsbRibRobLcbLcbRsbRebLcbLebRibRsbLobRobLcbLebLebLgbRibRobRobLobRcbL
obRobLibLsbRebLobLcbRjbRebLibRobRebLhbLobRobRibLsbRobLgbRebRcbRobLgbRo
bRcbRobLebRobRcbRcbLebLobLobLobLobLibLobLebRibLsbRcbLebLobRobLobRcbRob
RobLcbLebRcbRobLobRgbRebLobLibRobLgbLobLobLcbLibRobLebLhbRsbLobLcbRebL
ebRobRobRsbLebRobRcbRebRgbLcbLebRgbRgbRebRobLebRobLobRobLgbRobRibLobLo
bLobRobRcbRobLobRsbLebLcbLgbRcbLobRcbRobRcbLobRcbLobRibRobLobRebRcbLeb
RsbLgbLobRcbLobLobLcbRibLobRcbLobLebLebLebLebLobRobRcbLibRibRebLcbLhbR
ibRgbRobRhbLobLobLobRobLsbLobLobRobRebLebLobRebLobRebLgbRgbRgbRebRcbRe
bRobLobLobRjbLcbRebLobRobLibRobRobRcbRobRcbRobRebLgbLebRebLgbRobRcbRob
LobLsbRobRcbLobLobRobRobRebLebLibRobLebLobRobLobRobLobRobRobLebRobLobR
cbLobRgbLobLobRcbLebLobRebRobLobLibRebRobRobRibLcbLibRcbRobLebRobRobRo
bLobLgbRobRebRobRsbRobLebRcbRgbLobRjbLobLobRsbRsbLobRcbLebLobLgbLobRib
LsbLebLobRcbLcbRobLhbLhbLgbRobRcbLobRobLsbLcbRebRobRebRcbLobLhbLhbLobR
cbLgbRebRobRjbLobRibLobLcbLobLibLcbRebRjbRobRobLjbRibLobLebRibRebLebRo
bRebLhbLebLebRobRobRebLobRobLebRebLobLgbLibRcbRobLobLobLobLobRsbRebLeb
LobRobLgbLobRobRebLobLcbLsbRebLgbRobLibLcbRobRebRobLebLebLibRobRibRobR
obRjbLcbLobLobRobRgbRibRhbRcbRebLobRobRcbRebLgbRgbLcbRcbRobLobLebLobRe
bRebRgbLsbLsbRobRobLgbLibRsbLcbRebRcbLebRobRobRebLibRebRobRgbRsbLibLeb
RebRebLebRhbLcbLobRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRgbLcbRsLsbLoRsbRoRsmbsbsbsbsbsbsbRobRjLsbsbsbRsLsbRsbRsRsmbRsbRsbLsR
sbLsbLsLsmbRsbRsbRsbRsbRibLsbsbRsRsmbRgbRsbLsLsmbRsbRsbRsbRsRsRsmmbRsR
sRsmmbRsbRsRsmbRsbRsRsmbRsbLgbsbsbRsRsmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bLsRsbRsbsbRsRsmbRgRsmbRgbRgbsbRsbLsRsRsmbsbRgRsmbRsbRsLsbRsRsmbRsbRsb
RsbRsbRgRsmbRsbRsbLsbRsbLsLsmbLsLsmbLsLsRsmbLsLsLsmmbLsbRsRgRsmbRsRsmb
LsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLcbRgbLibRsbRobLgRsbRgbRgbRgbRgbLcbLhbRobLoRsbLgbRsbRibRgbRgRsmbRgbRs
bRgbLobRobRibRgbRsbRsbRgbLsbRgbRsRgbRgbRgbRgbRgbRgRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLobRobRgbRhbLebLebRebRobRobLjbRobRgbLebLcbRobLebRobLsbRobLobLcbLobRcb
RcbRhbLobRobLobLsbRhbRhbLibRobLobRsbRobRebLgbRobRcbRobLebRobLobLobRobL
cbLobLebLsbLobRobLobLobRgbLcbLgbRsbRgbLcbLobRobLobLobRsbRhbRobRobLobRo
bLebLobLobLibLsbLobLcbLebLobLibRobRobRobLebLobRobLcbLobLcbLebLebLcbRib
RcbRcbLobLobRebLobLobRebLobRebRobLobLsbLobRgbRobRebRebLobLebLcbRobLebR
obLebRebRobLobLobLebLebLcbRcbLgbLhbLobRebRobRobRebRebRobLobRobRjbRcbRc
bRebLobLcbRgbLgbLjbRobLobLobLobRcbLebLobLcbLcbLcbRobRsbLsbRsbRcbRobLob
RobRsbRebRcbRebRobLebLcbRebLebLebLibRcbLobRebRebRobLebRebLsRsbRsbLsbLs
RsbLsRsLsbLsRsbLsRsbLsbLsbsbLsbLsRsbLsRsbLsbLsbLsLsmbLsbRsbLsbRsbRsbRs
bLsbRsbLoRsLgbLhbRobLobLobRobLgbLobLebRcbLebLobRgbRobRcbLobRcbRibRibLo
bRobRobRobLobLebLobLcbLobLobRebRobLcbRobLobRsbLobRobLgbLgbRebRebRgbLob
RcbRcbLebLebRebRcbRobLcbLobRebRcbRsbLebLobLebRibLgbLsbRcbLibRibLobLobR
obRsbLcbLebLebLobLcbLcbLsbRibRobRcbRibLebLjbRebRobRgbLebRebRcbRobRcbLe
bRebLobRebLgbRsbRcbLebRgbRsbLibLobLobLebRobLcbLebRcbLibRgbRobLgbRsbRsb
RobRobRebRcbRcbRobRebLobLobRobLsbRcbLobRobRgbLgbLobRobRsbLsbRcbRobRobR
obLobLobRobRobRcbLebRobRebRobRebLsbRcbRcbRebRobLobLobRsbLobRcbLebLibLe
bRobLobRobRobRcbLebRcbRebRobLobLobRobRobRobLobRebLebRebLibRobRcbLjbRib
RcbRgbRobLebLsbRobLibRebLobRobRibLsbLobRobLobLobLibLobLebRgbLcbLcbLobR
obLobLebRobLebLsbLobRebRsbRsbRgbRobRebLebLobLobRebLobLobRobRgbRobLobRe
bLobLobRcbLobRobRobRgbRobLobRebLibLgbRcbRobRobLibLgbLobRobLobLobRobRob
LebRcbRibLobRebRobRibRobLobRebLobRebRcbRobRebRcbRobLsbRcbRgbRobLcbRibL
obLobRobRobRebLgbLsbLebRebLebLcbLibLobRcbLebLebLgbLebRebLobLibLebRgbRo
bRebRcbLobLibRobRobRebRgbRcbRcbLsbLoRsbLsLsLsRsmmbLsbLsLsRsmbRsbLsbLsR
sbsbLsLsmbLsbLsLsmbsbRsbRsbLsRsbRsbRsLsbRsLsRsLsLsLsmmbRsRsmbLsLsmbLob
LsbLobLsbLsbLebLsbLsbRebLebRebLobRobLsbRgbRobLgbRebLsbLebLjbLebRobRobR
jbRebLobLebLobLobLebRsbRobLibRgbRobLgbLobRebLgbRebLobLcbRibLibRobRebLs
bLobRobLobRebRebLobLsbLcbRgbRobRobRobRobLcbLobRgbRebRebLebRebRcbLobLeb
LebLibLibRgbLobLcbLobRibRobLsbLcbLobRobLebRcbRobLobRcbLebRgbLebRgbRcbL
obRcbRobRcbRobRobLibRsbRhbRjbLebRobRcbRcbRibLcbLobLsbLobRibRobLobLobLc
bRobLobRobLobLsbRcbLcbLsbLcbRobRobLsbRobLebLobRcbLibRebLobLobLobRobRob
RcbLobLcbLcbRobLobLsbRhbRobLibLibRgbRobLobRebRcbLobRgbLobLobRobLgbRobR
obLebRcbLobLcbLebRsbLobLibLebLebRobRobLebLgbRcbLebLhbLobRobRobLcbLebLg
bLebRhbLhbLebRebRobLobLebLcbLobRcbLobRsbLhbRobRibLobRobLgbLhbLebRcbRob
RcbRobLobLibRebLsbRobRobRebRobRobRsbRobRsbRobRibRobRebLsbRobLobLobLgbR
obLcbLobLobLobLebLobLobRobLcbRobRobLibRobRebRobRcbLcbLsbLobLobLgbLsbRi
bRobRcbLebRibRebLebRsbRebRgbRebRibLobRcbLsbLcbRcbRsbLebLobLobLsbRibRsb
LobRobLhbRebRhbRibLcbLibRobRcbRcbLobLgbLobRobLebRebRobRcbLobLobRobLsbR
cbRebLobRhbLebRobRcbLsbRgbRobRebRobRebRibRobRibRobRobRobLsbLcbLobRobLo
bLobRebRoLgbRobLsbLcbLjbRobLebRsbLcbLebRgbRcbLsbRobLcbLobRcbRcbLibLobL
ibLobLobRobRobRobLobLibLebRobRobLobLobLgbRgbRebRobRebRsbLebRgbLobLebLi
bLobRhbLobRgbRobRsbRsbRobRebLebLcbLibRcbLebLobLebLebLobRcbLebLobLobRob
RgbLebRcbRgbRebLebRebRsbRobLebRebRebLobRsbLgbLibRibRobLibRebLcbRobLgbR
cbLsbRibRjbRobLebLebRobLsbRgbRobLobLebRobLgbLebLobLebLebLibLcbLobLobRh
bRcbLsbLebLobLebLebLcbRgbRcbLcbRobRobLcbLobLcbLebRebRcbLebRgbLobRebLib
LobLsbLsbLobRobLobRobLobRebLjbLjbLebLobRobRcbRobRcbLgbLebLcbLebLebRobR
cbLcbLgbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bRiRsmbRibLsbLsbLsbRobRebRsbRsbLsbLsbLsbLibRebLebRcbLsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLsLsmbLsRsLsLsmbLgLsLgLsRsbLgLsbLibLsLsmbRsbLibLgbLsbLgbRoLsbLsbLsbLs
bLsLsmbLgLsbLgbLsbRsbLgLsbLgbLsbLsbRsbLgbRsbLsRsbLsbRsLgLsbLsLsLsmmbLs
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 31; Drug: APO 0.5
bsbLsRsbsbLsbLsbRsbLsRsbRsbLsbLsLsmbRsbLsRsLsbLsbRsbLsbLsbLsRsRsmbLsbR
sRsmbLsRsbRgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 32; Drug: APO 0.5
bLsbLjbLobRebRebLcbLibLjbLjbLebLjbLebRebRobLebLobRcbLsbRjbRobLobLobLob
LsbRebRebRobRebRobLobLobLebRebLcbRobRebLgbLsbRsbLcbRobLebLebLhbLcbRebL
ebLobRjbRjbRobLcbRebRebLobLcbLsbRobLobLebRebLcbRcbRcbRobLebLibRhbRobLo
bLibLobRebLebRebLobLgbLobRcbLebRobLobRgbLobRebRcbRobLobLgbLobRobRobRib
LsbLebRcbLobLcbLcbRhbLobRobLsbLcbLobLobLgbRobLcbRgbLcbLgbRobLobRsbLgbL
obLibRebRobRobRcbRobLobLebLobRebRibLobLobRibLcbRebLgbRcbLhbLibRcbLcbLo
bRhbRebRebRobRobLebLibRebRobRebRobLebLobLibRibLobRebLobRebLsbRebLgbRob
LebLcbLobLobRhbLobLobRebRibRcbLobLgbRobLgbRsbLobLebRobRsbLobRgbLobRobL
obRobLebLobLobRcbRcbLcbRibLibLcbLobLebRobRebLobLgbRobRibLebRcbLcbRobLe
bLebLobLcbRobLcbRobLebRobRobRgbRibRobRebRcbRhbRgbRobRobLcbLobLsbLobRob
RibRibLibLobLobLgbRebRcbRobRobLcbLibRobRobRhbRsbLcbLobRobRebLsbLcbLcbR
obRgbLobLcbRcbRobLebRobLebRcbLcbLebLebLebLhbRebLcbRcbRcbRobLcbRgbRobRc
bLobRgbLsbLsbRobLobLobLobLebLibLgbRibRobLsbRgbLobRobRobLobLobRcbRcbLsb
LobRobLebLsbLsbLgbRcbLobLsbRibLobRebLobLgbLibRebRobRobRibLebLobLobRibR
obLebRcbLobRobLobLibRobRobLobRobRobLobRobRgbLgbRgbRobRebLobRgbLobLebLc
bRobLobRcbLcbRobRebRibLcbLobRobLobRobRobLobRcbRebRebRcbLgbRibRebLobRcb
RcbRobRobRobLobLebLebRobRobRobLobLobRsbLobRobLcbLobRgbRibRcbRcbLobLcbR
obLobRsbLcbRibRobRcbLcbRgbLobRobRcbRebLobRcbLebRebRcbLobLibLgbLebRebLc
bLobLgbRgbLibLobLibRobLsbRebRhbLsbLebRobRsbRibLebLobLebLobLebRebLibReb
LobRebLjbRobLcbRebRobRcbRobLgbLobLobLcbLobLobLobRobRobRebLcbRcbLebRebR
ebRcbLebLebLcbLcbLcbLibRjbRobRcbLobLobRobRebLobRcbRcbRobRobRobLobLobLh
bRobRobRebLgbRobLebLebRobLebRobLobLgbLobRebLobRobRobRebLobLcbLobLgbLgb
LibLgbLobLobRcbRebLobRcbRgbRobLcbRcbRgbRebRcbLgbLibRobRgbLebLobLibRebR
obRhbRebRobRebRibRobLebLobRcbRobRobRcbLebRebRobRhbLibRsbRcbLibLobRcbRo
bRobRobLobRibRobLibRobRibRobLobLebLobRgbRcbLobLcbLgbRebLsbLebLcbRgbLob
RebLobRcbRebRobLcbLebRobLgbLobLebLebLobLsbRibLebRobLibLgbRhbRobLcbRcbR
hbRobLebLcbRebLhbLobLsbLobLobRibRcbLgbRebRcbLebLcbRgbRcbLhbRobRobLobRc
bRebLebRobRobRobRsbLgbLebLcbRcbLgbRibRgbLobLebLobRobRsbLibRcbLibLibLeb
LebRcbRcbLobRobLcbLebLebRcbLcbRcbRgbRcbRcbLgbLcbRebRibRebRobRobLibLcbL
ebLobRgbLobLobLibRobRcbRsbRobLebRobRcbLcbRobRobRibLsbRcbLobRcbRibLcbLo
bRhbRobLcbLibLibRebRgbRobRobLebRhbRobLebLibLgbLobRcbRobRgbRobLcbLgbLeb
LobRhbRobRcbRcbLibRobLobLebRobLcbRobLsbRibLobRobLebRsbLcbRobRcbRobRobL
gbLgbRobRcbLibLobLebLebLobLhbRebRobLebRsbLobRobRebLobLgbLebRobRcbLobRo
bLebRsbRobRcbLebRcbRcbRebRibLobLobLebLcbRcbLibRobLebLgbRebLebRebLobLcb
LgbRhbLobLobRcbLgbRsbLebRsbLcbLsbLobRcbRhbLhbRebRobRobRibRebRhbRebLsbL
obRobLcbLobRobLsbLobLobRcbLsbLobRobRcbLcbLcbLebLhbLcbLhbRebRobRobLsbLi
bRebRgbLobRcbRobLsbRibLcbRcbLobRobLobRebLobRibRcbRobLgbRobLobLobRobRsb
LebLhbLobRobLibRebRebLibRebRebLibLebLobLcbLobRebRobRebLobRcbRobRcbRhbL
obLgbLebRobRobRobRibLobLgbLobLcbRcbLsbLcbRcbLobRebRcbLcbLebRobRgbRibLo
bLibRebLebRobRobLobLobRebLobLobLobRobRcbLobLobLebLobRgbRibRobRibRobLob
LobRebLobLcbRgbLcbRobLsbRebLsbRobLobRebLsbLebLobRcbLgbLobLcbLcbRhbRobL
cbLobLobRgbLebLcbRcbLcbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 33; Drug: APO 0.5
bsbsbsbsbsbLobRobLebLgbLsRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 34; Drug: APO 0.5
bLcbLsbRsbLibLjbLibsbLsbRcbLibLjbRjbRjbLibLgbLhbRhbLibLibLgRsbLcbLibLi
bLhRsbLgbRjbRebLobLjbRibLcbLgbLsbLibLgbLjbLibLgbLibLhbLsbLobLhbLsbLjRs
bLgbRobRibLcbLobLibRjbRcbLcbLhbRsRsmbLcbLcRsbLibLsbLibLibLgbLiRsbLgbLi
bLibLsbLcbLjbRobLhbLibRgbLcbLgbsbLcbLgbLcbLiRsbLcbLhbRhbRgbLcbRgbRjbLg
bLjbRibRjbLcbRgbRebRobLjbLjbLsLsLcmbRgbRjbRjbRcbLcbLjbRobLobLobLcbRcbR
obsbRsbLhbsbLhbLiLsbLcRsbLiLsbLjbLibLgbLgbRjbLhbsbLhLsbRcbRibLjLsmbsbL
hbLjbLebLgLsLsmbsbLgbLjLsmbRibRjLsbRhbLcbRgbLjbsbRjbLjbRjbRcbRgbLibLjb
RcRsLsmbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 35; Drug: APO 0.5
bLiLsbRibReRsmbRibLsbLsbsbRcRsmbLsbRibRsbRgbRibLgbRibLgbLgLsbLebLhLsbL
gbRibRhbRgLsbRsbRgbLsbRsbRiRsmbRgbRiRsmbLsLsmbReRsmbLsLsmbRiRgbLsbLibR
iRsmbRibRibLcbRgbRsbRibLsbRiRsmbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 36; Drug: APO 0.5
bLjLsmbRhRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLiLsLsmbRsbRsbRgbRsbRsbRgbRsbLsbLsbRsRsmbRsRsRsRsmmmbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bsbRgbRgbRgbLgbRgbRsbLsbRgbLsbRsRsmbRgbRsRsmbRcbRgbRgbLsbLsbLsbRgbRgbs
bLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bsbsbRgbRgbRsbLsbLsRsbsbRsRsLsLsmmbRsRgbRjbRjbLobRibsbRibLhbLebLobLgbL
ibRsbRsbReRsLgmbRcbRsbRobRibLsbLsbLsbLsbLhRsbRjbLsbRobRsbRibLsbLibRsbL
oRsbRibRibRjbRiRsmbRjbRcbLsbRgbLgbRcLsbRjRsmbRhbsbRgbRgbRibRib

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsbLsbLgbRoRsmbLhb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRobRsbRsbRsbRsbRsbRsRsmbRgbRsbRsRsmbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRcbLcbRjbLcbRsbRhbLcbLgLsbRoLsbLjbLcbLcbsbRoLsbLcbRsbRcRsLsmbLibLoRsb
LiRsLsLsmbLgRsbLsbsbLsLsmbLgbLiLsbLcRsbLibLibLcLsRsmbsbLgbLibLobLoRsbR
gbLibRsRsmbLcbLjbLsbLsLsmbRobLibLibLsbLsLsmbRjbLibRobLobLobLhbLibRibRi
bLibRgbRgbRgbRibRobLgbLcRsbLgbLgbRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bLgbsbLsbLgbLsbLsbLgbLsbLgbLsbLsLsmbLgbLsLsmbLgbLsbLsLsLsmmbsbLsbsbLgb
LgbLsbsbsbsbsbRsbsbLsbRsbRsbRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bLibRgbRiRsmbRgbLsbLibRibLcbRobLsbsbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLsbLsbLsLsmbsbLsbLsbLsbLsLsLsLsmmmbLsbLsbLsLsLsmmbLsLsmbLsLsmbLsbLsLs
mbLsbLsLsmbLsbLsLsLsmmbLsbLsbsbsbLsbRsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRgbLsRsbRsbRgLsbLsRsbLsbRsbRgbRsbRsRsmbRsbRsbRsRsmbRgbReRsmbRsRsmbRsR
smbRsLsbRsRsmbRsbLibRebRgbRsbLibLsLjbLsbLgbLsbLsbLsRsbLsLsmbLsbLsLsLsm
mbLsLsmbLsbRsbRebRjbLjbLsbLsLsmbLsLsmbLsLsLsmmbLsbLsLsLsmmbLgbLsbLsLsm
bsbLsLsmbLsbLsbsbLsLsmbLgbLsbLsbLsbLsbLsbsbRsRsmbLsLsRsmbLsbLsbLsLsmbL
sbLsbLsbLsLsLsmmbLsLsmbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsLsmbLsbLs
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRjbLobRgbRhbRsbRibRgbRgbRgbLjbLobRsbLobRsbLsbRsRsmbRobLibRibRsLsbRobR
obRsbLhbRibRibLgbRhbRgbLjbLcbLobLobRcbRjbRibLjbRiRsmbRebRoLsbLjbLobRsb
LibRibRgbRsbLjLsmbLibLcbRobRobLcbRebLobRjbLobLibRgbRibLgbRibRgRsmbRgbL
gbRoRsRgRsmmbRibRjbRsbRcbRobLsbLsbReLsLsmbLcbRgbLobRibLsbRsbRibRsbRsbL
sRsbRiRsmbRsRsmbRsRsmbRsRsmbRgbRgbRgbRgRgbRgRsmbRgbRgbRgbRgRsLsmbsbRib
LebLobLobRsbRgRsmbRsbRibRsbRgRsmbLsbRibRgbRgbRgbRsbRobRsbRcbLgLsbRibRs
LsbRsbRhbLiRsbRgbLgbRibRsRsmbRsbRsRsmbRgRsmbRgbRgRsmbRiLsbLjbRibRgRsRs
mmbsbRgbRgbLsbRgRsmbLsbRgbLgbRiRsmbRgRsmbRsbRgbLsbRibRsbLsbRcbRibRsbRs
bRcbLjLsmbRhbLsbRcbRiRsmbLibRgRsmbRgbRibLibRebRibsbRobLobRobRcbRgbRsbR
sRsmbRsbRgbRibLgLsbRibLgbRcRsmbRgbRiRsmbsbsbLgbRsRsmbRsRsmbLoRsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132133; End: 132633;
Recording: 4-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLgbRsbRibRsbRsbLsbLsbLsbLsbLsLsLsmmbLobRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bLibLsbLsbLjbLoLsLgmbLgLsbLibLgLsLsmbLsLsmbLgLsbLgLsbLgbLgLsbsbLgbLgLs
bLgbLgLgbLgLsLsLsLsLsmmmmbLsLsLsmmbLgbLgbLgbLsLgRsbLgLsbLgLsbLiLsbLhbR
sbRsRsmbLibLsbLgLsLsmbLgbLgLsbLsRsbLsLsmbLsbLgbLgLsbLgbRsbLibRsLsLsmbL
gbLgRsbLgbLsbLgbLgbLsLsLsmmbLsLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bsbRjRsmbRsbRsbRjbRsLsbRgRsmbRiRsmbLsRsRsmbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLebLgbRcbRhLsRsbLsLsmbRibRsbsbLgbLsLsLsmmbRsRsmbsbRsbRgbRgRsRsmmbRsRs
RsmmbLsLsmbLsRsLsbLsbRibsbsbsbLsRsbRsbRibRsbLsbRsbLsbRsbLsRsbsbRibLsRi
bsbLobsbsbRsbsbsbsbRsbLgbLgbLgbRsLsRsLsbRsLsbRsbRsbLgLsLsLsLsmmmbLsLsm
bLgbRsLsbLsLsLsLgmmbLgbLgbLoLsmbLgbLsbRsbRibRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bRgRsmbRsbLsbRsRsLsmbRcRsmbRsbLsbRgbRsbLsbRsbRsbRsRsmbLsbRgRsmbRibLsRs
bRsbRsRsmbRsRsmbRsbRsbRsbRibRibRsLsbRsbRibRsbRsbRsbRsbRsbRgbLgbLsLsmbR
cLsbRsbLsRsbRoLsbLsbLsRsbRsLsbRjbRiRsmbRsbRsbRsbLsbRgbRsbLsRsbRibLsbRs
bLgRsbLsLsmbsbLsRsbRibRgRsmbRsbRgbRsLsbRgbLsbRsRsmbRsbRsLsbRsbRsbRsbRs
RsmbRsbRsLsbRsbRgbRgRsmbRsRsmbRsbLsbLgbRjbRcbsbLsRsbLsLsRsmbRsbRsLsbRg
bLsbRsbRsbLsbLgbRsbRsLsbRgbRsbRsRsmbRsbRsbRsLsbRsRsmbLsRsbRsRsmbRcbsbs
bLibRgbLsbLsbLgLsbLsRsbLsbLsbsbRsLsbLgbLsbLsLsmbLgbRsLsbLsbLgbRsbLsbLs
bLsLsmbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bLgbLgLsLsmbLgLsbLsLgLsbLgbLgbLgLsbLgbLsbLsLsLsmmbLgbLsbLgbRsLgLsRsbLg
bLgLsbLgbLgbLgbsbsbLgbLgLsbLsbLsbLsLsmbLgLsbLgbLgbLgbLgbLsbLsbLgLsbLgb
LsLsmbLibLsbLgbLgbsbLsbLgbLgbLgbLgbRsbLsbLgbsbLiLsbLsbLsLsmbLsbLgbLsbL
sRsbLsLsmbLsLsmbRsRsRsmmbsbLsbLsbLsLsmbLsbLsbLsbLsbLgbLsbLsRsbLgbLsbLg
bLgbLsbLgbLsbLsbLgLsbLsbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLibLsbLsbLhbLgbLcbLsbLgbLoRsbLhbRiLsbLibLibLibLsbLhbLsbLhbLgbLcbLibLo
RsRsmbLsbLsbLgbLobLsbLgbLsbLgbLibLcbRsbLgbLsbRsRsmbLsbRsbLsLsmbLsbRsbR
sbRsbRgbRsRsmbLsbLsbsbRsRsmbRsRsmbLsbRsRsmbsbRsbRsbLsRsbRsbRgLsbRsRsmb
LsbLebLhbsbLibRgbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 7; Drug: APO 0.5
bLobLobLibLiLsbLsbRcbsbLcbLoRsbLibsbRsbsbLcbLjLsmbsbRsbLsbRsbRsbLhbLob
LibRibLjRsbLibLsbRcbLobRibRibLiRsbRsbLiLgbLgbsbLeRsbRjbRibLsRsbLgbRsRs
LsmbLcbRgbLobLcbLjRsbsbRsbRgbLobLiRsbLibRsbsbsbLobLibLsbRsbRoLsbLibRgb
LhbLobsbsbRebRcbLgbRcbLcLsmbRsbRsbLgbRgRsmbRjbLjbLobLsLsmbLibRobRjbRhb
LcRsbsbLjbLjLsmbRsbLibsbRhbRsbRsbRoRsmbLgbLoRsbLgLsRsbRsbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 8; Drug: APO 0.5
bRgbRsbRsRsRsmmbRgbRsbsbLsbRjbLsbRsbRgRsmbRiRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 9; Drug: APO 0.5
bLgbLsbLjLsmbRjbRcbRibRebRebsbRgbRibRebRiLsbRibLgbLibLeLsbLebLibRsbLgb
LsbLgLsbLgbLibRsRgbLgbRsbLhbRibLibRgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 10; Drug: APO 0.5
bRibRgLsbLsbRgbLsbRsbRibRgbsbLsbLgbRgbRjbLsbRgbLsLebLgbRgRsmbRobLibLgb
RgbLgbLgbRjbRibRgbRgbRgbLsbLcbRibRgbRcLsbRibLgbLibRibRgbLgbRjbLjbLibRj
LsLsmbLsbRibRgbLgbRibRibRibLgRsbRgbRibRibLhbLjbLgbRsbLsbLsbRcbsbLjbLjb
RcbLgbRibRhbLibLjbLhbRjbLcbLibRjbRjRsmbRjLsbLibLsbRgbRsbRjbRcbsbLibLjL
smbRibLsbLgbRgbLcbLibRsbRjbRjbLsbLjbLibRhbLhbRsbRcbRjbLibRsbRjbRibLibR
jbRhbLjbLibRsbRgLsbRsbsbLgLsbRgbLjbRjbLjbRgLsbRjbLgbRibLsbLsbRibLgbRjb
RhLsbRsbLsbRgRsmbRgbLhbLcbRjbLibLibLgRsbLgLsLsmbLgbLgRsbLsbRhbRhbRibLg
bLsbRsbLobRgbLjLsmbsbRgbLibRgbRgbRsbRgbRsRsmbLcbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 11; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 12; Drug: APO 0.5
bLibRsbRobRcbRobRobLebRobRiLsbLibRcbRobRjbRjbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsLsmbRsbLsbLsLsmbRsbLsbLgbLsbLsLsmbsbsbsbsbsbsbsbLsbLgbLgbLhbR
sbLsRsbRsRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRgLsbLgLsbLgbLgbsbLsLsLsmmbLgbLsbLsbLgRsbLgbRsbLgbLsLsmbLsRsbRsLsbLsb
sbsbsbsbsbsbsbsbsbsbsbLgbLsbLsLsmbRsbsbLsbLsLsmbLsbLsbLgbLsbRsbLsLsmbL
gRsbLgbLsbLgLsbRiRsmbRsRsmbRsbLibLiLsbsbLsLsmbLsbsbLsLsmbLsLsmbLgbRsbR
sbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLsbsbsbLgbLgbRsbLhbLsbLsbLsbLgbLobRsbRibLgbRibLsbRsbLsLsmbLgLsbLibRcL
sbLcbRibLibLjbLibLibLgbLibLibRib

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLcbLgbLsbRsbLebsbRsbsbLjLsLsmmbLsbLsLsmbLeLsbLsRsbLsbRgbLcbLgbLgRsbLg
bLgbLgbLgbLsbLsLsmbLsLsmbLgbLsLsmbLsLsmbLsbLsLsLsmmbLsbsbRhRsmbRsLsbRj
RsmbRgbLgbsbLsbLsbRsbLsRsRsmbRgbRsRsLsmbLjbRjbRjbLibLjbLsLsmbRsbRgLsbL
sbRgRsmbRsRsmbRsbRgbLsRgRsmbRgbRgbRgbLjbLjLsLsmmbLsLsmbLsbLsLsmbLgLsLs
RsmbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bLsbRsbLsbRsbsbsbRsLsbRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRjbLcbRjbLhbRibRobLjLsmbRcRsLgmbLjbRhbRibLhbRhbLjbRjbLhbLibRgRsmbLibL
gbLobRgRsmbLsLsRsmbLjbLcbLibRjbRhbLgLsbRcbRjbRobLibLcRsbLiRsbLgbLsbLgb
RsbRibRjbLobRhbRhbLsbRcbLgbsbLoRcbLsbRgbRgbLsLcbRcbRoLsbLibRjbRhbRgbLi
bLgbLgbRgbRibLjbLgbRcbLsRibLgbRgbRibRjbLgbRhbLgbRcLsbLgbRibRhbLsbLsbLg
bLgLsbLsLsmbLgRsbLsLsmbsbLgbLsbLsbLsbLgbLsLsmbLsbsbLsbLgbLgLsbLgbLgbLg
bLgbLgbLsbLgLsbLgbRsRcbRhbLjbLibRcbLobLcbRgbLobRiLsLsLsmmbLgbLsbLgbLgb
LgbLgLgbLgbLsbLhbLcLsmbRsLsbRsbLgbRgbLgbLgbLgLsbLsbLgbRsbRhbRgRsmbLobR
ibLcbRcbLhbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bLebLgbRgbRgbRsbLsbLgLsbRgbRsbsbRsbLsbLsRsbsbsbLsLsmbsbLsLsmbLsRsbsbLs
bsbLsbLsbLsRsbLgLsbLibRgbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRsbLgbLsbLsbLsbRsbRsRsmbLsbRsbLsRsbLsbRibLcbLsbRsbRsbRsbRebRebRhbLcbR
ebRcbLebRobLjbRsbRobRsbRgbLebLcbLsbLcbLgbLgbLjbRsLcbRobRsbLjbRobRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRsRsRsmmbRgbRsRsmbLjbLgLsbLgLsbRsRsmbLsbLsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLcbRobRsbRobRcbLibLebRebRobRobLcbLobRobRobLebLobLhbLebRibRcbRibRgbRob
RebRibLobLcbLibRibLsbLobRgbLebRebLobRobLebRebRobRobLebRobRcbLobRobRgbR
ebRhbRobLobLcbLobRcbRobLebLibLcbLebLebLibRobLobRcbRobLobLibRobRcbRobLo
bRibLcbLjbRgbRibRebRsbRobRebLebRcbRcbRebRsbRobRibRibRobRobRebLobRobLob
RibLebRobLobRobLcbRcbLcbLebRobRsbRibRsbLobRebLibRibLhbRebLebRobLobLgbR
obRcbRobLobLsbRhbRcbLobLobRjbRcbRobLcbRhbRibRobRebRobRobLobLsbRebRebRo
bLobRsbRsbLebLobLcbLcbRsbLebLobLgbRsbRobRobLobLgbLobRgbRobRebLobRobLob
LobLcbLebLobRebLebLobRebLobRibLsbLibRobLibRcbLibRcbLcbRcbRgbLcbLobLebL
cbLibLebLibRcbLobRebRgbRcbRobLebLobLibRibLsbRebRobLobLebLobLcbRobLobRs
bRobRibLcbRobRsbLebRcbRsbRcbLobLebLcbRebRobLsbRibLsbLobLebLobRobLibLcb
RebLebRcbRobLebLcbRebRcbLebRobLcbLibRobRobRcbLgbRobRgbLobRcbRebLhbLobR
obLcbRebRobLibRgbLobRebLcbLobRibRobRobRobRebLobRobRcbLobLobRcbRobRgbLe
bLgbRebRhbRobRobRcbLebRcbLibLcbLebLebRcbRebLibRobLgbLcbRibRgbLobLobReb
LjbRebLcbRcbLobRibRebRcbLobLgbLobLobRobRgbRibLsbLobLobLebLobRibLobRgbL
ebRobLebRebRcbRobLobRebLibRobLebLobLjbLobRgbLobLebLobLebRobLebRobRcbRe
bLebRobRobRsbRcbLcbLebLgbLgbRgbLibLebLgbRibRebLebRobLebLebLobLobLcbReb
LobLobLebLobRobRsbRibLobRobLobLsbLobLobRcbLebLgbRcbLobRsbRcbRcbRebLobR
ebRebRebRebLebLobRobRcbLebRebRebLebRobRobLcbLgbRebRcbRjbRebRobRcbRcbLe
bLebRhbRebRebRobRobRibLebRgbRobLobLobLebRobRcbRobLobLobLcbRcbLebLobRob
RobLcbRebRobRebRobLobLgbLobLobLcbLobRebRgbRibRebRobLebRebLebLgbLibLobL
gbRobLibRobLebLebRobRebLobLibRibRcbRobRibLebLebLobLibRebLgbRsbLsbRobLs
bLibRobLebRebLobRgbLcbLobLobRobLebRebRobLcbRsbRcbRcbLobRsbRebLgbRcbRgb
RobRobRcbRobRobRibLebLobLobRebRebRebLebLhbRobLcbRgbLsbRcbLebLgbLobRcbL
obRobRibLebRhbRsbLcbRgbRobRcbLobRobRcbRobLebLobLobLgbRebLobLhbRobLsbLe
bLcbLebRobLobLgbLgbLobLcbRhbRobLobRebRebRobLobLcbLcbLcbRcbLhbLcbLebLeb
RobRobLcbRgbLobRcbRibRebLobRebRobRibRebRcbRebRgbRebRcbRobLobLobLcbLobR
obLobRsbRsbLobRibRobRobRebRibLobRobRebRcbRebRibRcbLebRobRibLobRcbLsbRg
bLibRebLsbRcbLcbLgbRcbLebLcbLgbRobLobRcbLobLebLcbLebRcbRebRebLobRobLeb
RibLhbRcbRobRebRobRobLcbLsbRobLibRobLobLobLobLobRhbRobRcbLobRobRebLebL
ibRcbRobLebRebLebRibLobRobRcbLcbLebRibRobRobLobLebRobLobLcbRcbRibRhbRc
bRobRobRobRobRebLobLebLibRebRobLhbRobRobLebLebLebRobLebRobRebLebLcbRcb
RobLcbLobRcbRcbRobLobRobRebRobLcbRobRebLobRebLcbRsbRobLobLcbRobLcbRebR
obRobLibLebLobRobRsbRsbLobLcbRsbLobRobLebRebRebLebLcbRcbLobLobRcbRcbLe
bLibLebRobRebRebLebLobLibRobLobLcbRobLebLebLibLobRobRobLobLibLobLobLob
LebRobRobLobLobRibRibLcbLgbLcbRobRobLobLobRebLcbLobLibRobLgbLcbLobLobL
obLobLibLgbLobLebLobRebRebRobRobLobRgbRobRebRobRibRsbRibLobRobRebRsbRe
bLsbLsbRgbRobRsbRibLebRibRobRobRobRebRobLebRobRibRobLobLebLebRebRobRgb
RebLobRobLibRobLebRobLcbLcbRebLobLibRcbRobRcbRebLibLobRcbRobRobLcbLobL
obRebLobLobRebRibLobRsbLibLcbRjbRobRebRgbRobRobRobRebLobLcbRcbRobLebRo
bRobLobLebLebRobRobLcbLobRcbLobRcbLobRhbLobLobRobLgbRcbLebLebRobLobLob
RobLebLcbLebRsbLcbRhbLobLobLobLebLsbRgbLsbLebLobRobLobLebLsbLobLebRcbL
obLobLebRcbRsbLgbRobLobLcbRcbLobLobRobRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRibLobLebRsRsmbLgbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRjbLgLsbLsbLsbRsLsbRsbRsbRsbRsbLgbLsbsbsbsbRgbRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bRsLsRsbRsLsbLsLsLsmmbRsbLsRsRsRsmmbRgRsmbRsbRsRsRsmmbLsRgRsmbRsbRsbRs
bLsbLsbsbRsbRgbRsRsmbRgRsmbRsbRsbLsRsRsRsmmbRsRsmbsbRgRsmbLsbLsRsRsRsL
smmbRgbRgbRsRsmbRsRsRsRsRsmmmmbRgbRsRsRsmmbRsLsbLsbRsLsRsbLsbLsLsLsmmb
LsbRsLsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bRibLibRhbRgbRgLsRsbRgbLsLsLsmmbsbRsLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLgbRsbRsRsmbLsbLsLsmbLgbLgbLgRsbLgbLgbLsLsLgmbLgbLsLsmbLgRsbLgbLgbLgL
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bLiLsLsmbLsbLgbLsbLsbRsLsbLgbRobReRgRsmbLsLsLsmmbLsbLsbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLsLsRsRsmmbRsRsmbLsRsbRgbRgbLsbLsbLjLsLsRsmmbLsLgbLsbLgLsbLsbLsbLsLsm
bLgbLsLsmbRsbRsbRsLsbsbLsLsmbsbsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 31; Drug: APO 0.5
bLsbRobRsbRsbLsbRjbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 32; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 34; Drug: APO 0.5
bRgbRibLcbLgbRibRsbLiLsRsbRsbRgbLoLsmbsbLobLcRsbLgbLhbLibLsbRobLcbRoLs
RsbLgbLibLcbLsbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 35; Drug: APO 0.5
bRebRibLsbRibLeRsbsbRsbRibRjbRjbRgbLibRibRibRhRsmbRgbRgbsbRibRibRebRgb
RhbRiLsbLgbRgRsmbRibRibRibRgbRsbRcbLsLsmbLsLsmbRsRgbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 36; Drug: APO 0.5
bRgbLhbRibLoLsmbRobRibLobRobLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bRsRjRhRsmbRibRsbLsRsRsmbRsbLsbRsbsbsbRsLsbRsLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bRjLsbRsbRsbRsRsmbRsbRgbRgbRsbRsRsmbsbsbRsbRsbRgbRsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bRibRsbsbLgbLjbRsbRebLgbLobLibRjbLibsbsbsbsbsbRsbLcbRjRsRsmmbLsbLsbRjb
RjbsbLjbLgbLgbLsLsmbLsbLibLsbLsLsmbRjbRibRcbRsbRibLibRiRsmbRsbRsbRcbLs
bLgbRjbRcRsmbRibsbRibLibLjRsbRgbRjbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRobLcLsmbRsLsbLgbRsLsbLsbLgbRsbsbsbRibRsbsbRsbsbRsbsbRsRsmbsbLsbLsbLs
bRsLsbRsbsbLsbLsbsbsbLsbLcRsLsbRsbLsLhbLsbLgLsbLsbLgLsbLsbLsbLgbRsbLsb
LsLsmbLgbsbLsbLsbRcbRsRcRsmbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRcLsbLgbLiRsbsbLsbLsbLoRsRsRsmmbRibRcbLjbRobLibRobLgbLibRsbLsLsmbLibL
iLsbLcbLobsbLjbLebsbsbLoLsmbRsRsmbLsbRgbLobLibRgbLcbRgbRibLsbRibLgbLgb
RobRcbLjRsbRgLsbLibLsbRobsbLibLsbLgbLsLsmbRobLibLsbLcLsmbRcbRsbLoLsmbR
oLsbLgbLhbRgbRobLibRibRibRgbRgbLsRsbRgbRgbLsbRibLjbRhbLcbRobRhbLgbRgbL
sbLibRobRjbRcbLcbLcRgbRcbRcbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bLsbLsbLsbLsbLsLsmbLsbLsbRsbLsLsmbLsbRsbLgbLsbLsbLsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bLsbRgbLsbRsRsmbRibLgbRsbRsbRsbRgbLoLsmbLgbRsbRibLibRgbRoLsbRsbsbLgbLs
RsbLsbRobLgbRsRibLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLsbLgbLsbLsbRsbsbLsbLsbLsbLgbLobRobLgbRobRibRsbLgbRob

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bLsbLsbLiRsbRsLsbRgLsbRgLgbRebRebRsbLebsbRsbLsbLsLsmbLsRsbsbsbRsbsbLsR
sRsmbRsRsRsmmbRsbsbsbRibRsRsRsmmbRsRsmbRsbRsbRibLsbRgbRsbRgbRebLsbLsbL
sLsmbLsbLsbLsbRjbLsbLsLsLsmmbLsLsmbLsbLsLsmbLsbLsLsLsmmbLgRhbRebRebLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRsRsmbsbRiLsbLgbRsbRsbLsLsmbRsbLsLsLsmmbRsbRoLsbLjbRhbLjLsmbLhbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 132635; End: 133136;
Recording: 5-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bsbsbsbLsbRsbLsbLsbLsbLsLsmbLsbLsLsmbLgbLsbRsbRsbLjbLjbLgbLsbLgbRsbRsb
LcbRibRsbLsbLcbLgbRsbLibLhbRsbRsbLsbRsbLebLgbLsbRibLibLcbRgbLgbLsbLcbs
bsbLsLsLgmbLsbRibLoRsbRsbLsbLsbLhbRsLsbLsbRibLibRobLgbLsbLsbLcbLgbLgbL
sLsmbLsbLsbLgbLibRsbLibRsbLhbRsLsbLibLgLsbLiLsLsmbLibLcbLibRibLibLgbLg
bLgbRsbLgbLsbLsbLgbLgbRsLsbLgbLgbLhbRgLgbLibLsbLgbLsbLgbLsbLgbRsbLgLsb
RsbLjRsbRcbLebLcbLibRsbLsbLgbLibRgbLgbLibRsbLgbRsbLgbLgbRsRsRsmmbLjbRc
bLibLibRcLsbLgbLibLsbRibRgbLsbLobRgbRebRobRsbLsbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bLgLgLsbLsLsmbLsLsLsmmbLgbsbLgRsLsbLgLsbLgLsbRsLgRsbLgbsbLgbLsLgbLgbLg
LsbLsLsLsmmbLsbLgbLgbLgbLgbLgbLibLibRsbRobLoRsbRsbLsbRsbLsLsmbsbsbLsbL
sLsLsLsmmmbLsLsLgmbLgbLsLsLsmmbLgbLsLsmbLgbLsbsbLgbLgbLsbLgLsbLgLsbLgb
LgLsLsmbLgbLgbLgbLsLgbLgbLibLsLsmbLgbLibLgbRgbsbsbRoLsRgbRgRsRsmmbRsRs
mb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bsbsbsbsbRgbLsbLsbRsRsmbLsRsbRsRsmbRsRsmbRsRsRsRsRsmmmmbRsRsmbRsbRsRsR
smmbRsLsbRcbLsbRsbsbsbLsLsmbLsbLsbRsbLsbLsbsbsbLsbsbLsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsbRgRsmbRgRgbLsRsLsRsRsmbRgbLsbLebRhLsbsbRsbRsbLsbLhbRsbLsbRsbRsLsbs
bRsbLgLgbLgbLgLsbsbsbLsbRgbRsbRsbsbLsLsmbRsRsmbsbRgRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bRsbLsbsbLsLsmbLgbLsbLsRsbLsbLsLsmbLsRsbLsLsmbLsLsmbLsRsbLcbRobLsLsmbR
obLcLsmbRgbLsbLgbLgbLsLsmbLgbLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bLsLsmbLsbLsbRcbsbsbsbsbLsbRsLsbLsRsLsLsmbRsbLsbLsRsbLsbRgbLsLsmbLsbLs
bRsLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLgbLsLsmbLgbLsbLsbLsbLsbLgbLgbLeRsLgbLobLsRsbRgbRiRsmbRibLibLebsbLgbL
gRsbsbLsbRsLgbLgbLgLsbLsbRsRsmbLsLsmbRsLsbLsLsRsmbLgLsLgbLgbLgbLgbLgbL
gLiRsbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 7; Drug: APO 0.5
bRsbRsbLsbLsLsmbRjbRjbsbRibLgRsbLiRsbLcbRsbRsbRjbLsLibRsbLsbLsbLgbLsLs
RsmbLsbRjbRhRsmbLoLsRsmbLibRobRhbRobLibLsLsmbRsbRgbRsbRjbLsbRsbRgbRsbR
hbLgbRgbRsbRcbRibLsbLibRsbRibRgLsbRsbLcRsbRibLsbLgRsbLjbLcbRjbLhbRgbRo
bLgbRcbLsbLsbRsbLsbLobLibRibLsbLsLgbLgbRgbLsbLibRsbLoLsmbLgRsbLsbLsbLg
LsbRibRgbLoLsmbsbLjRsbLgbRsbRibLibLibRcbRibLsbLgbRobLibLibRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 8; Drug: APO 0.5
bsbRsbRsLsRsbsbsbsbsbLcbLsbsbRsLsbsbsbsbLjbLjbLobLibLgbRsLsbRsbLsLsmbR
hbRobLibLsbLjbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 9; Drug: APO 0.5
bRgbLebRsRobLgLsbLibLgbsbsbLiLsbsbLhbLibLgbRsbLgbLobsbLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 10; Drug: APO 0.5
bRibLjbRjbLcbRjbLibRjbLjbLsRibLjLsmbRsbRsbRsbRsbRcbLibLebLgbRgbRsbRgbL
jLgbLsLsmbLibRibRgbRgbRebRjbLobLhbLibRgbRjbLiLsbLibRsbRcbRjbRgbLgbLsbL
hbLgbRjbLhbRsbRgbLibRjbRjbLjbRibRsRsRsLsmmbRgbLobsbsbLibLiLsbLgbRsbRib
LibLsbRcbRjbRgbLibRsbLjbLjbRjbRcbLjbRibLsbRibRoRsmbRgbLsbLsbLibLibsbRg
bLjbLgbLgbRsbLhbRsbRgRsmbsbLibLgbRsbRjbRoLsLsmbsbRjbsbLibRebLgbLsbLibL
gbLsLsmbRsbLsbRjLsbRgbLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 11; Drug: APO 0.5
bLibRcbRibLobLcbRobRibLjbRobLsbRhbRobRobLcbLcbLebRebRobRobLebLebLhbRgb
LobRobRobRsbRebRcbRobRebRebLobLgbLcbLsbRobLsbRjbLibRebRebRibRebRcbLcbR
ibLsbRobRebLobLobLgbLcbLobLjbRobLobLcbLcbLobLgbRcbLgbRhbLcbLebRebRjbRo
bLgbLcbRobRobLgbRobRobRobLobLobRobRgbLebRcbRobRobRobLibRobRcbLhbLcbRob
RobLcbRobLobLobLobRobLgbLgbRgbRcbLebLobLhbRobRobRobLcbLebRobRsbLobLgbR
ibRebRobRobRebRobRobRobLobRobLcbLobLebLebLebLobLgbRebLebRcbRobLgbLcbLg
bLibRgbRobLobRebRibLcbRobLcbRibLgbRsbLsbRcbRobLibRebRebRebRobRebRebLob
LibLibLebRobRebLobRobLobLcbRcbRcbLobLebRobRobLebRgbRcbRobRcbRobRcbRebR
ibLobRobLobRobLgbRobLcbRcbRobRcbRcbRebRcbRobLebLobRcbRcbRgbRobLobLgbRo
bLobLobRobRebLibLobLibRobLgbRebRsbRibRibRebRebLobRobRobLobRcbLcbRobRgb
LebLobLobLebLobRibRobLobLcbLsbLsbLobRsbLebRobLcbRobLjbRgbRobRcbLebRobL
obLobRsbLobLobRobRcbRgbRobLebLsbRgbLebRhbLobLobLibLobRobRobRebLebRcbLo
bLobRobRebRcbRebRobRgbRebRgbLobRobLobRebLebRebRjbRobLebRobLcbLobLobLcb
LobRobRebLebLobLcbLobLobRobRjbLibLcbRebRibLobRobLobRhbLgbRobLobRcbRobR
sbLobRobRobRhbLgbLobLobRgbRibLsbRobRgbLobRobRebLobRgbRcbLobRgbRcbRhbRo
bRcbLibRobRobLibRobRebLobLobLobLcbRcbRibRebRcbLebRcbLebLebLcbLhbLsbLcb
LobRebLhbLebRobRobRebRcbRebLobRebRgbRobLobRobLibRebLjbLebLebRgbRibRobL
obLibLebRgbRobRobLebLsbRebRebLobLebLobLobLhbLsbLobLobRebRebRcbRgbRhbLo
bRcbLibLcbRobLcbRebLebRibRsbRebRebRobRebLibLebRgbRebLebRsbLcbLobRcbLcb
LebLhbRobLibLibLebRcbRgbLebRebLobRobLobLobRobRcbLobLebRebRjbRebRobRsbL
cbLcbRobRebLobLobLibRibRobRobLcbRobRibLgbLobLcbRcbLebRgbLobLobLebRgbRs
bRebLobRobLcbRcbRobRcbRibRobLobLobLobRebRsbLibRobLobRobRcbLobRibLobRcb
LsbRobLebRobRsbRobRobRgbLobLebRsbLjbRebLsbLsbLibRebRgbLobRebRhbRcbRobL
obRcbLebRhbRgbLobLebLhbLcbRobRobRcbRebLobRcbRobRgbLcbLebRobLobLobRcbRi
bLobRgbRebRobRobRebRobRcbLcbLcbLsbLobLobRobLebRobRobRebLcbLobLgbLobLob
LobLebLobRobRebLebRsbRebRgbLobLobRibRobRobRcbRgbRcbRobLobLobLobLobRibL
ebLebRcbRgbLebLebLebLhbRebLobRobLobRibRobRebRebRibRobLobLcbLsbLgbLcbRo
bRgbRobRebRebLebRobRobLobLobRobRcbLsbRebLobRibRebRobLgbRibLcbLibLobRcb
LobRobLgbRobRebRhbRcbLgbLobLibLobLebLebRebRobRebLcbLcbLobLibRebRgbRcbR
obLobLobLobRobRjbRobLcbRobRebLebRcbRebLobLebLcbRobRcbLobRobRcbLobRebRo
bLhbLibRobLsbRebLobRobRhbRobLebRobLcbLcbLcbRebLcbRobRobRcbLobLebLobRhb
RobLsbLcbLobRebLcbLobRsbRobRcbRebRhbLibLebRebLebLebLobLobLgbRobRibLhbR
ibRebRebRsbRebLobRobLobLebLsbRobLebRebLhbRebLobRobLobLobRcbLcbRebLobRe
bRebRcbLsbRobLebRobRobRebLcbRobRobRebRebLhbRcbLcbLobRobLebRebRobLibLeb
LebLobRobRcbRebLibRhbLobRobRobRcbRebRibLibLebRebRcbRsbLibRibRebLhbLcbR
cbRobRibLcbRebRobLobLebRcbLobLcbRsbRjbRebRobRgbRibLebLebLgbRobRcbRhbLc
bRcbRebLobRebLobLcbLobRebRobRgbRobRgbLcbRebRibLebLebRhbLibRobLobLcbLcb
LebLjbRobLobRebRobLibLcbRhbRobRibRobLobRebLgbRcbRibLibLsbRgbLebLgbRobR
cbLibRebLibRobRobRebLebRcbRobRobLobRobLobRobRebLobRgbRebRibLebRsbLobLi
bRobLebRobRebRsbLebLebLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 12; Drug: APO 0.5
bsbsbsbLiLsbLobRsLsbLsbRsLsRsbLgbRgbLcbRsbLobLobRjbRjbRsbRsbLsbLsRsbRo
bLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRsbLsLsLsmmbsbLsbRsbLsRsbRsbRsbRgbRsbRsbRsRsmbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLgbLsRsbLsbLsLsmbRgRsmbLsbRsRsLsmbLsbRsLsbLsbLsbsbsbRsbRsbLsbRsbLsbRs
bRsbRsbLsbLsbLsbLsbLsLgbLsbLgLsbRsLsbRsbsbLsbsbLgbRsbLsbLsLsmbRsbLsbLs
RsbRsLsbLsbLsRsbLsbLsbLsbLgLsbLsLsmbLgLsbLsLsmbLsLsmbRsbLsLsmbsbLsbLsL
smbLsbLsbRsbLsbRsbLsbLsbsbRsRsmbLsLsmbLsRsbLsbLsbLsbRsbLsLsmbLsLsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bRsbLcbLsbLhbLgLsbLsbLsbLgbLgbLibLebLsbLsbLjbLibLibLiLsbRsbsbLobLsbRsR
sRsmmbLobLsbLsLsmbLibLgbLiLsbLsLsmbLsbLsRsbLgLsbLgbLgbLsLsmbLsbLsbLsbL
gbLsLsmbLgRsLsbLgbLgbLgbLsLsLsmmbLgLsbLgbsbLgbLgLsbRsLsbLhbLsbLgLsbLsL
gbLsRsbLobLsbLsbLgbLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bsbLsLsmbRsbLsbLsRsbLgbLsbRgbsbsbLsbLsLgbLsbLsbLsbLsLsmbLsbLsbLsbLiLsb
LsbLsbLsLsLsmmbLsbLgbLgbLgbLsRsbLsLsmbLsRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRgbRobLsbsbsbRgLsbLsbRsbRsbRsbRsbLsLsmbRsLsLsLsLsmmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRoLsbLsRsbLgLsbLoLsmbRsbLsbLjbLgbRcbLcbLibRibRibRgbRgRsmbRjbRhLsbRobL
sRsbLcRsbRgbRgbLsbRibLjbRjbRjRsmbRgbLcbLcbRhbLgbLgbLgbLgLsbLgbLgbLsLsm
bLgLsRsbLgLsbLsbLgbRjLsbRjbRoRsmbRibLjbLjLsmbLsLsmbLsbLsbRcbLsbLjbLgbL
ibLcbRibLibRsbRsbRiLsbLsbsbLjbLgbRjbRcLsbRcRsmbLgbLhRsRsmbLsbRibRcbRib
LsbRgbLsbLsbLiRsbLgbLobRibLoRsbRsLsbLgbLibRsbLgbsbRobRgbRibRibLjbRjbRc
LsbRcbLsbRcbRhbsbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRsbRgbLsbLsbLsbRsbLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bsbsbLsbRsbLsRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bLsLsmbRgRsRsmmbRgbLsbRgbRsbRobLsbRsbRobRgbsbRsRsmbRsbRcRsmbRsbLsbLsbs
bRgbsbRgbRsbLsbRsLsbLsbRobsbLsRjbLsbRsbLsbRsbRibRibLsbLsbRsbLjbRebLhbL
sLsmbLibLsbLsbLsbLgbLsbsbLibLsbLgbLgLsbLgLsbsbLsLsmbRsbsbLsbLsbRebRsLs
bRsbRgbsbLgRsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLobLjbRobLobLebLgbLebLjbLcbRjbLcbLebRebRsbLcbLcbLobLobLobRjbLjbRcbReb
LcbRjbRcbRcbLibRebLobLibLgbRcbLcbLebLobLebRebRebLibLcbRebLgbLcbRhbLcbL
obLebLobLobLgbRibRgbRebRcbLobLobLcbRibRobLibLobLobLcbRobLebRobLcbRsbRe
bLebRobRebRhbLcbRebLobRibLobRebLobRcbRebLcbRobLobRobRobRibLobRobLobRcb
LebRcbRebLgbLobRobRcbRebRobLobRsbRcbLgbLebRobLhbRsbLcbLsbLebLobRibLebL
ibLcbRcbRhbRebRebLhbLobLobRhbLcbLobRebLobRcbLobRebRcbRsbRcbLsbRobRebLe
bRebRebLebRgbLcbLobRobLebLebLebLobRsbLcbRcbLobLhbRobRobLibLebRebLcbLcb
LobRibRobLcbRobRobRobRobRobLgbRobRcbRcbRobLebLcbLgbLibLcbRebRhbLobLcbR
cbLcbRobLgbLobRcbLcbLebLebLobLgbLebRobLhbRobRcbRebRobRebRobRcbRobLobRe
bLobRobLcbLobRobLobRibRgbRibLobRcbLcbRibLobLebLobRobRhbLsbLobRobLgbRsb
RobRcbRobLobRobLebRobRobRobLcbRobRibLibLebRcbRgbRebRebLobLcbLebRobLibL
gbRobRobRcbLobLcbRebRobLebLobLebLobRcbRibRobRcbLcbLcbLcbRobRobLebLobRo
bLobLibLsbRobLobLobRobRobRcbLsbRobLsbLobLebRobRebLobLcbRobRsbRcbRsbLsb
RebLobRibRhbLgbLibLgbLibRcbLobRebLcbRebRgbRsbRibRobLobLcbLebRibLgbRcbL
cbLgbLobRgbLobRebLcbLobLcbLobLebRebLebLobRebRobRebLcbRobLebRobLobRobRo
bRsbRcbRobLibRebRobRobRebLebLibRebRcbLcbRsbRobLobRebRobLcbLibLebLebRgb
LsbRebRsbRibLsbLobLebLobLobRcbLebRebRobLobLcbLsbRobRobRobLobLobLsbLibL
obRebRcbLobRobLibLobLgbLcbLibLebLebLebRobLcbRgbRobRobLgbRobRobLcbRobRg
bRobLobLobLobLobRobRsbLobLhbRgbLebRebLsbLgbRobLebRebLebLobRobRebRobReb
RebRebLsbRebLobRobRcbLibRobRobRgbLebLobRhbLcbRobRobLjbLobLcbRobLgbLobL
ebLebLhbRibLobLobRobLgbRobRobLsbLobRobLgbRibLobRobRjbLobRobLcbLobRobRo
bRsbLcbRcbLobLsbRcbLobRebRebLobRobRebRobRebRobRobLcbLobRobRcbLibLebLob
RobLobRobLgbLgbLhbRjbRobRgbLebLcbRibLobLobRobRsbLobLobRebLebRobRcbLebR
ebRobRobRobRobRobRebLsbRobLibLebRobRebLobRobRsbLsbLibRcbRibLebLgbRsbRg
bRobLobRobRebLcbLobRebLobLobRhbRebLhbRebLgbLibRobLibRebRobRebRcbRebRcb
LebLgbLobLebLebRobLebLcbLibLibRobLobLobLobRebRobRobRobRobRcbLobLobRobL
obRebLsbRobRebLebRcbLebRibLebRibLcbRobLobLobRobRobRobRjbLebLobLobLibLo
bRobRebRobLhbLobRobRobRibRobRobLobRebLebLobRibRebLobRcbLibLobRobRobReb
RobLebLobLobLobLobRebRcbRobLcbLebRebLsbRobLcbRebRobLobLebRobLcbRobLhbR
ebLcbLobLebLobRobRcbLcbLobLobRebLobLobRebRibLcbRobLebRobRcbLibLgbLcbLo
bRibRsbRobRebRobRibRsbLebRebRgbLgbLobRobRobLibLebRebRsbLsbLgbLobLobLob
LcbRibRobRobLcbLobRobLcbRgbLobRcbLcbLobLobLobLebRcbLobLcbLobLcbRobLibL
ebLgbRcbLcbRobRobLebLhbRgbRcbRgbRobRcbRobLcbLcbRobRobRgbRcbRgbLcbLobRo
bRcbRobRobRibRebRsbLobRebRgbRobLobLobLgbRobRobLgbLgbRebRcbLobRobRobLib
RobLhbLcbLobLobRobRobRobRobLobRgbLgbRobLobLobLobLcbRobLobRhbRibRhbLcbL
ebLobRebLcbLibLebLibLgbLcbRobLebRobLsbRobRebLcbRobRobRobLobLobLobLgbLe
bRobRobRgbRsbRobLebRobLobRibLobRgbRobLobLebRobLebLobLebLobLebLobLobLeb
RobRobRobLebRebRibRebLobRebLebRobLcbRebRobRobRebRebRgbRcbRobLebRobRcbR
ebRibLobRobRcbLebRobRobLobLgbRcbRsbRobRobLcbRebLhbLebLobLsbRcbLobRobLo
bLobRebLsbLobLobLhbLibRobRibLcbLobLobLobLobLebRgbRobRibLobLobRebLibRcb
RobRcbRibLcbRsbLebLobRebLsbRobRobRobLebLibRobRobRibLebRhbRcbRobRebLobR
obRebRcbRobRgbLebLobLobRobLobLobLobLobRebRebRobRibLobLobRobLibLebRsbRe
bRobRebLebLebLobRebRobLobLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bRgRsRsmmbRsbLsbRsbRgLsbRsRsmbLsbRsbRsbRsRsmbRsbLsbRsbRsbRsbRsbRsbRsRs
mbRsbRsbRsbRsbRsRsmbRgbRiRsmbRsbRgbRgbLgbRgbRsRsmbRsbRsbRsbRsbRsRsmbRs
bRsbRsbRsbRgbRgbRsRsmbRgbRsbLeRsbRsbLsbLsLgRsbRsLsbLsbLsbLsbLsbLsbLsbL
sbsbsbLsbLgRsbLsLsmbsbLsbLsbLsbLgbLsbLsbsbsbLsbLsbLsbLsbLsLsmbLsbLgbLs
Lsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLsbRsLsbLibLsRsbLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRgbsbRsbLibLsbRebsbsbsbsbLsbsbsbsbLsbsbRsbLsbsbsbsbRsRsmbRgbRsRsmbRsb
RobLsbLoRsbLsRgbRsRsmbRgRsmbRgbRsbRgbRsbRsbRgbsbsbLsbRsbRsbRgbLsbRsRsm
bLsbsbRgbRgRsmbRgbRsRsmbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bsbsbsbsbsbRsRsLsmbLsLsmbLsbRsRsRsmmbRgRsmbRsRsRsRsmmmbRsbRsRsmbRsRsmb
RsbRsRsmbRsLsbRsbRsbRsbRsRsRsmmbRsbRsRsmbRsRsmbRgbsbsbRsRsmbRgRsRsmmbR
sRsmbsbsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLgbLsbLgRsbsbRgbLsRsbRsRsmbRsbRgbLebRobRibLsbRgbLsbRiRsmbRsbLhbLgLsbL
sbLsLsmbLgLsbLsbLsbLcbLibsbLgbLibLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bsbRebRsbLsbLsbLiLgbsbLsbRsbLsbLsbLsbRsbLsbLgLsbLsbLsbRsbLsbRiLsbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLsbLgbLsbLobLsbLsbLiLsRsbLgbRsLsbLgLsbLsbLsLsmbRgbLsLsmbLsLgRsbLgbLsL
sLsmmbLsbLsbLgbsbLsLsmbLsLsmbLgbLgLsbLgLsbLiLgLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 31; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 32; Drug: APO 0.5
bLsbLjbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 34; Drug: APO 0.5
bLcbLiRsbRcbsbRsLsRsbLcRsbLoRsRsmbsbLgbLobLobLibLsLsmbLsLsmbLcRsbLsbRo
bRsRsmbRsRsmbRsbLibLcbLsbLhbLibLibLibLgbLsbLcbLsbRsLsbLsRsbLsbLibLgbLg
bRsbLibLibRgbLjbLiLsbLsLsmbLsbLsbLsLjbLjbLcRsbLobLcbLoRsbLsbLjbLcbLibL
sbLsLsmbLobsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 35; Drug: APO 0.5
bRsbRsbLsbRgbLsbRibRsbRgRsmbRibRsbRibRibRjRsRsRsmmmbRibLsbsbLsbLebLgbL
ebRgbLgbLsbLsbLsbLsbRcbsbRgbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 36; Drug: APO 0.5
bRhbRibsbLsbsbsbsbsbLcbRcbLcbsbRjbLobLobLhbRgbLhbLgbRjbRibLjbsbRhbLibL
jbLsbLibLgLsbRsLsLsmbLobLibLib

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bRsRsRsmmbRsRsmbRsbRgRsmbRsbRsbLsLsmbLibLsbLsbLsbLsbLgbLsLsLsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bRsbRibRsbRsbRsbRgbLsLsmbRcbRsRgbLsbLgbLsbRsbLgLsbLsbsbsbsbLsbLsLsmbLs
bLsLsmbsbsbsbsbsbLsLsLsmmbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLibRgbRsbLoRsRsmbRiLsbRsbRgbRoRsmbRgbRgbRgbLjbRgbRsbsbLsbRhbRsbRibRsL
sbLsRsbRgbRhLsbRibRsbLsRsbLsbRibRcbLsbLjbRiRsmbRibLsLsmbLjbLgbLsbLsbLi
RsbRsbRibRgbRsbLcLsmbLsbLibsbLgbLsLsmbRibRgRsRsmmbRsbLsbRsbsbRsRsLsmbL
sbRcbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRob

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRibLobRsbLebRsbLsbLcLsmbRgbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRjRsmbRobLibRjbLsbLcbRobLjbLjbsbLcbsbRebLcRsbLibLhbLcLsmbRcbLibsbLsbL
ibLsRsbRobLgbLsbRoLsbLsbLsbLoLsRsmbLoRsLsLsRsLsmbLsbRcbLjbLsbRibLsbLib
LcbRobLibLsbRgbsbRsbLcbLsbsbsbsbsbsbsbsbsbsbRcbLcbLoRsbLgLsbRcbLiLsbRs
bRhbLibLsLsmbLibRjbRhbLjbLibRsLsbLibLgbRjRibRcbRcbLibRgbRgbLibRjbRibRg
bLiRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbsbLsbLsbLsbRsbLsbLsbLsLsmbLgRsbRsbsbLsLsmbLsbLsbLsbsbRsLsbRsbLsLsm
b

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bRsbRsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bRsbLsbRsbRgbRgRsmbRgLsbRsbRsRsLsmbRsbLsRsbRsbRsRsmbRsbRsRsmbRsbRsbRsR
smbRsbRsbRsbRgRsmbRsbRsRsmbRgbRsbRsbRsLsbRsbRsbsbRsLsbRebsbLebsbLsbRsL
obRsbRsbRjbLsbLsbLsRsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bLsbLgbLsbLsbLsbLsbLsLsmbLsLsmbLgLsbLgbLgbRebsbsbRsRsmbRobRsbsbLsbRcbR
sRsLsmbRsbRsRsmbRsbRsbsbRsbRsbRgRsmbLsLsRsmbRsbRsbLsRsRsmbRsbRsbRsRsmb
RsbsbRsbRsbLsRsRsmbRsRsRsmmbRsbsbsbsbRsRsmbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRjbRibRobRsbRsLsbRsRsmbRsRsmbRsbRgRsmbRsbRsRsmbLsRsbRsbRgbRgbRsbRsLsb
sbLsbRsbRsLsbLsbRsRsmbLsbLjbLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133137; End: 133638;
Recording: 6-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLibLibRcLsLiLsbLsbLsbRsbLibRsbLsLsmbLcbsbsbLibLsbRsbLiRsbLobLoRsLsRsb
RgbRgRsmbRobLsbRgbLsbRiRsmbLsbLgbLobRgbLsbLibLsbLhbLobRgbLibRgbLgbLibL
obLobLibRsLsbLjbRgLsbLgbLgbLgbLsbLcbLgLsbRsLsbLsbLgbLibRgbLibRgbLcbLhb
LibRsbLsbRibLcbLjbRgbLhbLibLsbRgbLgbLsLsmbLibLibLgbLsbLcbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRgbRsRsRsmmbRsRsmbRgRsmbRsRsRsmmbRsLsbRgbRsRsRsmmbRsRsRsmmbRsRsRsmmbR
sRsRsmmbRsRgbRgbRsLsbRgRsmbRsbRsRsmbLeLsbLsLsRsmbLgLsbLgbLsLsmbLgbLgbL
iLsbLgbLsbsbLgLsbRsbLsbLsbLgbLjbLobRsLsbRgbRsRsRsmmbRsRsmbsbsbsbsbRsRs
RsmmbsbsbsbRsbRsRsmbRgLsbRsRsmbRsbRsRsmbRgbRgbRsRsRsmmbRsRsRsmmbRgRsmb
RsbRgLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bsbsbsbsbRsbLsLsmbRsLsbLsLsmbLsRsbLsLsmbLsbsbLsbLsbLsbLsRsbLsLsmbLsLsm
bLsbRsbLsLsmbLsbLsbLgbLsLsmbLsbLsLsLsLsmmmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLgbRsbLsLgbLgbLiLgbLibLibLiRsbLsLgbLsLiLsbLsLsmbLgbLgbLgbLsLibLibsbRs
bLiLsbLiLsbLgbLgRsbLgRsbRsbLsLiLsbLsLsLsmmbLsLgLsbLgbLgbLsbLgbLsLsmbLs
LsmbLgbLsbRsLsLsmbLsbRgLeLibLibLgbLgbLgbLibLibLgbLiLsbLgbLsbLsbLsLsmbL
gLsbLibLiLsbLgLsbRgRsRsLsmmbLhbRhRsRsmmbRgbsbLeLsbLeRsLsbLgbLgbLgbLibL
gbLgbLgLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsbLsLsLsLsLsmmmmbLsbRsRsRsRsmmmbRsRsRsRgRsRsRsmmmmmbLsLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bLsbLsbLsbLsRsLsbLsRsRsmbRsLsbRgRsLsmbRsRsmbLsRsbRsLsbRsbRsbLsbRsbLsRs
bLsLsmbRsbRsbRsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLsbLsbRgRsmbRsbRsbRsRsmbRsbRsbRsLsbRsbRibRsbLibLgbLibRsbLcbLgbLgbLsbR
ibRsbLibLeLsbLsLgbRsbRsbLibLgbLsbRsbRsbLsbLsbRibLibRsbsbLsLsmbRsbRsbRs
bRsbLobLsLsmbsbLsbLsRsbRsLsbsbRsbLsLsmbRsbLsbLhbLgbLgbLibLsbRsbLsbLgLs
bLsbLgbLsbLgLsbLgbLgbLsbLgbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 7; Drug: APO 0.5
bRgbRgbLsbLjbLcbLibLgbLsbRsbRsbLobsbsbRobRsbRsRobLjbsbLcbRobsbLsbsbLcL
smbRgbLsbLsbLibsbsbRhbLsbLsRsbLibRjbLibLsbRibLobsbsbLhbLjRsbLsLsmbRgbL
ibRsbLhbRsbRsbLcbRobRhbRibRsbLgbLgRsbRoRsmbRsLsbLsRsbLcbLibLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 8; Drug: APO 0.5
bLebRsbLebRsbRgRsmbLgLsLsmbRhRsmbLjLsmbLjLsmbLcbRobLsbLibsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 9; Drug: APO 0.5
bRoLsbLibLcLsLsmmbLobLibLgbLcbLjbRcbsbLsRsbLgbRgbRsbRsRsmbLhbLibLsbLsb
RiLsLsmbRjbRsLsbLeRsbLobRsbRobRibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 10; Drug: APO 0.5
bRjRsmbLsbRjbRsbLsbRjbRgbLcbsbLsbRjbRjbRjbLjLsmbRsbRsbLjbLgbRsbLgbLhbL
sLcRsbLibLgbRgbLjLsmbRgbRsbLjbLjRsbLsLsmbRobRcLsLsmbRoLsbRgbLsbLhbLiRs
bRsbLjbRjbRobRibLcbLgbLsRsbLsbLsbRibRibRjLsbRsbLebLibRsbRsbRgbRsbRsbLs
bRsbLibRjbRibLibsbLgbRibLsRsbLjbRibRsbRgbReLsbRjbRgbLsbLgbLsbLibLsbLib
RsbLsbLgbRsbLhbRgbLcbLibLibRgbRsbRgbLcbLjbLsLsmbRsbRsbRsbRjbLjbLgbLibL
sLsLsmmbRgLsbLhbLibLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 11; Drug: APO 0.5
bLibRgbRobLcbLgbRobLcbRobLobRibLobRobRebRgbRobLebRobLgbRobRebRcbLebLcb
LobRgbLobLcbRobRhbLgbRebRibRhbLobLobRebLobLobRcbLobRebRebRgbRcbRgbLobL
obRobRobRobLobRcbLobLcbRibLobRgbLebLcbRsbLebRobLgbRibRcbRobRobLibLebRc
bLobRcbRsbRebLobRobLobRgbLobRgbLcbLebLebLgbLhbLsbLebLobRebRobRebLebLob
LobRobRobLebRobRcbLobLebLgbLebLobRjbRebLebRobRebLgbLebLibRobRebRcbRobR
jbLobRsbLobRobLsbRobLobRobLebLibLobRcbRebRsbRcbRobRobRebRebRobLcbLobLo
bLobLibRgbLobLobRobRcbRgbLcbLebLobRebLobLobRobRobLjbRcbLcbLobLcbLhbLgb
RobLcbRobLobRibLhbRobLobRgbRcbLcbRobRcbLobRebLebLobRobRobLebLebLobRobR
ebRcbLcbRibRobRebLibRobRobLobRebLgbRobLobRcbLebLcbLobLebLcbLobRgbRebLg
bLobLebRcbLobRobLcbRobRobLobLobRsbRcbRobRobLgbRebRobRcbLgbRebRcbLobRob
LsbRcbLobRobRibRcbLobRobLobRebRebRebRebLibLgbLebLobLgbRobLcbLcbRobLobR
obRebLsbRebRibLobRobLobRcbLebRebRibLobRibRobLebLgbRsbRgbRcbRebRobRobRe
bRcbRebRebRobRobRcbRobRibLibLobRobRebRcbRcbRibRebRobLhbLibLibRebRobRob
LobLgbRebRebLobRobLobRobRgbRebLobRobRobRgbRebLobLcbLobLobRebRobRobRobL
hbLhbRibRhbRcbLebLcbLobRobLcbLobRobLebLobRebLibLsbRebRhbLibLibRobLobLo
bLobLebRgbLobLobLcbLobLgbLobLhbRgbRobRhbRobLobRebRobLobRebLobLcbRebRhb
RobLobRgbLebLebRobRobRsbLobLcbLebRcbLgbRobRobLobRebRgbRibLobRsbRcbRebR
obLebRobLobRebRhbLobLobLebRsbRobRobLobRebRebRcbLcbRibLobLgbLobRobRebLo
bLobRcbLebRgbLebRebRobLgbLebLobLcbRobRobLcbRobRcbRgbLobRgbRobLebLobRcb
RsbLebLebRobLobLebLebLobRsbLcbLobLcbLcbLcbLobLcbLebLebLibLcbLebRobLobL
obRobRibRebRebLobLebRebRobRcbRobRobLobRebLobRobRobRebRobRobLebRibLsbRe
bLobRjbRgbRobLobRcbRobRibLebLebLsbLobRcbLebRobRgbRgbLobRebLhbLobRebReb
RobRobRobRsbLebRibLsbLobLobRebRobLgbLobRcbLsbLcbLebLobRcbRebLobRebLobL
cbLobRcbLobRobRebLobLobRobLobRebRcbLebRebRibRcbLsbLcbLebRebLhbRjbLebRo
bRcbRobRcbLobRobRebLcbLcbLobLobLibRcbLcbRobLobRobLobRsbRobLibLobRhbLeb
LsbRebLsbLobLcbLobRebRobRobLgbLobLebRebRobRebRobLobLebLobLobRebLobRobL
ebLobRobRobRcbRobLobRobRsbLgbRebLobLobRebLobRgbRgbRebLebRebRcbLebRobLe
bLobLobLebLebRobLobRibLebRcbLobRibRcbRobRcbLcbRcbRebRobLcbRcbRebRobLeb
LibLebRebLebRobLobRebLobLebLobLobRcbLibRgbRobRjbLobLobLobRcbLobRjbRobL
cbRibLcbLcbRcbLebLobRobLobRgbLgbLebLobRobLobLobLobLcbLebRcbRobRebLgbLo
bLobLebRcbLebRhbLobLobLobRebRobRobLebRobRhbRcbRjbLebRebRcbRebLebRhbRob
LcbRobRcbRebRobLebRobRebRebRobRobLebLebLobLgbLsbRebRobLcbLcbRobLebRebL
ebRobLgbLebRebLcbRibRebRcbLhbRibRgbLsbRobLcbLebRobRgbRsbLobLebRibRebRo
bLibRobLobLgbLebRebRobRobLsbRobRebLibRebLobLgbLebRgbLgbLcbLobRebLcbLcb
LcbRobRobRebLcbLcbRebLibRobRebLobRcbLsbLcbLgbLcbRcbLebRobLebRebRcbRobL
cbLobRcbLcbRebRcbRebRobRhbLsbRobRobLebRebLebLobRibRcbRebRsbRobRcbRsbRo
bRobLobLebRobLgbLobRebLobLcbRhbRsbLobLgbRebLobRcbRobRobLobRobLobRibRib
RobLebRebLcbRibRibRsbRebRcbRgbLobLobLgbRobRibLobRgbLsbRobLobRobRobRobR
cbRgbRebLcbRebLgbLibRobRobRobLcbRcbLcbLobRebLebRobLobRgbRgbLcbLobLebRi
bRobRebLibRobRebRjbLobLsbLibLjbRjbLebLobLobLsbLcbLobLobRobRcbLobRebLcb
RebLgbRobLobRebLcbRebLobLcbRebLcbLebRebRobLobLebRebRobRobRebRobRobLobR
obLgbRebRobRibRjbLcbLobLebLjbRebLgbRsbLibRcbRobRobRobRcbRebRobLhbLjbLc
bRjbRibLobLsbRsbRgbLebLobRhbLcbLobLibRgbRobRgbRcbLcbRebLsbRobRobRjbLcb
RebRobRebRobLob

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 12; Drug: APO 0.5
bRsbRjbRsbLibLhbRgbRebRsbRobRobLjbRjbLgRsbRsbLobLjbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRsbRsLsbsbLsbLsRsbRsbLsbRsbRsbRsbRsbRgbRsbRsRsRsmmbsbRgbsbLsbLjbLgbLs
bRsbLgbLsbRsbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsbLsbLsRsbRsbsbLsbRsbLsbRsRsmbLsbsbRsbRsbLsbRsbLsbLsbLsbLgbLsL
sLsmmbRsLsbLsbLsLsmbRsbRsRsLsmbLsbRsbLsbLsbLsbRsbLsbLgbLsRsbRsbLjbLsbL
gb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLibLsLsLsmmbLsbLsbLsRsbLsbLgbLsbRsRsmbsbLsbLsbLgbLgbLsbRsbRoLsbLsbRib
sbRsbRsbRsbRgbRsbRgbsbRgLsbRsbLsLsmbLjbLhbLsbRsbRsbRsLsbLsbLsbRsRsmbRi
bRibLsbLsbLgLsbLibLgbLsLsmbLgbLsbLgRsbLcbLsLsmbLsLsmbLcLsmbRsbLsbRiRsm
bLcRsbLhbLsLsmbRsbLgLsbLgbLibLsbLsLsRsmbLsbLsbLiRsbLibLibLgLsbLhLsbLsb
sbLibLsbLiLsbLgLsbLibLibLgbLsbLgbLobLibLgbLiLsbLgbLgLsbLsLsmbLibLgLsbL
gbsbLgLsbLgLsbLgbLgbLgbLgbLibLgbLgbLibLsbLibLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLgbLgbRsbRgbLsRsbLsbsbRsbsbRgbRsbLsRsbsbsbRsLebRsbRjLsLsmbLjbRjRsmbRg
bRsbRsRsmbRsbRgbRsbRsRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRsLsbRgbRsLsbRsbsbsbsbsbLsbLgLsbsbRsLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRgbLsbLsbLsLsmbLgbRjbLibRjbRibRcbLjRsbRobLsLjbRcbRiLsbLibRsLsbLobLsbL
ibRgbRgbLsbsbRgbLsRsbLjbRgbRgbLebLgbLgLsbLgLsRsbLgbLgLsbLgLsbLgbLsRsbL
gbLibRgbRjbRcbLoRsbRjbRcLsbRhbLsbRgbLsbLgbLgbRsbRjbRibLjbRjbRibsbRgbRg
bRjLsbLjLsmbRgbRibRjbLjbLobRgbLhbRsbRsbLibRjbRibLobRgbRhRsmbLjbRcbRibL
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bLobRobRsbLobRsbLebRobRsbRjbRcbRjbLjbRobLjbLjbRjbLebLebLebLsbLobRebLcb
RebRobRjbLebRjbRcbRjbRobRebRebRebLobLobLebLcbLebLcbRebRjbLjbRsbLobRsbR
ebLobLjbLebLebLjbLebRsbRjbRsbLobRebRsbLsbLjbLjbLebLcbLjbRebRcbLebLobRj
bRsbLjbLjbRobRcbRcbLcbRsbRebRobRcbRebRgbLcbLsbLsbRcbRobRobLebLjbLsbRjb
RobLebLobRjbLsbLsbLebLcbLobRjbRebRobRobRjbLobRjbLobLsbRobLobRjbRebLsbL
ebLobRjbLebLjbLjbLebRobRobLobLobLobLjbLjbLjbRobRebRobLobLobLobRebLjbRj
bLobRebLcbLjbRjbRobRsbRcbLsbRsbLobRcbLsbLjbLcbLebLsbLcbRcbLobRobLebRob
LobRobLobRcbLsbLobLebLcbLcbRebRebRcbLobRobRcbLsbLobLjbLgbRcbRhbRjbRsbR
obRobRobLjbRsbRebRjbRobLobRobLcbLebLobRobLcbRsbLjbLjbRobRcbRobLsbLobRe
bLebLebRcbRcbLjbLjbRjbLsbRobRcbLjbLobLjbLebLobRobLcbLgbLjbLobLobRsbLob
RobLcbRebRibLobRebLcbRebLobRebLobLobRebRobRjbRsbRjbRebLjbRobRhbLobLobL
obLebLjbLebRebRcbRcbRobLobRobLobRibLgbLobLcbLobRebRjbRobLobRobRobRibLi
bLebLebRsbRobLcbRsbRobRjbRobRjbLobRhbLjbLjbRobRebLsbRsbLsbLobLebRsbRob
LjbLjbRebRcbLcbLobRobRsbLebRebLobLhbLsbLsbLebRjbRebRebRebLcbRcbLebRsbL
ebLobRobLcbRobRjbRebRobRcbRgbRebLobRibLebRebRjbLsbRebRjbRobLebRobLjbRo
bRobRjbLobRebLsbLsbRobRebRebRgbLsbLibLjbRobRebRobLobRcbLjbRobLebRobLob
RcbRebLebLobLebLobRsbLebLsbLcbLcbRibRobRobRebLobRobRobRobLobLobRcbRobL
cbLobLebLsbRobRhbRjbLcbRsbLobRobRobLobLsbRsbRjbLjbRcbRibLobLobLsbLobRc
bLobRobLobRjbLobRebRobRjbRhbRsbRobLobLibRobLcbLcbLobLgbLcbRcbRsbRobLjb
RibLobLobLebRsbRebRcbRobLcbLebRsbRobRobLebRobLebLcbRibRobLebRobRebLgbR
obRcbRobRjbLsbRebLobRobRobLobLsbRobLobRcbRjbLobLobRobRibRebRjbLebLobLo
bLobRjbRgbRebLobRibLebRobLobLcbLcbRobLobLobRebRobRsbRsbRobLobLibRgbRob
LobLobRhbRcbRobLobRobRsbLobRobLcbRobRebLjbLsbRobLsbRebRobRibLobRobRjbR
ebLcbLobLsbRebLjbLobRobLebLobLjbRjbLebLebRjbRobRobLsbRcbLebRjbRjbLibRj
bRobLjbLjbLobLjbRobRobLobRobLobRobRcbLcbRebLebLobLobLcbRobRibLobRjbLob
LsbRcbRsbRobRebLobLebLjbRcbRsbRcbRebRobLobRebLobLobLgbLebLebRobRobLcbL
ebLobRebRobLobLjbLobLcbRebRebRcbLsbLobLjbRsbRjbLobRobLebRcbRobRobLobRe
bRibLjbRebRobRobLebLjbLebRebLcbRcbLobRobLobLcbRobRsbRebLjbRebRjbLjbRjb
LobRcbRebLebLjbRobLebLobLebRobRsbRjbRebLebLcbLebLsbRobLobRsbRobLobRobL
jbLjbLsbRebLebRjbRjbRcbRebLjbLobRjbLobLjbLobLebRjbRjbRobRcbRebRebRobLe
bLebLsbLebLsbLjbRjbRebRcbRjbRsbRebRobRsbLcbRobLebLobRcbRobLjbLebLebLjb
RjbRebLebRobLobRobRobRobRobRobRebLebRobLjbRcbLobLcbLcbRobLebRcbLjbRobL
sbRjbLebLjbRjbLsbLobLjbLobRhbRebLebLebLobLobRsbLsbLebLobRobLobRobRjbLo
bRebLebRobLebLebLebLibRobRjbRcbRobRobRobLobRobRobRcbLobRobLjbLjbRobLcb
LobLjbRobRhbRjbRobRjbRjbRebLobRobLcbLsbLjbRebLobLcbRjbRobLcbLobRobLsbR
ebRsbRobLobLobRsbRjbLcbRcbLjbLobLobLebRobLjbRjbLebLcbRobRobRobLobLsbRe
bRebRebRcbRebLcbRcbRjbLjbLebLebRcbRobRcbLobLobLsbRsbRobLsbRsbRsbLjbRob
RebLebRobRjbLcbRobRobLobRjbLobRjbLebLsbLjbLjbLjbRobLobRobRcbRebLcbLjbL
cbRebLobLebLobLebLobLobLsbLcbLebRebLsbLobRjbLjbRebRcbLsbLebLobLebRjbLj
b

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRsRsmbRsRsmbsbLsbLjbRibRsbRsRsmbLsbLsLsmbLsbLsLsmbLsRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLebLebRcbRibRibRhbLobLcbRobLibRobLobRobRobRobLebLcbLobLobRobLjbLibRcb
RgbLebRobRobRebRobRibRcbRobLobRobRebRgbLcbLobLebRobLcbRobLebLibRgbLcbL
obLibLobRgbRobLcbRobLcbLobRebRebLobRcbRobLebRhbLsbLobRobLobRebLobLebRh
bRebRcbLcbRsbRebLobRobRcbLobRebRobRibRcbLobRobLsbRebRcbRobRebRsbLebRob
RobLobLobRibLgbRebRgbRcbLebLcbLcbRgbRcbLebLobLibRobLgbLobRibLcbLgbLebR
obLibLobRcbLobLcbRebRebLobRobRibRobRobRcbLobRebLobLibRobLibLobLobRobLs
bLobLsbLebLobLobLebRhbRobRebLgbLcbLobLsbLobLobRobLsbRcbLcbLsbRibLobRsb
LobRsbRebLobRibLobRhbRobLebRcbRobLcbLibRobLobRcbLcbLibLobRobRibLebRobR
cbLobRobRcbLobLcbRebLsbRobLobLsbRsbRobRobRobLobLhbLcbRobRcbRcbRcbLcbLc
bLobLobLebRcbRcbRobRcbRobLgbRibLebLobLebLcbRibLcbRebRibRebLjbLcbLobRgb
RgbRobRobLobRhbRobRobLcbLobRibRgbRgbLobRebLgbRgbLobRebRcbRcbLebLgbRobL
ibLcbRhbLebLsbRcbRobLibRobRcbRsbLcbLhbLobRgbLhbRcbLibRobLcbRcbRibRgbRi
bRgbRebLobRobRobRobLobLobRgbRsbRobRgbLgbRebRobRgbLcbLebLebRobRobLcbLob
RobLobLobLebLobRebLobRibLgbRgbRebRobLobLobLcbRcbRobRebRebLebRobRobLobR
cbRobRobRcbLibLobRibLebLobLobLebLobLcbLhbLebLobRobRobLobLobLobRebLsbLc
bLibRibLibLobRobLobRhbRobLobRibRebRibRobRebLobLgbLobLebRobLobRcbLobLib
RobLebLebLobLsbRobLobLcbRobLobLobLibLgbRgbRebLibLibLebLjbRgbLgbLcbRobR
obLebLebRobRebRibRobRobRobRobRcbLibLgbLobRobRobRcbLebLcbRobLobRgbRobRo
bRobRibRebLcbRobLibLebLebRebRobRobLobLobLobLobLebLcbLobRcbRibRsbRebLeb
RobRgbLobLebLgbLobLgbLcbLebLobLgbRgbRibRebRobLobRobRcbRobRebLcbLobLobR
obRsbLebLjbLgbRibRebLobRobRebRcbRobRibRcbRebLebLsbRobLobLibLobLobLgbLh
bLebLebLebLsbRebLcbLgbLobRobRobRhbLobLobRcbRgbRobRobLcbLobLobLcbLobLcb
LhbLcbRobRgbLsbLebLobLobRobRebLobRebLgbRcbRebRsbLsbLebLobLobRobRsbLgbL
cbLebRebLebRebRgbRgbRhbRgbRsbLobLsbRjbLobRgbLsbLobLebLibRsbRibRebRobLo
bLobLobLobRebRebLobRibLebLobRgbLobRobRobLobRebLhbLibLcbLobLibLgbRobLob
RobRobRobRebRcbLebRebRebRobRebLobLcbRgbRibLebRobRobRebLobRgbRobLibRibL
obLebRobRcbRcbRobRebLebLebRcbLibLobRcbRobLobLgbRobLebLobLjbLsbLebLobLc
bLobLgbLsbLibRobRgbLobRobRibLebLcbRebRobRobRcbLobLebRobLebRcbLobRebRcb
RobLgbLhbRebLcbRebRobRcbRebRobLobRobRobLobLibLibRebLsbLebLobLobRebRgbL
cbLobLobLcbLcbLcbLobRebLobRebRhbLsbLgbLobRhbLobRcbLebRcbLhbLobRebLobRe
bRcbLobLibRsbLsbRobLobRcbLibRobLgbRcbRsbLibLcbRhbRcbRibLhbLcbRcbLibRcb
LcbRebLcbLobRobRebLcbLcbRobRsbLobLobLobLobRcbRobRcbLibRgbLobRcbRibLebR
ebLobRebLsbLobRebRibRebLhbRobLobRcbLebLcbRgbRobLibRobLobRibLebRcbLobLo
bRebLcbLgbRobLibLhbLobRebLobRibRcbLobLobRobRebLibRcbRcbRobRebRcbRibRgb
LgbRobLcbLobLcbLibLobRcbRsbRcbLobLobRobLebRobRebLibLibLcbLobRcbRobLcbL
gbLobRcbRobRgbRebLcbRcbLebRsbLcbRgbLobRobLobRobRsbRcbLobLgbLsbLobLebLe
bRobLcbLebLobLebRibRobRobRhbLhbRibLebRobLibRebLebLebRibRobRobRsbRcbLib
RobRibLcbRibRibLobLebLobRobLibRobLcbLebLobLebLcbRebRcbLobRobLobRobLcbR
ebLebLobRobRhbRobLobLebLebRebLsbLobLhbLobRebRobLobLobLobRobLgbLgbLobRo
bRobRebLhbRibRobLobLcbLcbRsbLebLobLcbLgbRobLobRobLobLebLobRibLcbLobLeb
LebLcbLobRcbRebRgbLebRobRcbRibRobRobRsbRcbLibRgbRobRobLebLebLebLobLobL
gbRobRobRcbRobLcbRobRcbRobLebLcbLhbLebRebLgbRobRobRcbRebLobLebLebLobRc
bRibLobLibRgbRebRcbRcbRobRcbRgbRobLcbRobLobRebLebLibLcbRobLobRcbLcbRcb
LobLebRibRobRsbLcbRcbLobLhbRgbLobLobLebLsbRebLobRebLcbRobRobLobLibLobR
sbLcbRsbLobLebRebLebLobLobLsbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLgbRsLsbRsLsbLsbRiRsmbRsbRgbRgbRsbRgbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRs
bRsbRsRsmbRsbLsbLsbLsRsbLsLsmbLsbLsbLsbLgbRsRsmbLsbLsbLgbLsLsLsmmbLsbL
sbLsbLgbLsbLsLsmbLgbLsbRsbLsbLsLsmbLsbLgLsbLgRsbLgbLsbLsbLgbRsbLsbRsLs
bLgbLsLsmbLsbRsbLsbRsbLsbLsbLsbLsbLsbLgbLsbLsbLgbLsLsmbLsbLsbLsbLsRsbL
sbLsLsLsmmbLsLsmbLsbLsbLsbRsbRsbLsbLsbLsbLgbRsbLsRsbLibLsbLsbRgbLjbLib
LsbLsbLhbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRsRsmbsbsbsbsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bLsbRsbRsbRsLsRsbRsbRsRsmbRsbsbRsbRsbRsRsmbRsbRsbRsbsbsbsbRsRsmbRsbsbs
bRsbRgbRsbRgbRsbRsbRsbRsbRsbRgbRsRsmbRiRsmbLsRsbLsLsmbRsbRsRsRsmmbRsRs
mbRsbRgbRsbRsbRgbLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bRsRsLsmbLsLsLsLsmmmbLsRsRsLsmbRgbRgbRsRsRsRsmmmbRgRsmbRibRsRsmbsbRsbR
ibRsRsmbRsRsmbRsbRsRsmbRgbLsRsbRsbLsRsbLjbLhbLgRsbRgbRsbRgLsLsmbRgRsLs
mbLsRjbLsbRsRsmbRgbRibRsRsmbRgbRsLsbRobRibRsbRsbRgRsmbRsbRsbRgbRgbRsbR
gbLsbRsbRsbRgbRgRsmbRgbRsbRsbRgbLsRsbRsbRsbRsbsbLsRsRsmbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLgbLsLsLsmmbLgbLsbLsbRebLsbRibRobRibRsRsmbLgbRsbsbsbsbsbsbsbsbsbLsbsb
LsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bRsbRsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bRsbRsbLsbLsbLsbsbRobsbRsbLjLsmbsbLgbRobRibRsbRsRsmbLsbRoLsbLsbLsbRsbL
ibRjbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLgbLsbLsbLibLgbLiLsbLsbLsbLsbLebLgbLgLsbLsLsmbRobRsbRsbRsRsmbsbLgbLjb
RgbRsRsmbRsRsmbRsbRsbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 31; Drug: APO 0.5
bRobRjbLhbLgRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 32; Drug: APO 0.5
bRibRsRobLcbRsRsRsmmbLsRgLsbLgbLgbLsbLgbRsbLsbLsbLsbLibLsbLsbLsbLsbsbR
sbLsbLgbLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 33; Drug: APO 0.5
bLsbLsbRsbLsbRjbRjbRebLsbLjbLobLgbLsbRjbRjbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 34; Drug: APO 0.5
bLobLhbLsbLsbLsbLsbLhRsLsbLcRsbLsbLsbLgbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 35; Drug: APO 0.5
bsbLebRhbRgbRiRsmbRgbLsbRiRsmbRibRsRsmbRibRjbRjbRgbLgbRsbLgbRsbRibRgbR
sbRsbRsbRgbRgLsbRgbLsbRhbRibRiLsbRsbsbRibRibRgLsbsbRsbLsRsbRsbRsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 36; Drug: APO 0.5
bLibRjbRcbLcbRcbRibLjRsbRgbLcbRhbRsLsbLcLsmbRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsRsbLsRsbLsbLsbLiLsbLsbLsLsmbLgbLsbLsLsRsmbLsbLsbLsbLgbLgbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsLsmbLsbLsbRsbLsbRoLsbsbsbRoRsmbsbsbRoRsmbLibLibLsbLsLsmbRsbLs
bLsbLsbLsbLsRsbLsbLsbLsbLsbLsbLsRsbLsbLsbLsbLsbLsbLsbLsbLsbLsbsbLsbLsb
LsbLsbLsLsLsmmbLgbLsbRsbLgRjbsbsbLsbLsLsLsLsmmmbLgbRsbLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bRgLsbRsbRsbLsbRsbRsbRsbRsbRgLsbLsbRsbLsbRibRsbRsbRsbRsbsbRgbRsLsbRgbL
sbLhbLgbLsbLoLsRsmbRsbRsbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bsbLobLcLgbLhbRjRsmbLoRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRsbLobLcLsmbLibLcLsmbLibLsbRobLgbLsbLgLsbLsbRcbRoLsLsmbLsbRgbLobRobRo
RsmbLgbRjbRgLsbLibLibLsLsmbsbLsRsbRsbsbLibRsbLgbLgbLgbRsLsbLsLsmbLsbRc
bLjbRibLcbLhbLibRsbLgbLjbLoLsmbRsbRcLsbLobRcbLsLgbLcbRjbLcbRsbRhbRgbRh
bLcLsmbLcLsmbRgbRhbRjRsmbLobsbsbRhbRjbRsbRgbLhbRgbRsRhbLibLjbRgbLibLgR
sbRsLsbLsbRobRibLsbRsLsbRcLsbRgLsbRsbRcbLibRibRcbLibRibLiRsbRiLsbLsbRj
bsbLsbRcbLgRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bLsbLsbLsbLsLsmbsbLsbLsLsmbsbLsLsmbLsLsmbLsRsbLsLsmbLsbLsbLsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bsbRgbRsbRsRsmbLsbRsbLsbLsLsmbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bRobLsLsmbLsbsbLsbLsbLsbLgLsbLsLsmbLsbRgbLsbLsbLsbLsbLsbLsbLebLsbLsbLs
bLsbLgbLsbLsLsLsmmbLsbLsLsmbLsbLsLsmbLsLsmbLsbLsLsmbLsRsbLsbLsbLsbLsLs
LsmmbLsLsLsmmbLiRsbLsbRsbLsRsbLsbRsLsRsbRjbLibLsbLsbLsbLgbLgbLsLsmbRsb
LsbLsbLsbLsbLsbLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRsbRsRsRsmmbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsRsmbRjLsLsmbLjbRsRsmbR
sbRsbRsbRsbRsbRsbRsbRsRsmbLsRsbRsRsmbRgbRgbRsRsmbRsbRsRsRsmmbRsRsRsmmb
RgbRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsbRsRsRsmmbRsbRsRsmbRsbRsRsmbRsbRsbR
gbRsRsmbRsRsmbRsRsmbRsRsmbRgbLsbRsbRsbRsbRsbsbRsRsmbRsbRsRsmbRsbRsbRsR
smbRsRsmbRsbRsbRsbRsbRsRsmbRsRsmbRgbRsbsbLobRsLibLjRibRibLoRsbRsbRgRsm
bsbRsRsmbRsRsmbRibLsbRsbRiLsbRsbRsbLebLsbRibLgbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRjRsmbLsbLsbLsbLgbLsLsmbsbsbsbsbsbRhbLibRsbRgbRsbLoLsmbsbRsbLsLsLsmmb
LsRsbsbsbsbLiRsbRsLsbLsLsmbRjbRobLsbLsRsbLsbsbRhbRobLsbsbsbRsLsbRgbRsR
smbRsbsbLsLgRsbRgbRsRsLsmbRsRsmbLsLsmbRsbRibsbsbRsRsmbRsRsmbLsLsmbRsbs
bsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 133639; End: 134140;
Recording: 7-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bRsRsRsmmbsbsbsbsbsbRsLsbLsbRsLsbLsbLsRsbLsbRsbRsbLsbRsRsRsLsRsmmbsbRs
LsbLsbRsRsLsLsmmbLsbRsLsbRsLsbRsLsLsmbLsbLsbLsbLsRsLsbRsbsbRsbRsbRsbRs
bRsRsmbRsLsbLsbLsbLsbLsLsmbLsbLsRsbLsRsbRsLsRsbLsLsmbLsLsmbLsbsbsbsbsb
sbsbsbsbsbsbsbsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRgRsmbRgRsRsRsmmmbRsRsmbRsRsRsLsmmbRgbRgbRgLsbRsRsRsmmbRsRsmbRgLsbRgR
smbRsbsbLebRgbRjRgRsmbLobRsbRibsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbLsRsbsbs
bLsbsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbsbsbLsbLsbRsRs
LsmbsbRsbLgbRsbRgbLsLsmbsbRsbRiRsmbRgbRgRgbRiLsbRgRsmbRsbRsbRgRsmbRsRs
mbRsbRsRgbRgbRsbRgRsmbRsbRgbRgbRsRsmbRgbRgRsRsmmbRgbLsRsRsmbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bLsLsmbsbLsRsbRsbRsbLsbLsbsbsbRsbRsLsbsbsbsbRsLsbRsbLibLgbLsbLgbsbLsLs
mbLsbLsbRebLsbsbsbsbRsbRsbLsbLgLsbLsLsLsmmbsbsbLsLsmbLsLsmbLsbRgbLsbRs
bLsbRsbLsbRsRsmbRgbsbRsbRgRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsLsmbLgbLgLsbLgbLgbLgLsRsLgbLsLsmbLgRsbLsbLgbLsLsRsLsmbLgLsbLgbLgbLi
bLsbLgbLibLgbLsbsbsbRsbRsbRsRsmbLsRsbLsbLsbsbRsLsbLsbsbsbLgLsLsmbLsLgR
sbLsLsmbLgbRsbLgLsbLgbLgLsbLsLsmbRsLsRsLsbRsLgbRsLsLsmbLgLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsLgLsLsmbLsbLgLsbRsLsRsbLgLsLsmbLsLgLsbRsbLsbRgLsLsmbLsbLsbLsbsbRsbL
sbRsbLsLsmbLsbRsbLsbRsbLsbLsbLgbLebRsbRsRsmbLjbRcbLsbRobLsbsbRsRsRsmmb
LsbRsRsmbRsbLgbRgRsmbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsbRsbLgRsbRsRsmbLsLsmbRsbRsRsmbRsbRsbLsLsmbLsRsbRsbRsbRgbRsbRsbRsbRs
bRsbRsRsmbLsRsbLsRsbsbsbLsLsmbRsbsbsbsbRgbRibRgbRsLsbRgLsbLsbRsbRsRsmb
RsbRsRsLsmbRsbRsRsmbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLgbLoRsbRsbLsRsbLsbRobRibRobLsbsbRgbRsbRsbRsbsbRsbRsRsmbRsbRsbRsbRsbR
sbsbLsbLgbLsbLsLsmbLsbLsbLsbLiRsbLgbLsbRobRgRgbRsbRgRsmbRsRsmbRsbRoLsb
LsbRsRobRsbRgbRsLsbLsbRsbRsbRsbLsRsbRsRsmbLsRsbRsRsRsmmbRsbRobLsbRhbRs
bLebLobLsbLgbLgbLgbLgLsbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 7; Drug: APO 0.5
bsbsbsbsbRibRsRsRsmmbLsRsbRsbRjLsbRobRgbLsbLobLhbLiLsbLsbRsRsmbRsbsbsb
sbsbLibsbRibLsRsRsmbRjRsmbRsbRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 8; Drug: APO 0.5
bLjLgRsbsbRsbsbsbsbLibRgRsmbsbsbLsbsbsbsbLjLsLsmmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 9; Drug: APO 0.5
bRgbLebRsbRibLebsbsbRsRsmbsbsbLsbRsLsRsbRcbLsLsmbLcLsmbLsRsLsbLsLgbLib
Lib

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 10; Drug: APO 0.5
bLjbLibLhbLgbRgbRgbLgbLibLiLsbLibLiLsbLsbLibLibRebLibRjbLsRhbLibLsbLgb
LsbLsbRibLibLgLsbLcbLhbLhbRsRiRgbRhbRsbLgbLsbRgbLjbLgbLjbRgbRsRsmbLibL
sLsmbRjbRibRsRsmbLibsbLibLgbRibRgbRibsbsbRgbLsbLobLobLgbLgbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 11; Drug: APO 0.5
bRjbRoRjbLsbLsbRsbLsbLobLobRsbLebLjbLebLsbLobRjbLebRebRobLjbRcbRebLobL
jbLjbRjbRobRsbRobRebRebRobLsbRebLobLobLcbLcbLebRebRebRjbRjbLjbLgbLgbLj
bLcbLsbLebLobLobLcbRebLcbRobRobLobLjbRcbLobRobRobLobRobLgbLjbRobRobLob
RobLsbRebLcbRobRjbRobLjbRebRobLobRobLebLibLhbRobLobRjbLebRebLcbRsbLcbL
sbLebLobRobRobLcbRjbLobLjbRjbRebRobLebLobRjbRobLjbLcbRobRcbRobRobRebLo
bLobLsbRobRebRsbRjbLobRebLobLcbLjbLsbLsbLobLobRobLsbLsbLcbRobRsbRobRsb
LjbRsbLobLobRebLobLcbLjbLsbLebLcbRjbLjbLsbLjbLebRobLobLobLebRebRebRebR
jbRsbLebLjbLobRjbRobRebRjbRobLjbRebRjbLobLobRebLobLebLebRobLsbLjbLsbRe
bLobLobRsbLcbRcbRebRebLebRobRsbLsbLibLobLsbLobLjbLobRcbRebLebRjbRebReb
LobLebRebRcbLcbLcbLobRebLobRebLebRjbLobRjbLjbRebRobLjbRjbRjbLcbRebRcbL
obRsbLebLjbLcbLcbLobRcbLobRobLsbLebLobRobLsbLebRjbLobLobRobLobRebRebRo
bLobLobRobLobLsbRcbLobRebRsbRjbRobLjbRebLobRebLjbRcbLobRjbRobRebLebReb
RcbLsbLebRebLebLebRsbLsbRobLsbRebLsbLhbLobRobRobLobRcbLgbLobLibLobLobL
jbLsbRobLsbLobLebRsbLsbLebLobLobLsbRobLcbLobLobRebRebRebRebLcbRobLebRo
bLjbLjbRebRsbRjbRcbLjbRjbLobLobLcbLjbRebLsbLebLobLsbLobLjbLobRsbLobRjb
LsbRcbLsbRobRsbLsbLjbLcbLobLebLobRobLobRobLebLjbLcbLebRobRjbLobRebRebR
ebLobRebLebRcbLobLobLobRjbRebRcbLobLebLobLobLjbLsbLebLebLjbLgbLcbRsbLo
bLsbRebLsbLebRobRsbRcbLebRsbLcbRcbLobLcbRebLebRobLsbLjbRebLebLjbRsbReb
RsbLhbRjbLsbLebRebRobRjbRjbLjbRobRcbRebRsbLobRcbLebRebLjbRsbLsbLjbLebL
obRjbRebLsbLobRsbRsbRobRsbRobRcbRebLsbRebLobRebLebRebRobRcbLsbLsbLobLe
bRobLsbRcbLcbLjbLibLobRobRsbRsbRebRobLebLebRcbRobRjbLebLobLebRebRobLjb
RjbRobRsbRobRjbRcbLobLjbRjbRcbRjbLebRsbLobRobLobLebLsbLobLobLebLebLsbR
obRobLsbRobRebRsbLebLobLsbRsbLobRobLsbLobLcbLebLebRsbRebLjbLcbRjbRobRe
bRebRebRobRebLobRsbRjbLcbRebRjbLobRobLebRebRjbLsbLjbLebLjbLebLobRsbLeb
RsbLobLjbRebLjbRjbRjbLjbRebLobRcbLsbLobLjbLsbLobRobRebRebLsbLsbLobRjbL
obRobRobLobLobRobLobLobLjbLobLebLebLjbLobRjbLebLebLsbLebRsbLebLobRsbRj
bLjbLebRcbRobRsbLobLsbRebLsbLcbRjbLjbRsbLobRobRebRsbRebLebRobLobLsbReb
LebRjbLebLobLobRebRobRobLobRcbLobLsbRjbRjbRsbRsbRebRjbLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 12; Drug: APO 0.5
bLsLgbLsbLsbRsbLsbLsbRjbLgbLjbRsRcRsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bLsbLgLsbLsbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRsbRgbLsbLgLsbsbRgbLsbLsRsbRsRsmbRobLsbLsbRsbLsbRsbLobRsbRsbLsbRoLsLs
mbRsbsbRsbLsLsmbLsbLsLsLsmmbRsLsLsmbLgbLsLsmbLsbLgLsbLgbLgRsbLobLjbLjb
RobRsbRgbRsbLsbRsLsbRsbRibRsLsbRgbRgLsbRsRsmbLsLsRsmbsbRsbRsbLsbRsRsRs
mmbRsbRsbRsbRsRsmbRsRsmbRsbLsRsbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bRgbRsLsbLgLsbLgbLgLsbLgLhLsLsmbRsbLsbLibsbLibLibRgbLgbLsLsmbRsRsmbLsR
sbsbsbsbsbLsLsmbLgLgbLgbLsLsLsmmbRobRgbsbLibRsbLebLsLsmbLgbsbRsLsbsbRs
bLgbLgLsLsmbLibLgLsbLibLibLsLsmbLgbLgbLibLiLsbLgbLgRsbLgbLgbLhLsbRsRsm
bLsbLgbLgLibLib

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLsRsbRsRsRsmmbRgRsmbRgbRsRsRsmmbRgbRgbRgbLcbLobRcbLcLsmbRhbLhbsbLgbLs
RsbLsbRsbLsbLebRsbRsbRsbRsbLiRsbLsRsbRgbRsLsbLgLsRsbLsLsmbRsbLsbLsbRgb
LsbRoRsmbRsLgbLsbLgbLgbLgbLgLsbLgbRsbLsLsLsmmbsbRoRsmbRgbRgRsmbLibRsbs
bRsLsbRsbRgbLsbsbLsbLjbLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bsbLsbLsbRsLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRibLsbLsbLgbLhbLcbRsbLsLgbsbLiLsbLobLgbLsbLjbLobLibLsbLiLsbLsbLgLsbLg
LsbRsLsLgbRsbLibRgbLgbRgbLjbRcbRibLsRiLsbLibLsbLobLibRcbLibRibRibLiRsb
sbsbsbsbLjbRibLgLsbLhbLibLibRsbLibLgLsbLgbLgbLgbLgbLiLsbLsLsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bLgbLsRsLsbRsbRsbLsbsbLgLsbLsbLsbLgbLsbRcbLsbRgbLgbRsbRgbRsbLsbLsbLsbR
sbsbsbLsbLjbRsbLsRsbLsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRgRsmbsbLsRsbLsbRsLsbsbRsbLsbLsbRsbRsbRsLsbLsbsbRsRsmbLsRsLsbLsbRsbsb
sbLsbRsbRsbLsRsbsbRsbRsLsbsbsbsbRjLsbLsbRgRsRsmmbRgbRsbRgbRgbRsbRgbRsL
sRsbRobLsbLgbLgbLsLsmbLsbLgbRsbRsbsbRgRsmbRsbsbsbRsbsbRsbLobLsbLsbLhbR
gbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bLobLebRjbRobLobRcbLobLobRcbLcbLibRibLebRobRobRgbRebRcbLobLobRgbLcbRob
LobLobLobRebLobRhbLcbLobLebRcbRcbLobRobLobRebRebLcbLobLgbRobLibRobLobR
cbRobLcbLobRobRobRgbRobLobLibRobLobLobLobLobLobRobLobLebLibLobLebLcbRo
bLibRebLobRobRebLobLibRebLobRebLobLobLobRsbRgbRobLebRgbRebLcbLgbLebLcb
LibRibLobRcbLobRebRebRobRjbLebLobLobLobLibLcbRobLibRobRobLobRobRcbRebR
ebRobRibRsbLjbLobLgbLjbLebRobLobRobRcbRobRcbRsbLgbLsbRobRobLebRcbLobLo
bLobRebRobLcbLobLsbRgbRobLjbLgbRobRibLebRsbRsbLebLobLgbLibRebLcbLobRcb
RibRobLsbRobLcbRobLcbLgbLobRhbLcbLobLebLsbRibLebRibRobLibRcbRebRcbRobR
sbLgbLobRsbLcbRgbRobRebRebRgbLsbRobRgbLobLobLobRjbRebLobLibLobLebLobLe
bLobRobRgbLobRobRebLobRobRibLsbRebRibRibLebLhbLobRobRibRhbRjbLsbLibLob
RobRobLobRebLebRsbLebLgbLobRobLsbLobLibLobLobLebLebLobRcbRsbRobRebRgbL
obRobLobLcbLcbLgbLobLcbRobRcbRobRsbLobRobRobRobLebLobLobLgbRobRibLgbLe
bLobRobLobRgbLobLibLcbLobRobRobRebRebLcbLsbLobRobRobRgbRibRcbLebRgbLob
RsbLhbLobLebRcbRebLobLobLebLibLibLcbRebRobLsbLobLsbLobRobLobLobRsbRhbR
cbRobLibRjbRobRobLobLcbLebRebLgbRobLgbRobLibLobLebRobRhbLcbRobRebLjbLo
bLgbRgbRebLcbRgbLobLobRgbLobRobLgbRcbLebLobLebLebLobRebRibLebLcbLcbRob
RobRobRebRebLebLibLebLebLebLobLgbRcbRebLobRcbLobLobRcbRcbRsbLebLebRgbR
sbRobLibLebLobLobRobRobLobRobRgbRobLobLcbLobLobLobRcbRcbLcbRobLobLcbRs
bLebRobRebRcbLobRobLibRibRobLobLibLsbRcbRobRcbRobLobLobLcbRobLgbRgbRcb
RsbLebRobLobLobLobRobLobRibRobRobLibRobRobLgbLebLebLebRobRobLobRebLobR
obRgbLgbRobRebRebLsbLobRebRobRcbRebRebRobRcbLebRobRobLebRobRobLebRobRo
bRgbRebLobRebLcbRobLhbRcbLcbLobLcbLcbRebRcbLobRebLobRobRobLobRebLsbRcb
RobRhbLobLobRobRgbRebLhbLebLcbRobRgbRebRcbLobRgbRcbRobRcbRobLebLcbLcbL
ebLcbRobRebRobLobLcbLsbRobRgbRcbRobLgbRcbRobRcbLcbLobLjbRcbRobLebRhbLo
bLcbRcbRcbLebLobRibRgbLsbLebRebRgbLobLobRcbRobRcbRobLcbRobRobRcbRobRib
RgbLobRobLebRobLibRobLibRsbLcbRobLcbLjbRcbLcbLsbLobRebLobRobLebLebRobL
obLcbLobRobLobLgbLebLobLsbLobRebLebRobRcbRobRobRibRebLobLibLhbLobRcbRs
bLebRebRebRobLobRcbLobRebRebRobLobRibRgbLobLobRebRobRobLhbLobLebLobReb
LibRebRhbLcbRobLcbRobRobRobLebRcbLobLebRobLsbRcbRibRibRobRobRobLebRcbR
ebRcbRobLibLsbLobLibRebLobRcbRebRobRcbLebRobRgbLibLobLobRobLobLobLobLc
bLobLebLobLebLcbRsbRebRobRhbRobLcbRcbRobLobRobLobRobLcbRcbRebLobLebRcb
LibRibRsbRcbRobLobLobLobRibRobLobLsbRobRhbRibLcbRobRebRhbRsbRgbLobRebR
ibRobRobRobLsbLcbLibLebRibLebRobLobRobRcbRebRebRobLcbLobRobRebLcbLobLc
bLsbRobRcbRobRjbLhbLebLobRobLgbLsbRobRobLobLcbLebRgbLebLebRobRhbRebLob
LobRobLobRobRobLebLebRsbLobRcbRibRcbLobLobRcbLhbLibLsbRobRebLobLobLibL
obLcbLibRebRobLcbRgbRgbLobRebLobLobLsbLgbLcbLebRgbRobRobRobRcbRgbLcbRo
bRebLebRcbLebRsbRebLebRgbLebLobRebLobRibRsbRobRcbLebRobLebLobRebRobRob
RobRobRhbRobLsbRhbLobLebLgbRobRjbLebRcbLcbRebRobLebLobLcbLobRhbRobRobR
obRcbLcbRcbLcbRcbRobLjbRcbRebRgbLcbLcbLebLcbRsbRcbRobRsbLobRebLebLobLo
bLobRibLobRibRobLgbLobRobRcbLobLobLobRgbLgbRebLsbLebRgbLobRebRobRobReb
LgbLcbLobLobLsbLobLobRobLcbRgbLobLebLcbLebLobRebLobRebRcbLcbLobLsbLcbL
jbLebRgbRobLhbRsbRebRibLebLobRsbRobLebRgbRcbLobLobRobLobRcbLobRcbRgbLe
bRcbRobLebRobLebRgbRcbLgbLhbRobLsbLobLcbLobLebRebLibReb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLiLsbLsbRsbLgbLgLsbRsbLcLsmbLsbLgLsbLsbLsbRibRsbRsRsmbRgbRjbRsRsmbLsb
RsLsbRsRsmbRsbRgbRsbRsbRgbRsRsLsmbRgbRsRsmbRsRsmbRsbRgbRsbRsbRsRsmbRsb
RsRsmbRsbRsRsmbRsbRsbRgLsbRsbRgbsbRsbRgbRsbRsbsbRsLhbRsRsmbRsLsbRsbRsb
RsbRsRsmbRsbRsbRsbRsbsbRsbsbRgbRsbRsRsRsmmbRsbRsbRgbRsbRgRsmbRgbLsbsbR
gbRgbRsbRsRibRsbRgbRsbLsbRgbRsbRsRsmbRsbRsRsmbRsRsRsmmbRsbRgbRsbRgbRsb
RsbRgRsmbLsbRsbRsbRsRsRsmmbRgbRsLsbRsbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsRsm
bLsLsmbRsRsmbRsbLsbRsRsmbRsbRgLsbRsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsRsmbR
sbLsbRsLsbRgbLsRsbRsLsbRsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRgbRsRsmbRsbLsbRgRsRsRsmmmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRsbRsRsmbRsRsmbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bRgbRgbsbsbRsRsRsmmbLsLsmbRsbsbsbsbLsbLsbLsbLsLsmbsbLsbLsRsbLsbLsbsbLs
bRsbRsbRsbRsRsmbLsRsbRsLsbLsLsmbLgRsbLiLsbLsbRsbLsRsbRsbsbsbsbsbLsbLsL
smbLsbLsbLsbRsRsmbLsbLsbLsbLsLsmbLsbLsbLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bsbRsbLsbRsbRgbLibLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bRsbRgRsRsmmbRgbLsLsmbLsbRsbLsLsLgmbLsLsmbLgbRsbLgbLsLsmbLgbLsbLobRsbL
sbRsbLsbLsbLibLsbLsLsmbLsbsbRgLsRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLgLsbLsLsLgmbLsRsbLgRsbLsbLgbLsLsmbLsbsbLoRsbLsLsmbLsRsbLsLsmbLgLiLiL
sLsmbLobLsbsbLsbLgbsbLsRsbRsRsRsLsmmbLsRsbRsLsbRsbsbRgbRgRsRsLsmmbRobL
sbLsLsmbRsRsLsRsmbLgbLobRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 31; Drug: APO 0.5
bsbRsbRgbRsbLgLsbRsRsmbLsbRsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 32; Drug: APO 0.5
bRgbRgbRgbRsLsRsbLsLsmbRgRsmbRgLsbRsbRiRsmbRibRsbRgbsbsbRibRibRgRsRsRs
mmmbRgbRgbLsbLgbRsbLgbLgbRsbsbRgbLsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 34; Drug: APO 0.5
bLsbsbLsbsbsbLsRsbLsRsLsbRsbRsRsRsmmbRsbLsbRsbLsRsbLsbLsbRsLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 35; Drug: APO 0.5
bRibRcbRjbRibRebRibRcbRibRibRcbRgbRhbRcbLsbRjbRjbRsbLsbRcbLsbRgbsbRgbR
ibRgbRibRgbRiRsmbRgbRibLsbRsbRgbRsbRgbLsbsbLsbsbsbRsbRsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 36; Drug: APO 0.5
bRiRebLhLsbLsbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsLsmbLsLsmbLsbLsLsLsmmbLsRsbLsLsmbLsLsmbLsbLsbLsRsbLsbLgbLsbRs
bLsLsmbLsbLsLsmbLgbLsLsmbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLiLsbLsbLsbLsLsmbLsLsmbLgbLsbLsbLgRsbLsbLsbLsbLgbLsbLgLsLsmbLsbLsLsLs
LsmmmbLsbLsbLsbLsbLsLsmbLsLsRsmbLsLsmbLsbLsRsbLgbLsbsbsbLibLsbLsbLsbLg
bLsbLsLsmbLsbsbLgbLsRsbLsbLsbLsbLsbsbRsLsbsbLsLsmbLsLsmbLsLsmbLsbLsbLs
LsmbsbLsLsLsmmbsbsbsbLsbLgbLsbLibsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bRoRsmbRsbLcLsLsmmbRsbRsbLibLsbLsbLgbRjbRsbRcbsbsbRsLsbRgbRgbRsbLsRsbL
obRsRsmbRgRsRgmbRgbRsRsmbRsRsLsmbRgbRiLsbLoRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bsbsbsbRjRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bLibRgbRibRhbRgbLsbLibLoRsbRsRsmbLgbRsbRcbLobRgbLsbRsRjbRcbLcbRcbRsbLc
bLhbRibLcbLobLhbLgbLoRsbLoLsmbLibRjbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRgRsRsmmbRsbRsRsmbRsbRsRsRsmmbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbsbRsLsbRs
RsmbRsbRsRsmbRsRsmbRsbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bLsbLsbLgbRsbRsbRsRsmbRsbRgbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLsLsLsmmbLsbsbLsbLgLsbLsLsLsmmbLgRsbLsLsmbLgbLsbLgbLsLsmbLsLsmbLsbLsb
LsbLgbRsbLsbLsLsmbLsbLsLsLsmmbLsbLgbLebLobLsbLsbLgbLsLsmbLsbLsRsbLsLsm
bLsLsmbLsbLsLsLsmmbLsRsbLsbLsRsbLgRsbLgbLsLsmbLsRsbRsbLsLsmbLsbLsbLsbL
sbLgbRebLebLobLsLsmbLsbLsLsmbLgbLsLsmbLsbLsbLgbLsbLsbLsLsmbLsbLsbLsbLs
LsmbLsbLsbLsLsmbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsbLsRsbLsLsmbLsbLgbLgbLsbL
sbLsbLsbLsbLsRsbLiRsbLsbLsLsmbLsbLsbLsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bLsbRsbRsbRsRsmbRsbRsRsRsmmbRsRsRsmmbRsbRsRsmbRsbRsbRsRsmbRsLsbRsbRsbR
sbRsRsmbRsbRsbRsbRsbRsbRsRsRsmmbRsbRsRsmbRsRsmbRgbRgbRgRsmbRgbRsbRsbRs
bRgbRsbRsbRsRsmbRsbRsRsmbRgbRsbRsRsmbRgbRsbRgbRgRsmbRsRsmbRgRsmbRgRsmb
RsbRsbLsbRsbRsRsmbRsbRsbLgbRsbRibLsbRebRsbRgbLsLsLsmmbLsbRsRsmbLsbRsbL
sRsbLgRsbRibRibLebRibRsRgbLsbRsbRsbRsRsmbLsRsRsmbRsbRsLsbRsbRsbRsRsmbR
sbRsbRgbRsbRsRsmbRgbRsbRsbRsbRgRsmbRsRsLsmbRsbRgbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bsbRjbRcbsbsbLgLsbLgLgbRibLibRebLcbRsbRsbRsbRhbRcbLcbRsbRsLsbsbLsLsmbs
bLsbRsbRsbLsRsbLsLsmbLsbLsbLsbLsbsbLgLsbLsRsRsmbsbLsbLsbLsbLsbLgRsRsmb
LsbLsbLsbLsbLsbLsbLgbRsbLsbsbLsLsmbLsLsmbLgLsbRsLsbLsLsmbLsLsmbLsbLsbL
sbLsbLsbRsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134141; End: 134641;
Recording: 8-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bRsbsbLsbsbRsRsmbLsbLsbLsbsbLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRsRsRsLsRsRgRgmmbRgbLsbRgRsmbRsbRgbRiLsbRsRsmbRsbRsbRsRsmbRsRsmbRsbLs
bLoRibRiLsbRibRgRsmbRgbRgbRgRsmbRsbRgbRgRsmbRgbRsbRsbRgbRsRsRsmmbRsbRs
RsmbRgbRgbRgRsmbRsRsmbRgbRsRsmbsbRsbLsbRsbLsbsbsbLsbsbsbsbsbsbsbsbsbsb
sbsbRsbsbsbsbsbsbsbsbRsLsbRobLgRsbRsbsbRoRsmbLgLsbLsbRcbRebLibRgLsbLhb
RsbRobLsbRsbRgbRgbRsbRsbRgLsbRsbRsbRsRsmbRsbRsbLsbsbsbsbLsbLsbLsLsmbsb
sbsbsbsbsbsbsbRsbsbsbsbsbsbRsbRgbRsbRsbRgbRgbRsbRsbRsbRgRsmbRsRsmbRgbR
gbRgbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bsbsbRgbRsRsLsmbRibRsbRsbRsRsmbRgbRsLsbRsbRsbRgbRsRsmbLsbRsRsmbRsRsRsL
smmbRgbRsbRsRsmbLsbLsbRsbRsbRsbRsbsbsbRsbLsbsbLsbLsLsmbLsLsmbRsbLsRsbs
bsbLsbLsbRsbRgbRgRsmbLsRsbRgbRgbRsbRsbLsRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLiLsLsmbLgbsbLsbRsbLgbLgbLgbLgbLiLsbLgLsbLsRsbLgLgbLgbLgLsbLgLsbLgbLs
RsbLgbLgbLgbLgLsbLiLsbLsbLsbLgbLgLsbLgbLgbRsLsbLgLsbLgbLsLsmbLsbLsLsmb
LgbLgbLsbLiLsbLgLsRsbLgRsbLgbLibLsLsmbLiLsbLibLgbLgbLgbLsLsmbLgLsbLsLs
mbLsbLsLsmbLgLsbLsbLsLsmbRsLgbLsbLsLsRsmbLgbLgbRoRsmbsbRibLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsRsRsRsmmbRsbLsbRsbRgRsmbRsRsmbRsbRsbRibRsRsmbRsbLsbRsbRgbRiRsmbRsRs
mbRsRsmbLsbRgbRsbRgbRsRsmbLsbRsbLsbRsLsRsbRsbRgbRobRgbRiRsmbRhLsbLsbRs
bLsRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsbRsRsmbRsRsmbRsbRsbsbRsRsmbRsbLsbRsRsLsRsmbRsLsbRsLsbsbsbLsbLsbRsLs
RsbRsbRsbRsbsbLsbRsbsbsbLsRsLsRsbsbRsbLsRsbRsbRsbLsbRsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLgbsbsbLgbLibLoRsbLgRsbRiLsbRibRgRsmbRgLjbLiRsbLibLsLsmbLsLsLsmmbLgbL
sbLgbLsLsmbLsLsLsLsmmmbLgRsbLsbLsbsbLsbsbLsLsmbLsbRsbLsbLsLsmbsbRsRsmb
LgbLsbRsbRsLsRsbLsbLgLsbLgbLgbLsLsmbLsLsmbLgbLibLsLsmbLsLsmbLibLgbLhbR
gbRgbLiLsLsmbLgbLsLgbRcbRgbRibRsbLobLsbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 7; Drug: APO 0.5
bsbsbRhbLobRgbLsbRebRebsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 8; Drug: APO 0.5
bRsRgbRcbLcLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 9; Drug: APO 0.5
bLgbLsRsbsbsbRibRsRgbRibRgLsbRsbsbRobRgbLsbLsbRgbsbLgbLgbRsLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 10; Drug: APO 0.5
bLcbLcbRobLobLiRsbLibLiRsbRsbRgbLsbRjRsmbRgbLsbLsbRjbLsbLjbLhbLsbLgbRj
RsmbRcRsmbRoLsbLgbLjRcRsmbRgbRsbRsbRgbLgbRcbLsbRsbRjbRibLjLsmbRsRsmbRi
bRgbRcLsbRgbLsbLsbLsbRsbLsLsmbLsbLsbLibRsbRibRcbLhbRobRibRjbLiLsbRobLs
LsmbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 11; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 12; Drug: APO 0.5
bRsLsbsbsbLibRobLsRcbLobLibRgbLgRsbLebLsLsmbRcbRcbRhbRibRsbLjLsLsmmbLs
LsmbLgLsbRgbLsbLgbLgRsbRsRsmbRsbRhbRsbsbsbRhbRobsbRsRsRsmmbLgbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRgRsmbRgbLgbRsbRsbRsbRsbRsRsmbRsbLsRsbLcbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bsbRsbLsbRsLsbRsbRsbRsbRsbRsLsbRsbLsbRsbRsbRsbRsbLsRsbRsRsmbRsbRsRsmbL
sLsmbRsbRsbRsbLsbRsbRsbRsbRsbRsbRsbRsRsmbsbsbRsbRsbsbLsbLsRsbLcbRhRsmb
LsLsmbRiRsmbRsLsRsbRebRhRsmbRhRsmbsbsbsbLsbRgLsbRsbLsLsmbRiRsmbRgbRsbR
gRsmbRsbRsbRsRsmbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLibLgLsLsmbLgbLgbsbsbLsbRsbLhbLhbLsbRsbLsbLgbLsbLgbLhbLsbRsRgbLsbLjLs
mbLcLsmbRsRsmbLsbLgbLgbLsbLsbLgbLgbLgbLgLsbLgbLgbLsLsmbRgbLsLsmbLgbRib
RsbRsLsLsmbRsbsbLsbLsbRsRsmbRsbRgbRsRsmbLsRsbLiLsbLibLgbRibRsbLsRsbRgR
smbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLgLsbsbsbLsLsmbLsbRgbRgRsmbRiLsbLgLsbLjLjbsbRibLsbLibRsbRgbRgbsbsbLgb
LgbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLiLsbLsbLhRsbRsbLhbLgbLgRsbRgLsbLgbRsbLsbLsbLobLsbLobLsbsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRhbRsbLcbRsbLsbLsbLsbLsLsmbLgbLebRobRsbsbRibLgbRiLsbRgbRsRsmbsbRibsbR
gbRibRsbLsbRsbRsbLsLsmbRsbRsLsbLcbRgbLsRsbRgbLgbLibLcLsmbsbLsbRsbRsbLi
LsbLsbsbRsbLgbLgLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRjbRsbRebRgbLsbRobLobLjbLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRobRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRcbLobRibRcbRibLcbRobRcbLsbRobLgbRobRebLcbLibRsbLibRgbLebLobLebRobRob
RcbRgbRsbRcbRebRcbRobRobLebRebLobRjbRebLebRebRcbRjbLobLcbLobLcbRgbRobL
obLebLcbRebLobLebLgbRobLcbLobLobRebRcbLsbRjbRcbLobRsbLobLcbRsbRobRebLo
bLhbRobLebRobRobLebRobLobLcbLobRobLebLobLibRcbLobLibLobLobLobRgbLobRob
LobLobLebLobLebLcbRebLobLobRibLebRebLibRobRcbRcbRcbLobRjbLebLobLjbRcbL
ibLobLgbRibRebRobLobLcbLebRsbLgbLobRebRcbLebRebLibRhbLibRobLebLobLcbLe
bLebLsbLobLebRibRobLobRobRobLobLobRibLobLobLobLcbRobLobRcbLobLebLebLcb
RibRcbRibRcbLobRhbLobLgbLebRcbLobRebLobRcbLibLobLobRibRebLjbRobRobRgbR
obRibRobRcbLebLibLebRobLobRibLobRobRibLobLgbRobLobLgbRcbRobLgbLebRebLi
bRebLobRibRobRebRgbLebRcbLobLibLcbLcbLcbLebLibRibLcbLobLgbLobRobLebRob
LebLcbLobRcbRobLebLobRebRebLobRsbRobLcbLobLobRobLebRobLobLcbRibRsbLibL
ebRobRibRhbLibRcbLebLobRebLgbRgbLobLobLcbRobRcbLebLsbRobLebRobRebRcbLg
bRebRobLobLobRebLobLebRobRobRobRibLobRobRobRibRsbRobLibRobRibLibLobRib
RsbRhbRhbLibRcbRebLobRhbLebLgbLcbRobLebRsbLebLobLcbRcbRebLebRibLhbRebL
cbLobRobRobRobRcbLebRobRobLcbLobRsbLibLsbLcbLcbLobLebLcbRobLobRcbRcbLc
bRobLcbRibRobRobRebRobRcbRobRobLobRgbRebRcbLhbLobRibLobLibRcbRebRebLhb
RgbLebRsbRebLobRebRibLhbRcbRobRebRjbLobRcbLibLibRebRsbLcbLcbRobLobRobL
obRobRobLebRebRcbLebRibRobRobRebRebLgbLobLobRgbRebLobRobLebRebRebRobRe
bLgbRcbLobLobRebLgbLobRobLhbLobLobRebLibRebLcbLebLobLobLobRobRcbLhbLcb
LobLsbLcbLebRebRobRcbRebRobLobRobLobRobRobRobRobLebRobRcbLcbRebLobLcbL
hbLobRobLebLobLebRobLobRcbRobLobRobLebRcbRgbLcbRobLobLobRobLobLobLobLc
bLcbLcbLobLebRjbRebRgbRibRobRcbLobLebRobRobRcbRobLgbRcbRcbRcbLobRcbReb
LibLebLcbLobLobRebRobRhbLobRebRobLsbLebLobRobRcbLobRobLobLobRobRcbRibR
cbRcbRebRebLobRibLebRobRobRsbLobRcbRibLobLobLobLobRsbLcbLgbLcbRobLobRo
bLibRcbLobLcbLcbRcbRebLhbLobRcbRgbLobRcbLcbRgbRebLebRobLobRobRibLcbLcb
LebLobLibLcbRobRobLobRcbLobLobLibRebLobLhbLobLibLibLsbLobLebLcbLobRibR
cbRebLcbLibRibLcbRebLibRebRcbRobLobRjbRebRobRibLcbRobRobLibRgbRebRebRo
bLgbRebRobLobRobRobRebLebRcbLgbLhbRcbRebRgbLibRobLobRibRebRobLebRebLob
LgbRobRobRebLgbLebRobLobRobLobRebLibRobLgbRgbRebRobLsbRobLibLcbLobLcbR
gbRcbRibRobLgbRibLgbRibRobLsbRobLcbLebLobLcbLjbLhbRcbLebLcbLcbRgbRibRh
bLibLebRjbLcbLobLsbLobRobRobLobLcbRebLebLobLcbRobLebLobRobRcbLibRobRgb
LgbRebRobLobLgbLebLebRebLobLibLibRobRcbRobLcbRobRebLobRebLhbRobRibRobL
ebLcbRobRobRobLcbLobLsbLobLobLobLibRebRhbLobRobRcbRebRcbLobLobLobRibLo
bLobLobLobRobLobLcbLcbRgbRebRibRcbRgbRobRcbLobRobRobLobLgbRobRjbLgbLeb
RjbRobRsbLobRsbRobLobRebRobLobLibRcbLibRcbLobLcbLgbLobRebLebLebRcbRcbL
obLobRobLobRobRcbLebRobRibRobRobRhbLcbRebLebRhbRobLebLcbRebLebRobLobRc
bRcbLobLhbLhbRgbRebRibLebLgbRobLibRebLobLebLcbRobLobLsbLobLcbLcbLsbReb
LgbRebRibLobLibLobLebRobLobRobRgbLobRibRgbLibLcbLebRobRcbRibLcbLibLobR
ebLgbRebRcbRobLibRcbLebLgbRobRcbRebRobLsbLebRobLebRobLobLobRebLgbLcbRc
bRobLebLibRebLhbLobLobLobLobRobRobLhbLebLcbLobRgbLobRebLobLebLobLebLeb
LcbLebLobRobLobLobLebRcbRcbRebRibRcbLobLcbRobRcbRhbRobLobRcbLobLobLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bRsbLsbRsbRsbRsbRsbRsbRsRsmbRsbRsLsbRsbsbRsbLsbLsbRsbLsbRsbRsbRsbRsbRs
bRgbRsbRsLsbRgbRsRsRsmmbLgbRsbRsLsbRsRsRsmmbRsRsmbRsbRsbRsbRsbRgbRgbRs
bRsbRgbRsbRsRsmbLgbRgbRsbRsbRgbRsbRsbRsRsRsmmbRsLsbRsLsbRsRsmbRgbLsbRs
bRsbLebReLsLsmbRsbsbLibLgLsbLsRsbLsbLsbLgbLsbLsbLsbLsbLgbLsLsmbLsbLsbL
ibRgbRsbLsbLsbLgbLibLgbLsLsmbLibRsbRgLsbLsbLgbLgbLsRsRsmbLsRsbLsbLsbLs
bLsbLsbLsRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRsbRsbRsLsbRsbRgbLsbRsRsmbsbRsRsmbsbRsbRsbsbLsbRsLsbRsbRsbRsRsmbRsRsR
smmbRsbRsbRgbRsbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRgLsbRsRsmbRgLsbRgbRsbRs
bRsRsmbRgbRsRsmbRsRsmbRsbRsbLsbRsbRgbRsRsLsmbLsbLsbRsRsmbRsbRsRsmbRsbR
sbRsRsmbRsbRsbRsRsmbRsRsmbRsLsbRsRsmbRsbRsbRsbRgRsmbRsbsbRsbRsbRsbRsbR
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bsbsbRsRsmbRsRsmbRgbRsRsmbRgbRsRsRsmmbRgRsmbRgbRsbLsbRsRsRsRsmmmbRsbRs
RsmbLsbRsRsmbRsRsmbRsRsmbLsbRsRsmbLsRsLsbRsbLsbRsLsbRsbRsbRsbRsbsbRsbR
sLsLsmbRsbRgbRsbsbsbsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bRgbLoRsbRsbRgbRsbLobRsbLgbLsbLsLsmbsbsbsbsbsbRjbLibRhRsmbRobLibRsbRsb
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bRgbRsbLsbRsbLsbLsbLsbRcbRgbRgbRsRsmbRgbLsbRcRsmbRgRsmbRibLsbLsbRibRsb
RsbRoRsmbRsbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bRsbRsbRsbLsLsmbLsLsmbRsRsmbRsRsRsmmbRsRsmbRgLsbLsLsmbRobRiRsmbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 31; Drug: APO 0.5
bLobsbRcbLcbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 32; Drug: APO 0.5
bRibLcbLgbRsRsmbLgbLgbLsbLsLsmbRgbLibLeLsbsbRhbRgbRsbRsbLgLsLgLsLgLsRs
bRsRsmbRgbLsbLsbRsbRsbRgbLibLsLsmbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 34; Drug: APO 0.5
bLjbLsbLsRsbLsbRcbRobRibRsRsmbRibRobRoLsbLjbLobRibRhbRibRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 35; Drug: APO 0.5
bRibLebLibRgbsbLsbRgbRsbLsLsmbLgbRiRsmbRebsbLsbRsLsLsmbRsRsmbLsbLsbRgb
LibLsRsbRibRibRgbRgbRibRsbRebRibRibRib

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 36; Drug: APO 0.5
bLcbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsbLsbLsbLsbLgbLsbLsbLsbLsbRsbRsbLsbLsbLgLsbLsRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bRgbRsbsbRgRsmbLsLsmbRsRsLsmbLsbLsbLsbLsLsLsmmbLibLgLsbLgbLsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLsLsmbLsbRobRgRsmbRsRsmbRgbRsbRcbRsbRsbRibRibRsbRsbRgbRgbRgbRsRsmbLsb
RgRsmbRsbRgbRsbRgbRgbRsbRsLsbRsbRgbRgbRsbLsbLsbRgbRgbRsLsbLsbRgbRsbRgb
RsRgbRsbRiLsbRsRsmbLibLcbLgbRebRibLjbLjbLibLgbsbLsRsbRsbRjbRgbRsRsmbRs
bLhbRgbRibRgbLibRsLsbRcRsmbLjLgbLgbReLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRsbLoRsRsmbRjbsbsbRiLsLsmbLsLsmbLsbRhbLsbLsRsbRsbRsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRiRsRsLsmmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bLibLsbLobLoLsmbLgbLibRsRobsbLcbLoLsRsmbRgbRsbRsbRsbRgbRgbLoLsmbLsbReb
RiLsRsbLsbLsbRhbLgbRcbLsbLsbRhLsbRgLsLsLsmmbLsbRhbLibLsbLiRsbLsRsbLgbR
oRsmbRgbRsRsmbRgbRgbLgbRgLsbLsbsbRibLsbLsLsmbRgbRibRibLsbRsbRcRsmbLibL
gLsbRgbLcbRjbLhbLibRjbRcLsLsmbLsbLibRibRoLsRsRsmbRgbLgRsbRsLsbLibRjbsb
RcLsbLjbLobRibRibsbRoLsbLsLsmbLibRgbRgbLsbRobRsbLcbLgLsbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bLsbRsbRsbRsbRsbRibLsbLsLsmbLsbLsbsbRsRsmbRsRsmbRsbRsRsmbRgbRsbRsbRsbR
gbRsRsmbRsbRgbsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bRsRsmbRgbRsbsbRsbRsRsmbLgLsbsbLsRsbLsbsbRobRibRsbRsRsmbRgbRibRsbRgbLs
bRgbLsRsbLjbRcbRibLsbRsbsbRgbRsRsmbRgbRsbRsbRsbRgRsmbLsbRsRsmbRsRsmbRs
bRsbRsbLsbRsbRsbRsbRsbRgbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLcbRsbLsbLsbLsbRgbLsbRsbRsRsmbRsbRsRsmbRsbRgbLsRsbRsbRgbRsRsmbRgbRgbR
sRsRsmmbsbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRsbRsbRsRsmbRgbRsRsmbRsbRsbRsRsmbsbLsRsRsmbRsRsmbRsbRsRsmbRsbRsRsmbsb
RsbRsbRsbRsRsmbRsRsmbRgbLsbRsbRsbRsRsmbRsRsmbRsbRsRsRsmmbRsRsmbRsRsmbR
sbLsbLgbRgbLibLsLsmbLsbLcbRsRsmbRsRsmbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRsbLsbRsbsbLgRsLsbRsbLsLsmbsbRgbRsbLsbRsbRsbsbsbLjbRjbLiRsbRsbLsLsRsm
bLsLsmbLsbLsbLibRsbsbLibLibLgbLsbLobLsLgbsbsbRjRsmbLcRsbRsRsmbLsbLibLs
bLsLgbLcbLsbRsbLsbRsbsbRsLsbRsLsbRsLsbLsbLsLsLsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 134643; End: 135143;
Recording: 9-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLobsbsbsbRsbRsRsmbLsRsbLsbRsbsbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRsbRgRsmbRgRsmbRsRsmbRsbRsbRgbRsbRsbRsbRsbRsbRgbRsRsmbRgRsmbRgbRgbRgR
smbRgbRsbRgbRsbRgbRgRsmbRcbLsbLsLsRsmbLgbLsbLgLsLsmbLgbLgbRsbRsLibLsLs
mbLsLsmbLgLsbLsLsLsmmbLsLsmbLgLsbsbRsbRsRsmbLsbsbsbsbRsbLsLsLsmmbLsbLs
LsmbLgbLsbRsLsLsmbLsbLsLsmbLgbLiRsbLibLsbRsbRsbsbRgRsRsmmbRsRsmbRsRsmb
LsRsRsmbRgRsmbRsRsmbRgbRsRgRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bRsRsmbRsbRgbRsRsmbsbRsbLsLsLsmmbLsbsbLsLsmbLsRsRsmbLsbLsbLsRsbsbRsRsm
bLgbsbLsbsbRsLsbRsLsbLsRsbRsbRgbLjbLsbsbRsRsmbsbRsLsLsmbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsbLsLsRsmbRgRsmbRsbRiRsmbRsbLoLobLibLgbLgbLgbLsLsmbLgLsbLgbLsbLgbLgL
sRsbLsbLgLgLsbLgbLsLsLsLgmmbLsLsLsmmbLgbLsLsmbLsbLgbLgbLgLgRsbLgbRsbLg
bLgbLgbLsLgbLsbLsLsmbRsbLgbLsLgLsbRsLsLgbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsbRsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsbLsLsmbRsLsbRsbLsbRsRsmbRsRsmbLsLsmbRsbLsLsmbLsbRsbLsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLsLsmbLobLsbLgbRgbLsbsbsbRibRsbRsbRgRsmbLsbRgRsmbRgbRsbRsRsmbRsRsmbRs
bRgbRjbRgbRgbRibRgbRgLsbLsbRibLgbLcbLhbLgbRsbLsRsbsbLobRsbRgbRsbsbRsbR
sbLsbRsbRsbLsbLsLoLsLiLsLsmmbLjbRoRsmbRgbRsbRoLsLsmbRgbLsbLsbRsbRgbRsb
RsbRsRsRsmmbsbLsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 7; Drug: APO 0.5
bRobLgRsbLsbRgbRsbLcbRsbLsbRsbRsbsbsbsbsbRibsbLobLob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 8; Drug: APO 0.5
bLgbLjLsRsmbLcbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 9; Drug: APO 0.5
bLgLsbLsLgbRcbRobRsLsbLcbLibRibRoLsbRgbRobRibsbRibLebsbRgbLibLsbRsbRsb
Rsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 10; Drug: APO 0.5
bRsbLsbRsRgLsbRsbLgbLgLsbLsbLjbLobRsbRgbRgbRgbLobLcbLgbLibRsbLjbLgbLgb
LjLsmbLgbLsLsmbLgLsbLsbsbRjRsmbLcbRgbRgbLsbsbLsbLsbLgbLsbLsbLsbRsbRsbL
sbRsbRoLsLsLsmmbLibLibRgbLsRsbRibsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 11; Drug: APO 0.5
bRobLibRebRebRobRobLobLebRcbLobRsbLgbLgbRgbLobLibRobLebLcbLebLobLobLcb
LobLsbLgbRibRsbLebLsbRgbLobLobRebRsbLcbRgbLgbLebLcbRobLebRcbLibRebLobL
obLobRobLobLcbRebRobRhbLobLcbLebLobLobRebLobRebRobLebLibRcbLcbLgbLcbRo
bRobLobLebLobLcbRcbLibRebRcbRebLcbLcbLobRcbLcbRgbLibRebRobLobRebRobRcb
LobLobLcbRcbRobRobLobRobRobLobLobLcbRebRebRebLsbLobRcbRibRobLobRobRebL
cbRebRibRobRobRobLcbRobLcbLebLebLobLcbRebLobLebLobLibLsbRebLebLobRobRi
bLsbRebRebRobRobRobLgbRhbLobLobRebRcbLcbRobRibLcbRcbRebRhbRgbRobLcbRob
LgbRebLibRcbLebRobRebLibRsbRebRobRhbLobRcbRibRcbLobLcbLibLgbLsbLcbLgbL
jbLobRsbLobRibLcbLobRobLobLobLgbLobRobRebLgbRobRebRgbLsbLobLgbLobRobRs
bLsbRcbRebRcbRobRgbRebRjbRebRibRcbLhbLgbLgbLibRsbLobRcbRobRobLsbRcbRob
LebLebLcbLgbRibLebRobRobRobRjbRibRebRebRebLobLgbRebRebLgbRcbLobRgbRjbR
ebLibLsbLobRibLobLobRibRebLibLebRgbLcbRcbRobLobRsbLibLcbRgbRobRcbLhbRo
bLebLebRibRebLobLgbRobRcbLebRobRcbLebRobRobLcbLobRobRobRcbLobLobLobLcb
LobRibRsbRobLobLebRobLebLibRibRobRcbLcbRgbRobLobLebLcbRobLobRcbLobLhbR
obLebLgbLcbLobRibRebRobRobRibLobRcbRhbLobRebLobLobLibRobRobLebLcbLobLs
bLobLobLibRobLobRobRebRobLobLgbRibRebLebRobLebRobLcbRebRebLebRobRobRob
RobRebRobRibRibRebLobRhbLebLebRobRsbLgbLobRcbRebRsbLibLebRebRobRebRcbR
obLobRobRobLcbRebLgbRebLobLobLcbLobRobLobRibRobLcbLobRebLibRebRobLebLs
bRgbRsbLobLsbRobLobRobRobLebLhbRobRebLobLibRcbRebRobLibRebLobLobRobLcb
LobLgbRcbLobLobRobLebLebRibRsbLebLibRcbLebRibRobLobLebRibRcbLobRobRobR
sbRebLibRobRcbLobLcbRsbLsbRobLgbLcbLobRebLibRobLebLebLhbRibLebLobRebRi
bLobRcbLibLgbLcbLcbLsbRcbLebLebLibLobLobRibLobLobRhbLcbRibRgbLsbRgbRcb
LibLibLobRibLobRobLgbLobLsbLobRobLcbLcbLobLobRcbLebRobLjbRgbLgbLgbLobR
ebRebRhbLobLobRobLjbLobLgbRebRebRcbLebRebRcbRobRsbRobLobLobLobRibLcbLe
bLcbLobRhbLobLibLcbLcbRobLebRgbRebRobLgbLgbLebRebLebLobLobLobRebRebRhb
RibRsbLobLobRobLebLebLcbLhbLobRibRcbRebLsbRebRcbRobRobLobRgbRobLobLgbR
cbRgbLhbLebRobLcbLibRobRcbRobLibRobLobLobLobLobRibLsbRobRobRobRibLcbLe
bLobLobLobLcbRebLobLobLebRsbLobLobLcbRhbRsbRgbRgbRcbRcbLebRcbLobLobReb
LebLobRgbLobLcbLgbRcbLsbRcbLcbLobRgbLebLebLibRibLjbLcbLsbLgbLibLobLibR
obLobLibLobLobRgbLcbLobRebLsbRcbRebRgbRobLobRobRobLibRsbRcbRobRobRobLo
bLcbLebRsbLcbLobLcbLobRsbRobRebRobRsbLobLebLcbLcbRcbRibLcbLobLebLobLob
RobLobLobLibRcbLcbRcbRcbLobLebRobRobLobLgbRobRobLobLobRgbLcbRgbLibLebL
ebLobLibLebRobRobLibLobLobRobLobLebLobRsbRobRcbRobLebLebLobRebLobLobRi
bRgbRgbLobLsbRebLebLibLsbRcbRobLebLsbLobRobRobRobLobLobLgbRobLobRibLeb
LibRobLsbLebLsbLobLcbRebLsbLebLobRobRcbRebRobRebLgbLebLcbRcbRcbLgbRebR
obLibRobLebRsbLebRobRobRcbLobRgbRobRcbLobLcbRobRobRebLobLcbLcbLobRobLo
bLcbRcbLobLobRobLibRobRcbLobRebRobRebRobRsbRobRebRobLebRebLobLebLobLib
LobRibRebLobRsbRebRobRobLgbLobLebLcbRebLebRcbRobRebRgbRibRobLobRobLobL
ebLcbLobLebLobLobLibRebRgbRsbLobLobRcbLobRhbRobRobRibRobLcbLobRebLebRe
bLjbRobRobRsbLobRcbLgbRebLebLobLebLcbLobRibLebLobRibLibLobRibLebLsbRob
LcbLcbLebRcbLobRebRebLgbRgbLobRobRcbLobRgbRsbRcbRcbLobLobRebLebLcbLobL
obLcbRobRibRebLcbLobRobLebLebRcbLobRebRhbRebLobLibRsbLobRobLgbRsbRobLo
bLobLcbRgbRobLebRebRcbRobRobRcbLobLobRobRobLibRobRobLebLobRebLibRobRcb
LobLobRebLobRibLobLcbLobRsbRsbLjbLobRobRsbLobLebLobLebReb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 12; Drug: APO 0.5
bRobRibLgbLcbRgbLsbRsbLsbRsbLgbLgbLhbLobRgbLsbRsbRibsbsbsbLgbsbsbRibLs
LsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bsbsbRgbRsbRgbRsbRgbLcLsmbsbLjRsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRsbRsbRgbRsbLsbRgbLsbRsbRsbRsbLsbLsLsmbLsbRgbRsbRsbsbRibLsbRsbsbLsbRg
bRiRsmbRsRsmbRsbRsRsmbsbsbRsbRsLsbRgbLsRsbRsbLsbLsbLsRsbsbRiRsmbRsbRsb
RgbRsbRgbRsbsbRsbRsbsbsbRgbRsbRsbRsRsmbRsRsRsmmbRgbRsbRgbRsbRsRsRsmmbR
sbRsbRsbRsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLsbRsbRgbLiLsbLgbRsbLgbLsLsmbLgbLibLsLgbRcLsbRsbLsbLibLibLgLsbLibsbLg
bLibLiLsbLibLcbLgbLibLsbsbLcbLsbLgbLsbLsbLsbLsbLgbLgRsbLsRsLsbLgbLgbLg
bLsbLgbRgLsbLgbLgbLibLsLsmbLgLsbLgLsbLibLgLsbRsbLsbLsbLgLsbLgbLiLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bsbsbLgbLsbLgbsbLgLsbLsbLsbRcbRibRsbsbRgbRgbRgbRgbsbRsbsbRsbRobRibLsbR
sbLsbsbRsRsmbRsRsRsmmbLsLsmbRgbLiLsbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRsbRsbsbRgLsbsbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLibLgbLsbLibRjbLibRjbLsbRibLgbLgRsbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRhRsmbRsRsmbRsbRsbLsbRsbLsbLsRsbsbRgRsmbLsbRsbRsRsmbLsbLsLsmbRsRsRsmm
bLsLsmbLsLsRsmbRsLsRsbRsbRsbsbRgbRsLsLsmbRsRsmbRsbLsbsbsbsbRsbRsbRsRsR
smmbRibLsbLsbRsbRsLsbLsbRsbRsLsbRgbRsbLsbLjbLgbRibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRsRsmbLsbLsLsmbsbRsbsbLsbLsbLebLebReb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRsRsLsLsLsLsmmmmbsbLsbsbsbRoRsmbLsbLibLibLsbLgbLiRsRsmbLsRsbRsbRoLsbR
sbRcbLsbLsbRsbsbLhbLsbRsbLsRsbRsbsbLsbRsbLsLsRsmbLsRsbLcbsbLsbLsLoRsbR
eRsmbsbRsbRsbRsbRgbLsLsmbLsbsbLsbsbRsRsmbRjRsRsmmbLsbRgbRsbLsbLebRjbRs
RiLsbRgbRsbLsbRgbLsLsmbRsbLsbLgbRgbRgbRsbLsbRsRsmbRibRsRsmbRgbLebLsbLg
bLsLsLsmmbLsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRsbRcbRebRgbLobRobRibRgbLobRebRebLobLobRebRgbLobRebRebRebLebLcbLcbReb
LobLcbRcbLobRebRobRcbRobLobRobRgbLjbLobLebLobLobRhbLobLgbLobLcbRebLobL
obLobRibRobLibLibRobLobRsbLobRobLcbLobRibRobLobRcbLcbRgbLobRebLgbLebRe
bRibRibRebLebRcbRobRobLobRobLcbLsbLgbLobLobLcbLebRsbRcbRhbRobRebRibLeb
RgbRobRcbRgbRobRhbRobLobLebRebLebLobLobLsbRcbRcbLobLobRebLibLebRobLobL
obLebRobRhbRibRobLcbLcbRhbLhbRobLobLcbRgbRobLibRgbLebRobRobRibRobLcbLo
bLobLebRcbRgbLebRcbLebRobRobRebRsbRebLcbRcbRgbLcbRibRcbLobRobLjbRobLob
LebRcbLibRobLebLobRgbRobRobRgbLibRcbLsbLobLibLobRebLobLebRobRibRcbLcbL
obRcbLcbLebLebLebLobRcbLgbRobRobRcbRebLgbRebRcbRobRebLgbLobLebLobLobLs
bRobRebRobLgbRebLcbLibRobRcbRibLgbRobLobLobRcbRgbRcbLebRebLobLebLobRob
LibLcbLcbRgbRobLobRcbRebRebRcbRsbRobRobLebRcbRobRcbRibRobLobRebLebRcbL
ebRhbLobLebLibLobRgbRsbRobRsbLcbRibRgbLebRobLebLobRebRobRebLobLobLebLe
bLobRebRobLobLhbRjbRcbRobRcbLcbRcbLgbLebRobLobLibRebRobLebLobLobLebLob
RobLebLgbRobRcbRebLobRibLhbLobRobRobRobRcbRobRobRsbRibLcbRobLobRhbRobR
obLobLobRcbRcbRebRibRcbRcbRcbLobLebRsbRobLebLcbRobLcbRobRobLgbLibRobLe
bRebRcbRibLobLobRobRibLobLebRobLobRebRobRebLobLobRebRcbLobRobRebLebRob
RobLobRobLebRobLebLebLgbRebLobRobLobLobRebRebLebRobLobLhbLebLobRhbRebL
cbLsbLebLebRebRcbRobRobLebRobRcbRsbRcbRobLobLebRcbLebLobLobLebLibLgbLo
bRobRibLibRobRebLebRebRibRhbRobRcbRgbRibRebLgbRobLebRobRobLebLibLobRhb
RjbLobLebLebRobLobLobLobRcbLobRobRgbLibLibLgbLobLsbLobRgbRobLsbLobLobL
obRgbLcbRcbRobLcbRcbRibLobRobLibRcbLibRebLobRebRibRebRobRgbRobRobLobRe
bRobLcbLebRebRibLebRebRobLebLobRcbRobRobRibLobLobRobLebLobLobRcbRebLob
LcbRcbLcbRobLobRgbLebRgbRibRebRgbLebRgbRibLebLsbRobRibLebLobLobRebLhbR
gbRebRgbRobRibLobLgbLibRsbLobRibLobRibLebRsbRebRcbLebRgbRobLibRobRgbLe
bLobLcbLebRobLgbRobLebLobLobLhbLobLcbLobLebLobRobRobRobLgbRobRobRebRcb
RobRibRsbRgbRcbRobRobRobRobRibRebLsbLsbLcbRobRebLgbRebRobLobRgbRibLobR
ebLgbRobLibLobRobLgbLcbLebRcbLebLebLhbRobLsbRibLebRcbRcbRobRebLobLgbLe
bLobRcbRobLcbLcbLcbLobLobLobRobRcbLobRsbLebLobLebLobLobLobRgbLebLcbReb
RobLebLgbRcbRobLsbRcbLhbLobRibRibRcbRobLcbLhbRsbRcbLobRebRgbRjbRebRjbR
ibLobRobRibLebRebLebLebRebRobLgbRobLebLebRcbRobLebRebRobRobLobLebRcbRo
bRcbRebRebLgbRebRebLobRcbLobRobLjbLobLobLobRebLhbRebLebRcbLgbLobRebLeb
LcbLobLebRobLcbRgbLcbRobRebLcbRgbLgbLobRebRcbRcbLsbRebRebLobLgbRobLobL
obLobRhbLibRcbRobRobRobLebRobLebRcbRobLgbRgbLebLobRebRcbRibRobLebRhbRo
bRobRobRobRhbLobLebLcbLobLibRibRebRebLobLobRgbLobRcbRebRobLobRobRgbLcb
RebRobLobRobLobRobLobRobRobLebLebLibRcbRebRcbRobRobLhbLobRebRgbRobLibR
obRcbRebLobRobLebLobRcbRobLobLebLobLibRcbRobLobRgbRebLobRobLebRebRobRh
bLsbLibLobLebRcbRobLibRobRcbLgbLobLobLebLibLcbLebLobLgbRobRobRcbRobReb
LebLgbRobLgbRcbRcbLcbRobLgbRobRsbLebRebLgbLibLgbLcbLgbRebLobRibLsbRobL
obLobLobLibRibLobRobRibRobLebRobLebLgbRobLebRobLobRobRobRobLebLebLobRs
bRobRobRgbLhbLcbLcbRobLebRgbRibRobLjbRobRobRobRobLobLobRobRobRobLgbReb
LobLcbLgbLsbRebRjbRsbRebRebLgbLebLobLjbRjbRcbRobLobRobRobRobRobLobRobL
obLobLgbRibLsbRibLibRobRebRobRibRibRobLebRibRibLcbRebRsbRobLobLcbLgbLc
bLobRibRobLibLibLebRobLebRobRobRibRobRhbRebLobLibLobRibLcbLsbLobRgbRcb
LebLibRsbRobRgbLcbLcbRsbRibLgbLebLobLibRibRobLobRobLibRcbRobRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLgbRsbLsbRsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsbLsbLsbRsbLsL
smbLsbRsbLsbsbsbRsbLsbLsbLgbLsbLsbLgbLoRsbLsbLsLsmbRsbLsbRsRsmbLsRsbRs
LsbRsbRsbRsRsRsmmbRsRsmbRsRsmbRsbRsbRgbRgbRgbRgbRsbRsbRsRsmbsbRsRsmbRs
bRsRsmbRsRsmbRsbLsbLsbLsbRsbRsbRsRsmbRsbRgRsmbRgbRsRsmbRsbRsbRsbRsbsbR
sbRsRsmbsbLsbRsbRgbLsLsmbRsbLobLgbRsLsbLsbLsRsLsLsmbsbRsbRsLsLsLsLsLsm
mmmbLjbLsLsmbLsLsmbLsLsmbLsbLsbLsbLsLsmbLgbRsLsbRsbRsbRgbRsbRsbRsbRsbR
eLsbRgbRibLsbsbLibLsbLgbLgbLsbLsbLgLsbRsbLsbLgbRsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bRsRsRsRsmmmbLsbsbRgRsRsmmbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRgbRsbRgbRsRsmbRgbRsbRsbsbRgRsRsmmbRsbRsRsmbRsbRgbRsRsRsRsmmmbRhbRsRs
mbRgbRsbRsRsmbLsbRsbRsbRsbRgbRsRsmbRgbRsRsmbRsLsbRsRsmbRsbRsbRsbRsRsmb
RsbRgbRgbRsbRsRsmbRgbRgbRsbRsbRsRsmbRsRsmbRsRsmbRsRsRsmmbRsbRsbRsbRsbL
sbsbsbRoLsbRsRsmbRsbsbRsRsmbsbsbsbsbsbRsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bsbsbsbsbRsRsRsRsRsmmmmbLsbLsbsbLsRsbLsbsbLsbLsbsbLsbLsbsbRsLgbLsbRsbs
bRsRgRsmbRsbLsbLsbRsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bRgLsbRsbRsbLsbsbLsbsbRsLsbRebRebRobLobLsbLebRobRjbRebRsbRibLjbRsbRgbL
obLsbLebLibLobLobLjbRcbRsbLjbRebLobLobLob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bRsRsRsmmbLsbRsbLsbLgLsbLsLsLsmmbsbLsbRsRsmbRsbLsbRsbLsbRsbRsbLsLsLsmm
bLgLsbLgbLsLsLsLsmmmbLsLsmbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bsbsbsbLsbLgbLoRsbLgbLsbLgLsbRob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLiLsLsLsmmbLsbLsbLsbLgbLgbLsbLsLsmbLgbLsRsbRsbLsLsLsmmbLsbLsLsmbLsbLs
bRsLsbLgLgbLsLsLsmmbLsbLsbLsbsbLsLsLsmmbLgLsLgbLgbLsbLsbLsbLsLgbLsbLsL
smbLsbRsLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 31; Drug: APO 0.5
bsbsbsbsbsbsbsbsbsbRhbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 32; Drug: APO 0.5
bRsbsbRsbRgbRgbRsbsbLobLsbLgbLsbRsbsbLgbLgbLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 33; Drug: APO 0.5
bRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 34; Drug: APO 0.5
bLcRsLsLcbLsRsbRoRibRobLibLcbLoLsmbRibLiRsLsbLobLhbRhbLibLjbRsbLibsbRi
bLjbRsbLsLsmbRibRjbRsbLsbLhbRgbLcbRibLibRsbLgbLgLsbsbLgLsbLsbsbLgbRibL
jbLobsbRcbRiLsLsmbLibLgbLibLibRoLsbLjbRjbLjbLibRcbRcbRiLsbLsbRsLsbLcbL
gbLibLgbLsbLsbLsbLibLibsbRsLsbLcbLiRsbLibLsbLsbLcbsbLiRsbLsLsRsmbLsbLg
bLjbLjLsmbLcbRibLibRsbLsbLgbLgLsbLgbLsbLibLhbLibRsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 35; Drug: APO 0.5
bRgbLgbRobLjbRgbLgbRgbRgbRibRibRibsbLjbRgbRgbLgbRiLsbLsbRgbLgbsbLgbLgL
sbLsbRgRsmbRsbLibRibsbLsbRibLsbRgbLgbRgLsbRgRsmbLsRsbRgbLsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 36; Drug: APO 0.5
bRsbLsbLsRsbLsRsLsbLsRsLsRsRsmbLsLsmbRsbRsbLsRsbLsbLsRsbLsbRsLobRsbLsb
LsbRsbRsbRsbLsbLsbLsbRsbRsRsmbLsbRsbRsLsbRsbLsbRsbRsbRsbRsbLsbRsbRsbRs
bRsbRsbLsbRsRsmbRsbRsRsmbLsbLsLsmbLsbLsbRsbRsbLsbLsLsmbLsbLsbRsbLsbRsR
sRsmmbLsbLsRgbRsRsmbsbsbRsbRsbRsbRsLsbLsLsmbLsbRsbRsbLsbLsRsbLsbLsRsbR
sLsLsmbRsbLsbRsLsbLsbLsbRsbLsRsbLsLsmbLsbLsRsbLsbRsbRjbRsbLsbLsRsbRsLs
bLsLsmbLsbLsbLsbLobLobLebRcbLcbRobLsbLsbRsbRobLjbRsbLsbLsbRjbRobLobReb
RobLobRobLobLobRcbLcbLgbRobLebLobLobLsbLjbRgbRsbRobLobLsbRobLsbRobRobL
ibRobRebLobRsbRobRebLobRjbLsbLobRjbLsbRsbLebLobRsbRsbRsbRobLobLsbRebRs
bLebRebRobLebRebRsbLsbLjRsLsbRsbRjbRobLebRsbRjbLoLsmbRsbRsbLsbRebRobLo
bRebRsbRsbLsbLsbRjbLobRsbLobRoRsmbRibRebRsbRebLsbRsLsbRebRebRsbLebLobL
obRsLsbLjbRebRsLsbRsbLobRjLsbRebRcbRobsbRcbLobLsbLobRebLobLsbLebRebRob
LjLsmbRsLsbRsbRsbLobRobLsbRebRobLobRsbLsbLsbLsbRsbLsbLebLsbLsRsbLcbLeb
LobLobLsbLobRsRsmbRebRsbLoLsmbLsbLobRebLjbRsbRsbRobRebRobRobRsLsbRsbLe
bRsbLobLcbRsbLebLobRebRobLcbRobLebRcbRsRebRsRsmbRebLcbRcbLsRsbLobLebRj
bLsbRsbLebLsbsbRjbLebLcbRjbLobRobRjbRebRobRebRcbLsbLsbLebLebLob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsRsbRsRsmbRsbRsRsmbRsbRgbRsRsmbsbRsRsmbRsbRsRsmbRsbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLsbLsLsmbsbRjRsmbRgbsbRgbLsbsbLsLsmbRibLgbLgbLsLsLsmmbLsbRsbRsbRsbsbL
gbLsLsLgmbLibRsbLsbRsbsbRcbLsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLgbRsbRebLjbLgbRgbRibRibRgLsbRjbRibLibLgbLsbLsbLsbLibRcbLjbLjbRibRibL
sbRibRgbRsbRsbRgbRgRsmbRsLsbLobRgbRsbRgLsRsLsbRjbLibLsRsbLgLsbLsbLsLsL
ombLsLsLsmmbLobRoRgbRibRsLsbLsbLsLsmbRsbLoLsRsmbRsbRsRsmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbRibRibLiLsRsbLsbLsbLobRsbRi
bRsbRsbLobRsbLiRsbRcReb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bsbLobRcRgbRcLsbLgbLobRiRsmbRjbLjbLobLoLsmbLibLgbLgLsLsmbRgbLobRjbLibR
sLsbRcbRgLsbRjbLsLsmbLibRcbsbRhbRcbsbRsbRiLsbLibRsbLibLsbLsbLgbsbLsbLs
bRsbLiRsRsmbLsbRsRsmbRsbLsbLcbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbRsRsmbRsRsmbRsRsmbRsbLsbRsbRsRsmbRgbRsbRsbsbRsRsmbRsRsmbRsbRsRsmbR
sbRsbRsbsbRsbRsbRsbRsbRsbRsbRsRsRsmmbRsLsbRsRsRsmmbsbRsRsmbRsbRsbRsRsm
bRsbsbRsbRsRsmbRsbRsbRsbRsRsRsmmbRsRsRsmmbRsRsmbRsRsmbRsLsbRsbLjLcbRob
RcbsbRgRsmbRsRsmbRsbRsbRsbRsbRsRsmbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bsbLsbLsbLsRsbLsbLsbLsbRsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLcbLsbLsRsbLgbLsbLgbLsbLsbLgLsbLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgbLg
LsbLgbLgbLsbLsLsmbLsbLsbRsbLsLsmbLgbRsbLiLsbLsLsmbLibRgbLobLobLjbLobsb
LsbLsbLsLsmbLsbLsbLhLsbLiLsbLsLsmbLgLsbLhbLgLsbLgbLsbLgLsbLgbLgbLgLsbL
gbLgLsbLsbLsLsLsmmbLgbRsbLgbLibRjbRob

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRsbsbRsbRsbRsRsRsmmbRsRsmbRsbRsRsmbRsbRsRsRsmmbRsRsmbRsRgbRsbRsRsLsmb
RsbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsbLjRsbRsbRobRsbRsRsmbRsRsmbRsLsbRgbRgb
RiRsmbRsbRsRsmbRsRsRsmmbRsRsmbRsRsmbRsRsmbRsbRsRsmbRsRsmbLsbRsbRsRsmbR
sbLsRsbRsRsmbLsRsbRsRsmbRgbRjbRsbRsbRsbRsbRsbRsRsmbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRiLsbRsRsmbLsbsbLeLsbRobLibLcbsbLibRsbRsbLibsbLjLgLsbLsLgLsbsbRsLsbLh
LsbRsbLibLgbLsLsmbLsbLsbLsLsmbLsbRsbRsLsLsmbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135145; End: 135646;
Recording: 10-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bRsRsmbsbsbRsbRsbRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bRsbRsbLsRsbsbLobRobLjbLgbLhbLibsbLsLsmbLsLsmbLgLsbLgLsRsbLgbLgLsLsLsL
smmmbLsLsLgmbLsLsmbLsbLsLgLsbLsRsbLsLsmbLgbLgLsbLgbLsLsLsmmbLgbLsLsmbL
gbLgLsbLsRsbLgbLsLsmbLgbLgLsbLgLsLsmbLgbLgLsbLsLsLsmmbLgbLsLsmbLsRsbLg
bLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bsbsbLsbRsbLsbLsbsbRsbLsbLsbLsbLsbLsLsmbRsbLgbRsbsbRgbRgbLsbLjLsmbRgbL
sbRgbRgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLsLsmbLsLsmbLgLgLsbLgRsbLsbLsLsLsLsLsLsmmmmmbLgLsbLsbLsbLsbLgbLsLsLsL
sLsRsmmmmbLsLsLgmbLgbLsLsLgmbRsLsLsLsmmbLgbLgbLgLgbLsbLgbLgLsbLgbLsbLs
LsLgRsmbLsRsbLsbLsbLsbLgLsbLgbRsRsRsmmbLsbsbsbsbRgbsbsbLsbRsbRsbsbRgbR
gbsbLsbsbLsbLsRsbLsbsbLsbLibRebRiLgbReLsbLsbLsLsmbLsLsmbLsRsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bRgRsmbRsbLsbRibRsbRsRsmbRiRsRsRsmmmbsbRibRsRsRsmmbRsbRsRsmbRgbsbRibLs
bLsRsbRibRsRsmbsbLsbRsRsmbsbRgRsmbRsLsbRsLsbRsRsmbRsRsmbRsbLsRsRsmbRgR
sLsmbRsbLsbRsbLsbLsbRsbRsbRgbRsbRsbRgbRsbRibRgbRsRsmbRibRibLsRsbRsRsmb
RgbRoRsRsLsmmbRiRsmbRsbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRsRsLsmbLsbLsbRsbRsLsLsmbRsbLibLsLsmbLsLsmbLsbLgbRsbLsLsmbLibLsbLsbLs
RsbLsRsbLsbRsbLsLsmbLsLsmbLsbLsbLsbLsbLsbLgbsbLsbsbLsbLsbRebLjRibsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLsRsbLsbRsbLsbLsLsRsmbsbLsRsbRsRsmbRsbLsbRobLsbLcRsbLobLsbLgbLsbLsbLs
bLsbLsLsmbLsLsmbLsbLgbLsLsmbRsbRgbRgbRsRsmbRsbRsRsmbLsbRgRsRsmmbRgbRsb
RgbRsRsmbRobRebRsbLsbLsbLsbLgbLgbLsLsmbLsRsbLsbLgbLsbLgbLhbLsbLsbRgbLi
bLsbLgLgbLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 7; Drug: APO 0.5
bLobLobRsLsRsbLsbsbRgRsmbRgbRgRsRsmmbRsLsLsmbRgbRsbRcLsbRcRsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 8; Drug: APO 0.5
bLiLsRsbLjLsmbLsbLsbLsbRobLjbLiLsbRjRgbRoLsbLsbRobRobRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 9; Drug: APO 0.5
bRgbRsbLoRsLsbRcbRgbLsbLgbLgbLgbRobLibLsRsbRsbRibRobRibRobRobRibRhLsbL
gbLhbRcbLjbLhbRobRjbRibLebLhbLjLjbLsbRhbRibRobRgbRsbsbRjbRobsbRsbRhbLe
LsbLsbRsbRibRsbLibLsRsbLsbLgbLsLsmbsbLgLsbRgLsbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 10; Drug: APO 0.5
bRgbRgbsbsbsbLcbLsLibLsbLsbLsbRjbLsbLhbRgbRsLsbRhbRcbRsbRgbRsbLobLhbRs
bLgbLgbLgRsbLsbLsbLgbLjbRobLjbLiLsbLgbLgLsbLsLsmbLgLsRsbLsbLgbRsbsbsbL
ibLsRsLsbLgbRsLsbLgbLsbRsbLgbRsbLibRgbsbsbLoLsmbRibRgbRgRsmbRsbRgbRgbR
gbLjbLhRsbLibRsbLsbLgbRsLsbLsbLsbRsRsmbLgbLsbRsbRsbLsbLjbLjbLsbLjbLiLs
bRsbLsbLgbRsbLgRsbLjRsbsbLgbLsbRsbRsbRsbLhbRjbsbsbLibLgbLsbsbLsLsmbsbs
bRsbsbsbRjbRhbRsbRsbRgbLsbLgRgbRibRibRcbRibLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 11; Drug: APO 0.5
bLsbRjbLcbRobRobRobRcbLobLobRebLobLcbLebRobLobRobLobLobRcbRjbRobLjbReb
LobLobRobLebLcbLobLebRobRebRsbLjbLsbLjbLobRebLebLjbLjbLebLobRobRsbRobL
sbLobLobLobRcbLobLobRebLjbRobRsbRobLobRobLjbRobRebLobLcbRjbRgbRjbLjbRo
bRcbRebRsbLobRobRjbRebLjbRobLebLebRobLobRobLebLobLobRebRobRcbLebRcbRob
RobLobRobRjbRobRjbLebLobLobRebRobLjbRobRebRobLebLcbLobLobRcbLebRebLebL
ebLobLjbRjbLobRebRebLebLebLebLebLsbRjbRjbRobLebLjbRebRjbRjbRobLebLjbRo
bRobRsbRebLjbLgbLobLebLobRjbRebRobRsbLebLjbLobLobLobRobRobLobLebRcbLob
RjbRobRjbRobLobRjbRobRobRebRobLobLcbRobRjbRobLebLebRobLobRhbLcbRobLcbR
obRobLhbRcbLobRcbRcbLebLgbLgbRebLobRsbLibRobRcbLobLcbLebRebRsbRobRibLo
bLebLebRebRebRobLebRobLgbRebLobLobRobLebRobRgbRobLcbRebRebRsbRebLobRob
RobLobLebLebRibRobRcbLobRcbLcbLcbLhbLebLibLebLebLobRebRobRobLgbLobRobR
ebLibLobLobLibRibRebRcbRsbRsbLobRcbRobLibRebLobRibLobRebLobLobRhbLobRo
bRobLgbLobRgbLibLcbLebLobRebLcbLobRobRobLobLobRcbLibLobRebLcbLobLgbRob
RebLobLobRebLobRebLgbLobLcbLobLsbRgbLobLobRobLgbRgbRcbRobRsbRebRobRobR
jbLhbLobRcbRobLebRobRebLhbLobLcbRobRibLobRobRobRcbRobRobRebRcbRibLobLc
bLobRibRebRebRcbLebRcbLebRebLcbRcbRobRebRcbRcbRcbRobRjbLcbRobRcbRibRob
LobLobRobLebRobLgbLebLobLgbLcbRobRcbLebLebRobLobLobLsbLcbRebRobLobLobR
obLobLobRcbLobLebLebRebRobLcbLebRgbRebRebRobRebLcbRobLobRobLobLobLobLi
bRobLgbRibRobLobLobLebRobRobLobRobRobLcbLcbLebLobRebLebRgbLobRcbLobRob
RhbLcbLcbRobLibRgbRobRobRgbRebRobRebLebLcbLebRobRobRobRobLhbRebLebLobL
cbRobRcbRcbRsbRjbRobLgbRsbRibLobLcbRebRobLobRobLobRebRcbRobLobLobRobLo
bLgbLebRhbRibRibRobLebLobRebLcbRjbLebRibRcbRebLcbLibLgbLjbLibLcbLibLcb
RobRebLhbRobRobLgbLobRgbRgbRcbLebLcbRobRcbRobLebRebLobLhbLobLobLgbLebL
obRebLcbRobRebRcbRcbRobRibRcbLhbRcbRcbRobRjbLobRobLcbLobRobRobLgbLobRc
bLobLebRcbLcbRobLobRobLibRobLobRibRobLgbLobRgbRsbLgbRobRhbLhbRebLgbReb
RcbRobLgbRobLcbLobRobRcbRebRebRcbLibLcbLobRcbRobLebLobLibRobRobLibLobR
ebLobRobRjbRhbRobRobLebRebLobLobRebRcbRebLebRebRebRobLcbLebLsbRobRebRi
bRebRobLobLebLobRcbRebLobRcbRgbLibLobRebRobRebRobLobRebRebRcbLcbRsbRob
RgbLebLobLobRcbRibRebRgbRobLcbRcbLsbRebRobRobLobRibLobRcbLsbRsbLobLobR
cbRobRebRgbLebLobLobLobRsbRcbRobRibRobRebRsbLcbLobRebRcbRebRobRgbRobLo
bLebRibLebLobRgbLcbRobLcbRobRcbRobLobLgbLebRobRgbLcbRobLobLcbRebLobLob
RobRcbLobLobLgbRobLobRcbLgbLcbRcbLobLsbLebRgbRcbLibRcbLebRobLcbRebLibL
ebLobRcbLcbRgbLobRebRgbLobRibRebLobRcbLibRgbLobLebLebLebRobRibRebLebLc
bRgbRgbLjbLebRcbRebLobRebLobLobRobRebLcbLobLcbLgbRobLobRebRsbRebLobLeb
RcbLobLebLgbLobLgbRgbRibLobRibLgbLcbRobRobRobRebRobLsbRebLobLibRebLobL
ebRobRebRebRcbRobRebRcbRibLobRobLibLcbLsbLobLobLgbRebRobLebLgbRobRcbRi
bRobRobLibRcbLobLobRobRebLibRobRibRobRibLobRobLcbLobLgbRebRobRebLobLgb
RibRcbRcbLsbLebLhbLcbLobLebRcbLobRebLobLobLobLibLcbLobLobRobLebRcbLobL
obLobLibLebRibRobLibRobLebRobRcbRebLobLobLgbLhbRsbLebLebRebRcbLcbLobRo
bLibRcbLcbRebRibLobLobRebRobRobRgbRebRebLebRobRcbRobRgbLsbRsbLibRjbLhb
LobRcbRobLibRgbRibRgbRobRobLobLibLsbLobRebRsbLobLgbRobRcbRcbLcbLibLebR
obLobLobRebRebLebRobLobRibLebRobLobRebRobLebRsbLobRcbRebRobLgbLcbLobRh
bLcbLobRhbRgbRobLebRobRobLobRebLobRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 12; Drug: APO 0.5
bLsbRibRsbsbsbRsbRsbRjbRsLsbLsbLsbRsbRsbRibRibRjRsmbsbsbLibLcbRsbLsbRg
b

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRjLsbRcbRgRsRsmmbsbLjbLsbRsRsmbRsbLjLsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bRgbRsbRsbRsRsmbRsbRsbRsbLsbRsRsRsmmbRsbRsbLsRsbsbRsbRsbRsbRsbLsbLsbRs
bRsbRsbRsbRsRsmbRsbRsbRsbLsRsbRsbLsbRebLgbRsbRsbsbRsRsmbLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLibLsbsbLibLibLgbLgbLhLsbLibLiLsbLcbLgLsbLgbLsbLsbLsLsmbLsLsmbLsbLgbR
sbLgLsbLsbLsLsmbLgbLsbLgLsbLsLsmbLsLsmbLgbLsbLsbRsLobLsbsbsbLhLsbLsLsm
bsbLgLsbLsLsmbLgLsbLiRsbLibLhLsbLgLsbLiLsbRibLsbLgbRgbLgLsbLibRsRsLsmb
LhLsbLibLgbLsbLcbLcbLsbLsbLsbLgbLsbsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLsRsbRsbRgbLjbsbRcRsmbRgbRgbRgLsbRgbLsbRgLsbRcRsmbRgbRsbLsbRsbRiRsmbR
iLsbRsbRsbsbsbRsbRsbRsbLsbLsbRgRsmbRsbLsbRsbRsRsmbRibRsbLjLsmbsbRibRsb
RsbLsbRsbLgbLsbLgLsbLgbLsLsmbLjbLibRsbRibLsRsbLsbRsRsmbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bRgbsbsbRgbRgbsbLsbLsRsbRsbsbsbLsRgbRgbRsbRgLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLibLiRsbLsRsbLgbLhLsLsmbLoRsbRiLsLsmbRibLobLgbLgRsLsbLgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRsbRsbRsRsRsmmbRibRcLsbLsbLsbLsbLsbLsbRsbRsRsmbRsbLsbRsRsmbLsbLsbRgbL
sLsmbLcbLgLsbLhLsbLsbRgbLsbLsbsbsbLsbsbRsLgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bLsbLgbsbRjbRsbLsbLsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRsLsRsbRsRsmbRsbRsbRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRcbLobRobRobRobLcbRebRcbLsbRobRobRcbLcbRobRebRobRebRobRebRobRobLgbRjb
LibRebRobLjbRobRebRobLibLjbLibLobRgbLcbRcbRobLobLobLibRobRobRebLcbLjbL
sbRsbRjbRobLsbLjbRebLcbRobLebLebRjbRjbRsbLgbLjbLjbLobRgbLobRobRobRebRe
bRobRjbRobLobRcbRobRebRebLjbRjbLgbRobLcbLjbLebLjbLobLobLjbLsbLebRcbLib
LibRobRobRebLjbRjbLobLebRjbRobRcbLebRcbLebLgbLjbRobRcbRgbLobRcbLobRobR
obLobLobRobRsbLobLsbRobLjbLobLjbRgbRobRibRobRobRobRgbLsbLobLcbRgbLobRo
bLebLobRebLobLjbLobRebLjbRebLjbRcbRcbRcbLobLibRibRobLobLsbRebRobRebLeb
RgbLcbLcbRsbLobRhbLgbRobRebLobRebLobLcbLgbRobRebRcbLebRibLebRcbLibRobR
cbLcbRebRobLibRsbRcbRobRsbLsbRcbRcbLcbRcbRhbRobRobRjbRcbRcbLobRobRobRs
bLebRobRobLobLcbLobLobLobRebRobRebRobLobLobLobLgbRebRcbLobRgbRgbLobReb
RobLobRsbRobLebRcbRibLobLcbLobLcbRobLobRebLcbLgbRcbRcbLcbLcbRibLcbRgbL
ebRibRebLebLebLebLobLhbLibRebLobRcbRobLebRobRobRibRibLobRobRsbLcbLebRc
bRsbRgbLebRebRibLobRebRgbRobLibRobLobLibRgbRobRebLebLobLgbLobRobLebRob
RcbRcbLobRobLobRobRcbLobLebLgbLgbLhbLcbLebLobLcbRobLcbLobRobLcbLebLcbR
obRobRsbLebRobLgbRobRobRgbRgbLgbLibLobRebRobRcbRobLcbRobRibLhbRhbRibLe
bLobRebRobLcbRobRobRebRibRibRhbRobRobLobRobLebRcbLobLobRcbLebLobLobLeb
RgbLobLobRcbLobRobRobLobRibRgbLebRobRsbRibRobLebRebLcbLsbLgbRsbRobRebR
obRebLobRebLobRebLjbRsbRibLobRibRobRgbLobLebRgbLobRibLebRobLibLsbLcbLi
bLgbLibRobRobLobLobLebRobLobLsbRgbLgbLibLjbRhbRgbLebRebRgbRobLcbLebReb
RcbRobLebLobRebRobRibLibLebLobRcbLobLobRobRobLcbRobRcbRcbLobRobLcbLobL
hbLgbLobRebLgbLibRgbRobRebRebLebLobLobRebLcbLobRhbLjbRobRobRebRobLobRe
bRobLcbLgbLcbLcbRebLebLobRobLobLobLebRcbLhbLcbLebRobLjbRgbLjbLcbRcbRgb
RobLobRebLebLobLgbRibRebRgbRcbLcbLebRobRobLobRebLobRobRobRobRsbLcbRebR
obLobRcbLibLhbLgbRobLobRcbLobLobRobLobRebRebRobRibRcbRcbLobRhbLgbRobRo
bRsbLebRobRebRgbLobLobRebLobLebRhbRgbLebRebRgbLhbLobLobRsbLobLcbLobRob
RcbLobRobLobRebLobRebLebLobRcbRebLobRhbRebLebRgbRobRobLobLsbRibLobRibR
obLibLebLobRibRobLobLebLcbRobLebLobLebLcbLobRcbRobLobRgbLcbLobRobRebRi
bLobLobRobRobLcbRobLobLibRcbRebLcbRobRcbLobRobRibLcbLobLobLgbLobLebReb
LibLebRcbLcbRobRobLgbRgbLcbLobRhbLsbRebLobRcbRobRobLibRebRobRebLobLgbL
ibLcbRcbLcbLcbRcbLebRcbLobRcbLcbLobLcbRobRebRebRobLgbRobRobLgbRcbLobLc
bLgbRibRobLobLobLcbLobRobLebLobRcbLcbRgbRobLsbRibLobLobRcbLcbLobLobRob
LobRobRibLebLebLobLobRobRobLibLobRebRebRcbLgbRgbLobRsbLobRibLibLcbRobR
cbLcbRcbRobRobLcbLhbRjbLgbRgbLobLgbLobLcbRebRebLebLobRobRsbLcbLsbLebRg
bRebLcbLibLcbLsbLebLsbLobLobLibRcbRebLebRobRobRobRobLobRobLobLobLobLib
LobRebRcbRcbRobRibRibRebLgbRcbLcbRebLcbLcbLobRobRobLcbRcbRsbLebLebRebL
cbLibRobRibLobLibLhbLobRsbRsbLcbRsbRobRhbLobRebRgbLsbLobLobRsbLcbLebRg
bLebRhbRobRobRobLcbLcbLibLobRobRobLcbLibRobLcbRebLobLobLebLgbLebLobLcb
RobLobLcbLobLcbLobRobRobRcbRebLebRebRobRebLcbLhbLsbLcbRsbLibRobLcbLhbR
ibRibLcbLobLobRobRebRcbLobLhbLibLebRebRgbRcbRobLibLebLgbRobLobRibRobLe
bLcbRgbLebRibRebRobRgbLobRebRobRobLobLebRebLobRcbLobRobLobRobRcbRebRib
LcbLobRhbLobRibRebRgbRebRobRobLibLebLgbLcbLibRibRobRebLobRcbRobRobRebR
cbRcbRobRebLcbRgbRsbLebLobRcbLebLobLebLhbRobLobRobLgbLcbLgbLobRcbLebLo
bRebLebRcbRebLibLobRgbRebRsbLobLebRobLobRgbLobRsbLsbRgbRobRobRhbLebRob
RebLobRobRobLcbLebRcbLcbRobLibRgbRgbRebLobRjbRobRob

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLgbLsLsmbLsbRsLsRsbLsbLsbLsLsLsmmbLsbLsbLsbLibLsLsmbLsbLsLsmbLsbLsbLs
bLsbLsLsmbLsbLsbLgbLsLsmbLsbLsbLsbRsbLgbLsLsmbLsbLsbLsbLsbLsbLsbLsbLsL
sLsmmbLsLsmbLsbLsbLsbLobRsbsbsbsbsbsbsbsbsbsbsbsbsbsbRsbRgRsmbRsbRsbRs
RsmbRsRsmbRsbRsbsbRsbLsbRgbLsbRsbRsbRsbRsbRsRsmbRsbRsbRsbRsbRsRsmbRgbR
sRsmbRsbRsRsmbRsbLsRsbLsbRsbRsbRsRsmbRsbRsRsmbLsbRsbRsRsmbRsbRsbLsbRsb
Rsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bsbsbsbRsbRsbsbLsLsmbLsbRsRsmbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bsbsbsbRsbsbRsbsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bRgbsbLsbRjbLsLsmbLgbLsRsLsbLgLsbsbLgbLgRsLsbLsbLsbRsbRsRsmbRsbRsbRsbL
sbLsbLsbsbLsLsmbsbsbsbRsbLsLsLsmmbLgRsbLsLsmbLsbLsbLgbLgbRsLsbLsbLsLsm
bLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bsbsbsbRsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbLsLsmbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLsbLsbLsLsLsmmbLgLsbLsLsmbLsLsmbRsbLsLsmbLsRsbLobLobLgLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bRibRsbRgLsbRsbLgLsLsLsmmbLsbLsLsmbRsbReRsLsmbRobLsLsmbRsRsmbRsbLsbLgb
LcbLsLsmbLsbLgbLsLsmbLsLgbsbLcRsbsbRsbRgbRsbLcLsmbRsbLsbLebLgbsbLsbRsb
RcbLsRsbsbsbsbRiRsmbRsLsbLsRsbRsbsbLcbLsbsbsbRibRsRsmbRibRsbRsbRibRsbR
sbsbLsbsbLibLsLsmbLsbRcbsbLsbLsbLsbsbRsLsbRsLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLgRsLsbLiLsbLgbLgbLiLsLsLgmbLgbLgbLsbLgbRsbLgbLgbLsbsbsbLgLsLsmbLsLsm
bLsLgbLgLsbLiRsbLiLsLsLsmmbLsbLiLsRsbRiRsmbLiLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 31; Drug: APO 0.5
bRgRsmbLibsbsbsbRsRsmbLgbRsbRsbRibLcbRhbRcbsbLsbLsLsmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 32; Drug: APO 0.5
bLsbLsbRsLsbRsLsbRsbLsRsbRsbRsbRsbRoRsmbRcbLsbsbRgbsbLhLsbLsbRsbRsbLgR
sbLsbLsbLsLsmbLsbRgbRsbRgbRsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 34; Drug: APO 0.5
bLgbRsbLgbLibLsbLgbLsbLgbLgbLsbLgbLibLgbLsbLgbsbLgbLgbLsbLgbRsLsbLgbRs
RjbRcbLibLiRsbRcbLgbLgbLgbLibLsbLsbLsbLgbsbLgbLgbLibLgbLgbLcbLhbLhRsRs
mb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 35; Drug: APO 0.5
bRibRsbRibRibRibRsbLsbRgbLgbRsbLsLgbsbLsbRsbLgbLgbRiLsbRgbRjbsbLibLsbR
ibLsbRgbLsLsmbLsbLgbRhbRiRsmbRibRiLsRsbLsbsbRgbRsRsmbLcbRsbLobRobRibRc
bRiRsmbLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 36; Drug: APO 0.5
bLjLsmbLibRobLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bRgbRcbLsbRgbRsbRsbRsbsbsbRsbRsbRsbRsRsmbLjbRibRgbsbRsbsbRsbLsbRgbRsbL
gb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bsbRoRsRsmmbRsbRgbRsbRsRsmbLsRsRsmbLsLsmbRsbRsbRgbLsbLgLsLsmbLsbRjbLsb
RsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bRsbRsbsbRsbRsbRgbRsbRiRsmbsbLsbRhbRsbRsbLsbLsRsbsbLgbLsbLgbLsLsmbLsbL
sbLsbRgbRsbLsbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRsbLjbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRcbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRhLsbLgLsbLsLsmbLsbLsbLoRsbLgbRjbRcbRibLjbLgLsbRibLibLcbRiRibLsbRjbLj
bLobLcbLibLibLiRsbLibRcLsbLsLgbRobLgbLgbLcRsbLsbRsbLgLsLsmbLsLsmbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbRsbRsbRsRsmbRsbRsRsmbRsbRsbRsRsRsmmbRcbRsbLsbLsbRsbLoRsbRsbsbRsbRs
bRsbRsbRsRsRsmmbRsbRsRsmbRsbRsbsbRsRsmbRsbRsRsmbRsRsmbRsRsRsmmbRsRsmbR
sbsbRsbRsbRsRsRsmmbRsRsmbRsbRsRsmbRsbRsbsbRsRsmbRsbRsbRsRsmbLsRsbRsbRs
bRgbLsbLsRsbRsbRsbRsbRsbRsbLsbsbRsbsbRsbRsbsbRsbRsRsmbRsRsmbRsbRsRsmbR
sRsRsmmbRsRsmbRsbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bLsRsbRsRsRsmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bRgbRsbLsbRgRsmbLsbRgbRsbLsbRsLsbRgLsbLsbRgRsmbRsRsmbRgRsmbRsbRsbRsRsm
bRsRsmbRsbLibRsbRsbRsbRsbRsbRsbRsbRsbRsbLsbLgbRgbRjbLjbRobRgbRsbLsRsbs
bsbRsbRsRsmbRsbRsbRgbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bsbRsbRsRsRsmmbRsbRgRsmbLibLsbRsLsRsbRiLsbLgLsbRsbRsRsRsmmbLobLsRsbLsL
smbLsbLgbLsbLsLsmbLsRsLsbLsLsmbLsbLobRebRsbRsbRsRsRsmmbRsRsmbLsbLebReL
ibLoLsmbLsRsLsbRsbsbsbsbRsRsmbLsbRsbRsbRsbRsbsbRsbRgbRsbLsRsbRsbRsRsmb
RsRsmbRsbRgbRsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRsbLsLsmbLsbRsbReRsmbLjLsmbLibLibLsbsbLiLsbLsbLiLsbRsbLgLsbRgbLibLobR
sbRobLgbLsbRsbsbRsbsbLsLsmbLsbLsbRsLsbRsRsRsmmbLibRibLgbLcbsbLgLsLsmbR
sbLsLgbLgLsLsmbLsbsbLsbLcbRsbsbRsbRsbRsRsRsmmbRsRsRsmmbRsbRsbRsRsmbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 135647; End: 140147;
Recording: 11-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLsbsbRgbLjbLsLsmbsbLsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bLsbRsLsbRsLgLsbLgbLgbLgbLgLsbLgbLgRsbLgbLgLsbRsbRsbRsRsmbLgbLsRsbLsbL
gbLgLsbLgbLgbLgbRgbRsbLsbLibLgbLsbLgbLgLsbLgbLgLsbLgbLsbLgbRsbLgbLgbLg
bLgLsbLsbLsLsLsmmbLsLsLsmmbLgRsbLgbLgbRsRsmbLgbLsLsmbLgLsLsLsmmbLsLsLs
mmbLsLgbLsbLgLsbLgbLsbLgbLgLsbLsLsmbLsLsmbLgLsbsbRsLsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bRgbLgbRgbLsbLsRsRsmbLsbRgbRsbRsbRsbRsbRgbRgbRsbRsbLsbLsbsbRsbRsbsbsbs
bRsbRsbRsRsmbLsbsbsbLsbLsbLsRsbLsbLsbsbsbsbRgbRgbRsRsRsmmbRgbRsRsmbsbs
bRsbsbRsbRsRsRimbRsRsmbRgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLcRsLsbLsLsmbLgbsbRsRsmbLsbLgbRjbLgbRsbLsbsbRsbRibRsbLsbRsRsmbsbRcbLs
bRsRobLsbRsRsmbLsbsbRsRsRsmmbLgbRiLsRgRsmbRsbRsbRgbRsbRsbRsbLibsbsbLsb
sbsbLsLsmbLobLsbsbRsRsmbRsbsbLsbLibRsbsbsbLsbLsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsLsLsmmbLsRsbLebReRsmbRsbLsbLibLsbLoRsbLsbLsRsbLsbLsbLsbLgbRsbRsbRsb
RsbRsRsRsmmbRsRsRsmmbRsbRgbRsbLcbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bLsRsLsbRsRsLsmbRsRsmbRsRsmbLsRsRsmbLsRsbLsRgbRsbLsRsbRsbLsbsbsbLsRsbR
sbRsbRsbRsbRsbRsRsmbLsbRsRsmbLsbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLgbRsLsbLsLsmbLgbLsbLsLgbLsbLsbLsLsmbLsbLgLsbLsRsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 7; Drug: APO 0.5
bsbsbRsbRsbsbRsbRsbsbsbRsbsbsbsbLsbLsbLsbLsbRsbLsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 8; Drug: APO 0.5
bLjbLiLsbsbsbsbRsRsmbRsbRsbLsRsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 9; Drug: APO 0.5
bRsbRibRsbsbLiLsbRgbRibRobRsbLiLsbLibRcbLobsbLjbLibLgbRibRgbRsbRsbRobL
cLsmbRebRgbRgbLgbRibRgbRjLsbLgbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 10; Drug: APO 0.5
bRsbLibRebRobLiRsbRhLsbRsbRgbRsbRobLsRsbRoRsLsmbLgbsbRgbLsbRsbRcbLsbLs
bRsbRsRsmbRsbRsbRsLsbLgbLsbRibLobRjRsRsmmbRsbLsbLsbLsbLibLoLsLsmmbLiLs
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 11; Drug: APO 0.5
bLebLebLcbLebRcbRobRebRobLibRgbRobLobRobRcbLcbRgbRgbRobRobRibRobLobRcb
LebLebLobLobLibLobRcbRgbLebLhbLobLgbLcbLobLobLobLgbRobLebRobRgbRibLobL
ibRobRgbLcbLobLsbRibRobLcbRcbRgbRcbLobRobRibRgbLcbRobLebLibLobLobLobLh
bRcbRebLobRobLobLobLibLsbLibRobRsbLobLebLebRcbLobRobLibLcbRgbRcbLibLob
RibLsbLobLebRobLobLcbLibLobRobRobLobLobLhbLebRebLibLgbLsbRebRgbLsbLobR
ebLobRibLibRsbRcbRobRibLcbRobRebLobRebLcbRebLobLobLhbRhbLobLibLebLobRg
bRsbRobRebLebRobRsbLobLobRebLebRebLcbRibRibRebRcbLebLibLobLebRobRjbRgb
LcbLobLebRebRcbLobLibRcbLobRobRebRobLebLobLcbLobRebRsbRobLgbRobLobLgbR
obRebRebLobRcbRgbLobLebLsbRebRebRobLebLsbLobRebRcbLcbLobLobLobRebLebLg
bLobLcbRcbRobLobRebRebRobRobLcbLcbLebLobLobLobLebRobLebLibRobRcbLcbLsb
LobRobRobRebRgbRcbRibRebRobLebLibLobLobRibLobLobRobLobRobRebLcbLibRibL
obLgbRobLobLebLebRobRobLibRobRhbLobRobLobLobLcbRobLobRobLobLebRibLebLc
bRsbRibRobLgbRgbRobRcbRcbRobRhbLibRobLobLjbLibRobRobRcbRibLebLebRibLcb
RebLibLebRobRobLobRobLcbRcbLebLebRgbLcbLgbRebLgbLobRobLobLobLebLobLibR
cbRibLobLobLcbLobRsbRcbRebLcbRcbRcbRcbRcbLobLobRobLobLebRibLobRobRebLe
bLgbRcbLibLobLobRobRcbLobLcbLcbLebRgbRgbLebLobLobRcbLobRobLebLobRobLob
LobRobLebLcbLobRibRcbLebLobLcbLobRobRebRcbLebLibRobLcbRobLsbLhbLebRebL
obLcbRsbRcbRobLcbRobLobRobLsbLobRibRcbRebLobRobRgbLsbLcbRobRobLgbLobLo
bRobRobRcbRcbRebLobLgbLebLobRobLobRobRebRsbRobRibLobLebRcbRebLebLcbLhb
RebRcbLebLebRebRsbLcbLebRobLobLobLebLsbRebLgbLobLjbRobRcbLobRebLsbRobR
hbLobRobLobRibRobRobLebRobLebRobRobRebRibRobLgbRobLcbRebRobRjbLebLcbLe
bLobLgbLobRibLobRcbRcbRobLcbLobLebLebRcbLgbLobLobLgbRcbLcbLebLebLobRib
RebRibRobRobRobLcbLobRcbRjbRibRibLgbLcbRobRobLebLebLgbRobLcbLebLibRobL
gbRhbLobRobRgbLgbRobRobRebLgbLcbLebLsbLobRobLsbLcbLcbLobRibRebLsbRsbLo
bLibRobLebRebLgbRcbLgbLcbLibLgbLgbRgbLobRobLcbRobLebRebRebLibRebRebRob
RibLgbRcbRebRebLcbLcbRhbRobLobRobRcbRobRebRcbLobLsbLebLebLgbLebLobRebL
ebLsbLsbLcbRebRgbRcbLsbRcbLobRibRibLebRgbLcbRcbLobRobRebRgbRibLibRgbLc
bRibRebRebRgbLobLebRobLobRhbLobRobRebRobLobRobRobRobRcbLebLobLcbRobLob
LebLobLgbRcbLobLebLobRebLebRhbLebRgbRebRobLebRcbRobLsbRobLebRobRobRobR
hbRobLibLobLebRsbRobRebLebLebRobRobRcbRcbRebRibLobRgbLobRsbRebRcbRibRe
bRobLgbLebRebRgbRobRebLobRobRobRobLobRebLgbLebLebLcbRebLcbLobLibRobLob
LgbRgbLobRobRcbRobRobLobLgbRobRobLcbLcbLobLcbRsbLsbLebRgbRcbRsbLcbRebL
obRsbRgbLibLebLebLcbRobLobRebLobLobLebLobLobLebRobRobRobLebRgbRobRibLo
bLobRcbLobRebRcbRobLcbLobLsbRobRgbLobLebRebRibRcbRobLebRobRobLobRhbLeb
RhbLebRebLcbRsbLobRcbLobLebLobLobLgbRgbLsbLcbLcbRobLsbLobLobLobLgbLebL
ebRebLebRobLcbLgbRhbRobRcbRobRibRcbRebRcbRobRsbRibLobLobRcbLcbLcbLgbLc
bRibRcbLobLhbRobLcbLobRobLobRebLebRobLobRcbRgbRebRebRebRobRebLjbRebLgb
RobLebLgbLebRcbLobRgbRibRebLobRhbRibLebLobRgbRobLsbLobLobRebRhbLhbLobR
obLobRsbRobLobRobRcbRcbRibRobRobLgbRcbRobLcbLibRebRibLcbLcbLsbLobLibLe
bLebRebRobRobRobRhbLobRcbRobRobLgbLebLgbLobLcbLobLcbLobLobLobLibLobLob
LobLobRgbLebLcbRebRebRebLgbRcbLobRobRebLsbLobLgbLobRcbLobRebLcbLobRebR
cbLsbRobRgbRsbRebLcbLibRobRcbRibLcbLibRobLcbLgbRobRcbLsbLebLebRgbRebLo
bRebRebRcbRebLobLebRcbLibRobLcbRcbLebLebRcbLgbRobLebLsbLcbRobRobRgbRob
RobLcbLobLibRgbRcbLobLobLibRebRobLcbLebLebRobRobRcbLgbLebRobRgbRobRobR
ibRebLobRobLobRibRcbLobRebRgbRobRebRibLsbRebRcbLobRobRcbLcbRgbRebRcbRe
bLobLcbLebLobReb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 12; Drug: APO 0.5
bRsbLsbRibRibLibLiLsbLsLsmbLsbLgbsbRibRibLibRgLsbRsbRsbRiRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bRsRsmbLsbLsbRibRgbRsbsbRsbsbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLsbRsbRsbRsRsmbRsbRsbRsbRsRsmbRsbRsbLsbRsbRsRsmbRsbRsbRsbLsbLsRsbRsRs
RsmmbRsbLsRsLsbRsbLsRsbLsbRsbRsRsRsmmbRgbRsbRsbRsbRsRsRsmmbLsbsbRsbRsR
smb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLgLsLsmbLsbLgLsbLibLjLgbLibRgLsbLsLsmbLiLsLsmbLcbLoRsbLsbsbRoRsmbLgbR
ibLgbLobLsbRsbLiLsbLgbLsLsmbLsLiLsbsbLsRsbRhbLsbRsbRsbRsRsmbLsbRsbRgbR
iRsmbLsbLsbLsLobLobLsbLgLsbLsbLsRsbLsbLsLsLsmmbLgbLsbLgLsbLgLsRsbRgbLi
RsbLgbLsbLsbLgLsbLgbLgbLsRsLsbLsbLsbRsbLeLsbLibLibLibLiLsbLcLsmbRsbLiL
sbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bRiRsmbLsbLibRjbsbsbLibRsRsRsmmbRsbRsRsmbsbLgbLsbLsbLsbLcbLjLsmbRcRsmb
RgRsmbRsbRgbRhLsbLgbLgbRsbRsRsRsmmbLsbLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
bsbsbsbsbLsbsbLsLsmbRsbRgbLhbLgbsbRgbsbRsbRobsbRsbRsbRibLsbRibsbRgbLgb
sbRgRsmbRgbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bLibRob

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bRgbLsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bRebRebRobLsbRsbRsbRsbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bRgLsbRgRsRsRsmmmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRcbRibRobLgbLebRcbLobLebLibLebLebLebRebRobLobLobRobLobRcbLobLebLebReb
LobRsbLebRcbLebRobLcbLobRebLhbLsbRebRebLebRcbLhbLebLcbRebLobLobRebLebL
cbRsbLsbRobRebLobLobLobLobLobRobLcbRobLobRebLcbLebLibLcbRobLebRebLibLe
bLcbRcbRgbRobLobLobLobRibRobRcbRhbRsbLobRhbLebLebLgbLobLobLebLcbRebLib
LobLcbRibLcbRobLobRobRcbLobLobRobRjbLobLobRebLobRcbLcbLobRgbRobLobRobR
ibLgbLobLobLsbRobLcbLebLebRsbLobRobLcbLobRebRcbLhbRobRgbLibRebLobLcbLi
bRebRebLibLsbRobRibRsbRhbLebRobRcbRobLobLobLobRibRgbLobRibLobRsbRobRob
RebRobRsbRobRhbLobRebRobLobRobRobLobLobLsbLobLobRgbLobRhbRobLobRebRebR
ebRibRebRcbLobRobRobLsbRibRebLjbRgbLobRobLcbLobLibLjbLobRobLsbLibRobRo
bRobRcbLobRobLobLebLcbLebLobRebRcbLcbRebLhbLobLebRsbRobLebLebLebLebLob
RgbRobRobLobRcbRgbLobLobRebRobRobRebLcbLebRgbRcbLhbLebLobLobRibLobRobR
ibRobRcbRcbLcbRcbRhbLobLobRcbLebRobRobRibLobRobLebLobLibLobRebLsbLobRo
bLibLebRjbLobLcbRhbRobLobRebLobLobLebLcbLobLcbLgbRebLcbRebLgbLobLebReb
RobRebRebLebRebRibRebRebRebLibRobRobLobLobLibLcbLobLobRobLobRcbRcbLobR
ebRebLobLobLgbRgbLibLobLobRobRhbRobRobLobRsbRebRcbLobRobLebRgbLobRgbRi
bLobRgbRobRcbLcbLebRebRobRcbLibLibRcbLobLebRebLebRobLobRcbRobLebRgbRob
RjbRobRebRebLobRebRgbRibLebLobLobRebLobRobLobLobRebLsbLobLibLgbRebLobR
ebRobRcbRebLebLobRebRebLebRcbLobLebRobRsbLhbRobLibLebRgbLobLobLibRobLe
bRobLobLebRobLebLobRobLsbLhbLebRebRobRebRobRibRjbLobRebRcbLgbRobRibLeb
RobLobRobLibRhbRobLobRobRgbLcbRgbRcbRebRebLgbLobRibRobRobLobLobRgbLjbL
obLobLobRcbRsbRjbRcbRsbRgbLobRjbRobRibRsbRobLebRobRgbLobLobLobRibLcbRo
bLobLobRjbLcbLobLobRobRibRobLcbRobLjbLebRebLebRobLobLobLebLcbLobLobRob
LebRjbLobRobLebLebLsbRgbLcbRobRibLobLcbRobLobLibRcbRobLebRebRobRobRhbL
ebRibLcbRcbLebRgbLobLobRobRcbRjbRobRebRobRobLobRhbLobLibLobLobLcbLibLo
bRgbLebLhbLgbRibRobLebRcbRobRobRsbRcbRgbRobLobRobLobRebRobLobRibRobLob
LcbRobLobRibRobRebRebLobRcbLobRcbRgbRobRobRebLobLobLjbRobLcbLsbRsbLcbL
obRobLobRjbRibLcbLgbRebRebRhbRjbLcbRebRibRcbRsbLobLobRebRobRobRobRobLo
bLcbLobLobRobLcbRobLebRobRobLobLibLobRebRobRobRcbRcbRgbRobRcbRsbRobRcb
RcbLsbRobRcbLcbRobRgbLebRebRhbRcbLobLebLobLebLobLgbRcbRcbRcbLsbRibLibL
ebRcbRcbRgbRcbLibRebLobLobRcbLobRsbRebLcbRobRobLebLobRobLcbRobLobLgbLc
bLgbRcbLobRgbLebRobLgbLgbLobRibRsbRgbRobRobRobLobLsbRebLobRebLsbLebLob
RobLebLobRobLobRgbRsbLobLgbRobRsbLibRobLcbLebRebRobLobLobRobRobRobLebL
obRobRcbLebRsbRhbRsbLgbRobRgbLibLjbLgbRebLobLobRgbLebLjbRcbRobRobRebRc
bRsbLebLobRobRebRcbRebRobLcbRobLcbRobLobRobRjbRebRobRebRibLobRobLebRob
RcbRibLebRebLsbRebLobLsbLobLgbRobLobLgbLebLjbLsbLobLobRobRobRobRcbLcbR
obRebRebLobLobLcbLebRsbLobRcbRobRobRibRebRsbRebRcbLebRobLebLebLobRcbRg
bRobRebLcbLobLebRobLcbLobRobLibRcbRsbLcbLobRibRobLobRebRobLibRibLobLeb
LhbLjbRebLcbRgbLibRgbLjbRebLobLibRcbLebLobRobRobRcbLobLobLobLobRobLobR
sbLcbRjbRsbLcbLebLob

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLsbRsbRsLsbRsbLsRsbRsbRgRgbRsbRsRsRsmmbRsbsbRsbRsRsmbRgbRsbRgbRsbRgbR
sbRsbRsRsmbRsRsmbRgRsmbRsbRgbRsRsmbRsRsmbRsbRsRsLsmbRsRsmbRsRsRsmmbRsb
RsbRsbLobRjbLjbLsbLgbLsbLgLsbRsbsbLgbLsbLsLsmbLsbLgbLgbsbRsLsbLsbLsbRs
bLgbRsbLsbRsbLsbLsLsmbLsRsbLsbLgLsbLsbRsbLsLsmbLibRsbRsbLsbsbRsLsbRsbs
bsbLgbLgLsbsbRsRgbRsbsbLhbRsLsRsbLibRsRsmbLgbLsbLsbLsbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
bRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bLsRsbRgbRsbRsLsbLsLsmbLsbLsbRsRsRsmmbRsbLsbsbsbsbLsLsmbLsLsmbRsbRgRsm
bRsRsRsmmbRsRsRsmmbRsRsmbRsRsRsmmbRsRsmbRgbRgbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bLsbLsRsbLsbLsbLsbRsbRsbLsbLgbRsLsbsbsbLsbRsLsLsmbRsbLsbsbLoLsmbLebLsb
LsbsbRcbRgbLgbLsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bLsLsLgmbLsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLobRgbLcbRebRobRobLhbRobLcbLcbRobLcbRebLobRobLsbLebRobLcbLebLobLcbLgb
RebLobLobRcbRhbLcbRobRgbLobRobRgbLobRobLcbRobLcbRebRobRibLcbLobLobRobR
cbRobRibRobLebLgbLsbRgbRebLobRcbRibLebLobLebRebLobRobLcbLcbLobLebRobRe
bLobRobLibLobRcbLibRebRobLebRjbLobRibRobRebLebLobRcbLcbLobLobRjbLobReb
LibLcbLobLobLebLebLobRobLgbLsbLgbRsbLobLobRsbLobRobRobLebLobLgbLobLcbL
sbLobLgbRobRobRobLobLhbLobLobRebRcbLebRsbLebLobRcbLobRgbLebRobRcbRcbRc
bLcbLobRebRobLibRgbRibLobRebLobLobLobRobRobRebRebLobRobRebRgbRcbLcbLgb
RebRcbLcbRcbLcbRsbRobLebRobRobLobRobLsbRobRsbRebRebRgbRcbRebLebLebLobR
ebRobLcbRobLobRobRcbLebRobRcbLsbRcbLobRsbLebRgbRgbRobLebLobRobLebLcbRo
bRobLsbLobRcbLibLcbRcbLobLcbLobRsbRcbLcbRebLcbRebRcbRebRgbLcbRcbLibLcb
RobLebRobRebRibRsbRgbRebRobRcbLcbLcbRhbLobLhbRobLobLcbRjbRebRobLobLebR
gbRebRobRibLobRobLebRebLgbLobLobLebRcbLebRebLebLgbRobRsbRcbLobRebLcbRo
bRebRcbRobLibRebLobRebRobRebRobLcbLebRcbLebRibRobLobLebRobRebRjbRobLeb
LebLibRgbRjbLebLobLobRibRebLobLobRgbLebRsbRobRobRebLebLobRibRobRebRcbR
ibLgbRobLebRobLibRobRibLebRcbRibRebRjbRobRibLobLobLobRgbRobLobLibRobLe
bLobRobRobRsbRobLcbRebLcbLobRgbLgbRobRobRobRobLobLebRcbLgbLobRebLobReb
LebLibLobRgbLgbRobLobLobRebLobLibLcbRobLobRobLcbLcbRhbLobLobLobRobLobL
ebLobLobLcbLobRobLobLobRobLcbRobRibRobLibLsbLibRcbRobRobLebRsLebLobLob
RobRgbLobLobRebLcbRsbLsbRebLebRcbRsbRibLcbRcbLsbLobLobLobRobRsbLibRsbR
sbLobRibRobLsbRebLcbLsbLobRsbLcbLebRebLcbRebLobLhbLobRobRibLobRobRsbRi
bLgbLibLebLobLhbRcbRobRhbLobLobLibLebRcbLobRobRobRebLebLobRcbRobRebRob
RobRebLebLgbRebLobLibLobRobLebLsbRebLebLobRobRebRebLobRibRibRibLebLebR
cbLgbLobRcbRebLsbRgbLgbLgbLobRibRobRobLobRobRgbRebRobLebLebLobRibLcbLo
bLobLsbLobRobLibRcbRobLobRobRobLibRobLobLcbRobLobLobLcbLjbRebRcbRobRob
LobRcbLgbLcbLebRsbLsbRsbRobLobLibRibRobRobLobRebRcbLibRebLobLhbLobRobL
cbRobLgbRobRobRgbLebLobRibRibLobLibRobLobRhbRcbLsbLobLcbRcbLcbLcbLebRi
bLcbRgbRebRobLebRobRebRobLebLobRobRobLcbRobRobLobLobRobRobLcbRebLhbRob
RebRebRobLebRibRsbLsbLebRobLobRibLebRcbRcbLsbRebLgbRobLebLobRobLcbLcbR
ibRobLobRobLhbRebLibLgbLgbLebLcbLobLebRobRcbRobLebLobLebLibRebLobRhbLe
bRibLobRhbRcbRebRobLobRobLobLobLobLcbRsbRobRebLcbRobRibRobLobLobLsLsLs
mmbLsRsbRsLsLsLsRsLsRsRsRsRommmmbLobLgbRobRhbRsbRobLobLsbLsbLebRobLobR
ebLobRebRobLebLebRebLcbLobLobLobRobLebLcbRgbRcbRebLobRgbRsbRebLobLebLg
bLebLobLgbLgbRsbRebLsbLobRibRgbLobRcbLobLobLobRsbLibRebLobRobLcbRcbLob
RhbLcbRebRobLgbLhbLobRobRobRgbRgbRobRgbRebLebLcbRebLgbRebRcbRobLcbLebR
cbRebLgbLobRibLsbLobRobLobLgbRebRsbRcbRcbLsbRobRebRebRgbRobLibRcbRobRo
bRebLobLobLobRhbRobRebLibRobLebRgbLgbRebLebRebLebLobRobLobLobLobRobLob
RebRebRcbRobRebLobLgbRobRobRobRibRebLobLebRobLibRobRgbLibRcbRebRgbRebR
obRcbLibRobLhbLobRebRebLcbLobRobRhbLobLobRibLcbRobRebRobLobLebRebRobLo
bLibRebLebLobLebLebLebRobRobRobLibLibLebLgbRsbLobLebRgbRcbLgbRobLobRob
RebLibRibRcbRcbLobRobLebRebRebLebLcbLgbRibRsbLobRcbRibLibLebLobLsbRobL
cbRebLcbLobRobRobRibRobRcbRobRebLebLobRobLobLibLcbRobRibRobRobLebRebRe
bLcbRobRibRcbLgbRcbRebLobRcbLebLobLcbRobRebLgbLgbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 31; Drug: APO 0.5
bsbLcLsmbRgbRibRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 32; Drug: APO 0.5
bReRsmbRobRsbRgRsmbLsbRsbLsbLsbLsRsbLgbRsbsbRibLsbLsRsbLsbRsbLjbLcbRsL
sbRsbRgbRsRsmbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 33; Drug: APO 0.5
bLsbRhbRebLeRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 34; Drug: APO 0.5
bLgRsbRsbLsbLibLobRgbRgbLsbRjb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 35; Drug: APO 0.5
bRhbRhbRsbRjbRibRgbLsbRoRsmbLibRcbRebLsRcbRibRebRgbRhbRjbRsRsmbLsbLiRs
bLsbRgbRgLsbLhbLgbLsbLsbRsbLsbLsRgbRibRibRgbRgLsbRjbLibRhbRibRsbRibRgb
RsbRgbLgbLibLibLgLsbRsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 36; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bLsbRgbLgbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLsLsmbRgbRgbRoRsmbLgbLsLsmbsbLsbRgbRsLsbLsbLgLsbLsbLsbLsLsmbLsbLsLsmb
LsbLsbsbsbsbLsLsmbLsbLsRsbLsbRsbLsbLsLsmbLsbLsLsmbLsbLsLsLsmmbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLobsbLjbRjbRsbLgLsbsbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bsbsbsbsbsbsbsbsbLsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbsbLsbsbL
sbsbRsbRjbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRgbRgbRgRsmbLsLsmbRsbRhbRsbRsbRgbRobsbLibRsbLoLsmbLgbLsbRsbRsbRsbRobs
bLsbRobRsbRsbsbsbLsbLobRsbRobRsbsbRobRsbsbRsbRsbRsbRobsbLibRsbRsbLsbRs
bRsbRjbRibRibRsbsbRsbsbsbsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bRgRsRsmmbLsbLsbsbLsbRcbLgLsbRibRjLsRsbRsbRhLsbLgbLsbLsLsmbLgLsbLgbLsb
RcbRsbRgbLsLsmbRjbsbLsLsmbLsRsbsbRibLgLsbLhbLgbLsbRgbRoRgbLcb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bRsbRsbRsbRsRsmbRsbsbRsbRoRsmbRsbRsRsLsmbLsbLsLsmbLsLsmbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bsbsbsbsbsbRsLsbLsbRsRsmbRsRsRsmmbsbLsRsRsmbLsLsmbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bLgbLgbRiLsRsLsbLsRsbRsbRiRsmbLsbLgLsbLsLsmbRsbLsRsbLsbLsbLsbLsbLsbLsL
smbLsLsmbLsbLsbLsbLsbLsLsmbsbLsbLsbLsbLcRsbLgbLebRhbLjbLcbLsbRsbRobRgL
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bRebRsbLsbLsbLsbLsLsmbLsbRsLsLsmbLebLsbLobRcLsbLsbLsbLsbLsbRsbLobRsbRs
bLsLsmbsbLsLsmbRsbRobRoLsbLsLsmbRsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bRsbRobLsLgbRsRsmbLgbRoLsbLibLsbRsbLsbLgbRsbLsLsmbLgRsbRgRsmbLsLsmbLgL
gLsbLgLsbLsbLcLsmbLgLsLsLsmmbsbLsLsmbLsbsbLgbLsLsmbRsRsLsmbRsbLsbLob

>ZF Recording 2016-04-14; tW: 300s; Start: 140150; End: 140650;
Recording: 12-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bsbLgLsbLsLsmbLsbLsLsmbLsLsmbsbLsbLgbLobRoLsLsLgmbLgbLgbLsbLgbLgbLgbLs
bLgbLgLsRsbRsbLgbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 1; Drug: PCAP2 10uM APO 0.5
bsbLgLsbLgbLgbLgbLgbLgbLgbLsRsbLsLsmbLgbLgbsbsbLsLsmbLsLsmbLsLgbLsbLsL
smbRsLsbLgLsLsmbLgbsbLgLsbLgLsbLgbLsbLgbRsbLgbLsbLgbLsbRsbRsbLsLsLsmmb
RsLsLsmbLgbsbsbsbLgLsbLgbLgbLgbRsLsbLgbLgbLsLsmbLsbLsbLgbLsLsmbLgbLgbL
gbLgLsbLeLsbLsLsmbRsbsbRgbsbsbRgbRgLsbRsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 2; Drug: PCAP2 10uM APO 0.5
bRgLsbRsbRsbRsbsbRibLsbLgbLsbLsbLsbsbsbRsbLsbRsbLgLsbLsRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 3; Drug: PCAP2 10uM APO 0.5
bLibLgLsbLgbRgbRsbRsbRsRsmbRsbRgbsbLobLgRsbsbLsbRsRsmbLsbLsbsbRsbRibLs
bsbLgbLgbLgbLgbLsLgbLgbLgbRsLsLsLsLsmmmbLgbLgbsbLsbLgbRsbLgLsbLsbLsLsL
smmbRgbLsbLsbLsLsmbLsbLgLsbLgLsbLsLgbLsLsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 4; Drug: PCAP2 10uM APO 0.5
bLsLsLsmmbRsbLsLsmbLsbLsbLsbLgbRsRsmbLsLsmbLsLsmbLsLsmbLsbLgbLsbLgbRsb
LoLsmbLsbLsbLsbLsbsbsbsbsbsbRsbsbLsLsmbLsbRobLsbRgbRiRsmbRsbRsbRgbRsbR
cbLsbRsLsbLsRsbRsbLsbRgLsbRhbRsbLsRsbLsbsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 5; Drug: PCAP2 10uM APO 0.5
bRjLsbLsbLsbLsRsbRsRsmbLsbLsbLsbLsbLsbRsbLsbRsLsbLsLsmbLsbLsbRsRsmbRsb
RsRsmbLsbRsbRsbRgLsbLsRsbLsRsbRsbRsbRsRsmbRsbRsbRsLsbRsLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 6; Drug: PCAP2 10uM APO 0.5
bLsRsbLgbLsbLgbLibRibRiRiLsbRgbRsbRsbRjbLgbRgbRsRgRgbRgLsbRgbRsbRsLsbR
hbRgbRsbLsbRsbRsbRsbRsRsmbRsRsmbRjbRsbRsbRsRsmbRsbRsbRsbRsbLsRsRsmbLsb
LsRsLsRsRsmbLsbsbRgRsmbRsRsmbRgbRsLsbRsbRsbRsbLoLsmbLsbLibLsbLgLsbsbRs
bsbRsbRcb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 7; Drug: APO 0.5
bsbsbsbsbRgLsbRobLgbRsbLcLsLsmmbLiLsbLsbRobLoLsLsmmbLibRhbRcbRcbLhRsbL
sbLsbsbsbRcbRcbRcRsLsmbRhLsbLiRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 8; Drug: APO 0.5
bRsRsmbLsbsbsbRsbRibLsbsbRsLsbLsbRsbRsbRsbLsbLsRsbLsLsmbLsbLsbsbLsbRsb
LsbsbLsbRsbsbsbRsbRsLsbLsbLsbRsLsRsbsbRsRsmbLsbsbLsbRsbRsbRsLsLsmbRsbR
sbsbRsLsbsbRsLsbLsLsmbRsbLsbLsbLsbLsRsbLsLsmbRsbRsbRsbsbRsbRsRsmbRsbRs
RsmbLsbRsbLsbRsbRsbsbRsRsLsmbRsbsbsbLsLsLsmmbRsRsmbsbLsbsbsbsbRsbRsLsb
LsbRsbLsRsbRsbLsbLsbsbLsbLsRsLsbLsbLsLsmbRsbLsRsLsbRsbLsbRsbLsbLsbLsRs
bLsbRsbRsLsbRsbLsbLsRsbRsbLsbLsLsmbRsbsbLsRsbLsRsbLsRsbsbLsLsmbsbsbRsb
LsbRsbsbLsbLsLsmbRsLsbRsRsmbRsLsbRsRsmbLsbRsbRsLsbLsRsbLsbLsbLsbLsbsbL
sLsmbRsbRsLsbRsbLobLsRsbLsRsbLsRsbsbRsbLsbsbRsbRsLsbLsbLsbLsbRsLsbLsbR
sbLsRsRsmbRsRsRsmmbLsbLsbLsbRsLsRsRsmbRsLsbRsRsmbsbRsRsmbsbRsbLsbRsbRs
bLsRsbRsbLsbRsbRsbRsbRsbRsLsLsmbRsbLsRsbLsRsbRsbsbLsbRsRsmbLsbsbLsbsbL
sRsbRsbsbsbRsLsbsbRsbsbLsLsmbRsbRsbLsRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 9; Drug: APO 0.5
bRiRsRsmmbLibLjLsLsmmbRcLsbsbRhLsbLcLsmbRgbLhLgbRoLsbLebsbRsbRebRgbRgb
LsbLsbRsbLobsbLcLsmbLgbsbRsbLhbsbLebLjLsmbRebsbLsbLgbRibsbsbsbRgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 10; Drug: APO 0.5
bLibRsbLsbLobLjRsbLjLsmbLgbLsbLsbLsbLjbLjbLibRsbsbRsRsmbLiLsbLsbLsLsmb
LsbRsLsbRobRgbLsbsbRsbRcbRoLsbLsLsmbLibLcbLibLgbLsLsmbsbLibRsbRsbRsbRc
bRsbLjbRsLsbRgbRsbLsbRsbLhLsbRsbLsbLsbRsbRsbLsbLsRsLsbLgbLjbLsbRsbLibR
sb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 11; Drug: APO 0.5
bLobLobRobRebLebLcbRobLobLgbLebRobRibLobLobRobLebLebRobLcbRobRobRobReb
LobLebRgbRgbRobRobLobLobLibRgbLcbRcbLobLsbRebRebRobRebRsbRobRgbLobLobL
obLobLibRobLobRobLobRobLcbRhbRcbLebRobLobLcbRebRobRobRobLebLibRibRobRc
bLobLobLobLobLsbLibLhbLgbLcbRhbRhbRebLobRebRebRobRobRebRcbLobLobRebLeb
LobRebRcbRebLcbLobRobRgbLobRebRebLcbRobRobLobRcbLobLibRobRobRobRobLobL
obRobLcbLcbRobLibLgbLcbRobLobLobRobLsbRobLhbLebLobRcbRobRobRobRebLibLe
bRhbRcbLgbLobLibLobLebRebLsbLebLobLobRsbLobRebLobRgbLobRcbLobLobRobLeb
LobRobRobLcbLobLobLibLebRcbLibRobRibRebRobRobRsbRcbLhbRibRcbLobRobRhbR
ebLobLibLebLobLibLcbLebLibRcbRcbRobLsbLibLobRobRsbRobRcbRgbRebLcbLebRg
bRgbRobLobRobRobRobLibLebLobLobRobLsbLebRcbLebRobRobRebLebLobRcbLobRob
RebRcbRebRobRsbLibRebLobLcbRcbRobLobRebRobLsbRobRobLcbRobLibRcbRobRcbL
obRobLobLebRobLibLobRhbLobLobLobRcbLcbLcbRgbRobLobRebLgbRobRobLsbRcbRo
bRobRobRgbRobLibRebLcbLsbRibLobRobLobRobRobLhbLcbRibRgbRebLcbLcbRcbLob
LobLobLobRobRgbLsbRobRobLobLobRcbLcbLobRobRebRibLebLobLebRobRobLebRibL
ibLobRebLcbRebLhbRebLobRgbLobRebLcbRcbRobLobRebLobRgbRebRobLebLebRobRg
bLcbRhbRebRhbLibRobLobLobLobLobRebLobLobLebLobLobRgbLobRgbLobRcbLcbReb
RebRcbLebRcbRebRibLgbLgbRobRobRcbLobRhbLebLibLhbLebRobRebLebLobRebLsbR
ebLobRsbLcbRebRobLebLcbLsbRsbRebRebLgbRcbLebRobLobRcbLobLobLgbRebRobRi
bRebRgbLobRibLobLebRebLobRibLobRgbRgbLebLobRobLebLebLgbLcbLgbLobLibRgb
RebRcbRebRebRobLobLgbRebLobRebLobRgbRobLobLebRobLebLobLcbLobLobRobRebR
obRobLebLebLgbLebRsbRibLcbLcbRsbRebLobRebLobRebRobLebRcbRibLobLcbLobLc
bRebLobRobLebRcbRebRibRibRcbRobRobLgbRobLobLibLsbLcbLebLcbLobLobLobLcb
LebLobRibRsbLcbRgbLebLobRobRebRibLobRebRhbLobRobLobLebRhbRibRebRcbRibR
obLobLobRobLobLobRobLibRebRobRcbRobRebRcbLobLobLcbLobRobRobLebLobLobLg
bRcbLobLebRsbRobRhbLobRebLibLobLgbLobLcbLhbRsbRobLebLcbRobRgbRebRobReb
LobLobLobLobRobRobRgbRobRobRebRebRebLcbLibLcbLjbLebRobLibRebLebRhbRobR
obRcbRcbRibRcbLsbRsbRcbRgbLcbRibLebLobLcbRcbRgbRibRobLibRcbLibLsbLcbRe
bLcbLgbRobLobLobLobRobRebRebRebLobRcbRobLebRebLebRobRibLibLobLcbLobLob
RibRebLibLebRsbRibRibRebLobLcbLobLebLcbLobRsbRebLobRobLibLobRhbRebLsbR
ebRobRobRcbRgbRibLobLobRcbLebLobLobRjbLibLobRobLebRobRebLgbRobRebRobRg
bLgbRgbRobRibLebLhbRebLobRobLobRhbRhbRsbRebRcbRebLcbLobLcbRobLobRcbRhb
RcbLobRobLobRobRebLobLobRsbLibRobRjbLobRebRobLebRobRcbRobLcbRsbLobLebL
cbLobLgbRgbLobRobLobRcbLobLcbLgbRgbRsbLobRobLhbRobRsbRobRebRobRobRgbRo
bRibLcbRebRebLibLsbRobRobLebLebRibLgbLobRebLibLhbRobRsbLobRebLibLobRob
LebRobRibLcbLcbLgbLobRobRsbRebRsbLibLebLcbRebLcbLobLebLobRcbLcbRobRobL
sbRobLobRobRcbLobRebRgbLcbLcbRsbLgbRcbLobLgbLcbLgbRobRjbRcbRcbRebLobLg
bRebRobLebRcbLobRebRobRibLobRobRobRebLobLobRobLobRebRibRobRobLibRgbLib
RebLobRcbLjbLebRibLobRebLjbLcbRobRebLebRgbLebLobRcbRcbRobRebRobLgbRobL
gbLcbLgbLobRebLgbRobLebRobRsbLsbLobLibLobRcbLobLsbLcbRebLgbRcbRebLobLe
bLcbLebRhbLcbRcbLgbRibLcbLobRobLsbRobRibLobLebLobLobLobRcbRobLobLobLob
LjbRsbLobRebLobRcbLibRsbRebRebRgbRcbLobLobRebLibRobRebRebRebRcbLobLobR
obRgbRebLcbRcbRebRcbLobLgbRebRjbRobLobLebRobRebLibRgbLebLcbLgbLobRcbRc
bRobRobLobRebRobLgbRebLibLebRcbLebRobLobLhbRjbRobRobRgbRobLsbLobRobRob
RibRobRobRebRobLebRcbRebLobRobRobRobRobRobRsbLobRibRobRobLobRebRebRsbL
gbLcbLcbRibRob

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 12; Drug: APO 0.5
bRsRsmbRoLsLsmbRibLibRgbLsRsbRcbRobRibRjbLhbLiRsbLibRibLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 13; Drug: PCAP2 1uM APO 0.5
bLibRsbRgbLibsbsbLoLsmbRsLsRsbLibLsbLsLsmbLsLsmbLcRsbRsbRsRsmbRsRgRsmb
sbRiRsmbRsbsbLsbLibRsbRsbLgLsbRsbRsbRsRsmbLsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 14; Drug: PCAP2 1uM APO 0.5
bLsRsbRsRsmbRsbLsbRsRsmbRsRsRsmmbRsbRsRsRsmmbLsbLsRsbLsRsbRsbRsbLsbRsb
RsbRsbRsbLsbRsbLibRsbRsbRsRsmbRsbLsbRsbLsbRsbRsbRsbRsbRsRsmbRsbRsRsmbL
sbRsbRsbLsbRsRsLsmbRsbRsbRsbRsbRsRsLsmbRsRsmbRsbRsbRsRsRsmmbRsbRsbRgbR
sbLsRsbRsRsmbRsbRsbRsbRsRsmbRsbsbRgRsRsmmbRsRsLsmbLsbRsLsbLsbLsLsmbLsR
sbRsRsmbRsLsbLgbRgbsbRibRsbRsbRsbRsbsbRsbsbRsLsbsbRsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 15; Drug: PCAP2 1uM APO 0.5
bLsbLgbLgbLgLsbLsbRibLibLgLsLsmbRibRibLgbLcbLgLsbLibLgLsbLeRsLsbLsbRsb
sbsbRsLsbRjbRsbRgbRsbsbRgbRsbRsbsbRsbLgbReb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 16; Drug: PCAP2 1uM APO 0.5
bLjbRjRsmbRsbLgbLsbRjbRsRsRsmmbRsbsbLjLgLsbRgbLsbRsbLibLgbsbsbRgbLjLsm
bRebRgbRsbLsbReLsbRiRsmbRibsbLjLsmbLibRcbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 17; Drug: PCAP2 1uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 18; Drug: PCAP2 1uM APO 0.5
bRsbRgRsmbLsbRsbLsRsbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 19; Drug: PCAP2 3uM APO 0.5
bLjbRsbLhRsbsbLoLsmbLsLsmbRobLgLsbLsLsmbLhbLibsbRobLibLsbLsbsbRsbLsbsb
sbLsbsbsbsbLgLsbLsLsmbLibsbRsbRsRsmbRsbRsbsbsbRsbLsbsbsbLsbsbLsLsmbLsL
gbRiRsmbLsbLsbRsbLsLsmbsbsbLsbLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 20; Drug: PCAP2 3uM APO 0.5
bLsbLsbLsbRsLsbRsbRsLsbLsbLsbLsbLsLsmbRsbLebRebRsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 21; Drug: PCAP2 3uM APO 0.5
bLgRsbRsbLsLsmbRsbLsLsmbLsLsRsmbLsbLsbRsRsmbRsbRsLsbRsbLsbLsbLsbLsbLsR
sbRcbsbsbRsLsbRgbRgbRibRsbReLsbLsbLsbsbLibLsbLgbLsbLsbLgbRsLsbLobLgbsb
LsbRibLsbRibLsRsRsRsmmbLgbLsbLsbLgbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 22; Drug: PCAP2 3uM APO 0.5
bRobRebRibLgbRobLebLobLcbRcbLibRhbRibRebLobRebLobRobRobRebLobLobRsbRgb
LcbLebRobLobLobRgbLcbRcbLibLebLsbRobLobLobLobRcbLobRobRebLobRcbRobRobR
ebRobLibLobLobRcbLobLobLebRcbLcbLebRsbLcbLobRcbRebLcbRobLebRgbRsbLobRe
bLcbRobLcbLebRebRcbRgbLobRobLcbRebRobLebRibRobLcbRebLobLobRebRsbRobLgb
RibRobLobLcbRhbRcbRgbLobLibRobLobRobLhbLgbLebLobRcbRobLobRebRebRibLobL
obRcbLebRobRgbLobRcbRobRobRobRhbRcbLibRobLibRcbRobRobLibRcbLebLgbLsbRo
bLobRebLebRibLobLsbRhbLgbRobLebLobLebLebLcbLobRobLsbLibLebRcbLcbRobLcb
LebRobLebLobLobRobRobRobLobRebRobRsbLobRcbLobLebLobLebLcbRobRebRobLebR
ebLobLjbRobLgbRebLobLcbRcbRgbRobRebRibRebRobRobRsbLobLcbLobRhbLobRobLs
bRobLobLhbLobRgbLsbLebLobLobLobLhbRobRibLobRobRobRobLobRsbRobRgbRebReb
RcbLobRcbLibLcbLobLobLobLsbLobLebRebRcbLobRsbRebRgbLibRobRobRebRgbLobR
obRobRibLobLobRobRgbLobLebLebRsbRhbRcbLsbLebRibLibLcbRobRobLobRebRobRs
bLcbLcbLobRebRsbLobRibLobLjbRebRobLobRobLobRibRobLobRobLcbRcbRobLibRgb
RebRebRebLobRobRcbLobLobRobRobRobRjbRobRobRcbLobRobRobLebRobRebRobRebR
obRebRobLobRcbLobLobLebRebRgbLobRcbLibRebRobRebLobRibRcbRobLsbLibLobRg
bRibLcbLobRebRebRcbRcbLcbLebRebRobLobLebRsbRobLobRobRsbLibLobLsbLobRcb
LebRsbRobRibRobRsbLgbRebRebRjbLibLcbLobRjbLcbRobLebRobRsbLgbLebRcbRobL
obLobRsbLebLobLobRobRcbRibLebRobRobRobRebRobRebRobLebRebLobLobLsbRobRs
bRebLcbRibLebRgbLebLobLebLgbRcbLcbRgbLobLgbLibRobRebLebLebRobLibRsbRjb
LcbLobRebRebRobRcbLebLebLebLebLobRcbRobRcbRcbLobRcbLobRobRebLgbRobLobR
ibLebRobLcbLobLobLobLobRobRibRhbLhbLobLobLgbRsbLebRcbLobLcbLobRobLcbLo
bRcbRcbLobLibRcbRibLgbRebLhbRibLobLobLebLobLebRobLgbLobLcbLebLobRebRob
LcbLebRgbRebRobRcbRobLcbLobLgbLobRobRobRcbRebRcbRsbRobLebLebLgbRgbRobL
ebLebLebLobLcbLsbRobRebLgbLobRobRobLgbLcbRibLcbLobLsbRebRebLebLobLebRo
bRebRobRobRcbLebLhbRhbLobLobLobLebLobLobRobRobRebLgbRibRobLobLgbRobLeb
LobLhbRebRebLebLobLobLobLibLobRibRobLibLobLcbLcbLobLobRobRibLhbLobRibL
gbRobLobRobLgbLcbRobLebRobLobLebLobRobLobRcbRcbLebRebRobLcbLobLobRcbLi
bLcbLobLebRobLebLhbRcbLcbLobLobRebLobLcbRgbLobLebLcbLobLgbRgbRebRobRob
RobLcbLebLebLebLobRebRsbRobRebLobRebRibLibRobRebLobRgbLobLebRobLcbLobL
cbRibLobLebRobRebRobRobLibLgbLobLobRgbLobLebLobLebRobLcbRobLcbRebLobRe
bLebRebLibRsbRobRobLebLcbRobRebRhbLebRobLobLcbLgbRcbLgbRhbRjbRebRobLeb
RobLobLibRobRobRobRobRobLobRgbRobRebRebRebLjbRcbLsbLobLibRhbLobRebLebR
obLgbLobRobLibLgbRobRobLcbRobRcbRebRcbRobLobRebRibLobLebRobRcbRobLcbRo
bRobRcbLobLobLcbRobLebLcbRgbRobLibRcbLcbRcbLebRcbLebRobLobLobLebLcbRob
LobRebLcbRobLebRibRobLibRgbLgbLobLobLjbLsbRcbLobRsbLobLobLebRebLgbLebL
obLobLibLobLobLobLobLsbRobLobRibLgbRobRsbRcbRsbRebLcbRcbLcbLcbRgbRebLe
bLibLebLobLcbRobLobLcbRobRobLcbRebRcbRobRobLebLobLobLebLobLobRobRobLgb
RobRsbLobRobRebLobLobRobRcbLobRobRobRobRebRobRobLgbRobRebRobLobLobRgbR
sbRobLcbRobRgbRobRebLgbLcbLcbLibLobLobLebLobRebRebLsbLhbLibRcbLcbLobLo
bRcbLebRebRobRebLibLobRgbRibRcbRcbLebRebLobRibRebLobLebRebLebLobLcbLob
LebRibRobRgbRobRcbLobRobRcbLgbLobLobLibRebRobLobRcbLobLsbLhbRobRibLobL
obLibLobRebRcbRsbRobLobRebLobLobLobLobLobLcbLebLebLibLebLobRsbRsbRobRe
bRobRobLebRcbLobRobLobRibLcbRgbRebRcbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 23; Drug: PCAP2 3uM APO 0.5
bLsbLsbLsbLsRsbLsLsmbLhbsbRsbRsLsbRsbLsbsbLsbLsbLsbLgbLgbLsRsbLsbLsbLs
LsRsmbLsbLobLsbLsbRsbRsbRsRsmbRsbRsbRsbRsbRsbRsRsmbRsRsmbRsbRsbRsbRsbR
sbRsbRgbLsLsmbsbRsLsbRsLsbLsRsLsbRgLsbRsbRsbRsbRsbRsbRgbLsbRsLsbRsbRsb
LsbRsbRsbRsbRsbRgbRsbLsRsLsbRsbRsbRsLsbRsbRsbRsRsmbRsbLobLgbRsRsmbLsbL
sbLsbRsLsbRsbLsLsRsmbLsbLsLsmbLgLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 24; Drug: PCAP2 3uM APO 0.5
bLobRsbRobRjbLjbLebRobLebLjbLebLobLsbRsbRobLobRcbRjbLebRebLebRobRcbLob
RcbRobLobLobRobRcbLobRebRobRjbLsbRobRsbRibLobRobLjbLobLjbLobLebRcbLsbL
obLobLcbRcbRebLebLcbRcbRsbRjbRebLjbLjbLobLjbRsbLjbLjbRobRcbLsbLjbLobRc
bRobLobRobLjbLobLebRobRjbRobRobLcbRobLjbRobRobLobRebRcbLobRcbRcbRebLjb
LsbLobRebRobLobLcbLobLobRobLobRobLcbLebRobRsbLjbRobLebLobLobLcbRcbLcbR
sbLobLjbLcbRcbLobLibLobRjbLobRjbRobRobLobRobLcbRebRobLobLjbLebLobLsbLo
bLobRobRobLobRobLobLcbRjbLobLobRjbRobRobLobRobRobLobRobLobLobLobRebRjb
LebRobRsbRjbLjbRobRobLsbLobLjbLobRobRjbLobLobLobRobRjbRsbLjbRcbLobRjbR
cbLebLobRcbRgbLebRobRobLjbRebRcbLobRcbLcbLsbRobLebRobLjbLobLcbRobLobLj
bLobLobLsbLobRhbLobLobRjbLobRobRcbRjbLcbLjbLcbLcbLjbLcbLjbRobLobLobRob
RobRcbLcbRobRcbLobLjbRobRebLobLobRsbRebLobRobLobRobLsbLsbLobLebRsbLobL
obRobRcbRebLsbRebRebRobRobRcbRcbLebLcbLobLsbRebRebRebLobRobLjbRjbLcbRe
bRsbLebLobRcbLobRobLsbLebLjbRcbLebLobRcbRcbRobRobRcbLobRobLobRsbRjbRob
RobLcbLsbRsbLobLobLjbLobRobLobLcbLobRebRebLcbRobLjbRobRsbLebRcbLebLcbR
cbLcbRobRsbRobLobRobLobRcbRjbLjbLjbRobLebLobLebRobLcbRobRobRobLsbLobLe
bLsbLobRobLjbRobRcbLobLcbLsbRobRcbRebRobRobLsbRobLcbLobRebLobLsbRcbLob
LsbRobRjbRjbRebLobLobRcbRsbRebLebRobLjbRjbRcbLobLobLobLsbLjbLebRcbRcbL
jbLobRobRobLobLjbLcbRsbLcbRcbLobLobRobRebRobLcbLobRsbRobLebRobRcbRebLo
bLobLobLobRobLjbLobRjbLobRcbRobRobLobLjbLebRobLobLobRcbRcbLobLobRjbLjb
RobLjbRebRcbLobLobLobLjbLobRcbLobRobLobRobRsbLobRobLobLobRobLcbLebLcbL
sbRobLobLjbLebLobLjbRobRcbLcbRcbLsbRsbRobRebLobLsbLebRcbLjbRobLobRobRo
bLobLcbLcbRobLsbRcbLebRobRjbLebRjbLobLobRobLobLobLebRebLjbLobRsbRcbRgb
LjbRobLcbLjbRobLsbLcbLobRobRcbLcbRcbRebLobRobLobRjbLobRsbLobLsbRjbRobL
cbLebRjbRjbRcbLobLobLebRsbLebLsbLobRebRebLobRobLebRobLjbRobRjbRebRobRo
bLebLibLobLjbLobRsbRobLobLobLsbRjbLjbRebLobRebRcbLobRebLobRjbRcbRjbLob
LsbRjbLobRobLobLobRobLobLcbLjbLcbRcbLobRjbLobLebRcbRobLjbLebLcbLebLobR
jbLobRsbRobRjbLcbRsbLebLjbRobRsbRjbLjbRobLcbRobLobLjbRobLebLebLobLjbRe
bRjbRjbLebLcbRsbRebRjbRjbLcbRcbRobLjbLobLcbLobRobRcbRobRobLebRebLobRob
RsbRobLobLebRebLebRobRjbRjbLcbLobLobLebRcbRobRobRebRebLobRcbRobLcbRcbL
cbLobLsbRobRobRcbLebRcbLobRcbRcbRobRobRcbRcbLjbLgbRcbLobRjbRebRobRobLc
bLjbRobLobLjbLcbLgbRobLsbRjbRobLsbRsbRebRebLobRjbLobLebLjbRobLobLjbLcb
RebLebRobRobLcbLobLcbRobRcbLcbRebLjbLsbLobLebRjbRsbRobLcbLobRjbLcbLobL
ebLjbRcbRobLobLobRobLsbRobRobRcbLobRebRcbRobRcbLebRobLjbRjbRobLebRebLo
bLobLcbRsbRobRcbRcbRcbLcbRjbRobLobRcbRcbLobLcbLebLjbRsbLobLebLobLobLeb
LcbLsbLobRebRjbLobRobLjbRobRjbRjbRebRebLebRebLcbLsbLobRcbLebRobLebRobR
cbRjbRcbRcbLjbLobRsbRjbLobRobLjbLobRobLobRjbLebLsbLsbRsbRebLobLobRebLe
bRjbLcbLobRjbRebLsbRjbRebRebLobRebRobRobLobRjbLjbLcbRobRobLebRsbRjbLeb
LebRobRsbRebLjbRsbLcbLobLobLcbRjbLcbLsbRebRebLobLobLobLjbLobRebLjbLobR
cbRobLcbLobLsbRobRobRebRobRcbRebRebLobRjbLcbLjbLebLobRobRebRobLebLcbLc
bLcbRobLobLsbLobRcbLobLjbLobLebRebLjbLebRobRobRobRebLobLobRobRcbLcbReb
RebRobRsbRebLobLsbLjbRjbRjbLobRobLsbRebLcbLebLjbRobLebLebLebRcbRobRebL
sbRjbLebLebLjbLsbLobRsbLsbRjbRebRobRcbRobLebLjbRjbLjbRsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 25; Drug: PCAP2 10uM APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 26; Drug: PCAP2 10uM APO 0.5
bRsbLsbRsLsbRsbRsRsmbRsbRsLsbLsbRsLsbsbRsbsbsbsbsbsbsbsbLsbRsbsbsbsbsb
RsRsmbRsRsmbRsRsRsmmbLsbRsbLsbLgbRsRsRsmmbRsbsbRsbsbsbsbsbRsbLsbsbLcbR
gbRsbRsbRsbRgbRsRsmbRsRsmbLsRsbRsRsmbLsbRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 27; Drug: PCAP2 10uM APO 0.5
bRcbRsbRoRsmbLsRsbRcLsbRsbRibsbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 28; Drug: PCAP2 10uM APO 0.5
bLgbLcbLobRebLobRibRobLebLebRebLgbRobRebRebRcbRibLobLebRcbRcbLobLobLob
LobRcbLcbLebLobRobLebRobLobRebRobLcbLobRibLobLobLgbLebLebRgbLebLobRebL
obRobLobLsbRebLobLebLibRobRobRobLobRobLgbLobRibRebRobRobLcbLobLobLebRe
bLebRgbRobLobRgbRebLobLebRobRgbLgbRibRsbRsbLsRsLsLsLsmmbsbLsRsLsbLsbLs
RsLsbRsLsRsbRsLsRsLsbRsLsLsLsmmbsbRsLsbLsLsmbLsbRsLsLsLsRsmmbRsLsbLsLs
mbRsbLsbRsbLsLsmbLsLsLsRsRsLsmmmbRsbLsbLsLsmbRsLsRsbLsbLsbRebRobRobLob
LobRobLobRobLsLebRobLebRcbLobLobLsbLsbLsbRobRgbRebRobLgbRobLobRobRebLi
bLsbRcbLgbLebRobLebLobLibRcbLobRebLibLsbRebRobLsbRobLobLebLobLhbRebLob
RobLcbLobRobRibLgbLibLebLebRobLibLobLobLhbRobRebRebLgbLcbLcbRjbRcbLgbL
obRobRebRhbLobLobLcbRobRebLobRgbLobLobRobLibLcbLebRgbLibLgbLcbLebRcbRo
bRcbLebRcbLcbLobRobRebLebLobRebLibRobRobLcbLobRcbRsbRobRobLgbRobRhbLib
RobLobLsbRcbRebRobRebRobLobLebRebLobLobLgbRibRobRebRobLobLebRibLibLgbL
cbLcbRebRobRebRcbRibLobLcbLhbLobLobRebRcbRobLgbRcbRcbLcbLobRobRebRebLo
bLobLobRebLgbLcbRcbRsbLebLhbRebRobLebLobRobRobLebRgbRobLibRobLobLobLob
RgbLgbLebRibRgbLcbRobRobLcbLjbLebLebRobRcbRobLgbLsbRobRgbRcbLobLibRebL
obRibLobLebLobRebRgbRcbLobRgbLcbLobRebLobRobLebLcbRibRgbRobLjbRobRobLo
bRhbRebRobRjbLcbLobRobLibRobLcbRobLsbLcbLsbRebLgbLgbLobLibRobRcbRebRob
RobRebRebRsbRebRobRcbLsbRobLebRcbLjbRsbRobRibLsbLebRhbLobRebRgbRebLebR
ebLobRcbRobRebLobRebRebRebRcbLobRebLobRebLobLebLcbLcbLobRobLobRebRobLg
bRebRgbLibLobLebRebRcbRebRibLebLibRcbRcbLibRobLhbLcbRcbRobRgbRobLobLeb
LobRobRcbRgbLobRobRobRobRebLebLobLibRgbRcbLibLebLgbRcbRobRgbRebLebLobR
ibLgbLsbRsbRobLibRcbLgbLebLobLobRibLcbLobLebLobLobLibRobLebRsbRebRebRo
bRibLcbRgbRebLebRobLobRebLebLobRebRibLgbRcbLebLgbRobRobRcbLcbLsbRebRsb
LobRebLcbRobRobRibRobRcbLobLgbRobRgbLobRobLcbRsbRcbLebRobLcbRebLobRobL
ibLibLobRgbRcbRcbRobLebLobRebRcbLebRobRebLebRcbLobRcbRcbRcbLebLcbRgbLs
bRebLebRebRobRobLsbRobLebLebLebLobRebLcbRebRobRibLobRcbRgbRcbLibLobRob
RibLebRebLobLebRobLobRobRebLebRibRsbLsbRcbLebRobRobRobRcbRobLgbLcbLobL
obRcbRebRebLobRebRobLebLobLibRobLebRcbRobLebLobRibRobRcbLobRgbLcbLcbLe
bLhbLibRcbRibRobLcbLobRebLobRobLobLcbRebRcbRobLobLebRebLsbLcbLobRebRob
RebLcbRobLcbRobRebLcbRhbLebLebLibLobLobLebLcbRobRcbRobLobLsbRebRobRebL
gbRebRgbRobLobLobRsbRobRebRobLcbLobRobLobRebRcbRobLcbRobRobRhbLebLobLe
bRgbRibLcbRebRebLebRobRibLcbRobRcbLcbRobRobLobLebLobLobRibRcbRobRcbLeb
RcbLibLgbRgbRcbLobRcbRobRebRcbRobRobRobLgbRebLcbRobLebLobRgbRobRebLcbL
ebLcbRcbRebLobLgbRibLobLgbRebRobLobRibRibRcbRobRcbLgbRobLgbRcbLobRebLe
bRgbRcbRebLobRobLobLgbRebRcbRobLobLobLhbLobRsbRobLsbRobLobLibLebRobLob
LobRibLcbRobLibLebLobLobLobRobRebRcbLsbLebRobRsbRobLebRobLcbLhbRhbLebL
obLcbLobRobLobLhbLgbRobRobRgbLibLebRobRobRibRobLobLebRebLobRobLobRgbRc
bLcbLebRobRgbLsbLcbRebLgbLebRibLcbLhbLhbLibRebRgbRobRcbRibLibRsbRgbReb
LcbLgbRobRcbLobLobLsbLobLobRebRebLibRobRobRobLibRibLobLcbRcbLobLgbRebL
ebRobLsbRobLibRibRcbLebLobRobLebLobRobLobLobRgbLibRebRobRobLibRhbRcbRo
bRcbRcbRebRsbRibRebRhbRcbLobRobRgbLebLcbLobLgbRcbLcbRgbRcbRibLobLebRib
LobLibLebLobLobLobLibRebLsbRcbLgbLobLobRobLobLibRgbLebLebRobLobRobLgb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 29; Drug: PCAP2 10uM APO 0.5
bLcbLsbRoRsmbRsbRsbLcRsRsmbRsbRsbRhbRsbLsbLsbLsbLsLsmbLsbLgbLgLsbLsbLo
LsRsmbRcRsmbRsbRobLsbLgLsbLsLsmbLsbLgLsLgbLgbLsRsbLsbLsbLsbRsbRsRsRsmm
bRjbRobLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 30; Drug: PCAP2 10uM APO 0.5
bLebLebRobLebLgbLsbRcbRobRobLobRsbRebRcbLcbRobRsbRebRebLhbRcbRibRebLgb
LebLobLobLhbLobRcbLgbLobLobRcbRebRebLsbRsbLcbLebRobLgbRcbLcbLobLobRobL
gbLobLcbLobLsbRebRobRcbRebLobRobLcbLcbRobLcbRcbLebLcbRebRebRcbRjbLebRo
bRebRebLibRebRobLcbRobLobLibRebLebRebLobLobLebRebRobLcbLibRcbRobLcbRib
RcbRobRobRsbLcbLobLhbRobLobRobLobLibRobRobRobRcbLgbRebRibLobLebLebLobL
ebRibRobRobRebLobRsbRebRobRobRcbLhbRibRgbLobRgbLobRebLobLobRobLebRobRo
bLcbRobRobRobLobRobRebRobRobRobRibRobRobLgbLsbLebLibRobLcbRobLobLebLeb
LobLobRobRsbLebLibRobRcbRebLobRcbLobLgbLgbRebRobLebLobLebLebLobRobRgbR
sbLibLibLcbLobLgbRcbRgbRobLebRobRobLobLebLcbRibRsbRobLebLebRobRobLebLo
bRcbLcbRcbRibRobLobRebRobRgbLobRobRobLcbLebRobRebLobRobRobLibLibRobReb
RebRobLcbLobRebRebRobRobRobLebLobLobLobRebRobLsbLebLobRobLcbLebLgbLobR
obRebLobRcbLebRebRcbRobRebRebLobRcbLgbLobLsbRobRobRobRobRobRsbRgbLobRi
bLobLobRgbRjbLobLobRobRgbRobRcbLobLgbLebRobRobLgbRebLobLhbLobLibRebLcb
RobRcbLebRobRcbRebLcbRebRcbLobLobLobLebLebRibRebLebLcbRebLobLcbRcbRibR
ibLobRgbRcbRobRobRobLobLibLibRobRobLgbRcbRebRgbRobLibLsbRjbLebLebRebLc
bLobLebLobRcbLobLobLgbLebLibLcbRebLebRobRibRebRobRebLobRsbRibRcbLobRob
LobLgbRobLobRebLcbLcbRibLsbRsbRebLebRibLobLobRobLcbRobRgbLobRobRgbLobL
obRebRebLebRobLcbLebLobRobRhbRobLebRjbLhbRgbRobRcbLebLobRobLebRobLebRe
bRebLcbRobLgbLcbLgbLebRobLebLebLebLobRobRebLobLobLebRobRebLibRcbRebLeb
RebRgbRgbRobRobRibLebRobLgbRebLgbLibRobRcbLgbLcbLibRebLobLobLobLsbRobR
sbLcbRgbRobLebLobLebRobLcbRibRobRobRebRcbRobRobLgbRcbRobLcbRcbRobRebLo
bLobRobLcbRgbLebRebLobLobRobLcbRobLobLobLebLgbRobLibRobLibRcbLibRobLgb
RebLobLobLcbLcbLebRobLebRibRebRebRobRobRobLcbLebRebRibRcbLebLebLcbRcbR
gbRobRobLcbRgbLobLgbRebRibRibLcbLobLcbRhbLibRcbLibRobLibRobLcbLibRsbLc
bLsbLobRobLobRobLibLebLobRibLebLobLcbLebLobRsbRsbRebLobRcbLibRobRsbLeb
RobLobLgbRobLobLobRebRsbRgbLobRibRgbRobLobLobRibRebRebRgbRobLobLebRibR
cbLebRcbLibLobRobLibRobRebRobRobRgbLobLebRebRebRsbRcbLobLgbRgbLgbLsbLi
bRobLcbLobLobRsbLobLsbLebRcbRebRebLgbRobLebRcbRebLcbRebRsbRgbLobLsbRob
RcbLebLsbLebRebLsbRebLebLobRobLebRebRgbLcbRcbLgbLebRobRebRibLobLebRebL
jbLibLcbRgbLobLobRibRsbLsbLobLcbRcbLobRobRebRebLcbLebRcbLcbRobLebRebLo
bRebLsbLobRcbLebLobLobRibRobRebLsbRgbLebRobLobRibLsbRebLobLebLgbRobLeb
RobLobLebRgbRebRobLebLobRobLgbLcbRcbRobLibLobLcbLebRobLcbLhbRobLcbRobL
obLcbRobLebRcbRobRebLobRsbLobLebRcbLgbRcbRcbLobLcbLobRsbLobLebRebLebLg
bRebLobLobRobRobRebLebLibRibRcbLobRobLobLobLibLobRobRebRcbRobLobRibReb
LcbRobRebRebRibLobRobRobLgbLcbLebRobLcbLobLobLebLobRcbLobRhbLgbLebLibL
obLobRcbRobLobRobLcbRebRobRobRebRjbLobRcbLcbLebRobRibLibRebLcbLibRobLo
bLobLcbLobLobLcbLcbLobLhbRcbLobRcbLebRobLobRjbLobLgbLhbRobLebLjbLibLgb
RibRebRobLcbRobLgbLebLibRebRebLebLobLebLobRcbLebLsbLobLcbRcbRobLcbRebR
obLobRebLobRobLcbLhbRcbLobRobRebLobRobRobRebRobRsbLobLobLgbRcbRobLebRs
bRhbRibLebRobRobLebLobLeb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 31; Drug: APO 0.5
bRsRsmbRsbsbLsbLsbLsbLsbLsRsbLsRsbLsRsbRsbLjb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 32; Drug: APO 0.5
bLiLsbLibLcbLgbLgbRsRsmbRsbRsRsmbLsbRibRibRjbLhbRsbRgbRsbRibRibRjRsmbR
gbLiLsbLgbLsbLsbRsRsmbRsbRsLsbRsbLgLsbsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 33; Drug: APO 0.5
b

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 34; Drug: APO 0.5
bLgbRgbLobLcbLcRsbRoLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 35; Drug: APO 0.5
bRgbRsbRsLsbRebLsLjLsmbLsbLsLsmbLsbLgbRgbLsbsbLgLsbRsbLgbLgbRgbsbLsRsb
RgbLsLsmbRsLsbLsRsbsbRsbLsbRgbLsRsbsbLcbLebRiRsmbLgbRibLsLsmbRgbsbLsbR
gbLibRgbsbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 36; Drug: APO 0.5
bsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 37; Drug: PCAP2 1uM APO 0.5
bRsRsmbsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 38; Drug: PCAP2 1uM APO 0.5
bLgbsbLsLsmbLsbsbLsbLsLsmbLgbRgbsbRsbLsbRsbsbsbLsRsbRsbsbRsbLsbLsbLsLs
mbLsbRsbLgbLsbLsLsmbRsbRsbRsbRsbLsLsmbLgbLsLsmbsbLsbLsbLsLsmbLsbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 39; Drug: PCAP2 1uM APO 0.5
bLsRsbRobRgRsRsmmbRsRsRsmmbRsbRgbRsbRsbRsbLsRsbRsbRsbRgbsbRsbLsLsmbRsb
RsbRsbRsbRsbRsbRsbRsbLobRsbLjbLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 40; Drug: PCAP2 1uM APO 0.5
bRsbRsRsmbLsbRsLsbsbsbRsbRsbRsbLgLsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 41; Drug: PCAP2 1uM APO 0.5
bRjbsbsbLsbsbsbsbRcbLsbLgbLsLsmbLgbRsbRsbsbLib

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 42; Drug: PCAP2 1uM APO 0.5
bLsLsmbLsLsLsmmbLsbLiLsbLsbLsbLcbLgLsbsbRsbLsRsbRjRsmbLsbLsbLsbRsbLobL
cbLsbLsbsbLsLsLsmmbLsbLcbLsbLsRsbLsLsmbsbsbsbsbLcbLsbRsbLsbLeRsb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 43; Drug: PCAP2 3uM APO 0.5
bsbRsRsRsRsmmmbRsRsRsmmbRsbRsRsmbRsRsmbRsRsRsmmbRsRsRsmmbRsbRsRsmbRsRs
mbRsRsmbsbRsbRsbRsbRsbsbsbsbRsbsbsbsbRgbRsbLsbRsbRsRsmbRsbRsbRsbRsbRsb
RsbRsbRsRsmbRsbRsLsbRsbsbsbRsbRsRsRsmmbRsRsRsmmbsbRsbRgRsmbsbRsRsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 44; Drug: PCAP2 3uM APO 0.5
bRjbLiLsRsbRsbLsbRsbRsbRjRsmbRcRsmbLsbsbRgbRibRsbRsRsmbRsbRsbLgbLsLsmb
LsbLgLsLsmbLibRgRsmbRsbLsbLsLsmb

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 45; Drug: PCAP2 3uM APO 0.5
bsbsbsbLsbLsbLsLsmbRsLsbLgbRsbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsbLibsbLsbLs
LsmbLsbLsbLsbLgbRjbLibRgRsRsmmbLsbRsLsbLsbLsbRebLobLjbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 46; Drug: PCAP2 3uM APO 0.5
bLsbLsLsLsmmbsbLsbLsLsmbsbRsLsbLsLsLsLsmmmbLsbLsbLsLsmbLsbLsbLsbLsLsmb
LsbLsbLsbLsbLsbLgLsbLgLsbRsRsmbRgbLsbLsLsmbLsbLsbLsLsmbLsbLsLsmbLsbRsb
LsRsbRsLsbLsbLsRsRsmbLsLsmbLsbLsbLsbLsLsmbLsLsmbRsLsbLsRsbRsbRsLsbRsLs
bLsbRsRsmbRgbRsbRsbLobRsbRsRsmbRsbsbRsbRsbRjLsbRgLsbRsbLjbRib

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 47; Drug: PCAP2 3uM APO 0.5
bLsbLgLsbLsLsmbLsbRsLsbRsbRsbRibLsLsmbsbLsbLsbLsbLgbRsRsmbLsLsmbRsbRib
RsLsbRsRsmbRsbLgRsbsbsbLcbLoRsbLsbLibLsLsmbLjLsmbLcbLobLibsbRoRgbLsbLs
bLsbLsbLsbLsbLsbsbRsbsbLsbRjbLsbRsbRgbRgbRgbRgbRgbRgbRgRsmbRsbRgbRgbRg
bRsRsmbRsRsmbRgRsmbRsbRgbRsRsmbRgbRsbRgRsmbRgbLsbLebRibLsbLibLibRsRgbR
ib

>ZF Recording 2016-04-14; tW: 300s; Start: 140652; End: 141153;
Recording: 13-1; Individual: 48; Drug: PCAP2 3uM APO 0.5
bLgbLiRsbsbRsbRsbRsbsbsbLibLibsbsbLsbRsbsbLsbRsbsbLsRsbRsbRsbRsbRsLsbR
sbRsbRsLsbLsRsRsmbRsb

